
<html lang="en"     class="pb-page"  data-request-id="c327a2f9-0a96-4acd-96a3-7e92d278725d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2012.55.issue-15;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm300407t;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Kallikrein Protease Activated Receptor (PAR) Axis: An Attractive Target for Drug Development" /></meta><meta name="dc.Creator" content="Giuseppe  Caliendo" /></meta><meta name="dc.Creator" content="Vincenzo  Santagada" /></meta><meta name="dc.Creator" content="Elisa  Perissutti" /></meta><meta name="dc.Creator" content="Beatrice  Severino" /></meta><meta name="dc.Creator" content="Ferdinando  Fiorino" /></meta><meta name="dc.Creator" content="Francesco  Frecentese" /></meta><meta name="dc.Creator" content="Luiz  Juliano" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 12, 2012" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300407t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300407t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300407t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300407t" /></link>
        
    
    

<title>Kallikrein Protease Activated Receptor (PAR) Axis: An Attractive Target for Drug Development | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300407t" /></meta><meta property="og:title" content="Kallikrein Protease Activated Receptor (PAR) Axis: An Attractive Target for Drug Development" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300407t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300407t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300407t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300407t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300407t&amp;href=/doi/10.1021/jm300407t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6669-6686</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300207s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm301017v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Kallikrein Protease Activated Receptor (PAR) Axis: An Attractive Target for Drug Development</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Caliendo">Giuseppe Caliendo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Santagada">Vincenzo Santagada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisa++Perissutti">Elisa Perissutti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatrice++Severino">Beatrice Severino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ferdinando++Fiorino">Ferdinando Fiorino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Frecentese">Francesco Frecentese</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luiz++Juliano">Luiz Juliano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Chimica Farmaceutica e Tossicologica, Università degli Studi di Napoli “Federico II”, Via D. Montesano, 49, 80131, Napoli, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Três de Maio 100, São Paulo 04044-020, Brazil</span></div><div class="corresp-info"><strong>*</strong>Phone/Fax: +39(81)678649. E-mail: <a href="/cdn-cgi/l/email-protection#7d1e1c1114181319123d081314131c531409"><span class="__cf_email__" data-cfemail="debdbfb2b7bbb0bab19eabb0b7b0bff0b7aa">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300407t&amp;href=/doi/10.1021%2Fjm300407t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6669–6686</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 18, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 March 2012</li><li><span class="item_label"><b>Published</b> online</span>12 June 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 August 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300407t" title="DOI URL">https://doi.org/10.1021/jm300407t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6669%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGiuseppe%2BCaliendo%252C%2BVincenzo%2BSantagada%252C%2BElisa%2BPerissutti%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D15%26contentID%3Djm300407t%26title%3DKallikrein%2BProtease%2BActivated%2BReceptor%2B%2528PAR%2529%2BAxis%253A%2BAn%2BAttractive%2BTarget%2Bfor%2BDrug%2BDevelopment%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6686%26publicationDate%3DAugust%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300407t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1680</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300407t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Kallikrein Protease Activated Receptor (PAR) Axis: An Attractive Target for Drug Development&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Caliendo&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Santagada&quot;},{&quot;first_name&quot;:&quot;Elisa&quot;,&quot;last_name&quot;:&quot;Perissutti&quot;},{&quot;first_name&quot;:&quot;Beatrice&quot;,&quot;last_name&quot;:&quot;Severino&quot;},{&quot;first_name&quot;:&quot;Ferdinando&quot;,&quot;last_name&quot;:&quot;Fiorino&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Frecentese&quot;},{&quot;first_name&quot;:&quot;Luiz&quot;,&quot;last_name&quot;:&quot;Juliano&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6669-6686&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300407t&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300407t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300407t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300407t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300407t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300407t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300407t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300407t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300407t&amp;href=/doi/10.1021/jm300407t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300407t" /></input><a href="/doi/pdf/10.1021/jm300407t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (708 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300407t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300407t%26sid%3Dliteratum%253Aachs%26pmid%3D22607152%26genre%3Darticle%26aulast%3DCaliendo%26date%3D2012%26atitle%3DKallikrein%2BProtease%2BActivated%2BReceptor%2B%2528PAR%2529%2BAxis%253A%2BAn%2BAttractive%2BTarget%2Bfor%2BDrug%2BDevelopment%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D15%26spage%3D6669%26epage%3D6686%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jmcmar.2012.55.issue-15/production/jmcmar.2012.55.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All living prokaryotic and eukaryotic organisms, from bacteria to mammals, as well as viruses, express proteolytic enzymes with similar or distinct functions.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Apart from their well appreciated roles in protein catabolism, generating active polypeptides from protein precursors and functioning as digestive enzymes, several proteinases are now known to play a hormone-like role by triggering signal transduction pathways in target cells; for example, it is well-known that thrombin, a classical serine protease, circulates in the blood to reach its target tissues. The serine proteinase family currently numbers 176 members, which represent about 30% of the known proteolytic enzymes<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> and most are secreted enzymes.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Chromosomes 19 and 16 contain the two largest clusters of serine proteinases: the kallikrein family and the tryptase family, respectively, both belonging to the family S1, clan SA (currently known as clan PA) of serine proteinases along with chymotrypsin, trypsin, and elastase.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Kallikrein 1 (KLK1), or the tissue kallikrein, has long been defined as glandular kallikrein to distinguish it from the later discovered plasma kallikrein (KLKB1). KLKB1 and KLK1 are serine endopeptidases that cleave high and low molecular mass kininogen (HMWK and LMWK, respectively), generating bradykinin and Lys- bradykinin, respectively. KLKB1, which is part of the plasma contact activation system, is a complex multidomain protein and structurally related to coagulation factor XI, whereas KLK1 displays a simpler structure and related to that of trypsin. Mason et al.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> demonstrated that the mouse and the rat genomes carry several genes that are closely related to KLK1, but for a long time, only three glandular kallikreins were identified in humans: KLK1,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> KLK2,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and KLK3,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> also known as prostate-specific antigen (PSA). At around the turn of the millennium, three research groups independently discovered that the human kallikrein locus on the long arm of chromosome 19 carries a number of genes encoding serine endopeptidases that are related to KLK1.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a></div><div class="NLM_p">Human kallikreins (hK) are a multigene family of 15 secreted serine type proteases situated 7.5 Mb from the telomeres of the long arm of chromosome 19, in the cytogenic region q13.3–4.<a onclick="showRef(event, 'ref14 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17 ref18">(14, 16-18)</a> The locus spans 265 kb and carries 15 functional genes and at least 1 pseudogene. According to the recent nomenclature, kallikreins are now indicated as kallikrein-related peptidases, with the exception of KLK1, for which the older nomenclature has been retained.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Gene and protein numbers are assigned in sequence starting from the centromere to the telomere (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kallikrein-Related Peptidases Family: Gene and Protein Nomenclature<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">gene</th><th class="colsep0 rowsep0" align="center">other gene symbols</th><th class="colsep0 rowsep0" align="center">protein</th><th class="colsep0 rowsep0" align="center">other protein names</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK1</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KLK1</td><td class="colsep0 rowsep0" align="left">pancreatic/renal/urinary kallikrein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK2</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KLK2</td><td class="colsep0 rowsep0" align="left">human glandular kallikrein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK3</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">KLK3</td><td class="colsep0 rowsep0" align="left">prostate-specific antigen (PSA)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK4</i></td><td class="colsep0 rowsep0" align="left"><i>PRSS17</i>, <i>KLK-L1</i></td><td class="colsep0 rowsep0" align="left">KLK4</td><td class="colsep0 rowsep0" align="left">prostase, KLK-L1 protein, EMSP1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK5</i></td><td class="colsep0 rowsep0" align="left"><i>KLK-L2</i></td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">KLK-L2 protein, SCTE</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK6</i></td><td class="colsep0 rowsep0" align="left"><i>PRSS9</i></td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">zyme, protease m, neurosin</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK7</i></td><td class="colsep0 rowsep0" align="left"><i>PRSS6</i></td><td class="colsep0 rowsep0" align="left">KLK7</td><td class="colsep0 rowsep0" align="left">SCCE</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK8</i></td><td class="colsep0 rowsep0" align="left"><i>PRSS19</i>, <i>TADG14</i></td><td class="colsep0 rowsep0" align="left">KLK8</td><td class="colsep0 rowsep0" align="left">neuropsin, ovasin</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK9</i></td><td class="colsep0 rowsep0" align="left"><i>KLK-L3</i></td><td class="colsep0 rowsep0" align="left">KLK9</td><td class="colsep0 rowsep0" align="left">KLK-L3 protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK10</i></td><td class="colsep0 rowsep0" align="left"><i>PRSSL1</i></td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">NES1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK11</i></td><td class="colsep0 rowsep0" align="left"><i>PRSS20</i></td><td class="colsep0 rowsep0" align="left">KLK11</td><td class="colsep0 rowsep0" align="left">TLSP, hippostasin</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK12</i></td><td class="colsep0 rowsep0" align="left"><i>KLK-L5</i></td><td class="colsep0 rowsep0" align="left">KLK12</td><td class="colsep0 rowsep0" align="left">KLK-L5 protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK13</i></td><td class="colsep0 rowsep0" align="left"><i>KLK-L4</i></td><td class="colsep0 rowsep0" align="left">KLK13</td><td class="colsep0 rowsep0" align="left">KLK-L4 protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK14</i></td><td class="colsep0 rowsep0" align="left"><i>KLK-L6</i></td><td class="colsep0 rowsep0" align="left">KLK14</td><td class="colsep0 rowsep0" align="left">KLK-l6 protein</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>KLK15</i></td><td class="colsep0 rowsep0" align="left"><i>HSRNASPH</i></td><td class="colsep0 rowsep0" align="left">KLK15</td><td class="colsep0 rowsep0" align="left">prostin</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Adapted from ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>.</p></div></div></div><div class="NLM_p">Within the human family, homology reaches the level of 30–50% at the gene and protein level, with the exception of KLKs 1–3 that show more striking similarities when compared to each other (80%).<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> Even the mouse KLK and rat KLK gene families are composed of a large number of closely related members that possibly arose from gene duplication events.<a onclick="showRef(event, 'ref9 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref9 ref21 ref22">(9, 21, 22)</a> Similarly, the number of the kallikrein isoforms may be even higher than these 15 members because of alternative splicing of kallikrein genes; a recent review has reported 82 different kallikrein gene transcript forms, including reference forms.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The members of mouse, rat, and human kallikreins have a high degree of amino acid identity but present different substrate specificity, particularly toward oligopeptides.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29">(24-29)</a> The protein products of the genes are characterized by a 16–34 residue amino terminal signal peptide that leads them to the endoplasmic reticulum for secretion. Thus, the signal peptide is cleaved off to yield the inactive zymogen form of the peptidase, from which the fully active enzyme is generated by removal of the propeptide by specific proteolysis. Kallikrein-related peptidases show a high degree of homology with trypsin; this similarity is not limited to the primary structure, as they display similar catalytic mechanism. All but four kallikrein-related peptidases present an Asp residue homologous to that of trypsin, located at the base of the substrate-binding pocket, addressing the specificity toward positively charged Lys and Arg residues. A tryptic or Arg restricted specificity has been confirmed with KLK2, KLK4, KLK5, KLK6, KLK8, KLK10, KLK12, KLK13, and KLK15, while the activity is chymotrypsin-like for KLK7 and KLK9, which present at their S1 site Ser or Asn or Gly, or mixed-type for KLK3, KLK11, and KLK14.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31 ref32">(28-32)</a></div><div class="NLM_p last">The natural substrates and the substrate specificities of the kallikreins are known only for a few of them. KLK1 is the best characterized kallikrein. It is a glycoprotein expressed most abundantly in pancreas, salivary gland, kidney, and urine, releases Lys-bradykinin by limited proteolysis from high and low molecular weight kininogens by cleavage at the Met379–Lys380 and Arg389–Ser390 bonds, and has both trypsin- and chymotrypsin-like activities.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37 ref38">(33-38)</a> KLK2 is present in the seminal plasma, hydrolyzes certain components of the semen coagulum, and cleaves substrates with restrictive trypsin-like specificity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In contrast, KLK3/PSA has only chymotrypsin-like activity and is expressed in the glandular epithelial cells of the prostate gland. KLK3 rapidly hydrolyzes both semenogelin I and semenogelin II in vivo and synthetic substrates derived from these proteins and was reported to be strongly activated by Na<sub>2</sub>SO<sub>4</sub> and by heparin.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a> KLK6 is possibly involved in myelin turnover and demyelination processes, modulation of ionotropic glutamate receptors, and activation of PAR2.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Recently crystal structures of KLK4, KLK5, KLK6, and KLK7 have been available. By combination of these data with enzyme kinetic studies and extended substrate specificity profiling, a better understanding of the non-prime-side substrate preferences of these peptidase has been obtained. The shape and polarity of the specificity pockets S1–S4 confirm the trypsin-like specificity for KLK4, KLK5, and KLK6 in contrast with KLK7, displaying a unique chymotrypsin-like specificity for Tyr, which is also preferred at P2.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Kallikrein-Related Peptidases as Hormones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As mentioned above, KLKs are expressed in several tissues as inactive preproforms that are processed to inactive proforms, secreted into the circulation and other major biological fluids, such as cerebrospinal fluid, vaginal fluid, nipple aspirate fluid, and tumor ascites fluid.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Mature peptidases are then obtained by specific proteolytic removal of their N-terminal propeptide either via autocatalytic activity or by another KLK or other endopeptidases. After secretion, KLKs can migrate through the bloodstream or other biological fluids to surrounding and/or distant cells to reach their targets, exerting their biological actions by means of proteolysis. Several processes, mainly represented by (auto)activation, (auto)degradation, and inhibition by serine proteinase inhibitors (SERPINs), have been evolutionarily produced in order to functionally control KLK activity and to eliminate any chance of unwanted or unlimited proteolysis. Mature KLK enzymes, for example, are amenable to inactivation by endogenous inhibitors such as kallistatin that inhibits KLK1, KLK7, and KLK14<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> and LEKTI (lymphoepithelial Kazal-type inhibitor), which is encoded by SPINK5 (serine protease inhibitor Kazal-type 5).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> A remarkable feature of KLKs is that they share a wide range of expression in different tissues; groups of kallikreins, in fact, are coexpressed in several physiological and pathological settings. This observation has produced several hypotheses including a common biological role or cooperativity among the coexpressed peptidases. KLK coexpression is represented, for example, by KLKs 2, 4, 11, 15 in the prostate, KLKs 1, 4, 11, 13, 14 in the skin, KLKs 5, 6, 10, 13 in the breast, and KLKs 6, 9, 14 in CNS.<a onclick="showRef(event, 'ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref20">(17, 20)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> KLK Expression in Cancer and Inflammation</h3><div class="NLM_p">Aberrant KLK expression patterns have been reported mainly in hormone dependent malignancies, such as those in breast, ovary, and prostate, and have been widely implicated as cancer biomarkers (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref17 ref20 ref46'); return false;" href="javascript:void(0);" class="ref ref17 ref20 ref46">(17, 20, 46)</a> Most of the evidence obtained so far points to dual roles of KLKs in cancer, as their function may depend on the tissues, tumor types, and cancer stages. Moreover, concentration and/or activity levels have to be taken in account, as also described for other proteases.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> As is known, prostate cancer cells produce a large amount of PSA/KLK3, and it is used extensively as a valuable biomarker for monitoring prostate cancer, detecting recurrence after local therapies, and to follow response to systemic therapies for metastatic disease. Accumulating evidence suggests that PSA may be more than just a biomarker and may play a role in the pathobiology of prostate cancer.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Other kallikreins such as KLK2, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9, KLK10, KLK11, KLK13, and KLK15 were found to be candidate biomarkers for several endocrine-related malignancies.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Human KLKs as Biomarkers of Prostate, Breast, and Ovarian Cancer<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cancer type</th><th class="colsep0 rowsep0" align="center">gene or protein<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">clinical application</th><th class="colsep0 rowsep0" align="center">cancer type</th><th class="colsep0 rowsep0" align="center">gene or protein<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">clinical application</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK2</td><td class="colsep0 rowsep0" align="left">diagnosis, prognosis, and monitoring</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK3/PSA</td><td class="colsep0 rowsep0" align="left">diagnosis, favorable prognosis, resistance to therapy</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK3/PSA</td><td class="colsep0 rowsep0" align="left">diagnosis, prognosis, and monitoring</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">diagnosis,</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK7</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK11</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK7 (full length variant)</td><td class="colsep0 rowsep0" align="left">favorable prognosis<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK11</td><td class="colsep0 rowsep0" align="left">diagnosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK9</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK14</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">resistance to therapy</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">prostate</td><td class="colsep0 rowsep0" align="left">KLK15</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">predictive of invasiveness</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK14</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK13</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK14/KLK14</td><td class="colsep0 rowsep0" align="left">diagnosis<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></td><td class="colsep0 rowsep0" align="left">breast</td><td class="colsep0 rowsep0" align="left">KLK15</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK4</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK9</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK4</td><td class="colsep0 rowsep0" align="left">resistance to therapy<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis, diagnosis, and monitoring</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis, diagnosis<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis and diagnosis</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK11</td><td class="colsep0 rowsep0" align="left">favorable prognosis and diagnosis<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK6/KLK6</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK11</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">diagnosis and monitoring</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK13</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK7/KLK7</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK14</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK8/KLK8</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK14</td><td class="colsep0 rowsep0" align="left">diagnosis</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK8</td><td class="colsep0 rowsep0" align="left">diagnosis and monitoring</td><td class="colsep0 rowsep0" align="left">ovarian</td><td class="colsep0 rowsep0" align="left">KLK15</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Adapted from refs <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a> and <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last"><i>KLK</i> = kallikrein-related peptidase gene. KLK = kallikrein-related peptidase protein.</p></div></div></div><div class="NLM_p">In addition to hormone-related malignancies, KLK expression has been related to several other types of tumors, summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human KLKs as Biomarkers of Other Types of Cancer (Testicular, Uterine, Cervical, Brain, Head and Neck SCC, Skin SCC, Melanoma, Colon, Pancreas, Leukemia)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cancer type<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">gene or protein<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">expression and/or clinical application</th><th class="colsep0 rowsep0" align="center">cancer type<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">gene or protein<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">clinical application</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testicular</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testicular</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="left">KLK7</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testicular</td><td class="colsep0 rowsep0" align="left">KLK13</td><td class="colsep0 rowsep0" align="left">diagnosis</td><td class="colsep0 rowsep0" align="left">uterine</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">monitoring and prediction to therapy<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testicular</td><td class="colsep0 rowsep0" align="left">KLK14</td><td class="colsep0 rowsep0" align="left">favorable prognosis</td><td class="colsep0 rowsep0" align="left">uterine</td><td class="colsep0 rowsep0" align="left">KLK8/KLK8</td><td class="colsep0 rowsep0" align="left">up-regulation<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cervical</td><td class="colsep0 rowsep0" align="left">KLK7/KLK7</td><td class="colsep0 rowsep0" align="left">up-regulation</td><td class="colsep0 rowsep0" align="left">uterine</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">diagnosis<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cervical</td><td class="colsep0 rowsep0" align="left">KLK8/KLK8</td><td class="colsep0 rowsep0" align="left">up-regulation</td><td class="colsep0 rowsep0" align="left">salivary gland</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">down-regulation<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">head and neck SCC</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">up-regulation</td><td class="colsep0 rowsep0" align="left">salivary gland</td><td class="colsep0 rowsep0" align="left">KLK13</td><td class="colsep0 rowsep0" align="left">up-regulation<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">non-small-cell lung AC</td><td class="colsep0 rowsep0" align="left">KLK5</td><td class="colsep0 rowsep0" align="left">up-regulation<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" align="left">skin SCC</td><td class="colsep0 rowsep0" align="left">KLK8</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">non-small-cell lung AC</td><td class="colsep0 rowsep0" align="left">KLK7</td><td class="colsep0 rowsep0" align="left">down-regulation<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></td><td class="colsep0 rowsep0" align="left">skin SCC, melanome</td><td class="colsep0 rowsep0" align="left">KLK6/KLK6</td><td class="colsep0 rowsep0" align="left">up-regulation<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">non-small-cell lung AC</td><td class="colsep0 rowsep0" align="left">KLK8</td><td class="colsep0 rowsep0" align="left">favorable prognosis<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="left">KLK1</td><td class="colsep0 rowsep0" align="left">down-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">non-small-cell lung AC</td><td class="colsep0 rowsep0" align="left">KLK10/KLK11</td><td class="colsep0 rowsep0" align="left">up-regulation<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neuroendocrine C2 lung AC</td><td class="colsep0 rowsep0" align="left">KLK11</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis</td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="left">KLK8</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">non-small-cell lung AC</td><td class="colsep0 rowsep0" align="left">KLK13/KLK14</td><td class="colsep0 rowsep0" align="left">up-regulation<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></td><td class="colsep0 rowsep0" align="left">colon</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">leukemia</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">down-regulation</td><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RCC</td><td class="colsep0 rowsep0" align="left">KLK6</td><td class="colsep0 rowsep0" align="left">unfavorable prognosis<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></td><td class="colsep0 rowsep0" align="left">pancreas</td><td class="colsep0 rowsep0" align="left">KLK10</td><td class="colsep0 rowsep0" align="left">up-regulation</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Adapted from refs <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a> and <a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">46</a>.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">AC = adenocarcinoma;. SCC = squamous cell carcinoma. RCC = renal cell carcinoma.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last"><i>KLK</i> = kallikrein-related peptidase gene. KLK = kallikrein-related peptidase protein.</p></div></div></div><div class="NLM_p">Up-regulation of KLK6 and KLK10 has been identified in uterine serous papillary tumors, an aggressive type of endometrial cancer. These two KLKs are overexpressed in pancreatic and colon cancer. KLK7 and KLK 8 have been related to cervical cancer, one of the most common gynecological tumor (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), while KLK11 is overexpressed in a specific subgroup of neuroendocrine lung carcinomas. KLK5, KLK10, and KLK14 may possess clinical value for testicular cancer prognosis, and KLK13 may aid in diagnosis of this type of cancer (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">The biological roles of KLK1 in inflammation have been thoroughly studied.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> It has been shown in vitro that some of KLKs can proteolytically activate hormones and growth factors, other proteinases, or extracellular matrix components possibly affecting tissue function (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref17 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref20">(17, 20)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potential substrates via which KLKs can regulate tissue function. Selected examples are given for each suggested substrate group. MBP stands for myelin basic protein, VIP for vasoactive intestinal peptide, TGF-β for tissue growth factor type β, and pro-uPA for the zymogen of urokinase plasminogen activator. For details about the potential KLK substrates, see refs <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a> and <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As mentioned above, KLKs can also induce cell proliferation, as keratinocytes;<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> furthermore, it has long been known that KLK1 has mitogenic effects by generating active kinin peptides from their kininogen precursor (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The kinins can subsequently trigger the activation of the bradykinin B2 G-protein-coupled receptor.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Recent studies have shown that KLKs can regulate cell signaling by cleaving and triggering the activation of protease-activated receptors (PARs) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref30 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref30 ref68 ref69">(30, 68, 69)</a></div><div class="NLM_p last">PARs 1–4 are members of the G-protein-coupled receptor superfamily. They have been implicated in a number of physiological and pathological signaling pathways in a variety of tissues.<a onclick="showRef(event, 'ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref70 ref71 ref72">(70-72)</a> Thus, these receptors are additional targets by which KLKs, like hormones, can transmit their chemical messages in an endocrine, paracrine, or autocrine manner.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Kallikreins as Regulators of Proteinase-Activated Receptors Signaling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Accumulating evidence suggests that KLKs are activators of PARs that comprise four G-protein-coupled receptors (PAR1, PAR2, PAR3, and PAR4). They are irreversibly activated by the action of proteinases mainly from serine proteinase class and with trypsin-like substrate specificity for cleavage following arginine or lysine residues.<a onclick="showRef(event, 'ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75">(73-75)</a> Accumulating evidence suggests that the cleavage occurs within the amino terminal exodomain of the receptor following either an arginine or lysine residue, generating a new amino terminal. This unmasked tethered ligand binds intramolecularly, causing allosteric changes within the PAR, followed by receptor coupling to heterotrimeric G proteins and signal transduction. Importantly, proteinases may also cleave downstream of the activation site or within a PAR extracellular loop, leading to disarming of the receptor.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Synthetic peptides mimicking the tethered ligands can also activate PARs even in the absence of proteinases intervention.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> These synthetic receptor-activating peptides are named PAR-activating peptides (PAR-APs). They have been proved to be key reagents for the study the pharmacology of the PARs and their role in pathobiology. Moreover, they have been employed as starting point for the design of novel receptor ligands in order to assess the key structural features needed for the interaction with the receptor. The obtained results in terms of both involvement in pathophysiological conditions and research of PARs agonists and antagonists have been extensively reviewed.<a onclick="showRef(event, 'ref71 ref72 ref76 ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref76 ref77 ref78 ref79">(71, 72, 76-79)</a></div><div class="NLM_p">The characteristics of PARs family are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PAR Family<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">receptor</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">PAR1</th><th class="colsep0 rowsep0" align="center">PAR2</th><th class="colsep0 rowsep0" align="center">PAR3</th><th class="colsep0 rowsep0" align="center">PAR4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amino acid composition</td><td class="colsep0 rowsep0" align="left">425 aa (h)</td><td class="colsep0 rowsep0" align="left">397 aa (h)</td><td class="colsep0 rowsep0" align="left">374 aa (h)</td><td class="colsep0 rowsep0" align="left">385 aa (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tethered ligand sequence</td><td class="colsep0 rowsep0" align="left">SFLLR (h)</td><td class="colsep0 rowsep0" align="left">SLIGKV (h)</td><td class="colsep0 rowsep0" align="left">TFRGAP (h)</td><td class="colsep0 rowsep0" align="left">GYPGQV (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">SFFLR (m, r)</td><td class="colsep0 rowsep0" align="left">SLIGRL (m, r)</td><td class="colsep0 rowsep0" align="left">SFNGGP (m)</td><td class="colsep0 rowsep0" align="left">GYPGKV (h)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selective agonist peptide</td><td class="colsep0 rowsep0" align="left">TFLLR-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">SLIGRL-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">unknown</td><td class="colsep0 rowsep0" align="left">AYPGKF-NH<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">major activating proteinase</td><td class="colsep0 rowsep0" align="left">thrombin</td><td class="colsep0 rowsep0" align="left">trypsin tryptase</td><td class="colsep0 rowsep0" align="left">thrombin</td><td class="colsep0 rowsep0" align="left">thrombin trypsin</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">major disarming proteinase</td><td class="colsep0 rowsep0" align="left">trypsin cathepsin G</td><td class="colsep0 rowsep0" align="left">elastase, chymase</td><td class="colsep0 rowsep0" align="left">cathepsin G</td><td class="colsep0 rowsep0" align="left">unknown</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">h stands for human, m for mouse, and r for rat receptors.</p></div></div></div><div class="NLM_p">Stemming from studies with both PAR-activating peptides and receptor antagonists, as well as PAR-null mice, it has become evident that the PARs and therefore their activating/inactivating proteinases play important roles in a number of pathophysiological processes, such as cardiovascular responses,<a onclick="showRef(event, 'ref80 ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82 ref83">(80-83)</a> neuronal cell survival,<a onclick="showRef(event, 'ref71 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref71 ref84 ref85">(71, 84, 85)</a> platelet aggregation, inflammation, and epidermal function.<a onclick="showRef(event, 'ref86 ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88">(86-88)</a> Moreover, PAR receptors are involved in mediating disease-associated cellular changes including those necessary for cancer progression such as dysregulated cell proliferation and migration.<a onclick="showRef(event, 'ref75 ref89 ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref75 ref89 ref90 ref91 ref92">(75, 89-92)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> KLKs and PARs in Cancer and Inflammation</h3><div class="NLM_p last">Several studies have been performed confirming that KLK signaling via PARs is associated with both inflammation and cancer. Much of the data supporting a role for KLKs in regulating cell function have come from studying the effects of KLKs on PAR expressing cell lines in vitro. KLK4, highly expressed in normal prostate, has been associated with prostate cancer progression, and this effect has been correlated to PARs.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Confocal microscopy analyses indicated that KLK4 initiates loss of PAR2 from the cell surface and receptor internalization. Immunohistochemical analysis indicated the coexpression of KLK4 and PAR2 in primary prostate cancer and bone metastases. By use of PAR1 knockout mouse lung fibroblast cell line transfected with PAR1 (KOLF-PAR1) or PAR2 (KOLF-PAR2), it was demonstrated that KLK4 activates both PAR1 and PAR2 whereas KLK2 activates PAR2.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> KLK4 interaction with PAR1 and the subsequent initiation of ERK1/2 signaling can play a major role in tumor–stroma interactions in androgen-independent prostate cancer.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> A similar paracrine function has also been suggested for KLK6 strongly expressed in keratinocytes and stromal cells located adjacent to benign nevi, primary melanomas, and cutaneous metastatic lesions.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Finally, KLK4 and KLK14 signaling via PAR1 and PAR2, respectively, are involved in colon tumorigenesis.<a onclick="showRef(event, 'ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref97 ref98">(97, 98)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> KLKs and PARs in Skin Pathology</h3><div class="NLM_p last">Other possible pathophysiological roles for local kallikreins may be found in the skin, where PARs and kallikreins are coexpressed either in normal or in pathological settings such as psoriasis. KLKs 5, 7, and 14 have been isolated in their active forms from the outermost layers of the stratum corneum.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a> KLK8 is another human KLK, which is abundantly present in the stratum corneum.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> A KLK cascade involving KLKs 5 and 7 has been identified and may effect skin desquamation via the degradation of intercellular (corneo)desmosomal adhesion molecules.<a onclick="showRef(event, 'ref99 ref102'); return false;" href="javascript:void(0);" class="ref ref99 ref102">(99, 102)</a> By use of immunofluorescence analysis and functional activation by measurements of changes in intracellular calcium levels, it was demonstrated that KLK5 and KLK14, but not KLK7 or KLK8, induced PAR2 signaling.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> KLK5, in particular, can play a major role in pathobiology of the Netherton syndrome (NS), a rare genetic skin disease with a profound skin barrier defect and severe allergic manifestations.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Briot et al. have demonstrated that KLK5, via PAR2 signaling, increases expression of proinflammatory cytokines and chemokines such as thymic stromal lymphopoietin (TSLP), tumor necrosis factor α, IL-8, and intercellular adhesion molecule 1 (ICAM-1) in human primary keratinocytes.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Moreover, a novel signaling mechanism of KLK1 in promoting skin cell migration and wound healing in keratinocytes has been described. KLK1’s stimulatory effect was inhibited by small interfering RNA for PAR1 and by PAR1 antagonist, demonstrating the involvement of the PAR1–PKC–Src–MMP pathway.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> KLKs and PARs in CNS Pathology</h3><div class="NLM_p last">A number of KLKs are expressed in the central nervous system. Among them, KLK6 is the most studied, and its involvement in several neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis has been documented.<a onclick="showRef(event, 'ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref107 ref108">(107, 108)</a> In particular, it has been suggested that KLK1 and KLK6 are directly implicated in neurodegeneration and could be useful tools to follow multiple sclerosis progression.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Starting from the consideration that PARs are highly expressed in both the central and peripheral nervous system where PAR1 and PAR2 are primarily responsible for triggering inflammation, it is hypothesized that a pathological role of KLKs/PARs axis is also in this setting. Supporting data for this hypothesis are that PAR2, whose activity can be regulated by KLKs, has been implicated in a murine experimental autoimmune encephalitis model of multiple sclerosis.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> A recent study demonstrated that KLK6, but not KLK1, signals through PARs. KLK6 evoked intracellular Ca<sup>2+</sup> flux was mediated by PAR1 in neurons and both PAR1 and PAR2 in astrocytes.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> The KLK6-mediated PAR1 activation also participates in promoting lymphocyte survival. Insufficient lymphocyte apoptosis is a well-known participant in autoimmune and lymphoproliferative disease but in excess can promote immunodeficiency. Scarisbrick et al. demonstrate for the first time that KLK6 is able to promote survival of murine splenocytes as well as the human leukemic Jurkat T cell line, suggesting a novel molecular mechanism regulating lymphocyte survival that could be important for a range of immunological responses that depend on apoptosis for immune clearance and maintenance of homeostasis.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Kallikreins and PARs as Therapeutic Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Given the wide range of pathophysiological conditions in which PARs are involved, it is expected that their activation or inhibition would be critical for many pathological conditions. This consideration renders the kallikrein–PAR axis an attractive target for drug development. Research on kallikrein inhibitors has led to compounds with insufficient enzyme specificity. A great abundance of serine proteinases are able to activate PAR receptors, rendering kallikreins attractive diagnostic and therapeutic targets, only in particular pathological conditions such as prostate cancer and skin diseases. Research on PARs antagonists has produced interesting results particularly regarding design and synthesis of PAR1 antagonists and their use in cardiovascular diseases. PAR1 antagonists are expected to be safer than currently available antiplatelet agents, since they do not influence thrombin induced cleavage of fibrinogen, which is the first step in coagulation. Additionally, experimental and clinical data show the roles of PARs regulating several inflammatory responses, as well as tumor growth and metastasis.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Kallikrein Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54802" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54802" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several natural inhibitors, such as the small peptides chymostatin (<b>1</b>), leupeptin (<b>2</b>), antipain (<b>3</b>), the polypeptides soybean trypsin inhibitor (SBTI) and aprotinin and/or synthetic small molecule inhibitors, such as diisopropyl fluorophosphate (DIFP, <b>4</b>), phenylmethylsulfonyl fluoride (PMSF, <b>5</b>), and tosylphenyl chloromethyl ketone (TPCK, <b>6</b>) have been used in order to gain insight on the primary substrate specificity of the respective kallikrein-related peptidase, allowing also a more complete characterization of the enzymes (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Low specificity small peptides and small molecule KLK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the usually low specificity of these inhibitors, the data obtained allowed the design of more specific compounds. Aldehydic peptides <b>1</b>, <b>2</b>, and <b>3</b>, in which the C terminal residue is arginal or phenylalaninal, are produced by microorganisms as protease activity attenuators or inhibitors that target host proteases.<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114, 115)</a> These peptides act by forming a hemiacetal adduct between their aldehyde group and Ser and/or Cys nucleophiles, affording a transition-state-like inhibiting protease complex, which is reversible. Peptides <b>2</b> and <b>3</b>, characterized by the presence of an Arg residue at P1 position, are more specific for triptic KLKs, while <b>1</b>, presenting a leucylphenylalaninal moiety, is directed against chymotryptic proteases. Other small molecules, mainly employed for purification and/or characterization purposes, since their low specificity and/or high toxicity does not allow a therapeutic development, are (i) benzamidines, (ii) sulfonyl fluorides and diisopropyl fluorophosphate, and (iii) chloromethyl ketones. Benzamidines (such as benzamidine (<b>7</b>) and <i>p</i>-aminobenzamidine (<b>8</b>)) are tryptic inhibitors, since their aromatic rings fit the S1 pocket and their amidino moieties interact with the negatively charged Asp189 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Because of the absence of other interactions with the enzymes, these inhibitors show inhibition constants ranging from high micromolar to millimolar values. Nevertheless, these molecules have been very useful in crystallographic studies. In fact more than 100 crystal structures of <b>7</b> or <b>8</b> complexed with several proteases have been reported. Compounds <b>4</b> and <b>5</b> are irreversible and toxic protease inhibitors that react with serine and cysteine residues inhibiting serine protease but also esterase enzymes. Chloromethyl ketones are also irreversible inhibitors that covalently link the enzymes but, similar to aldehydic derivatives, allow the design of more specific compounds. Tosyllysyl chloromethyl ketone (TLCK, structure not disclosed), for example, was an efficient inhibitor for KLKs 1, 4, and 8, while KLK7 was successfully crystallized with Ala-Ala-Phe-CMK and succinyl-Ala-Ala-Pro-Phe-CMK (structures not disclosed).<a onclick="showRef(event, 'ref116 ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref116 ref117 ref118">(116-118)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Designing KLK Inhibitors</h3><div class="NLM_p">Designing KLKs inhibitors has been very challenging because of the sequence homology within the 14 members of the family that usually does not permit highly selective molecules that could interact with just one or a few members of the family.</div><div class="NLM_p last">The increasing amount of information regarding the three-dimensional structures of many KLKs in conjunction with the advance in synthetic methodologies and high-throughput screening assays has stimulated several research groups to prepare small molecules able to inhibit several components of the KLK family. The interest has been focused particularly on those KLKs that appear as attractive diagnostic and therapeutic targets, such as the members of the family that are involved in prostate cancer and skin diseases.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Peptide and Peptide-Mimetic KLK Inhibitors</h3><div class="NLM_p">In 2001, Juliano et al. presented the first description of substrates or inhibitors for KLK1 using internally quenched fluorescent peptides Abz-F-X-S-R-Q-EDDnp and Abz-G-F-S-P-F-X-S-S-R-P-Q-EDDnp [where Abz is <i>o</i>-aminobenzoic acid, EDDnp is <i>N</i>-(2,4-dinitrophenyl)ethylenediamine], which were based on the human kininogen sequence at the C-terminal region of bradykinin. At the X position were inserted non-natural basic amino acids aiming at mapping the specificity of the S1 subsite of this enzyme. The longer peptides were more susceptible to KLK1, while in the shorter series the compound Abz-F-Ama-S-R-Q-EDDnp (<b>9</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), where Ama is 4-(aminomethyl)cyclohexylalanine, inhibited KLK1 with a <i>K</i><sub>i</sub> of 50 nM with high specificity compared to human plasma kallikrein, thrombin, plasmin, and trypsin.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Peptide and peptide-mimetic KLK1 inhibitors obtained by drug design approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The following series was designed based on phenylacetyl-Phe-Ser-Arg-EDDnp (structure not disclosed), a quite specific inhibitor for KLK1 that showed significant analgesic and anti-inflammatory effects. Phe was substituted by amino acids containing larger aliphatic or aromatic side chains as well as by unnatural basic amino acids, combining a large hydrophobic and/or aromatic group with a positively charged group at their side chains. The most effective competitive inhibitor for KLK1 was phenylacetyl-Aca-Ser-Arg-NH<sub>2</sub> (<b>10</b>), where Aca is <span class="smallcaps smallerCapital">l</span>-<i>cis/trans</i>-4-(aminocyclohexyl)alanine, with a <i>K</i><sub>i</sub> of 0.11 μM.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Finally, the S′<sub>1</sub> and S′<sub>2</sub> subsite specificity of KLK1 was examined using the peptide Abz-Ala-Ile-Lys-Phe-Phe-Ser-Arg-Gln-EDDnp (structure not disclosed), corresponding to the reactive-center loop sequence of kallistatin, a serpin that displays high specificity for KLKs, being a strong inhibitor of KLK1 and KLK7, while KLK14 is slowly inhibited.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> The information recovered with several derivatives of the reported sequence led to the synthesis of six shorter peptides that inhibited KLK1 in the range 20–30 nM. Among them acetyl-<span class="smallcaps smallerCapital">d</span>-Lys-Phe-Phe-Pro-Leu-Glu-NH<sub>2</sub> (<b>11</b>) showed a surprising inhibitory potency, <i>K</i><sub>i</sub> of 8 nM, toward human plasma kallikrein, known to be a restricted arginyl hydrolase.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> By screening of a phage display library, expressing 10 or 11 amino acids long linear peptides, six KLK2 binding peptides were identified. Among them, three compounds (corresponding to the sequences SRFKVWWAAG, AARRPFPAPS, and PARRPFPVTA; structures not disclosed) were shown to be specific and efficient inhibitors of the enzymatic activity of KLK2. Alanine scanning of SRFKVWWAAG led to ARFKVWWAAG (structure not disclosed), which showed the strongest inhibition with a <i>K</i><sub>i</sub> of 1.41 μM.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> On the basis of these results and to obtain more stable products for in vivo use, cyclic analogues were prepared and their biological activity and structural stability were compared.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Inhibition of KLK3/PSA is one of the major targets among the KLKs for medical and pharmaceutical research. Identification of highly selective peptide inhibitors, in fact, could be helpful for development both of novel pharmacological treatment and of targeted imaging agents for prostate cancer. Structure-guided approach has been employed for designing several peptides whose binding to PSA has been assessed by surface plasmon resonance (SPR) that showed strong binding affinity of PSA toward peptides with hydrophobic and basic residues.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Starting from the previously known PSA peptide substrate Ser-Ser-Lys-Leu-Gln (SSKLQ, structure not disclosed), a rational and iterative approach has been used to develop peptidyl boronic acid based PSA inhibitors. From these studies a peptidyl boronic acid with the sequence carbobenzyloxy-Ser-Ser-Lys-Leu-(boro)Leu (<b>12</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) has been identified as a potent and specific PSA inhibitor with a <i>K</i><sub>i</sub> of 65 nM.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Peptide and peptide-mimetic KLK3/PSA inhibitors obtained by drug design approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A subsequent optimization led to the identification of the compound morpholinocarbonyl-Ser-Ser-Gln-Nle-(boro)-Leu (<b>13</b>) with a <i>K</i><sub>i</sub> of 25 nM and with the desirable property to be linked to a single amino acid chelate (SAAC) group. Labeling with Re afforded the inhibitor <b>14</b> functioning well as an inhibitor of PSA with a <i>K</i><sub>i</sub> of 28 nM.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> A combination of molecular modeling and virtual positional scanning studies has been employed in order to define the binding mode of peptide substrates into the catalytic pocket of KLK3. The utility of the obtained molecular insights was demonstrated by synthesizing several peptide sequences containing aldehyde functionality at the C-terminal.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Finally, Juliano et al. have reported a detailed study on the effect of sodium citrate and glycosaminoglycans on the proteolytic activity of KLK3. These two substances have been chosen, since they are very concentrated in prostate and seminal fluid. The obtained results demonstrated that sodium citrate can modulate KLK3 activity, enhancing the hydrolytic efficiency at Arg, Gln, and particularly Pro residues, thus suggesting that promising inhibitors can be designed based on the structure of <i>o</i>-phenanthroline and from compounds derived of proline.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> KLK4 represents another interesting target related to prostate cancer development and progression. A sparse matrix peptide library of 125 individual tetrapeptide-<i>p</i>-nitroanilides (pNAs) has been designed. The found optimal cleavage sequence has been substituted into the naturally occurring sunflower trypsin inhibitor (SFTI) scaffold, affording an inhibitor with a nanomolar <i>K</i><sub>i</sub> that is able to block stimulation of PAR activity.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Another natural occurring inhibitor used as template for drug design is LEKTI consisting of 15 inhibitory domains (D1–D15) separated by 14 spacing segments. All of them, except for D1, showed specific and differential inhibition of KLK5, KLK7, and KLK14 with the inhibitory domains D8–D11 showing the strongest inhibition toward KLK5.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Recently, the 68-residue LEKTI domain 6 has been produced by the fragment condensation approach and site-directed cystine bridge formation, inhibiting KLK5 equipotently to the recombinantly produced peptide.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Small Molecule KLK Inhibitors</h3><div class="NLM_p">Most of the synthesized small molecules designed as serine protease inhibitors are characterized by the presence of peptidomimetic moieties that are able to bind some key groups in the specificity pockets of the enzyme associated with an altered “scissile” bond which usually may react with the catalytic serine. Several patents have been recently published related to aminothiazoles,<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> azaindoles,<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> and [6-aminopyridin-3-yl)methyl]amide derivatives as KLK1 inhibitors.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Heterocyclic compounds, inhibiting KLK3/PSA at submicromolar concentrations, were identified by a high-throughput screening approach. Benzoxazinone derivative <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), with a <i>K</i><sub>i</sub> of 300 nM, and triazole derivative <b>16</b>, with a <i>K</i><sub>i</sub> of 500 nM, were used as lead compounds to perform a structure–activity relationship study.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Small molecule KLK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Some natural isocoumarins showed a promising inhibitory activity toward KLK5 and KLK7. In particular, vioxanthin (<b>17</b>) remains the most potent inhibitor of KLK5 (<i>K</i><sub>i</sub> = 22.9 μM), while 8,8′-paepalantine (<b>18</b>) showed a <i>K</i><sub>i</sub> of 12.2 μM toward KLK7.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">PAR Agonists and Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Design and preparation of peptide-mimetics or small organic molecules acting on PARs have been very challenging, since the tethered ligand binding mechanism is energetically preferred. It is very difficult to compete against this intramolecular binding with a small-molecule ligand. Very few details about the three-dimensional structure of the receptors are available. This means that a highly empirical approach has been used so far. Several detailed overviews on PAR ligands have been published focusing on pathological conditions in which PARs are involved, such as cardiovascular diseases, inflammation, and tumor progression. In this section of the review we will analyze the most recent developments in the preparation and biological evaluation of PAR ligands. The classification of the molecules is based first on the specific target and second on the chemical structure. In particular we analyze (i) peptide/peptidomimetic PAR1 antagonists, (ii) small molecules as PAR1 antagonists, (iii) peptide-mimetic PAR2 agonists, (iv) small molecules as PAR2 agonists and antagonists, (v) peptide-mimetic PAR4 agonists and antagonists, (vi) small molecules as PAR4 antagonists, and (vii) pepducins as PAR4 antagonists.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Peptide/Peptidomimetic PAR1 Antagonists</h3><div class="NLM_p">Extensive structure–activity relationships studies, started using as model the sequence of the small peptides that selectively activates the thrombin receptor (SFLLRN or SFLLR), led to the identification of a “three-point model”, constituted by the ammonium group, the center of the benzene ring (Phe residue), and the central carbon of the guanidine group (Arg residue). These features in conjunction with different molecular templates such as benzene, naphthalene, benzimidazole, indole, and indazole allowed the discovery of several potent peptide-mimetic PAR1 antagonists embodying 6-aminoindole (<b>19</b> and <b>21</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and 6-aminoindazole (<b>20</b>) nuclei that met the spatial requirements for displaying the three key substituents in the correct three-dimensional configuration.<a onclick="showRef(event, 'ref136 ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref136 ref137 ref138">(136-138)</a></div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Peptide/peptidomimetic PAR1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Peptide-mimetic antagonists containing novel heterocyclic scaffolds, such as 2-methylindole and 1,4-benzodiazepine, were described. The pharmacological activity was assessed using human platelet aggregation induced by PAR1-AP in order to test the antagonist potency. Compound <b>22</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) differs from <b>21</b> only because of the presence of a methyl group in position 2 of the 6-aminoindole moiety. This small structural modification shifted the biological activity toward a more potent derivative (IC<sub>75</sub> analysis gave 0.1 μM for the reference compound <b>21</b> and 0.02 μM for <b>22</b>).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> A different approach to receptor inhibition involved the use of N-palmitoylated peptides, termed pepducins, that, targeting the intracellular loops, can cause activation and/or inhibition of G protein signaling only in the presence of the parent GPCR. Attachment of a palmitate lipid to peptides based on the N-terminal or the C-terminal portion of the i3 loop of PAR1 yielded the full antagonist P1pal-12 (pal-RCLSSSAVANRS-NH<sub>2</sub>, structure not disclosed) or P1pal-7 (pal-KKSRALF-NH<sub>2</sub>, structure not disclosed), respectively.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140, 141)</a> The latter, tested in xenograft models of advanced peritoneal ovarian cancer, reduced production of ascites and angiogenesis and, when administered in combination with docetaxel, inhibited metastatic progression of peritoneal ovarian cancer.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Small Molecules as PAR1 Antagonists</h3><div class="NLM_p">Several authors have described low molecular weight thrombin receptor antagonists resulting from the examination of structure–activity relationships performed on peptide-mimetic antagonists or from high-throughput screening. Among the non-peptide thrombin receptor antagonists the pyrroloquinazoline-based derivative <b>23</b> (SCH-79797) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), first reported by Ahn et al. in 1999,<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> has shown an interesting cardioprotective effect related to its ability in inhibiting PAR1 attenuating myocardial injury and dysfunction related to myocardial I/R injury when given before or during ischemia.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Small molecules as PAR1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Testing in an in vivo angiogenesis model provided direct evidence that PAR1 is involved in the initiation of the angiogenic cascade.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a><b>23</b> has shown a remarkable antiproliferative effect in several cell lines, even though the observation that it was able to slow the proliferation rate of mouse PAR1 null cells as well suggested that this pharmacological effect was likely not mediated by PAR1 inhibition.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> PAR1 antagonist <b>24</b> (E-5555, named atopaxar), based on a bicyclic amidine motif, has been reported to inhibit platelet aggregation with no change in bleeding time in phase I studies, and it is currently under development as a potential treatment for critical care acute coronary syndrome. The safety and tolerability of <b>24</b> have been assessed in two parallel, international, phase II randomized, controlled studies: LANCELOT-CAD, conducted on 720 individuals with coronary artery disease (CAD), and LANCELOT-ACS, conducted on 603 patients who had experienced an acute coronary syndrome (ACS).<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146, 147)</a> In the dose-ranging study of patients with CAD, treatment with <b>24</b> resulted in platelet aggregation inhibition, more minor bleeding, and numerically but not statistically fewer ischemic events. In patients after ACS, <b>24</b> significantly reduced early ischemia on Holter monitoring without a significant increase in major or minor bleeding. Larger-scale trials are needed to determine whether the results could be translated into clinically meaningful effects and to fully establish the efficacy and safety of <b>24</b>. In 2005, high affinity, orally active, low molecular weight non-peptide PAR1 antagonists, based on the natural product himbacine, were reported.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> Several structure–activity relationships studies were performed in order to optimize the substitution of important structural motifs for himbacine derivative PAR1 binding such as the lactone ring<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> and the pyridine ring.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Moreover, quinoline-based antagonists and other derivatives characterized by different tricyclic or heterotricyclic core were described.<a onclick="showRef(event, 'ref151 ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref151 ref152 ref153">(151-153)</a> Exploration of the C-7 region of the tricyclic motif led to a further optimization of himbacine-derived PAR1 antagonists, allowing the discovery of <b>25</b> (SCH-530348, named vorapaxar) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), characterized by high potency in several in vitro functional assays and excellent oral bioavailability in multiple species.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Compound <b>25</b> has been evaluated in patients undergoing nonurgent percutaneous coronary intervention and was generally well tolerated. It did not cause increased thrombolysis in myocardial infarction (TIMI) bleeding, even when administered in association with aspirin and clopidogrel.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> These results have allowed the design of a large phase III program, TRA·CER, a multicenter, randomized, double-blind, placebo-controlled study.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> A part of this study, named TRA2°P-TIMI 50 trial, has been designed in order to evaluate the efficacy and safety of <b>25</b> during long-term treatment of patients with established atherosclerotic disease receiving standard therapy (up to 27 000).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> At the beginning of 2011, Merck announced that <b>25</b> would be discontinued in patients who experienced a stroke prior to entry or during the trial because of an increase in intracranial hemorrhage in these patients. A more water-soluble analogue of <b>25</b> has been obtained through the incorporation of polar substituent on the pyridine ring. Compound <b>26</b> showed PAR1 affinity and antiplatelet effect in vivo in a cynomolgus monkey model comparable to those of vorapaxar with 20-fold increased aqueous solubility (<i>K</i><sub>i</sub> = 8 nM for <b>25</b> and <i>K</i><sub>i</sub> = 19 nM for compound <b>26</b>; kinetic solubility of <5 μM for <b>25</b> and 75 μM for compound <b>26</b>). In a Folts model of thrombosis, <b>26</b> showed dose-dependent antithrombotic efficacy that was additive when coadministered with the ADP antagonist cangrelor.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Perez et al. have reported phenylpentadienoylpiperazines and cinnamoylpiperazines able to inhibit SFLLR-induced human platelet aggregation and active by both iv and oral administration routes in a rat thrombosis model without any significant impact on bleeding time. Two of the described compounds, <b>27</b> (F16618) and <b>28</b> (F16357) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), are the most promising in terms of antithrombotic activity and ADME profile.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> These compounds displayed antithrombotic activity in an arteriovenous shunt model in the rat. In particular, <b>27</b> exerted a potent antithrombotic activity by intravenous and oral routes, without affecting bleeding time. Furthermore, the antithrombotic activity was potentiated when combined with aspirin or clopidogrel.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Further pharmacological characterization has demonstrated that inhibition of PAR1, mediated by antagonists such as compound <b>27</b>, represents a highly effective treatment of restenosis after vascular injury, by inhibition of TNFα, MMP7, and smooth muscle cell migration and proliferation in addition to an antithrombotic effect.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> As a consequence of an in-house high-throughput screening program, the same research group has identified a novel inhibitor hit, <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), that was synthesized as a mixture of enantiomers. Compound <b>29</b> has been used as starting point for a SAR study. After modifications of the ether substituent, of the aryl group, of the imidazole ring, and of the thioether functionality, compounds <b>30</b> and <b>31</b>, tested as mixtures of enantiomers, were identified displaying an increase in potency with respect to <b>29</b> and strong antithrombotic activity in vivo associated with a sufficient stability against human liver microsomes.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Two series of cinnamoylpiperidine and cinnamoylpyridine derivatives were described as a result of profound structural modifications of the lead <b>28</b>. Several substitutions have been performed, such as incorporation of a fused phenyl–alkene system, replacement of the central carbonyl moiety by the known cyclobut-3-ene-1,2-dione bioisostere, and exploration of the piperazine portion that led to the most active compounds such as the pyridine analogue <b>32</b>, which revealed a very comparable pharmacological profile with respect to the reference compound <b>28</b>, and piperidine analogue <b>33</b>, displaying a significantly improved activity in the rat antithrombotic model.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Peptide-Mimetic PAR2 Agonists and Antagonists</h3><div class="NLM_p">Research of PAR2 receptor ligands has been directed toward identification of agonists and antagonists, since both of them may have therapeutic value. PAR2 antagonists are of particular interest in order to relieve, for example, inflammatory symptoms in rheumatoid arthritis.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> On the other hand, activation of PAR2 could play a relevant role as gastric cytoprotective and/or airway smooth muscle relaxation mediator.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Research for PAR2 ligands, based on chemical modifications of short peptides corresponding to the newly exposed N-terminus of the receptor, such as PAR2-AP, led to more potent agonists, namely, 2-furoyl-LIGRL-NH<sub>2</sub> (<b>34</b>) and 2-furoyl-LIGRO-NH<sub>2</sub> (<b>35</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165, 166)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Peptide-mimetic derivatives as PAR2 agonists and antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Starting from these compounds, Barry et al. has reported a small compound library based on a XLIGRLI-NH<sub>2</sub> hexapeptide motif. Some chemical modifications have been performed such as heterocyclic replacement for the N-terminal serine, truncation and optimization of very short peptides, and then substitution of the C-terminus with nonpeptidic fragments. Among the reported derivatives, agonist <b>36</b> (GB110), showing an EC<sub>50</sub> of 0.28 μM, selectively induced PAR2-mediated, but not PAR1-mediated, intracellular Ca<sup>2+</sup> release in HT29 human colorectal carcinoma cells, while antagonist <b>37</b> (GB83), with an IC<sub>50</sub> of 2 μM, is the first compound at micromolar concentrations to reversibly inhibit PAR2 activation by both proteases and other PAR2 agonists.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Despite the interesting activity of these derivatives in many PAR2 cellular and molecular studies, the furane ring cannot be considered as a safe structural element for drug design, since it can be metabolically activated by cytochrome P450 to form electrophilic intermediates that are able to bind covalently to liver proteins and cause hepatotoxicity in vivo. For these reasons Boitano et al. have designed and synthesized a set of 15 analogues to investigate the effects of N-terminal modifications on the ability to activate PAR2. They found that the most potent agonists share a common structural feature, nitrogen based heterocycle (thiazole or pyridine) with an amino group orientated in the position ortho to the nitrogen. In particular 2-aminothiazol-4-yl and 6-aminonicotinyl derivatives (<b>38</b> and <b>39</b>) were discovered as selective PAR2 agonists.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> A further pharmacological characterization of compounds <b>35</b>, <b>38</b>, and <b>39</b> have been reported showing that all of them are able to stimulate PAR2-dependent in vitro physiological responses, MAPK signaling, and Ca<sup>2+</sup> signaling with an overall rank order of potency of <b>35</b> ∼ <b>38</b> > <b>39</b> ≫ SLIGRL-NH<sub>2</sub>. Moreover, their evaluation in models relevant to nociception showed that all three agonists activated Ca<sup>2+</sup> signaling in nociceptors in vitro, and both <b>35</b> and <b>38</b> stimulated PAR2-dependent thermal hyperalgesia in vivo.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> From the screening of a peptide-mimetic compound library based on the structures of PAR2 agonist peptides, compound <b>40</b> (K-14585) was identified as able to inhibit PAR2-dependent calcium and proinflammatory signaling but not attenuating MAPK signaling acting as a partial PAR2 agonist.<a onclick="showRef(event, 'ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref170 ref171">(170, 171)</a> A recent attempt to optimize the pharmacological profile of compound <b>37</b> has led to the identification of a more potent small molecule peptide-mimetic antagonist, <b>41</b> (GB88, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> This compound, evaluated for blockade of intracellular calcium release in colonocytes and for anti-inflammatory activity in acute (PAR2 agonist-induced) versus chronic (TNBS-induced) models of colitis in Wistar rats, provided the first evidence that in vivo pharmacological targeting of PAR2 with an antagonist attenuates experimental colitis.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Small-Molecule Compounds as PAR2 Agonists and Antagonists</h3><div class="NLM_p">The development of small-molecule non-peptide PAR2 agonists and antagonists has proved to be challenging. From the screening of a chemical library containing more than 250 000 small-molecule druglike compounds a small number of active structures were identified. Agonist activity at the human PAR2 was evaluated utilizing a high-throughput functional screening, such as R-SAT. A focused library around <b>42</b> (AC-55541, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), made by reacting a number of aromatic aldehydes or ketones with the parent hydrazide, led to the preparation of the more active derivative <b>43</b> (AC-264613).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Small-molecule compounds as PAR2/PAR4 agonists and antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compounds <b>42</b> and <b>43</b> have been characterized in vitro and in vivo, displaying high potency and efficacy for PAR2 receptors in a variety of functional assays including cellular proliferation, calcium mobilization, and PI hydrolysis assays, and both compounds stimulated internalization of PAR2 receptors.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Very few small molecule PAR2 antagonists have been described to date. The piperazine derivative <b>44</b> (ENMD-1068, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), based on the sequence LIGK-NH<sub>2</sub>, has shown the ability to block trypsin and PAR2-AP activation of the receptor and, despite its very low potency, has proved of use in in vivo studies.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The obtained results allowed PAR2 antagonism to be identified as a potentially powerful strategy for treatment of arthritis.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Small-Molecule Compounds and Pepducin-Based PAR4 Antagonists</h3><div class="NLM_p last">PAR4 antagonism can be considered an interesting strategy in order to get antithrombotic agents, since PAR4 receptors are expressed along with PAR1 on human platelets. However, only few molecules have been reported acting on this receptor subtype. Among them, the indazole derivative <b>45</b> (YD-3, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) inhibited thrombin-stimulated murine platelet aggregation.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> However, in human platelets, which also express PAR1, this compound blocks platelet aggregation induced by the PAR4 peptide agonist GYPGKF-NH<sub>2</sub> but not by thrombin. The application of the pepducin approach to the search of PAR4 antagonists has led to the identification of a selective PAR4 antagonist <b>46</b> (structure not disclosed), named P4pal10, whose sequence is pal-SGRRYGHALR-NH<sub>2</sub>.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140, 141)</a> This compound completely inhibits platelet aggregation, prolongs bleeding time, and prevents systemic platelet activation in mice.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a><b>46</b> and a structurally unrelated PAR4 antagonist, <i>trans</i>-cinnamoyl-YPGKF-NH<sub>2</sub> (structure not disclosed), showed a cardioprotective effect due to the unmasking of adenosine receptor signaling, supporting the hypothesis of a coupling between thrombin and adenosine receptors.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> The effects of PAR4 inhibition have been tested in a model of systemic inflammation and disseminated intravascular coagulation (Shwartzman reaction), furnishing circumstantial evidence that the primary cellular target of <b>46</b> may be neutrophils rather than platelets or endothelial cells. This finding suggests a possible development for PAR4 antagonists in the treatment of systemic inflammation.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Kallikrein-related peptidases (KLKs) are a family of serine proteases that are involved in many biological functions. KLK activity needs to be tightly regulated by means of several modulators such as ions and reversible/irreversible protein inhibitors. Many pathological conditions in humans arise from a failure in controlling KLKs activity. Several members of the family have been found to be involved in pathological conditions such as cancer and inflammation affecting different tissues. Protease activated receptors (PARs) have been recently identified as KLK substrates in many different physiological and pathological settings. Several pharmacological studies have then proposed the PAR–KLK axis as a useful pharmacological target for drug research. Interesting results have been obtained in the field of PAR antagonists, in particular with the molecules that are able to block PAR1 receptor. Most of the pharmacological studies involve their employment in cardiovascular diseases. In the future, attention should be also addressed to the evaluation of PARs antagonists in disease models where KLKs play a pivotal role exerting their actions through PAR activation.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm300407t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Caliendo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Chimica Farmaceutica
e Tossicologica, Università degli Studi di Napoli
“Federico II”, Via D. Montesano, 49, 80131,
Napoli, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b7d4d6dbded2d9d3d8f7c2d9ded9d699dec3"><span class="__cf_email__" data-cfemail="f89b9994919d969c97b88d96919699d6918c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Santagada</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Chimica Farmaceutica
e Tossicologica, Università degli Studi di Napoli
“Federico II”, Via D. Montesano, 49, 80131,
Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisa Perissutti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Chimica Farmaceutica
e Tossicologica, Università degli Studi di Napoli
“Federico II”, Via D. Montesano, 49, 80131,
Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrice Severino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Chimica Farmaceutica
e Tossicologica, Università degli Studi di Napoli
“Federico II”, Via D. Montesano, 49, 80131,
Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferdinando Fiorino</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Chimica Farmaceutica
e Tossicologica, Università degli Studi di Napoli
“Federico II”, Via D. Montesano, 49, 80131,
Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Frecentese</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Chimica Farmaceutica
e Tossicologica, Università degli Studi di Napoli
“Federico II”, Via D. Montesano, 49, 80131,
Napoli, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luiz Juliano</span> - <span class="hlFld-Affiliation affiliation">Department
of Biophysics, Escola Paulista de Medicina, Universidade
Federal de São Paulo, Rua Três de Maio
100, São Paulo 04044-020, Brazil</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Giuseppe Caliendo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Giuseppe Caliendo</b> received his B.Sc. in Pharmacy from University of Naples Federico II, Italy, in 1981. Currently, he is Full Professor of Medicinal Chemistry at the Faculty of Pharmacy of Naples. He has published over 120 peer-reviewed papers and some scientific books in the field of peptidomimetics and synthesis by microwave of biologically active compounds. His research is focused on identification and characterization of heterocyclic derivatives acting on some of the most attractive targets for medicinal chemists such as serotonin receptors, protease activated receptors, and kallikreins. In recent years, he has been interested in the development of hybrid structures containing H<sub>2</sub>S-releasing moiety in order to produce novel pharmacological tools able to highlight the therapeutic potential of modulation of the H<sub>2</sub>S pathway.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Vincenzo Santagada</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vincenzo Santagada</b> received his B.Sc. in Pharmacy from University of Naples Federico II, Italy, in 1982 and his Ph.D. in Medicinal Chemistry in 1987. Currently, he is Full Professor of Medicinal Chemistry at the Faculty of Pharmacy of Naples. He has published over 120 peer-reviewed papers and some scientific books in the field of peptidomimetics and synthesis by microwave. His scientific interests cover design and synthesis of pharmacologically active peptides and peptidomimetics that have been evaluated for their antitumoral, anti-inflammatory, antiviral, or analgesic properties. Recent years have seen a deep interest in the application of microwave technology to medicinal chemistry and in the development of H<sub>2</sub>S-releasing molecules.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Elisa Perissutti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elisa Perissutti</b> obtained her B.Sc. in Pharmacy from University of Naples Federico II in 1984 followed by a Ph.D. in Pharmaceutical Sciences in 1989. Currently she is a member of the Department of Pharmaceutical and Toxicological Chemistry and is Associate Professor of Medicinal Chemistry at the Faculty of Pharmacy. She has published over 70 full articles in international journals. Her main scientific interests include structure–activity relationship studies on heterocyclic derivatives acting as serotoninergic ligands, identification and characterization of PAR ligands, and application of novel technological tools to drug discovery. She is also coauthor of a book on the applications of microwave in peptide and organic synthesis.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Beatrice Severino</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Beatrice Severino</b> obtained her Bachelor’s degree in Medicinal Chemistry in 1997 from University of Naples Federico II, Italy. In 2003 she earned a Ph.D. in Pharmaceutical Science, working on a project focused on the design and synthesis of peptidomimetic derivatives acting on protease-activated receptors. In 2006 she held the position of Assistant Professor in Medicinal Chemistry at Faculty of Pharmacy, where she serves as a full-time researcher. Her scientific interest is mainly focused on development of peptidomimetic derivatives acting on several pharmacological targets such as PARs, kallikreins, and more recently sphingosine kinases. Her results are documented in 49 publications in international journals.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Ferdinando Fiorino</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ferdinando Fiorino</b> graduated from University of Naples Federico II, Italy, with a degree in Pharmacy in 1995. His interest in medicinal chemistry started at the Department of Pharmaceutical and Toxycological Chemistry, and he received his Ph.D. in Pharmaceutical Science in 1999 from University of Naples Federico II. In 2005 he held the position of Assistant Professor in Medicinal Chemistry at Faculty of Pharmacy, where he serves as a full-time researcher. His research has focused on the synthesis and structure–activity relationships of heterocyclic compounds with serotonergic activity in order to obtain ligands with greater potency and selectivity on 5-HT1A receptors. More recently he has devoted his attention to the synthesis and structural characterization of peptide fragments of prion protein in order to clarify the mechanism by which the physiological form is converted to the pathological form. He is author of 50 publications in international journals.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Francesco Frecentese</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Francesco Frecentese</b> graduated from University of Naples Federico II, Italy, with a degree in Pharmacy in 2003. Then he received his Ph.D. in Pharmaceutical Science in 2006 from University of Naples Federico II, working on a project concerning the application of microwaves in the synthesis of pharmacologically active heterocyclic, peptidic, and peptidomimetic molecules. He is currently a full-time researcher at Faculty of Biotechnology, and his interest is focused on development of PAR ligands and agents acting as H<sub>2</sub>S releasing molecules and/or inhibitors of enzymes involved in H<sub>2</sub>S production pathway. His scientific results are reported in 21 articles in international journals.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Luiz Juliano</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=bio7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Luiz Juliano</b> received his M.D. degree in Medicine in 1968 and his Ph.D. in Biological Science–Molecular Biology in 1974 from the Federal University of São Paulo, Brazil. Currently is a Full Professor at the same university. Luiz Juliano has experience in the area of biochemistry, with emphasis on proteins, working mainly on themes related to proteases and biological active peptides.</p></figure></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i32" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i32"> Abbreviations Used</h2><tr><td class="NLM_term">Abz</td><td class="NLM_def"><p class="first last"><i>o</i>-aminobenzoic acid</p></td></tr><tr><td class="NLM_term">Aca</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-<i>cis</i>/<i>trans</i>-4-(aminocyclohexyl)alanine</p></td></tr><tr><td class="NLM_term">ACS</td><td class="NLM_def"><p class="first last">acute coronary syndrome</p></td></tr><tr><td class="NLM_term">Ama</td><td class="NLM_def"><p class="first last">4-(aminomethyl)cyclohexylalanine</p></td></tr><tr><td class="NLM_term">CAD</td><td class="NLM_def"><p class="first last">coronary artery disease</p></td></tr><tr><td class="NLM_term">EDDnp</td><td class="NLM_def"><p class="first last"><i>N</i>-(2,4-dinitrophenyl)ethylenediamine</p></td></tr><tr><td class="NLM_term">hK</td><td class="NLM_def"><p class="first last">human kallikrein</p></td></tr><tr><td class="NLM_term">HMWK</td><td class="NLM_def"><p class="first last">high molecular mass kininogen</p></td></tr><tr><td class="NLM_term">ICAM-1</td><td class="NLM_def"><p class="first last">intercellular adhesion molecule 1</p></td></tr><tr><td class="NLM_term">KLK</td><td class="NLM_def"><p class="first last">kallikrein-related peptidase</p></td></tr><tr><td class="NLM_term">KLKB1</td><td class="NLM_def"><p class="first last">plasma kallikrein</p></td></tr><tr><td class="NLM_term">KOLF-PAR1</td><td class="NLM_def"><p class="first last">knockout mouse lung fibroblast cell line transfected with protease activated receptor 1</p></td></tr><tr><td class="NLM_term">KOLF-PAR2</td><td class="NLM_def"><p class="first last">knockout mouse lung fibroblast cell line transfected with protease activated receptor 2</p></td></tr><tr><td class="NLM_term">LEKTI</td><td class="NLM_def"><p class="first last">lymphoepithelial Kazal-type inhibitor</p></td></tr><tr><td class="NLM_term">LMWK</td><td class="NLM_def"><p class="first last">low molecular mass kininogen</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">myelin basic protein</p></td></tr><tr><td class="NLM_term">NS</td><td class="NLM_def"><p class="first last">Netherton syndrome</p></td></tr><tr><td class="NLM_term">PAR</td><td class="NLM_def"><p class="first last">protease activated receptor</p></td></tr><tr><td class="NLM_term">PAR-AP</td><td class="NLM_def"><p class="first last">protease activated receptor activating peptide</p></td></tr><tr><td class="NLM_term">pNA</td><td class="NLM_def"><p class="first last">tetrapeptide-<i>p</i>-nitroanilide</p></td></tr><tr><td class="NLM_term">pro-uPA</td><td class="NLM_def"><p class="first last">zymogen of urokinase plasminogen activator</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">prostate-specific antigen</p></td></tr><tr><td class="NLM_term">R-SAT</td><td class="NLM_def"><p class="first last">receptor selection and amplification technology</p></td></tr><tr><td class="NLM_term">SAAC</td><td class="NLM_def"><p class="first last">single amino acid chelate</p></td></tr><tr><td class="NLM_term">SBTI</td><td class="NLM_def"><p class="first last">soybean trypsin inhibitor</p></td></tr><tr><td class="NLM_term">SERPIN</td><td class="NLM_def"><p class="first last">serine proteinase inhibitor</p></td></tr><tr><td class="NLM_term">SFTI</td><td class="NLM_def"><p class="first last">sunflower trypsin inhibitor</p></td></tr><tr><td class="NLM_term">SPINK5</td><td class="NLM_def"><p class="first last">serine protease inhibitor Kazal-type 5</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TGF-β</td><td class="NLM_def"><p class="first last">tissue growth factor type β</p></td></tr><tr><td class="NLM_term">TIMI</td><td class="NLM_def"><p class="first last">thrombolysis in myocardial infarction</p></td></tr><tr><td class="NLM_term">TNBS</td><td class="NLM_def"><p class="first last">trinitrobenzene sulfonic acid</p></td></tr><tr><td class="NLM_term">TSLP</td><td class="NLM_def"><p class="first last">thymic stromal lymphopoietin</p></td></tr><tr><td class="NLM_term">VIP</td><td class="NLM_def"><p class="first last">vasoactive intestinal peptide</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 179 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Travis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">Are bacterial proteinases pathogenic factors?</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=405-407&author=J.+Travisauthor=J.+Potempaauthor=H.+Maeda&title=Are+bacterial+proteinases+pathogenic+factors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTravis%26aufirst%3DJ.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DAre%2520bacterial%2520proteinases%2520pathogenic%2520factors%253F%26jtitle%3DTrends%2520Microbiol.%26date%3D1995%26volume%3D3%26spage%3D405%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Klemba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. E.</span><span> </span><span class="NLM_article-title">Biological roles of proteases in parasitic protozoa</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1146%2Fannurev.biochem.71.090501.145453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12045098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Cltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=275-305&author=M.+Klembaauthor=D.+E.+Goldberg&title=Biological+roles+of+proteases+in+parasitic+protozoa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological roles of proteases in parasitic protozoa</span></div><div class="casAuthors">Klemba, Michael; Goldberg, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275-305</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Proteases from a variety of protozoan parasites were characterized at the mol. and cellular levels, and the many roles that proteases play in these organisms are coming into focus.  Central roles were proposed for proteases in diverse processes such as host cell invasion and egress, encystation, excystation, catabolism of host proteins, differentiation, cell cycle progression, cytoadherence, and both stimulation and evasion of host immune responses.  Detailed structural and functional characterization of parasite proteases has led to novel insights into the workings of these fascinating catalytic machines.  The possibility of developing selective inhibitors of key proteases of pathogenic parasites into novel chemotherapeutic strategies is being vigorously explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor1gqvbjIuoLVg90H21EOLACvtfcHk0lgXP5uVVCKErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Cltrw%253D&md5=0375e4211b1f5546bcfec5194933f52c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.71.090501.145453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.71.090501.145453%26sid%3Dliteratum%253Aachs%26aulast%3DKlemba%26aufirst%3DM.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26atitle%3DBiological%2520roles%2520of%2520proteases%2520in%2520parasitic%2520protozoa%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2002%26volume%3D71%26spage%3D275%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Monod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capoccia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechenne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaugg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jousson, O.</span><span> </span><span class="NLM_article-title">Secreted proteases from pathogenic fungi</span> <span class="citation_source-journal">Int. J. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1078%2F1438-4221-00223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12452286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Khsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2002&pages=405-419&author=M.+Monodauthor=S.+Capocciaauthor=B.+Lechenneauthor=C.+Zauggauthor=M.+Holdomauthor=O.+Jousson&title=Secreted+proteases+from+pathogenic+fungi"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Secreted proteases from pathogenic fungi</span></div><div class="casAuthors">Monod, Michel; Capoccia, Sabrina; Lechenne, Barbara; Zaugg, Christophe; Holdom, Mary; Jousson, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">405-419</span>CODEN:
                <span class="NLM_cas:coden">IMEMFV</span>;
        ISSN:<span class="NLM_cas:issn">1438-4221</span>.
    
            (<span class="NLM_cas:orgname">Urban & Fischer Verlag GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Many species of human pathogenic fungi secrete proteases in vitro or during the infection process.  Secreted endoproteases belong to the aspartic proteases of the pepsin family, serine proteases of the subtilisin family, and metalloproteases of two different families.  To these proteases has to be added the non-pepsin-type aspartic protease from Aspergillus niger and a unique chymotrypsin-like protease from Coccidioides immitis.  Pathogenic fungi also secrete aminopeptidases, carboxypeptidases and dipeptidyl-peptidases.  The function of fungal secreted proteases and their importance in infections vary.  It is evident that secreted proteases are important for the virulence of dermatophytes since these fungi grow exclusively in the stratum corneum, nails or hair, which constitutes their sole nitrogen and carbon sources.  The aspartic proteases secreted by Candida albicans are involved in the adherence process and penetration of tissues, and in interactions with the immune system of the infected host.  For Aspergillus fumigatus, the role of proteolytic activity has not yet been proved.  Although the secreted proteases have been intensively investigated as potential virulence factors, knowledge on protease substrate specificities is rather poor and few studies have focused on the research of inhibitors.  Knowledge of substrate specificities will increase our understanding about the action of each protease secreted by pathogenic fungi and will help to det. their contribution to virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYRKE3cdYkLVg90H21EOLACvtfcHk0lhW93Sut05HQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Khsr8%253D&md5=9b102f1af1f5ab38f9f4e0c59e81dc5a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1078%2F1438-4221-00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1078%252F1438-4221-00223%26sid%3Dliteratum%253Aachs%26aulast%3DMonod%26aufirst%3DM.%26aulast%3DCapoccia%26aufirst%3DS.%26aulast%3DLechenne%26aufirst%3DB.%26aulast%3DZaugg%26aufirst%3DC.%26aulast%3DHoldom%26aufirst%3DM.%26aulast%3DJousson%26aufirst%3DO.%26atitle%3DSecreted%2520proteases%2520from%2520pathogenic%2520fungi%26jtitle%3DInt.%2520J.%2520Med.%2520Microbiol.%26date%3D2002%26volume%3D292%26spage%3D405%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Viral proteases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4609</span><span class="NLM_x">–</span> <span class="NLM_lpage">4626</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010184f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4609-4626&author=L.+Tong&title=Viral+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr010184f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010184f%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26atitle%3DViral%2520proteases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4609%26epage%3D4626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Otin, C.</span><span> </span><span class="NLM_article-title">Human and mouse proteases: a comparative genomic approach</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnrg1111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12838346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVWgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=544-558&author=X.+S.+Puenteauthor=L.+M.+Sanchezauthor=C.+M.+Overallauthor=C.+Lopez-Otin&title=Human+and+mouse+proteases%3A+a+comparative+genomic+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Human and mouse proteases: A comparative genomic approach</span></div><div class="casAuthors">Puente, Xose S.; Sanchez, Luis M.; Overall, Christopher M.; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">544-558</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The availability of the human and mouse genome sequences has allowed the identification and comparison of their resp. degradomes, i.e., the complete repertoire of proteases that are produced by these organisms.  Because of the essential roles of proteolytic enzymes in the control of cell behavior, survival and death, degradome anal. provides a useful framework for the global exploration of these protease-mediated functions in normal and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFfpMsn9HKerVg90H21EOLACvtfcHk0lj4gvtk4-zE3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVWgu7k%253D&md5=64c4142954441dddc975af7c7117bdf5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrg1111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1111%26sid%3Dliteratum%253Aachs%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DSanchez%26aufirst%3DL.%2BM.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DLopez-Otin%26aufirst%3DC.%26atitle%3DHuman%2520and%2520mouse%2520proteases%253A%2520a%2520comparative%2520genomic%2520approach%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2003%26volume%3D4%26spage%3D544%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopolovic, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Genomic overview of serine proteases</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=28-36&author=G.+M.+Yousefauthor=A.+D.+Kopolovicauthor=M.+B.+Elliottauthor=E.+P.+Diamandis&title=Genomic+overview+of+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DKopolovic%26aufirst%3DA.%2BD.%26aulast%3DElliott%26aufirst%3DM.%2BB.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DGenomic%2520overview%2520of%2520serine%2520proteases%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26spage%3D28%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">López-Otín, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">Emerging roles of proteases in tumour suppression</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnrc2228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17851543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOnsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=800-808&author=C.+L%C3%B3pez-Ot%C3%ADnauthor=L.+M.+Matrisian&title=Emerging+roles+of+proteases+in+tumour+suppression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of proteases in tumor suppression</span></div><div class="casAuthors">Lopez-Otin, Carlos; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">800-808</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Proteases have long been assocd. with cancer progression and metastasis, however studies have also revealed proteases with tumor-suppressive effects.  What are the implications of these findings.  Proteases have long been assocd. with cancer progression because of their ability to degrade extracellular matrixes, which facilitates invasion and metastasis.  However, recent studies have shown that these enzymes target a diversity of substrates and favor all steps of tumor evolution.  Unexpectedly, the post-trial studies have also revealed proteases with tumor-suppressive effects.  These effects are assocd. with more than 30 different enzymes that belong to three distinct protease classes.  What are the clin. implications of these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6806krUkPrVg90H21EOLACvtfcHk0lj4gvtk4-zE3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOnsr3I&md5=9ce3f849d58d4760c3d9738909d193fd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2228%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Ot%25C3%25ADn%26aufirst%3DC.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DEmerging%2520roles%2520of%2520proteases%2520in%2520tumour%2520suppression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D800%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Barrett, A. J.; Rawlings, N. D.; Woessner, J. F.</span> <span class="citation_source-book">Handbook of Proteolytic Enzymes</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Elsevier Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=A.+J.+Barrett&author=N.+D.+Rawlings&author=J.+F.+Woessner&title=Handbook+of+Proteolytic+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26btitle%3DHandbook%2520of%2520Proteolytic%2520Enzymes%26pub%3DElsevier%2520Academic%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mason, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, R. I.</span><span> </span><span class="NLM_article-title">Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=1983&pages=300-307&author=A.+J.+Masonauthor=B.+A.+Evansauthor=D.+R.+Coxauthor=J.+Shineauthor=R.+I.+Richards&title=Structure+of+mouse+kallikrein+gene+family+suggests+a+role+in+specific+processing+of+biologically+active+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DA.%2BJ.%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DCox%26aufirst%3DD.%2BR.%26aulast%3DShine%26aufirst%3DJ.%26aulast%3DRichards%26aufirst%3DR.%2BI.%26atitle%3DStructure%2520of%2520mouse%2520kallikrein%2520gene%2520family%2520suggests%2520a%2520role%2520in%2520specific%2520processing%2520of%2520biologically%2520active%2520peptides%26jtitle%3DNature%26date%3D1983%26volume%3D303%26spage%3D300%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Fukushima, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Nucleotide sequence of cloned cDNA for human pancreatic kallikrein</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">8037</span><span class="NLM_x">–</span> <span class="NLM_lpage">8043</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00348a030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1985&pages=8037-8043&author=D.+Fukushimaauthor=N.+Kitamuraauthor=S.+Nakanishi&title=Nucleotide+sequence+of+cloned+cDNA+for+human+pancreatic+kallikrein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi00348a030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00348a030%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DD.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DNucleotide%2520sequence%2520of%2520cloned%2520cDNA%2520for%2520human%2520pancreatic%2520kallikrein%26jtitle%3DBiochemistry%26date%3D1985%26volume%3D24%26spage%3D8037%26epage%3D8043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Schedlich, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennetts, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, B. J.</span><span> </span><span class="NLM_article-title">Primary structure of a human glandular kallikrein gene</span> <span class="citation_source-journal">DNA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1089%2Fdna.1987.6.429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=2824146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVOhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1987&pages=429-437&author=L.+J.+Schedlichauthor=B.+H.+Bennettsauthor=B.+J.+Morris&title=Primary+structure+of+a+human+glandular+kallikrein+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure of a human glandular kallikrein gene</span></div><div class="casAuthors">Schedlich, Lynette J.; Bennetts, Bruce H.; Morris, Brian J.</div><div class="citationInfo"><span class="NLM_cas:title">DNA</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-37</span>CODEN:
                <span class="NLM_cas:coden">DNAADR</span>;
        ISSN:<span class="NLM_cas:issn">0198-0238</span>.
    </div><div class="casAbstract">To isolate a human glandular kallikrein gene, a human genomic library was screened with a probe made from a mouse kallikrein cDNA (pMK-1).  Overlapping clones were obtained, and nucleotide sequence detn. showed that they together contained a human glandular preprokallikrein gene, hGK-1, of 5.2 kb.  The gene encoded a unique preproprotein of 261 amino acids.  The sequences of the mature 237-amino acid protein had 66% homol. with the sequence predicted for human kallikrein synthesized in the pancreas, kidney, and salivary gland.  Moreover, it had even stronger homol. (78%) with human prostate-specific antigen.  The latter lacks an aspartic acid residue essential for kallikrein-specific cleavage, whereas the sequences of this new protein had all of the attributes needed to confer kallikrein-like specificity.  Southern blotting indicated that the no. of glandular kallikrein genes in man could be limited to 3, a situation very different from mouse and rat, which each have a large multigene family.  Furthermore, unlike kallikrein genes in the mouse, hGK-1 was not closely linked to other human kallikrein genes.  In other respects, the structure of the human kallikrein gene resembled that in mouse; coding sequences in the 5 exons were organized similarly, homol. was higher with other members of the kallikrein gene family in the same species, and the 3 key amino acid residues required by serine proteases for their catalytic activity, together with the residue that confers kallikrein-specific cleavage, were conserved and located on different exons.  Thus, if hGK-1 is expressed, its product represents a new, and possibly the only other, enzyme with true kallikrein-like specificity in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIssE1CkCISLVg90H21EOLACvtfcHk0lijW_pVkaD-YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVOhtLk%253D&md5=6362b55bfae275b0904972d2773c7e04</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1089%2Fdna.1987.6.429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdna.1987.6.429%26sid%3Dliteratum%253Aachs%26aulast%3DSchedlich%26aufirst%3DL.%2BJ.%26aulast%3DBennetts%26aufirst%3DB.%2BH.%26aulast%3DMorris%26aufirst%3DB.%2BJ.%26atitle%3DPrimary%2520structure%2520of%2520a%2520human%2520glandular%2520kallikrein%2520gene%26jtitle%3DDNA%26date%3D1987%26volume%3D6%26spage%3D429%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lundwall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">Molecular cloning of human prostate specific antigen cDNA</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1987&pages=317-322&author=A.+Lundwallauthor=H.+Lilja&title=Molecular+cloning+of+human+prostate+specific+antigen+cDNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLundwall%26aufirst%3DA.%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520of%2520human%2520prostate%2520specific%2520antigen%2520cDNA%26jtitle%3DFEBS%2520Lett.%26date%3D1987%26volume%3D214%26spage%3D317%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argonza-Barrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCuaig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paeper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span> </span><span class="NLM_article-title">Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2000&pages=119-130&author=L.+Ganauthor=I.+Leeauthor=R.+Smithauthor=R.+Argonza-Barrettauthor=H.+Leiauthor=J.+McCuaigauthor=P.+Mossauthor=B.+Paeperauthor=K.+Wang&title=Sequencing+and+expression+analysis+of+the+serine+protease+gene+cluster+located+in+chromosome+19q13+region"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DArgonza-Barrett%26aufirst%3DR.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DMcCuaig%26aufirst%3DJ.%26aulast%3DMoss%26aufirst%3DP.%26aulast%3DPaeper%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DSequencing%2520and%2520expression%2520analysis%2520of%2520the%2520serine%2520protease%2520gene%2520cluster%2520located%2520in%2520chromosome%252019q13%2520region%26jtitle%3DGene%26date%3D2000%26volume%3D257%26spage%3D119%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Harvey, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. A.</span><span> </span><span class="NLM_article-title">Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">37397</span><span class="NLM_x">–</span> <span class="NLM_lpage">37406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=37397-37406&author=T.+J.+Harveyauthor=J.+D.+Hooperauthor=S.+A.+Myersauthor=S.+A.+Stephensonauthor=L.+K.+Ashworthauthor=J.+A.+Clements&title=Tissue-specific+expression+patterns+and+fine+mapping+of+the+human+kallikrein+%28KLK%29+locus+on+proximal+19q13.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DT.%2BJ.%26aulast%3DHooper%26aufirst%3DJ.%2BD.%26aulast%3DMyers%26aufirst%3DS.%2BA.%26aulast%3DStephenson%26aufirst%3DS.%2BA.%26aulast%3DAshworth%26aufirst%3DL.%2BK.%26aulast%3DClements%26aufirst%3DJ.%2BA.%26atitle%3DTissue-specific%2520expression%2520patterns%2520and%2520fine%2520mapping%2520of%2520the%2520human%2520kallikrein%2520%2528KLK%2529%2520locus%2520on%2520proximal%252019q13.4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D37397%26epage%3D37406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2000&pages=125-133&author=G.+M.+Yousefauthor=A.+Changauthor=A.+Scorilasauthor=E.+P.+Diamandis&title=Genomic+organization+of+the+human+kallikrein+gene+family+on+chromosome+19q13.3-q13.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DGenomic%2520organization%2520of%2520the%2520human%2520kallikrein%2520gene%2520family%2520on%2520chromosome%252019q13.3-q13.4%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D276%26spage%3D125%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2000&pages=251-259&author=G.+M.+Yousefauthor=L.+Y.+Luoauthor=S.+W.+Schererauthor=G.+Sotiropoulouauthor=E.+P.+Diamandis&title=Molecular+characterization+of+zyme%2Fprotease+M%2Fneurosin+%28PRSS9%29%2C+a+hormonally+regulated+kallikrein-like+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DLuo%26aufirst%3DL.%2BY.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DMolecular%2520characterization%2520of%2520zyme%252Fprotease%2520M%252Fneurosin%2520%2528PRSS9%2529%252C%2520a%2520hormonally%2520regulated%2520kallikrein-like%2520serine%2520protease%26jtitle%3DGenomics%26date%3D2000%26volume%3D62%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Borgono, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">The emerging roles of human tissue kallikreins in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnrc1474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15516960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=876-890&author=C.+A.+Borgonoauthor=E.+P.+Diamandis&title=The+emerging+roles+of+human+tissue+kallikreins+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging roles of human tissue kallikreins in cancer</span></div><div class="casAuthors">Borgono, Carla A.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-890</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiol. roles.  Although primarily known for their clin. applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis.  They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQTk6Djzi7LVg90H21EOLACvtfcHk0liUEP967TCSHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D&md5=a5bd96fc35210ea97a97703942827d0d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc1474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1474%26sid%3Dliteratum%253Aachs%26aulast%3DBorgono%26aufirst%3DC.%2BA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520emerging%2520roles%2520of%2520human%2520tissue%2520kallikreins%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D876%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">The new human tissue kallikrein gene family: structure, function, and association to disease</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1210%2Fer.22.2.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=11294823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=184-204&author=G.+M.+Yousefauthor=E.+P.+Diamandis&title=The+new+human+tissue+kallikrein+gene+family%3A+structure%2C+function%2C+and+association+to+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The new human tissue kallikrein gene family: Structure, function, and association to disease</span></div><div class="casAuthors">Yousef, George M.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-204</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The human tissue kallikrein gene family was, until recently, thought to consist of only three genes.  Two of these human kallikreins, prostate-specific antigen and human glandular kallikrein 2, are currently used as valuable biomarkers of prostatic carcinoma.  More recently, new kallikrein-like genes have been discovered.  It is now clear that the human tissue kallikrein gene family contains at least 15 genes.  All genes share important similarities, including mapping at the same chromosomal locus (19q13.4), significant homol. at both the nucleotide and protein level, and similar genomic organization.  All genes encode for putative serine proteases and most of them are regulated by steroid hormones.  Recent data suggest that at least a few of these kallikrein genes are connected to malignancy.  In this review, we summarize the recently accumulated knowledge on the human tissue kallikrein gene family, including gene and protein structure, predicted enzymic activities, tissue expression, hormonal regulation, and alternative splicing.  We further describe the reported assocns. of the human kallikreins with various human diseases and identify future avenues for research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0QpkM-LBKh7Vg90H21EOLACvtfcHk0ljtsO5rgBRc1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D&md5=ca1b47cc183643d953e8abecd25cc730</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fer.22.2.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.22.2.184%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520new%2520human%2520tissue%2520kallikrein%2520gene%2520family%253A%2520structure%252C%2520function%252C%2520and%2520association%2520to%2520disease%26jtitle%3DEndocr.%2520Rev.%26date%3D2001%26volume%3D22%26spage%3D184%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lundwall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petraki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span> </span><span class="NLM_article-title">A comprehensive nomenclature for serine proteases with homology to tissue kallikreins</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=637-641&author=A.+Lundwallauthor=V.+Bandauthor=M.+Blaberauthor=J.+A.+Clementsauthor=Y.+Courtyauthor=E.+P.+Diamandisauthor=H.+Fritzauthor=H.+Liljaauthor=J.+Malmauthor=L.+J.+Maltaisauthor=A.+Y.+Olssonauthor=C.+Petrakiauthor=A.+Scorilasauthor=G.+Sotiropoulouauthor=U.+H.+Stenmanauthor=C.+Stephanauthor=M.+Talieriauthor=G.+M.+Yousef&title=A+comprehensive+nomenclature+for+serine+proteases+with+homology+to+tissue+kallikreins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLundwall%26aufirst%3DA.%26aulast%3DBand%26aufirst%3DV.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DClements%26aufirst%3DJ.%2BA.%26aulast%3DCourty%26aufirst%3DY.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DFritz%26aufirst%3DH.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DMalm%26aufirst%3DJ.%26aulast%3DMaltais%26aufirst%3DL.%2BJ.%26aulast%3DOlsson%26aufirst%3DA.%2BY.%26aulast%3DPetraki%26aufirst%3DC.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26atitle%3DA%2520comprehensive%2520nomenclature%2520for%2520serine%2520proteases%2520with%2520homology%2520to%2520tissue%2520kallikreins%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D637%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Borgono, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human tissue kallikreins: physiologic roles and applications in cancer</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15192120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslajtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=257-280&author=C.+A.+Borgonoauthor=I.+P.+Michaelauthor=E.+P.+Diamandis&title=Human+tissue+kallikreins%3A+physiologic+roles+and+applications+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer</span></div><div class="casAuthors">Borgono, Carla A.; Michael, Iacovos P.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">257-280</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Tissue kallikreins are members of the S1 family (clan SA) of trypsin-like serine proteases and are present in at least six mammalian orders.  In humans, tissue kallikreins (hK) are encoded by 15 structurally similar, steroid hormone-regulated genes (KLK) that colocalize to chromosome 19q13.4, representing the largest cluster of contiguous protease genes in the entire genome.  HKs are widely expressed in diverse tissues and implicated in a range of normal physiol. functions from the regulation of blood pressure and electrolyte balance to tissue remodeling, prohormone processing, neural plasticity, and skin desquamation.  Several lines of evidence suggest that hKs may be involved in cascade reactions and that cross-talk may exist with proteases of other catalytic classes.  The proteolytic activity of hKs is regulated in several ways including zymogen activation, endogenous inhibitors, such as serpins, and via internal (auto)cleavage leading to inactivation.  Dysregulated hK expression is assocd. with multiple diseases, primarily cancer.  As a consequence, many kallikreins, in addn. to hK3/PSA, have been identified as promising diagnostic and/or prognostic biomarkers for several cancer types, including ovarian, breast, and prostate.  Recent data also suggest that hKs may be causally involved in carcinogenesis, particularly in tumor metastasis and invasion, and, thus, may represent attractive drug targets to consider for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3PIYdWcNnhrVg90H21EOLACvtfcHk0ljtsO5rgBRc1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslajtr0%253D&md5=4f6d5f54a20dca35e8d96a8c67edd6c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgono%26aufirst%3DC.%2BA.%26aulast%3DMichael%26aufirst%3DI.%2BP.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520tissue%2520kallikreins%253A%2520physiologic%2520roles%2520and%2520applications%2520in%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2004%26volume%3D2%26spage%3D257%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Evans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkwater, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, R. I.</span><span> </span><span class="NLM_article-title">Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">8027</span><span class="NLM_x">–</span> <span class="NLM_lpage">8034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8027-8034&author=B.+A.+Evansauthor=C.+C.+Drinkwaterauthor=R.+I.+Richards&title=Mouse+glandular+kallikrein+genes.+Structure+and+partial+sequence+analysis+of+the+kallikrein+gene+locus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DDrinkwater%26aufirst%3DC.%2BC.%26aulast%3DRichards%26aufirst%3DR.%2BI.%26atitle%3DMouse%2520glandular%2520kallikrein%2520genes.%2520Structure%2520and%2520partial%2520sequence%2520analysis%2520of%2520the%2520kallikrein%2520gene%2520locus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8027%26epage%3D8034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wines, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southard, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, R. J.</span><span> </span><span class="NLM_article-title">Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity</span> <span class="citation_source-journal">J. Mol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=476-492&author=D.+R.+Winesauthor=J.+M.+Bradyauthor=E.+M.+Southardauthor=R.+J.+MacDonald&title=Evolution+of+the+rat+kallikrein+gene+family%3A+gene+conversion+leads+to+functional+diversity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWines%26aufirst%3DD.%2BR.%26aulast%3DBrady%26aufirst%3DJ.%2BM.%26aulast%3DSouthard%26aufirst%3DE.%2BM.%26aulast%3DMacDonald%26aufirst%3DR.%2BJ.%26atitle%3DEvolution%2520of%2520the%2520rat%2520kallikrein%2520gene%2520family%253A%2520gene%2520conversion%2520leads%2520to%2520functional%2520diversity%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D1999%26volume%3D32%26spage%3D476%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kurlender, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obiezu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis., E. P.</span><span> </span><span class="NLM_article-title">A survey of alternative transcripts of human tissue kallikrein genes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1755</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1755&publication_year=2005&pages=1-14&author=L.+Kurlenderauthor=C.+Borgonoauthor=I.+P.+Michaelauthor=C.+Obiezuauthor=M.+B.+Elliottauthor=G.+M.+Yousefauthor=E.+P.+Diamandis.&title=A+survey+of+alternative+transcripts+of+human+tissue+kallikrein+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurlender%26aufirst%3DL.%26aulast%3DBorgono%26aufirst%3DC.%26aulast%3DMichael%26aufirst%3DI.%2BP.%26aulast%3DObiezu%26aufirst%3DC.%26aulast%3DElliott%26aufirst%3DM.%2BB.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis.%26aufirst%3DE.%2BP.%26atitle%3DA%2520survey%2520of%2520alternative%2520transcripts%2520of%2520human%2520tissue%2520kallikrein%2520genes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1755%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span> </span><span class="NLM_article-title">Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">4969</span><span class="NLM_x">–</span> <span class="NLM_lpage">4974</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00136a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=4969-4974&author=J.+R.+Chagasauthor=I.+Y.+Hirataauthor=M.+A.+Julianoauthor=W.+Xiongauthor=C.+Wangauthor=J.+Chaoauthor=L.+Julianoauthor=E.+S.+Prado&title=Substrate+specificities+of+tissue+kallikrein+and+T-kininogenase%3A+their+possible+role+in+kininogen+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi00136a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00136a008%26sid%3Dliteratum%253Aachs%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DHirata%26aufirst%3DI.%2BY.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26atitle%3DSubstrate%2520specificities%2520of%2520tissue%2520kallikrein%2520and%2520T-kininogenase%253A%2520their%2520possible%2520role%2520in%2520kininogen%2520processing%26jtitle%3DBiochemistry%26date%3D1992%26volume%3D31%26spage%3D4969%26epage%3D4974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazure, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span> </span><span class="NLM_article-title">Purification and characterization of active recombinant rat kallikrein rK9</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1547</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1547&publication_year=2001&pages=387-396&author=M.+Zaniauthor=M.+Brillard-Bourdetauthor=C.+Lazureauthor=L.+Julianoauthor=Y.+Courtyauthor=F.+Gauthierauthor=T.+Moreau&title=Purification+and+characterization+of+active+recombinant+rat+kallikrein+rK9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZani%26aufirst%3DM.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DLazure%26aufirst%3DC.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DCourty%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DT.%26atitle%3DPurification%2520and%2520characterization%2520of%2520active%2520recombinant%2520rat%2520kallikrein%2520rK9%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2001%26volume%3D1547%26spage%3D387%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">El Moujahed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span> </span><span class="NLM_article-title">Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins. Identification of a T-kinin-releasing rat kallikrein</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1432-1033.1997.00652.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=9266709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVCmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1997&pages=652-658&author=A.+El+Moujahedauthor=M.+Brillard-Bourdetauthor=M.+A.+Julianoauthor=T.+Moreauauthor=J.+R.+Chagasauthor=N.+Gutmanauthor=E.+S.+Pradoauthor=F.+Gauthier&title=Kininogen-derived+fluorogenic+substrates+for+investigating+the+vasoactive+properties+of+rat+tissue+kallikreins.+Identification+of+a+T-kinin-releasing+rat+kallikrein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins. Identification of a T-kinin-releasing rat kallikrein</span></div><div class="casAuthors">El Moujahed, Abderrahman; Brillard-Bourdet, Michele; Juliano, Maria A.; Moreau, Thierry; Chagas, Jair R.; Gutman, Ninette; Prado, Eline S.; Gauthier, Francis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">652-658</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Peptide substrates with intramolecularly quenched fluorescence that reproduce the rat kininogen sequences at both ends of the bradykinin moiety were synthesized and used to investigate the kinin-releasing properties of five rat tissue kallikreins (rK1, rK2, rK7, rK9, rK10).  Substrates derived from rat H- and L-kininogen were cleaved best by rK1, esp. that including the N-terminal insertion site of bradykinin, Abz-TSVIRRPQ-EDDnp(Abz = O-aminobenzoyl, EDDnp = ethylenediamine 2,4-dinitrophenyl), which was cleaved at the R-R bond with a kcat/Km of 12400 mM-1 s-1.  Replacement of the P2' residue Pro by Val in Abz-TSVIRRPQ-EDDnp gave a far less specific substrate that was rapidly hydrolyzed by all five rat kallikreins and human kallikrein hK1.  Peptidyl-N-Me coumarylamide substrates, which lack prime residues, also had low specificities.  The importance of the P2' residue for rK1 specificity was further demonstrated using a human-kininogen-derived substrate that included the N-terminal insertion site of bradykinin (Abz-LMKRP-EDDnp).  This was cleaved at the M-K bond by hK1 (kallidin-releasing site), but at the K-R bond (bradykinin-releasing site) by rK1.  Competition expts. with Abz-TSVIRRPQ-EDDnp, which is resistant to most kallikreins, and Abz-TSVIRRVQ-EDDnp, a general kallikrein substrate, demonstrated that the former competitively inhibited hydrolysis by rK9 and hK1, with Ki values similar to the Km values for the substrate.  Thus Pro in P2' does not prevent the peptide binding to the enzyme active site, but impairs cleavage of the scissile bond.  The T-kininogen-derived substrate with the T-kinin C-terminal sequence (Abz-FRLVR-EDDnp) was cleaved by rK10 (Kcat/Km = 2310 mM-1 s-1) and less rapidly by rK1, rK7 and hK1, at the R-L bond, while that corresponding to the N-terminal (Abz-ALDMMISRP-EDDnp) of T-kinin was resistant to all five kallikreins used, suggesting that none has T-kininogenase activity.  But this substrate was hydrolyzed by a semi-purified sample of submandibular gland ext.  Another kallikrein, identified as kallikrein rK3, was isolated from this fraction and shown to hydrolyze Abz-ALDMMISRP-EDDnp; rK3 also specifically released T-kinin from purified T1/T2-kininogen after HPLC fractionation.  Injection of purified rK3 and of Abz-ALDMMISRP-EDDnp-cleaving fractions into the circulation of anesthetized rats caused transient falls in blood pressure, as did purified rK1 but none of the other purified rat or human kallikreins.  This effect occurred via activation of the kinin system since it was blocked by Hoe140, a kinin receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvsoH18aMxEbVg90H21EOLACvtfcHk0liDdoIWGZ4YgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVCmsrw%253D&md5=6725c0e64c6ede8bc84e70b9a65893d9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.00652.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.00652.x%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BMoujahed%26aufirst%3DA.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DMoreau%26aufirst%3DT.%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DGutman%26aufirst%3DN.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26aulast%3DGauthier%26aufirst%3DF.%26atitle%3DKininogen-derived%2520fluorogenic%2520substrates%2520for%2520investigating%2520the%2520vasoactive%2520properties%2520of%2520rat%2520tissue%2520kallikreins.%2520Identification%2520of%2520a%2520T-kinin-releasing%2520rat%2520kallikrein%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D247%26spage%3D652%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fogaca, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2004&pages=775-781&author=S.+E.+Fogacaauthor=R.+L.+Meloauthor=D.+C.+Pimentaauthor=K.+Hosoiauthor=L.+Julianoauthor=M.+A.+Juliano&title=Differences+in+substrate+and+inhibitor+sequence+specificity+of+human%2C+mouse+and+rat+tissue+kallikreins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFogaca%26aufirst%3DS.%2BE.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DHosoi%26aufirst%3DK.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DDifferences%2520in%2520substrate%2520and%2520inhibitor%2520sequence%2520specificity%2520of%2520human%252C%2520mouse%2520and%2520rat%2520tissue%2520kallikreins%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D380%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lundwall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2019</span><span class="NLM_x">–</span> <span class="NLM_lpage">2038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1007%2Fs00018-008-8024-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18344018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVykt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=2019-2038&author=A.+Lundwallauthor=M.+Brattsand&title=Kallikrein-related+peptidases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidases</span></div><div class="casAuthors">Lundwall, A.; Brattsand, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2019-2038</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Kallikrein 1 (KLK1), a key component of the kallikrein-kinin system, originates from a locus on the long arm of chromosome 19 that contains several related serine endopeptidases.  The biol. role of these kallikrein-related peptidases is not clear, but emerging evidence suggests that they might be important in several physiol. systems, e.g., in male reprodn., skin homeostasis, tooth enamel formation, and neural development and plasticity.  The kallikrein locus has undergone some major evolutionary events.  Most spectacular are relatively recent duplications of KLK1 that have created 13 and 9 functional genes that are unique to the mouse and the rat, resp.  Human paralogs are KLK2 and KLK3: the latter encoding the cancer biomarker prostate-specific antigen.  Here, the authors focus on the evolution of kallikrein-related peptidases, their role in skin homeostasis and semen liquefaction, and their utility as cancer biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqVQsvj2Xj-7Vg90H21EOLACvtfcHk0lgivdFLeaTXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVykt78%253D&md5=bc10a0ab2a2c2d4005c8e0cb76d3c06d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8024-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8024-3%26sid%3Dliteratum%253Aachs%26aulast%3DLundwall%26aufirst%3DA.%26aulast%3DBrattsand%26aufirst%3DM.%26atitle%3DKallikrein-related%2520peptidases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D2019%26epage%3D2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pampalakis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Functional roles of human kallikrein-related peptidases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">32989</span><span class="NLM_x">–</span> <span class="NLM_lpage">32994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=32989-32994&author=G.+Sotiropoulouauthor=G.+Pampalakisauthor=E.+P.+Diamandis&title=Functional+roles+of+human+kallikrein-related+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DPampalakis%26aufirst%3DG.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DFunctional%2520roles%2520of%2520human%2520kallikrein-related%2520peptidases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D32989%26epage%3D32994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Angelo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Substrate specificity of human kallikrein 6: salt and glycosaminoglycan effects</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">3116</span><span class="NLM_x">–</span> <span class="NLM_lpage">3126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=3116-3126&author=P.+F.+Angeloauthor=A.+R.+Limaauthor=F.+M.+Alvesauthor=S.+I.+Blaberauthor=I.+A.+Scarisbrickauthor=M.+Blaberauthor=L.+Julianoauthor=M.+A.+Juliano&title=Substrate+specificity+of+human+kallikrein+6%3A+salt+and+glycosaminoglycan+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngelo%26aufirst%3DP.%2BF.%26aulast%3DLima%26aufirst%3DA.%2BR.%26aulast%3DAlves%26aufirst%3DF.%2BM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DSubstrate%2520specificity%2520of%2520human%2520kallikrein%25206%253A%2520salt%2520and%2520glycosaminoglycan%2520effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D3116%26epage%3D3126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Andrade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, J. A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1709</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=1701-1709&author=D.+Andradeauthor=D.+M.+Assisauthor=J.+A.+N.+Santosauthor=F.+M.+Alvesauthor=Y.+I.+Hirataauthor=M.+S.+Araujoauthor=S.+I.+Blaberauthor=M.+Blaberauthor=M.+A.+Julianoauthor=L.+Juliano&title=Substrate+specificity+of+kallikrein-related+peptidase+13+activated+by+salts+or+glycosaminoglycans+and+a+search+for+natural+substrate+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrade%26aufirst%3DD.%26aulast%3DAssis%26aufirst%3DD.%2BM.%26aulast%3DSantos%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DAlves%26aufirst%3DF.%2BM.%26aulast%3DHirata%26aufirst%3DY.%2BI.%26aulast%3DAraujo%26aufirst%3DM.%2BS.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DSubstrate%2520specificity%2520of%2520kallikrein-related%2520peptidase%252013%2520activated%2520by%2520salts%2520or%2520glycosaminoglycans%2520and%2520a%2520search%2520for%2520natural%2520substrate%2520candidates%26jtitle%3DBiochimie%26date%3D2011%26volume%3D93%26spage%3D1701%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Andrade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2010&pages=74-82&author=D.+Andradeauthor=D.+M.+Assisauthor=A.+R.+Limaauthor=J.+R.+Oliveiraauthor=M.+S.+Araujoauthor=S.+I.+Blaberauthor=M.+Blaberauthor=M.+A.+Julianoauthor=L.+Juliano&title=Substrate+specificity+and+inhibition+of+human+kallikrein-related+peptidase+3+%28KLK3+or+PSA%29+activated+with+sodium+citrate+and+glycosaminoglycans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrade%26aufirst%3DD.%26aulast%3DAssis%26aufirst%3DD.%2BM.%26aulast%3DLima%26aufirst%3DA.%2BR.%26aulast%3DOliveira%26aufirst%3DJ.%2BR.%26aulast%3DAraujo%26aufirst%3DM.%2BS.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DSubstrate%2520specificity%2520and%2520inhibition%2520of%2520human%2520kallikrein-related%2520peptidase%25203%2520%2528KLK3%2520or%2520PSA%2529%2520activated%2520with%2520sodium%2520citrate%2520and%2520glycosaminoglycans%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D498%26spage%3D74%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fiedler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysath, G.</span><span> </span><span class="NLM_article-title">Substrate specificity of porcine pancreatic kallikrein</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1979&pages=261-271&author=F.+Fiedlerauthor=G.+Leysath&title=Substrate+specificity+of+porcine+pancreatic+kallikrein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiedler%26aufirst%3DF.%26aulast%3DLeysath%26aufirst%3DG.%26atitle%3DSubstrate%2520specificity%2520of%2520porcine%2520pancreatic%2520kallikrein%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1979%26volume%3D120%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Axen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkop, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, M. E.</span><span> </span><span class="NLM_article-title">Release of kinin activity from human kininogens and fresh plasma by cyanogen bromide</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1966&pages=353-357&author=R.+Axenauthor=E.+Grossauthor=B.+Witkopauthor=J.+V.+Pierceauthor=M.+E.+Webster&title=Release+of+kinin+activity+from+human+kininogens+and+fresh+plasma+by+cyanogen+bromide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxen%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DE.%26aulast%3DWitkop%26aufirst%3DB.%26aulast%3DPierce%26aufirst%3DJ.%2BV.%26aulast%3DWebster%26aufirst%3DM.%2BE.%26atitle%3DRelease%2520of%2520kinin%2520activity%2520from%2520human%2520kininogens%2520and%2520fresh%2520plasma%2520by%2520cyanogen%2520bromide%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1966%26volume%3D5%26spage%3D353%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portaro, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span> </span><span class="NLM_article-title">Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1995&pages=63-69&author=J.+R.+Chagasauthor=F.+C.+Portaroauthor=I.+Y.+Hirataauthor=P.+C.+Almeidaauthor=M.+A.+Julianoauthor=L.+Julianoauthor=E.+S.+Prado&title=Determinants+of+the+unusual+cleavage+specificity+of+lysyl-bradykinin-releasing+kallikreins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DPortaro%26aufirst%3DF.%2BC.%26aulast%3DHirata%26aufirst%3DI.%2BY.%26aulast%3DAlmeida%26aufirst%3DP.%2BC.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26atitle%3DDeterminants%2520of%2520the%2520unusual%2520cleavage%2520specificity%2520of%2520lysyl-bradykinin-releasing%2520kallikreins%26jtitle%3DBiochem.%2520J.%26date%3D1995%26volume%3D306%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Del Nery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=1995&pages=233-238&author=E.+Del+Neryauthor=J.+R.+Chagasauthor=M.+A.+Julianoauthor=E.+S.+Pradoauthor=L.+Juliano&title=Evaluation+of+the+extent+of+the+binding+site+in+human+tissue+kallikrein+by+synthetic+substrates+with+sequences+of+human+kininogen+fragments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BNery%26aufirst%3DE.%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DEvaluation%2520of%2520the%2520extent%2520of%2520the%2520binding%2520site%2520in%2520human%2520tissue%2520kallikrein%2520by%2520synthetic%2520substrates%2520with%2520sequences%2520of%2520human%2520kininogen%2520fragments%26jtitle%3DBiochem.%2520J.%26date%3D1995%26volume%3D312%26spage%3D233%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Specificity of human tissue kallikrein towards substrates containing Phe–Phe pair of amino acids</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1999&pages=473-479&author=D.+C.+Pimentaauthor=J.+Chaoauthor=L.+Chaoauthor=M.+A.+Julianoauthor=L.+Juliano&title=Specificity+of+human+tissue+kallikrein+towards+substrates+containing+Phe%E2%80%93Phe+pair+of+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DChao%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DSpecificity%2520of%2520human%2520tissue%2520kallikrein%2520towards%2520substrates%2520containing%2520Phe%25E2%2580%2593Phe%2520pair%2520of%2520amino%2520acids%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D339%26spage%3D473%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa Pozzo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5226</span><span class="NLM_x">–</span> <span class="NLM_lpage">5232</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi002003u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=5226-5232&author=R.+L.+Meloauthor=R.+C.+Barbosa+Pozzoauthor=D.+C.+Pimentaauthor=E.+Perissuttiauthor=G.+Caliendoauthor=V.+Santagadaauthor=L.+Julianoauthor=M.+A.+Juliano&title=Human+tissue+kallikrein+S1+subsite+recognition+of+non-natural+basic+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi002003u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi002003u%26sid%3Dliteratum%253Aachs%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DBarbosa%2BPozzo%26aufirst%3DR.%2BC.%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DHuman%2520tissue%2520kallikrein%2520S1%2520subsite%2520recognition%2520of%2520non-natural%2520basic%2520amino%2520acids%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D5226%26epage%3D5232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Bourgeois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deperthes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span> </span><span class="NLM_article-title">Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">29590</span><span class="NLM_x">–</span> <span class="NLM_lpage">29595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=29590-29595&author=L.+Bourgeoisauthor=M.+Brillard-Bourdetauthor=D.+Deperthesauthor=M.+A.+Julianoauthor=L.+Julianoauthor=R.+R.+Tremblayauthor=J.+Y.+Dubeauthor=F.+Gauthier&title=Potential+involvement+of+kallikrein+hK2+in+the+hydrolysis+of+the+human+seminal+vesicle+proteins+after+ejaculation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBourgeois%26aufirst%3DL.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DDeperthes%26aufirst%3DD.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DTremblay%26aufirst%3DR.%2BR.%26aulast%3DDube%26aufirst%3DJ.%2BY.%26aulast%3DGauthier%26aufirst%3DF.%26atitle%3DPotential%2520involvement%2520of%2520kallikrein%2520hK2%2520in%2520the%2520hydrolysis%2520of%2520the%2520human%2520seminal%2520vesicle%2520proteins%2520after%2520ejaculation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D29590%26epage%3D29595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Rehault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span> </span><span class="NLM_article-title">Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1596</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1596&publication_year=2002&pages=55-62&author=S.+Rehaultauthor=M.+Brillard-Bourdetauthor=L.+Bourgeoisauthor=G.+Frenetteauthor=L.+Julianoauthor=F.+Gauthierauthor=T.+Moreau&title=Design+of+new+and+sensitive+fluorogenic+substrates+for+human+kallikrein+hK3+%28prostate-specific+antigen%29+derived+from+semenogelin+sequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRehault%26aufirst%3DS.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DBourgeois%26aufirst%3DL.%26aulast%3DFrenette%26aufirst%3DG.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DT.%26atitle%3DDesign%2520of%2520new%2520and%2520sensitive%2520fluorogenic%2520substrates%2520for%2520human%2520kallikrein%2520hK3%2520%2528prostate-specific%2520antigen%2529%2520derived%2520from%2520semenogelin%2520sequences%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1596%26spage%3D55%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoell, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazegh-Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashjian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeles, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timasheff, S. N.</span><span> </span><span class="NLM_article-title">Modulation of recombinant human prostate-specific antigen: activation by hofmeister salts and inhibition by azapeptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">11734</span><span class="NLM_x">–</span> <span class="NLM_lpage">11741</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi010364j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=11734-11741&author=X.+Huangauthor=C.+T.+Knoellauthor=G.+Freyauthor=M.+Hazegh-Azamauthor=A.+H.+Tashjianauthor=L.+Hedstromauthor=R.+H.+Abelesauthor=S.+N.+Timasheff&title=Modulation+of+recombinant+human+prostate-specific+antigen%3A+activation+by+hofmeister+salts+and+inhibition+by+azapeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi010364j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi010364j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKnoell%26aufirst%3DC.%2BT.%26aulast%3DFrey%26aufirst%3DG.%26aulast%3DHazegh-Azam%26aufirst%3DM.%26aulast%3DTashjian%26aufirst%3DA.%2BH.%26aulast%3DHedstrom%26aufirst%3DL.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26aulast%3DTimasheff%26aufirst%3DS.%2BN.%26atitle%3DModulation%2520of%2520recombinant%2520human%2520prostate-specific%2520antigen%253A%2520activation%2520by%2520hofmeister%2520salts%2520and%2520inhibition%2520by%2520azapeptides%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D11734%26epage%3D11741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Rehault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monget, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazerbourg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">2960</span><span class="NLM_x">–</span> <span class="NLM_lpage">2968</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1046%2Fj.1432-1327.2001.02185.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=11358513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=2960-2968&author=S.+Rehaultauthor=P.+Mongetauthor=S.+Mazerbourgauthor=R.+Tremblayauthor=N.+Gutmanauthor=F.+Gauthierauthor=T.+Moreau&title=Insulin-like+growth+factor+binding+proteins+%28IGFBPs%29+as+potential+physiological+substrates+for+human+kallikreins+hK2+and+hK3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3</span></div><div class="casAuthors">Rehault, Sophie; Monget, Philippe; Mazerbourg, Sabine; Tremblay, Roland; Gutman, Ninette; Gauthier, Francis; Moreau, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2960-2968</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Insulin-like growth factors (IGFs) are important growth regulators of both normal and malignant prostate cells.  Their action is regulated by six insulin-like growth factor binding proteins (IGFBPs).  The proteolytic cleavage of IGFBPs by various proteases decreases dramatically their affinity for their ligands and therefore enhances the bioavailability of IGFs.  To elucidate the putative biol. role of prostatic kallikreins hK2 and hK3 (prostate-specific antigen) in tumor progression, the authors analyzed the degrdn. of IGFBP-2, -3, -4 and -5 by these two tissue kallikreins.  The authors found that hK3, already characterized as an IGFBP-3 degrading protease, cleaved IGFBP-4 but not IGFBP-2 and -5, whereas hK2 cleaved all of the IGFBPs much more effectively, and at concns. far lower than those reported for other IGFBP-degrading proteases.  The proteolytic patterns after cleavage of IGFBPs by hK2 and hK3 were similar and were not modified in the presence of IGF-1.  Heparin, but not other glycosaminoglycans, enhanced dramatically the ability of hK3 but not hK2 to degrade IGFBP-3 and IGFBP-4.  More importantly, the IGFBP fragments generated by hK2 and hK3 had no IGF-binding capacity, as assessed by Western ligand blotting.  The authors' results suggest that the prostatic kallikreins hK2 and hK3 may influence specifically the tumoral growth of prostate cells through the degrdn. of IGFBPs, to increase IGF bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAqAzviXJyDLVg90H21EOLACvtfcHk0lhybflcUhuwLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSktLo%253D&md5=617645c37afd1276a2a905f4dcf0f458</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02185.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02185.x%26sid%3Dliteratum%253Aachs%26aulast%3DRehault%26aufirst%3DS.%26aulast%3DMonget%26aufirst%3DP.%26aulast%3DMazerbourg%26aufirst%3DS.%26aulast%3DTremblay%26aufirst%3DR.%26aulast%3DGutman%26aufirst%3DN.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DT.%26atitle%3DInsulin-like%2520growth%2520factor%2520binding%2520proteins%2520%2528IGFBPs%2529%2520as%2520potential%2520physiological%2520substrates%2520for%2520human%2520kallikreins%2520hK2%2520and%2520hK3%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D2960%26epage%3D2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Debela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaufort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettig, P.</span><span> </span><span class="NLM_article-title">Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=623-632&issue=6&author=M.+Debelaauthor=N.+Beaufortauthor=V.+Magdolenauthor=N.+M.+Schechterauthor=C.+S.+Craikauthor=M.+Schmittauthor=W.+Bodeauthor=P.+Goettig&title=Structures+and+specificity+of+the+human+kallikrein-related+peptidases+KLK+4%2C+5%2C+6%2C+and+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebela%26aufirst%3DM.%26aulast%3DBeaufort%26aufirst%3DN.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DSchechter%26aufirst%3DN.%2BM.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DBode%26aufirst%3DW.%26aulast%3DGoettig%26aufirst%3DP.%26atitle%3DStructures%2520and%2520specificity%2520of%2520the%2520human%2520kallikrein-related%2520peptidases%2520KLK%25204%252C%25205%252C%25206%252C%2520and%25207%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26issue%3D6%26spage%3D623%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Luo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span> </span><span class="NLM_article-title">Inhibition profiles of human tissue kallikreins by serine protease inhibitors</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=813-816&author=L.+Y.+Luoauthor=W.+Jiang&title=Inhibition+profiles+of+human+tissue+kallikreins+by+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DW.%26atitle%3DInhibition%2520profiles%2520of%2520human%2520tissue%2520kallikreins%2520by%2520serine%2520protease%2520inhibitors%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D813%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Zhou, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span> </span><span class="NLM_article-title">Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">25873</span><span class="NLM_x">–</span> <span class="NLM_lpage">25880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=25873-25880&author=G.+X.+Zhouauthor=L.+Chaoauthor=J.+Chao&title=Kallistatin%3A+a+novel+human+tissue+kallikrein+inhibitor.+Purification%2C+characterization%2C+and+reactive+center+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%2BX.%26aulast%3DChao%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DJ.%26atitle%3DKallistatin%253A%2520a%2520novel%2520human%2520tissue%2520kallikrein%2520inhibitor.%2520Purification%252C%2520characterization%252C%2520and%2520reactive%2520center%2520sequence%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D25873%26epage%3D25880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Obiezu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human tissue kallikrein gene family: applications in cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.canlet.2004.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15911097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2005&pages=1-22&author=C.+V.+Obiezuauthor=E.+P.+Diamandis&title=Human+tissue+kallikrein+gene+family%3A+applications+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Human tissue kallikrein gene family: applications in cancer</span></div><div class="casAuthors">Obiezu, Christina V.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes.  Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes.  These genes, and their protein products, share a high degree of homol. and are expressed in a wide array of tissues, mainly those that are under steroid hormone control.  PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker.  In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been assocd. with several types of cancer.  For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer.  New evidence raises the possibility that some kallikreins are directly involved with cancer progression.  We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVQ3Ly8oHCbVg90H21EOLACvtfcHk0liZv00eoNP_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D&md5=837a7e70ff67c0e7d17986f0b833ddc7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DObiezu%26aufirst%3DC.%2BV.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520tissue%2520kallikrein%2520gene%2520family%253A%2520applications%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D224%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=312-329&author=S.+A.+Williamsauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Does+PSA+play+a+role+as+a+promoting+agent+during+the+initiation+and%2For+progression+of+prostate+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DDoes%2520PSA%2520play%2520a%2520role%2520as%2520a%2520promoting%2520agent%2520during%2520the%2520initiation%2520and%252For%2520progression%2520of%2520prostate%2520cancer%253F%26jtitle%3DProstate%26date%3D2007%26volume%3D67%26spage%3D312%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fritzsche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansukh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgono, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayordomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span> </span><span class="NLM_article-title">Expression of human kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjc.6602956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16434994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=540-547&author=F.+Fritzscheauthor=T.+Gansukhauthor=C.+A.+Borgonoauthor=M.+Burkhardtauthor=S.+Pahlauthor=E.+Mayordomoauthor=K.+J.+Winzerauthor=W.+Weichertauthor=C.+Denkertauthor=K.+Jungauthor=C.+Stephanauthor=M.+Dietelauthor=E.+P.+Diamandisauthor=E.+Dahlauthor=G.+Kristiansen&title=Expression+of+human+kallikrein+14+%28KLK14%29+in+breast+cancer+is+associated+with+higher+tumour+grades+and+positive+nodal+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status</span></div><div class="casAuthors">Fritzsche, F.; Gansukh, T.; Borgono, C. A.; Burkhardt, M.; Pahl, S.; Mayordomo, E.; Winzer, K-J.; Weichert, W.; Denkert, C.; Jung, K.; Stephan, C.; Dietel, M.; Diamandis, E. P.; Dahl, E.; Kristiansen, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">540-547</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human kallikrein 14 (KLK14) is a steroid hormone-regulated member of the tissue kallikrein family of serine proteases, for which a prognostic and diagnostic value in breast cancer has been suggested.  To further characterize the value of KLK14 as a breast tumor marker, we have carefully analyzed KLK14 expression in normal breast tissue and breast cancer both on the RNA level by real-time RT-PCR (n=39), and on the protein level (n=127) using a KLK14-specific antibody for immunohistochem.  We correlated KLK14 protein expression data with available clinico-pathol. parameters (mean follow-up time was 55 mo) including patient prognosis.  KLK14 RNA expression as quantified by real-time RT-PCR was significantly more abundant in breast tumors compared to normal breast tissue (P=0.027), an issue that had not been clarified recently.  Concordantly with the RNA data, cytoplasmic KLK14 protein expression was significantly higher in invasive breast carcinomas compared to normal breast tissues (P=0.003).  Furthermore, KLK14 protein expression was assocd. with higher tumor grade (P=0.041) and pos. nodal status (P=0.045) but was not significantly assocd. with shortened disease-free or overall patient survival time in univariate analyses.  We conclude that KLK14 is clearly overexpressed in breast cancer in comparison to normal breast tissues and is pos. assocd. with conventional parameters of tumor aggressiveness, but due to a missing assocn. with survival times, the use of KLK14 immunohistochem. as a prognostic marker in breast cancer is questionable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2dz15isTbrVg90H21EOLACvtfcHk0liZv00eoNP_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ersrs%253D&md5=4d1a1725e38fe4136dab08870583df0a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602956%26sid%3Dliteratum%253Aachs%26aulast%3DFritzsche%26aufirst%3DF.%26aulast%3DGansukh%26aufirst%3DT.%26aulast%3DBorgono%26aufirst%3DC.%2BA.%26aulast%3DBurkhardt%26aufirst%3DM.%26aulast%3DPahl%26aufirst%3DS.%26aulast%3DMayordomo%26aufirst%3DE.%26aulast%3DWinzer%26aufirst%3DK.%2BJ.%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DDahl%26aufirst%3DE.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DExpression%2520of%2520human%2520kallikrein%252014%2520%2528KLK14%2529%2520in%2520breast%2520cancer%2520is%2520associated%2520with%2520higher%2520tumour%2520grades%2520and%2520positive%2520nodal%2520status%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D540%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Xi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klokk, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saatcioglu, F.</span><span> </span><span class="NLM_article-title">Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer</span> <span class="citation_source-journal">Gynecol Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ygyno.2004.03.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15262123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslOqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=80-85&author=Z.+Xiauthor=J.+Kaernauthor=B.+Davidsonauthor=T.+I.+Klokkauthor=B.+Risbergauthor=C.+Trop%C3%A9author=F.+Saatcioglu&title=Kallikrein+4+is+associated+with+paclitaxel+resistance+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer</span></div><div class="casAuthors">Xi, Zhijun; Kaern, Janne; Davidson, Ben; Klokk, Tove Irene; Risberg, Bjorn; Trope, Claes; Saatcioglu, Fahri</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-85</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Carcinoma of the ovary is the most fatal malignancy of the female genital tract in western countries.  The effectiveness of chemotherapy is limited by the acquisition of drug resistance.  Several members of the kallikrein (KLK) family were recently shown to be expressed in ovarian cancer and implicated in disease prognosis.  One of these is KLK4, whose increased mRNA expression was identified as a poor prognostic marker in ovarian cancer.  The goal of this study was to investigate if KLK4 protein (hK4) is expressed in ovarian carcinoma lesions and if it is assocd. with paclitaxel resistance.  Immunohistochem. was used to assess hK4 expression.  The 126 lesions were from a cohort of 46 patients with platinum-resistant tumors, which were treated with weekly paclitaxel for recurrent disease.  The overall response rate to weekly paclitaxel was 52% (24 of 46) and for patients with tumors resistant to std. three weekly paclitaxel treatment 48% (16 of 33).  Immunohistochem. indicated that 85% (79 of 93) of lesions from paclitaxel-resistant patients expressed hK4, while only 61% (20 of 33) of lesions were pos. for hK4 from paclitaxel sensitive patients.  Statistical anal. showed that the intensity of hK4 staining was significantly assocd. with paclitaxel resistance (P = 0.005), whereas hK4 staining extent showed marginal significance (P = 0.05), but was significantly correlated with higher histol. grade (P < 0.001).  These data show that hK4 is expressed in ovarian cancer and suggest that hK4 expression might be a predictive marker for paclitaxel resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHYjkAoBtDs7Vg90H21EOLACvtfcHk0lg7AcTq0kTRsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslOqsbs%253D&md5=880f456417c4354792146406b9c829e2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2004.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2004.03.044%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%26aulast%3DKaern%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DB.%26aulast%3DKlokk%26aufirst%3DT.%2BI.%26aulast%3DRisberg%26aufirst%3DB.%26aulast%3DTrop%25C3%25A9%26aufirst%3DC.%26aulast%3DSaatcioglu%26aufirst%3DF.%26atitle%3DKallikrein%25204%2520is%2520associated%2520with%2520paclitaxel%2520resistance%2520in%2520ovarian%2520cancer%26jtitle%3DGynecol%2520Oncol.%26date%3D2004%26volume%3D94%26spage%3D80%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Talieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourgiotis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathioudaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span> </span><span class="NLM_article-title">Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=14691584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=180-186&author=M.+Talieriauthor=E.+P.+Diamandisauthor=D.+Gourgiotisauthor=K.+Mathioudakiauthor=A.+Scorilas&title=Expression+analysis+of+the+human+kallikrein+7+%28KLK7%29+in+breast+tumors%3A+a+new+potential+biomarker+for+prognosis+of+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: A new potential biomarker for prognosis of breast carcinoma</span></div><div class="casAuthors">Talieri, Maroulio; Diamandis, Eleftherios P.; Gourgiotis, Dimitrios; Mathioudaki, Kostandina; Scorilas, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">180-186</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Kallikreins are a subgroup of serine proteases that are involved in the post-translational processing of polypeptide precursors.  Growing evidence suggests that many kallikreins are implicated in carcinogenesis.  Human kallikrein gene 7 (KLK7; HSCCE) is a new member of the human kallikrein gene family.  KLK7 is expressed in normal breast tissue and is up-regulated in breast cancer cells by estrogens and glucocorticoids.  In the present study, expression of the KLK7 gene in 92 breast cancer tissues was analyzed by reverse transcription-PCR (RT-PCR) and direct sequencing of several samples.  The results were correlated with other clinicopathol. variables and patient outcome.  KLK7 gene expression was significantly lower in breast cancer patients of low stage (I/II) (p = 0.011) and patients with pos. progesterone receptors (p = 0.022).  Survival anal. showed that breast cancer patients with KLK7 pos. tumors have relatively shorter disease-free survival (DFS) and overall survival (OS) than patients with KLK7 neg. tumors.  These data suggest that KLK7 gene expression may be used as a marker of unfavorable prognosis for breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLtnwQi8jl7Vg90H21EOLACvtfcHk0lg7AcTq0kTRsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D&md5=23134f1e50c39714b7998f39b2942263</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DGourgiotis%26aufirst%3DD.%26aulast%3DMathioudaki%26aufirst%3DK.%26aulast%3DScorilas%26aufirst%3DA.%26atitle%3DExpression%2520analysis%2520of%2520the%2520human%2520kallikrein%25207%2520%2528KLK7%2529%2520in%2520breast%2520tumors%253A%2520a%2520new%2520potential%2520biomarker%2520for%2520prognosis%2520of%2520breast%2520carcinoma%26jtitle%3DThromb.%2520Haemostasis%26date%3D2004%26volume%3D91%26spage%3D180%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Holzscheiter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotzsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farthmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baretton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjan-Heijnen, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Span, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span> </span><span class="NLM_article-title">Quantitative reverse transcription-PCR assay for detection of mRNA encoding full length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer</span> <span class="citation_source-journal">Clin. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1373%2Fclinchem.2005.065599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16627559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=1070-1079&author=L.+Holzscheiterauthor=J.+C.+Biermannauthor=M.+Kotzschauthor=P.+Prezasauthor=J.+Farthmannauthor=G.+Barettonauthor=T.+Lutherauthor=V.+C.+Tjan-Heijnenauthor=M.+Talieriauthor=M.+Schmittauthor=F.+C.+Sweepauthor=P.+N.+Spanauthor=V.+Magdolen&title=Quantitative+reverse+transcription-PCR+assay+for+detection+of+mRNA+encoding+full+length+human+tissue+kallikrein+7%3A+prognostic+relevance+of+KLK7+mRNA+expression+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer</span></div><div class="casAuthors">Holzscheiter, Leon; Biermann, Julia C.; Kotzsch, Matthias; Prezas, Panagiotis; Farthmann, Juliane; Baretton, Gustavo; Luther, Thomas; Tjan-Heijnen, Vivianne C. G.; Talieri, Maroulio; Schmitt, Manfred; Sweep, Fred C. G. J.; Span, Paul N.; Magdolen, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1070-1079</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">Background: The human tissue kallikrein gene family (KLK1 to KLK15) encodes a group of 15 serine proteases (hK1 to hK15), several of which have been implicated in cancer-related processes.  Methods: We established a specific quant. reverse transcription-PCR assay for full-length KLK7 mRNA that excluded amplification of the exon 2 deletion splice variant (the latter does not encode a functional protease), and evaluated full-length KLK7 mRNA expression [normalized to human glucose-6-phosphate dehydrogenase (h-G6PDH)] in tumor tissue specimens from 155 breast cancer patients.  Results: High KLK7 mRNA expression (continuous) was significantly assocd. with a better patient out-come according to both univariate (P = 0.005) and multivariate (P = 0.046) Cox survival anal.  Sepn. of patients by optimized dichotomization revealed a significantly better prognosis for patients with high KLK7 mRNA status (n = 89) compared with patients with low KLK7 mRNA status (n = 66) [univariate hazard ratio (HR) = 0.45 (P = 0.001); multivariate HR = 0.50 (P = 0.005)].  In the subgroup of patients not receiving adjuvant treatment (n = 69), KLK7 mRNA status was a significant prognosticator [univariate HR = 0.29 (P = 0.002); multivariate HR = 0.40 (P = 0.034)].  This subgroup was least influenced by postoperative treatment and thus best showed the impact of KLK7 expression on the natural course of breast cancer disease.  Conclusion: Expression of full-length KLK7 mRNA may represent a new prognostic marker in breast cancer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMKw2XfLV5h7Vg90H21EOLACvtfcHk0lg7AcTq0kTRsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSrtb0%253D&md5=f55950880d34f6f31bf1130b92093bc8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2005.065599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2005.065599%26sid%3Dliteratum%253Aachs%26aulast%3DHolzscheiter%26aufirst%3DL.%26aulast%3DBiermann%26aufirst%3DJ.%2BC.%26aulast%3DKotzsch%26aufirst%3DM.%26aulast%3DPrezas%26aufirst%3DP.%26aulast%3DFarthmann%26aufirst%3DJ.%26aulast%3DBaretton%26aufirst%3DG.%26aulast%3DLuther%26aufirst%3DT.%26aulast%3DTjan-Heijnen%26aufirst%3DV.%2BC.%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DSweep%26aufirst%3DF.%2BC.%26aulast%3DSpan%26aufirst%3DP.%2BN.%26aulast%3DMagdolen%26aufirst%3DV.%26atitle%3DQuantitative%2520reverse%2520transcription-PCR%2520assay%2520for%2520detection%2520of%2520mRNA%2520encoding%2520full%2520length%2520human%2520tissue%2520kallikrein%25207%253A%2520prognostic%2520relevance%2520of%2520KLK7%2520mRNA%2520expression%2520in%2520breast%2520cancer%26jtitle%3DClin.%2520Chem.%26date%3D2006%26volume%3D52%26spage%3D1070%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Shvartsman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deavers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershenson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span> </span><span class="NLM_article-title">Overexpression of kallikrein 10 in epithelial ovarian carcinomas</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2FS0090-8258%2803%2900257-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12821340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVaqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2003&pages=44-50&author=H.+S.+Shvartsmanauthor=K.+H.+Luauthor=J.+Leeauthor=J.+Lillieauthor=M.+T.+Deaversauthor=S.+Cliffordauthor=J.+K.+Wolfauthor=G.+B.+Millsauthor=R.+C.+Bastauthor=D.+M.+Gershensonauthor=R.+Schmandt&title=Overexpression+of+kallikrein+10+in+epithelial+ovarian+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of kallikrein 10 in epithelial ovarian carcinomas</span></div><div class="casAuthors">Shvartsman, Hyun S.; Lu, Karen H.; Lee, John; Lillie, Jim; Deavers, Michael T.; Clifford, Stephanie; Wolf, Judith K.; Mills, Gordon B.; Bast, Robert C.; Gershenson, David M.; Schmandt, Rosemarie</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-50</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Objective.  The authors wanted to identify genes up-regulated in ovarian tumors that might serve as early markers for ovarian cancer.  One promising focus is the family of genes that encode secreted proteases, which play essential roles in tumor invasion and metastasis.  Kallikrein 10 (KLK10) is a member of the kallikrein family of serine proteases which include 15 proteins, including the prostate-specific antigen (PSA), also known as hK3.  The authors investigated whether KLK10 and its related protein, hK10, might serve as equally accurate markers for ovarian carcinoma.  Methods. Transcriptional profiling was performed using RNA isolated from normal ovarian epithelium, ovarian cancer cell lines, and primary ovarian tumors.  Microarray data were confirmed by Northern blot anal. of 66 ovarian tumor samples and 6 ovarian cancer cell lines.  In situ hybridization and Western blot anal. confirmed the Northern blot findings.  Results. KLK10 was more highly expressed by primary ovarian tumors than by NOE.  Thirty-two of 35 primary serous ovarian carcinoma samples (91.4%) expressed higher levels of KLK10 than NOE did.  Eleven of 15 nonserous epithelial ovarian carcinoma samples (73.3%) and 8 of 11 primary peritoneal carcinoma samples (72.7%) also expressed KLK10.  Overall, 84.8% of all epithelial ovarian and peritoneal carcinoma tumor samples showed elevated expression of KLK10.  Similarly, Western blot anal. demonstrated that levels of the KLK10-related protein, designated hK10, are elevated in primary ovarian tissue lysates, but the protein is undetectable in immortalized ovarian epithelium.  Finally, in situ hybridization established that KLK10 mRNA is much more highly expressed by tumor tissue than by normal epithelium and stromal tissues.  Conclusions.  The authors' data support recent immunoassay findings of elevated levels of hK10 in the tumor tissue and serum of ovarian cancer patients.  Thus, it is likely that KLK10 and other kallikreins will serve as useful diagnostic and prognostic markers in patients with ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc1dqVut07crVg90H21EOLACvtfcHk0lgIrsC_d570nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVaqs7s%253D&md5=55c62b69a73ce2e9495c2a78601f831f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0090-8258%2803%2900257-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-8258%252803%252900257-9%26sid%3Dliteratum%253Aachs%26aulast%3DShvartsman%26aufirst%3DH.%2BS.%26aulast%3DLu%26aufirst%3DK.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLillie%26aufirst%3DJ.%26aulast%3DDeavers%26aufirst%3DM.%2BT.%26aulast%3DClifford%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DJ.%2BK.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DBast%26aufirst%3DR.%2BC.%26aulast%3DGershenson%26aufirst%3DD.%2BM.%26aulast%3DSchmandt%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520kallikrein%252010%2520in%2520epithelial%2520ovarian%2520carcinomas%26jtitle%3DGynecol.%2520Oncol.%26date%3D2003%26volume%3D90%26spage%3D44%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">McIntosh, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4422</span><span class="NLM_x">–</span> <span class="NLM_lpage">4428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1078-0432.CCR-06-2224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17671125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlGqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=4422-4428&author=M.+W.+McIntoshauthor=Y.+Liuauthor=C.+Drescherauthor=N.+Urbanauthor=E.+P.+Diamandis&title=Validation+and+characterization+of+human+kallikrein+11+as+a+serum+marker+for+diagnosis+of+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma</span></div><div class="casAuthors">McIntosh, Martin W.; Liu, Yan; Drescher, Charles; Urban, Nicole; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15, Pt. 1</span>),
    <span class="NLM_cas:pages">4422-4428</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The serum tumor marker CA 125 is elevated in most clin. advanced ovarian carcinomas, and currently, one of the most promising early detection strategies for ovarian cancer uses CA 125 level in conjunction with imaging.  However, CA 125 is elevated in only 50% of early-stage ovarian cancer and is often elevated in women with benign ovarian tumors and other gynecol. diseases.  Addnl. markers may improve on its individual performance if they increase sensitivity and specificity and are less sensitive to other gynecol. conditions.  The human kallikrein 11 (hK11) marker has been reported to have favorable predictive value for ovarian cancer, although, by itself, it may be inferior to CA 125.  Exptl. Design: We here validate the performance of hK11 on an independent data set and further characterize its behavior in multiple types of controls.  We also investigate its behavior when combined with CA 125 to form a composite marker. hK11 had not previously been evaluated on these serum samples.  CA 125, hK11, and the composite marker were evaluated for their performance in identifying ovarian cancer and for temporal stability.  RESULTS: hK11 significantly distinguished ovarian cancer cases from healthy controls and is less sensitive to benign ovarian disease than is CA 125.  CONCLUSION: We conclude that hK11 is a valuable new biomarker for ovarian cancer and its temporal stability implies that it may do even better when used in a longitudinal screening program for early detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwkX4sCMggzLVg90H21EOLACvtfcHk0lgIrsC_d570nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlGqt70%253D&md5=2962348f5d716667b62a988e4708e1ac</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2224%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DM.%2BW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDrescher%26aufirst%3DC.%26aulast%3DUrban%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DValidation%2520and%2520characterization%2520of%2520human%2520kallikrein%252011%2520as%2520a%2520serum%2520marker%2520for%2520diagnosis%2520of%2520ovarian%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D4422%26epage%3D4428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Monte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyetant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmazes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemarié, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span> </span><span class="NLM_article-title">KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2005&pages=1260-1266&author=C.+Planqueauthor=M.+de+Monteauthor=S.+Guyetantauthor=J.+Rollinauthor=C.+Desmazesauthor=V.+Panelauthor=E.+Lemari%C3%A9author=Y.+Courty&title=KLK5+and+KLK7%2C+two+members+of+the+human+tissue+kallikrein+family%2C+are+differentially+expressed+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3Dde%2BMonte%26aufirst%3DM.%26aulast%3DGuyetant%26aufirst%3DS.%26aulast%3DRollin%26aufirst%3DJ.%26aulast%3DDesmazes%26aufirst%3DC.%26aulast%3DPanel%26aufirst%3DV.%26aulast%3DLemari%25C3%25A9%26aufirst%3DE.%26aulast%3DCourty%26aufirst%3DY.%26atitle%3DKLK5%2520and%2520KLK7%252C%2520two%2520members%2520of%2520the%2520human%2520tissue%2520kallikrein%2520family%252C%2520are%2520differentially%2520expressed%2520in%2520lung%2520cancer%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D329%26spage%3D1260%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sher, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, K.</span><span> </span><span class="NLM_article-title">Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">11763</span><span class="NLM_x">–</span> <span class="NLM_lpage">11770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11763-11770&author=Y.+P.+Sherauthor=C.+C.+Chouauthor=R.+H.+Chouauthor=H.+M.+Wuauthor=W.+S.+Changauthor=C.+H.+Chenauthor=P.+C.+Yangauthor=C.+W.+Wuauthor=C.+L.+Yuauthor=K.+Peck&title=Human+kallikrein+8+protease+confers+a+favorable+clinical+outcome+in+non-small+cell+lung+cancer+by+suppressing+tumor+cell+invasiveness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSher%26aufirst%3DY.%2BP.%26aulast%3DChou%26aufirst%3DC.%2BC.%26aulast%3DChou%26aufirst%3DR.%2BH.%26aulast%3DWu%26aufirst%3DH.%2BM.%26aulast%3DChang%26aufirst%3DW.%2BS.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3DYu%26aufirst%3DC.%2BL.%26aulast%3DPeck%26aufirst%3DK.%26atitle%3DHuman%2520kallikrein%25208%2520protease%2520confers%2520a%2520favorable%2520clinical%2520outcome%2520in%2520non-small%2520cell%2520lung%2520cancer%2520by%2520suppressing%2520tumor%2520cell%2520invasiveness%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11763%26epage%3D11770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aïnciburu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuzé-Vourc’h, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Régina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Monte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span> </span><span class="NLM_article-title">Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues</span> <span class="citation_source-journal">Biol Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=783-788&author=C.+Planqueauthor=M.+A%C3%AFnciburuauthor=N.+Heuz%C3%A9-Vourc%E2%80%99hauthor=S.+R%C3%A9ginaauthor=M.+de+Monteauthor=Y.+Courty&title=Expression+of+the+human+kallikrein+genes+10+%28KLK10%29+and+11+%28KLK11%29+in+cancerous+and+non-cancerous+lung+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3DA%25C3%25AFnciburu%26aufirst%3DM.%26aulast%3DHeuz%25C3%25A9-Vourc%25E2%2580%2599h%26aufirst%3DN.%26aulast%3DR%25C3%25A9gina%26aufirst%3DS.%26aulast%3Dde%2BMonte%26aufirst%3DM.%26aulast%3DCourty%26aufirst%3DY.%26atitle%3DExpression%2520of%2520the%2520human%2520kallikrein%2520genes%252010%2520%2528KLK10%2529%2520and%252011%2520%2528KLK11%2529%2520in%2520cancerous%2520and%2520non-cancerous%2520lung%2520tissues%26jtitle%3DBiol%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D783%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bléchet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayadi-Kaddour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuzé-Vourc’h, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyétant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Mezni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span> </span><span class="NLM_article-title">Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=781-786&author=C.+Planqueauthor=C.+Bl%C3%A9chetauthor=A.+Ayadi-Kaddourauthor=N.+Heuz%C3%A9-Vourc%E2%80%99hauthor=P.+Dumontauthor=S.+Guy%C3%A9tantauthor=E.+P.+Diamandisauthor=F.+El+Mezniauthor=Y.+Courty&title=Quantitative+RT-PCR+analysis+and+immunohistochemical+localization+of+the+kallikrein-related+peptidases+13+and+14+in+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3DBl%25C3%25A9chet%26aufirst%3DC.%26aulast%3DAyadi-Kaddour%26aufirst%3DA.%26aulast%3DHeuz%25C3%25A9-Vourc%25E2%2580%2599h%26aufirst%3DN.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DGuy%25C3%25A9tant%26aufirst%3DS.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DEl%2BMezni%26aufirst%3DF.%26aulast%3DCourty%26aufirst%3DY.%26atitle%3DQuantitative%2520RT-PCR%2520analysis%2520and%2520immunohistochemical%2520localization%2520of%2520the%2520kallikrein-related%2520peptidases%252013%2520and%252014%2520in%2520lung%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D781%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Petraki, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregorakis, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaslamatzis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papanastasiou, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1159%2F000090150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16340244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCks7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1-7&author=C.+D.+Petrakiauthor=A.+K.+Gregorakisauthor=M.+M.+Vaslamatzisauthor=P.+A.+Papanastasiouauthor=G.+M.+Yousefauthor=M.+A.+Levesqueauthor=E.+P.+Diamandis&title=Prognostic+implications+of+the+immunohistochemical+expression+of+human+kallikreins+5%2C+6%2C+10+and+11+in+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma</span></div><div class="casAuthors">Petraki, Constantina D.; Gregorakis, Alkiviadis K.; Vaslamatzis, Michael M.; Papanastasiou, Panagiotis A.; Yousef, George M.; Levesque, Michael A.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Human kallikreins 5, 6, 10 and 11 (hK5, 6, 10 and 11) are expressed by many normal tissues, and it has been suggested that they may represent candidate tumor-diagnostic or -prognostic markers.  In patients with renal cell carcinoma (RCC), outcome is unpredictable despite the use of conventional prognostic factors.  The aim of this study is to evaluate the immunohistochem. expression and the prognostic value of the above kallikreins in RCC.  The study comprised 95 patients who underwent radical nephrectomy for RCC.  The median follow-up period was 60 mo (range 1-180 mo).  Fifty-seven RCC cases were immunostained for hK5, 70 for hK6, 70 for hK10 and 69 for hK11.  The streptavidin-biotin-peroxidase method of immunostaining was performed using anti-hK5, anti-hK6, anti-hK10 and anti-hK11 monoclonal and polyclonal antibodies.  The immunohistochem. expression of these kallikreins was correlated with tumor size, histol. type, histol. malignancy according to the Fuhrman four-grade scale, mitotic index, pathol. stage and disease survival.  For the statistical anal., four grades were collapsed into two by which RCC cases were categorized as low malignant (LM) and high malignant (HM).  In the normal renal parenchyma adjacent to the tumors, the renal tubular epithelium showed a cytoplasmic expression of all four kallikreins.  In RCC, immunohistochem. expression was decreased: 33 of 57 cases (58%) were pos. for hK5, 27 of 70 (39%) for hK6, 46 of 70 (66%) for hK10 and 32 of 69 (46%) for hK11.  A statistically significant pos. correlation was obsd. among the immunohistochem. expression of all kallikreins.  HM-RCC expressed all kallikreins in a higher percentage of cases than LM-RCC, but statistically significant differences were only obsd. for hK6 and hK10 (55 vs. 27%, p = 0.016, and 79 vs. 56%, p = 0.044, resp.). hK6 and hK11 expression showed a pos. correlation to pathol. stage: hK6 with both Robson and TNM 2002 staging systems (p = 0.010 and p = 0.017, resp.), and hK11 only with the Robson staging system (p = 0.045).  In both the Kaplan-Meier and the univariate Cox regression analyses, hK6 expression was neg. correlated with disease-specific survival (p = 0.05 and p = 0.038, resp.).  In univariate anal., nuclear grade, Robson stage and TNM stage also correlated with disease-specific survival.  However, in the multivariate anal., TNM stage was the only independent prognostic factor.  In conclusion, although the immunohistochem. expression of hK5, hK6, hK10 and hK11 was downregulated in RCC, tumors of high grade and late stage expressed one or more of the above kallikreins in a higher percentage of cases, and hK6 may predict a poor disease outcome in RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIPqhnEbMxrVg90H21EOLACvtfcHk0ljyi_xBcQ9v8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCks7jJ&md5=fb718f3d5187df366e4576792625b447</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1159%2F000090150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000090150%26sid%3Dliteratum%253Aachs%26aulast%3DPetraki%26aufirst%3DC.%2BD.%26aulast%3DGregorakis%26aufirst%3DA.%2BK.%26aulast%3DVaslamatzis%26aufirst%3DM.%2BM.%26aulast%3DPapanastasiou%26aufirst%3DP.%2BA.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DLevesque%26aufirst%3DM.%2BA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DPrognostic%2520implications%2520of%2520the%2520immunohistochemical%2520expression%2520of%2520human%2520kallikreins%25205%252C%25206%252C%252010%2520and%252011%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DTumor%2520Biol.%26date%3D2006%26volume%3D27%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Prezas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yfanti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viktorov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnanti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talieri, M.</span><span> </span><span class="NLM_article-title">The role of human tissue kallikreins 7 and 8 in intracranial malignancies</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">1607</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=1607-1612&author=P.+Prezasauthor=A.+Scorilasauthor=C.+Yfantiauthor=P.+Viktorovauthor=N.+Agnantiauthor=E.+P.+Diamandisauthor=M.+Talieri&title=The+role+of+human+tissue+kallikreins+7+and+8+in+intracranial+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrezas%26aufirst%3DP.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DYfanti%26aufirst%3DC.%26aulast%3DViktorov%26aufirst%3DP.%26aulast%3DAgnanti%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DTalieri%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520human%2520tissue%2520kallikreins%25207%2520and%25208%2520in%2520intracranial%2520malignancies%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D1607%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Santin, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soosaipillai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecorelli, S.</span><span> </span><span class="NLM_article-title">Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3320</span><span class="NLM_x">–</span> <span class="NLM_lpage">3325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1078-0432.CCR-04-2528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15867230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3320-3325&author=A.+D.+Santinauthor=E.+P.+Diamandisauthor=S.+Belloneauthor=A.+Soosaipillaiauthor=S.+Caneauthor=M.+Palmieriauthor=A.+Burnettauthor=J.+J.+Romanauthor=S.+Pecorelli&title=Human+kallikrein+6%3A+a+new+potential+serum+biomarker+for+uterine+serous+papillary+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer</span></div><div class="casAuthors">Santin, Alessandro D.; Diamandis, Eleftherios P.; Bellone, Stefania; Soosaipillai, Antoninus; Cane, Stefania; Palmieri, Michela; Burnett, Alexander; Roman, Juan J.; Pecorelli, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3320-3325</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The discovery of novel biomarkers might greatly contribute to improve clin. management and outcomes in uterine serous papillary carcinoma (USPC), a highly aggressive variant of endometrial cancer.  Exptl. Design: Human kallikrein 6 (hK6) gene expression levels were evaluated in 29 snap-frozen endometrial biopsies, including 13 USPC, 13 endometrioid carcinomas, and 3 normal endometrial cells by real-time PCR.  Secretion of hK6 protein by 14 tumor cultures, including 3 USPC, 3 endometrioid carcinoma, 5 ovarian serous papillary carcinoma, and 3 cervical cancers, was measured using a sensitive ELISA.  Finally, hK6 concn. in 79 serum and plasma samples from 22 healthy women, 20 women with benign diseases, 20 women with endometrioid carcinoma, and 17 USPC patients was studied.  RESULTS: hK6 gene expression levels were significantly higher in USPC when compared with endometrioid carcinoma (mean copy no. by real-time PCR, 1,927 vs. 239, USPC vs. endometrioid carcinoma; P < 0.01).  In vitro hK6 secretion was detected in all primary USPC cell lines tested (mean, 11.5 μg/L) and the secretion levels were similar to those found in primary ovarian serous papillary carcinoma cultures (mean, 9.6 μg/L).  In contrast, no hK6 secretion was detectable in primary endometrioid carcinoma and cervical cancer cultures. hK6 serum and plasma concns. (mean ± SE) among normal healthy females (2.7 ± 0.2 μg/L), patients with benign diseases (2.4 ± 0.2 μg/L), and patients with endometrioid carcinoma (2.6 ± 0.2 μg/L) were not significantly different.  In contrast, serum and plasma hK6 values in USPC patients (6.1 ± 1.1) were significantly higher than those in the noncancer group (P = 0.006), benign group (P = 0.003), and endometrioid carcinoma patients (P = 0.005).  CONCLUSIONS: hK6 is highly expressed in USPC and is released in the plasma and serum of USPC patients. hK6 may represent a novel biomarker for USPC for monitoring early disease recurrence and response to therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4iXfKMgCC7Vg90H21EOLACvtfcHk0liJGjwxQ7JBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOqtrs%253D&md5=d2fdd22cca30214aa3e5fe5f01d55fe1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2528%26sid%3Dliteratum%253Aachs%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DBellone%26aufirst%3DS.%26aulast%3DSoosaipillai%26aufirst%3DA.%26aulast%3DCane%26aufirst%3DS.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DRoman%26aufirst%3DJ.%2BJ.%26aulast%3DPecorelli%26aufirst%3DS.%26atitle%3DHuman%2520kallikrein%25206%253A%2520a%2520new%2520potential%2520serum%2520biomarker%2520for%2520uterine%2520serous%2520papillary%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D3320%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemasa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yunokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T. J.</span><span> </span><span class="NLM_article-title">Expression of tumor-associated differentially expressed gene-14 (TADG-14/KLK8) and its protein hK8 in uterine endometria and endometrial carcinomas</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1159%2F000094741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16888409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlaitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=274-282&author=H.+Jinauthor=N.+Nagaiauthor=K.+Shigemasaauthor=L.+Guauthor=H.+Tanimotoauthor=M.+Yunokawaauthor=K.+Ohamaauthor=Y.+Kudoauthor=T.+J.+O%E2%80%99Brien&title=Expression+of+tumor-associated+differentially+expressed+gene-14+%28TADG-14%2FKLK8%29+and+its+protein+hK8+in+uterine+endometria+and+endometrial+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Tumor-Associated Differentially Expressed Gene-14 (TADG-14/KLK8) and Its Protein hK8 in Uterine Endometria and Endometrial Carcinomas</span></div><div class="casAuthors">Jin, Honghua; Nagai, Nobutaka; Shigemasa, Kazushi; Gu, Lijun; Tanimoto, Hirotoshi; Yunokawa, Mayu; Ohama, Koso; Kudo, Yoshiki; O'Brien, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">274-282</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">To clarify the biol. behavior of TADG-14/KLK8, we investigated TADG-14/KLK8 mRNA by semiquant. RT-PCR and hK8 expression by immunohistochem. using 37 normal endometria and 44 endometrial carcinoma tissues.  TADG-14/KLK8 mRNA expression levels were significantly higher in proliferative compared to secretory phase endometria (p = 0.0143).  Levels of TADG-14/KLK8 mRNA expression correlated with hK8 protein levels. hK8 was detected in 73.3% (11/15) of endometria with a significantly higher detection rate in the proliferative compared to secretory and atrophic phase endometria (p = 0.0002).  High expression of hK8 was found in 61.4% of endometrial carcinomas compared to 35.1% of endometrial tissue samples (p = 0.0187). hK8 expression was significantly higher in stage I (p = 0.0433, 0.0038) and grade 1/2 (G1/2) of the tumors (p = 0.0195, 0.0044).  We suggest that expression of TADG-14/KLK8 may be regulated by sex steroid hormones in endometria.  Our results indicate that elevated TADG-14/KLK8 expression is an early event in endometrial carcinogenesis, and may potentially serve as a useful early biomarker for the detection of endometrial carcinomas in menopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGgWOFl0U1jbVg90H21EOLACvtfcHk0liJGjwxQ7JBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlaitLg%253D&md5=045ebd080afe53aa1e2825d974ba18fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1159%2F000094741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000094741%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DN.%26aulast%3DShigemasa%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DTanimoto%26aufirst%3DH.%26aulast%3DYunokawa%26aufirst%3DM.%26aulast%3DOhama%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BJ.%26atitle%3DExpression%2520of%2520tumor-associated%2520differentially%2520expressed%2520gene-14%2520%2528TADG-14%252FKLK8%2529%2520and%2520its%2520protein%2520hK8%2520in%2520uterine%2520endometria%2520and%2520endometrial%2520carcinomas%26jtitle%3DTumor%2520Biol.%26date%3D2006%26volume%3D27%26spage%3D274%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Santin, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marizzoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papasakelariou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsaros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecorelli, S.</span><span> </span><span class="NLM_article-title">Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas</span> <span class="citation_source-journal">Am. J. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ajog.2005.10.794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16647913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVGhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2006&pages=1296-1302&author=A.+D.+Santinauthor=E.+P.+Diamandisauthor=S.+Belloneauthor=M.+Marizzoniauthor=E.+Bandieraauthor=M.+Palmieriauthor=C.+Papasakelariouauthor=D.+Katsarosauthor=A.+Burnettauthor=S.+Pecorelli&title=Overexpression+of+kallikrein+10+%28hK10%29+in+uterine+serous+papillary+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas</span></div><div class="casAuthors">Santin, Alessandro D.; Diamandis, Eleftherios P.; Bellone, Stefania; Marizzoni, Moira; Bandiera, Elisabetta; Palmieri, Michela; Papasakelariou, Catherine; Katsaros, Dionyssios; Burnett, Alexander; Pecorelli, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Obstetrics and Gynecology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">AJOGAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9378</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Objective: Kallikrein 10 is a secreted serine protease recently implicated in the growth and invasion of several human tumors.  The goal of this study was to investigate the expression and secretion levels in vitro and in vivo of kallikrein 10 in uterine serous papillary carcinoma, a highly aggressive variant of endometrial tumor.  Study design: Human kallikrein 10 gene expression levels were evaluated in 11 snap-frozen uterine serous papillary carcinoma biopsies and 6 normal endometrial cell biopsies by real-time polymerase chain reaction.  Secretion of kallikrein 10 protein by 10 primary tumor cultures including 3 uterine serous papillary carcinomas, 2 endometrioid carcinomas, and 5 ovarian serous papillary tumors was measured using a sensitive ELISA.  Finally, kallikrein 10 concn. in 75 serum and plasma samples from 22 healthy women, 20 women with benign diseases, 21 women with endometrioid carcinomas, and 12 uterine serous papillary carcinoma patients was studied.  Results: Kallikrein 10 gene expression levels were significantly higher in uterine serous papillary carcinoma when compared with normal endometrial cell biopsies (mean copy no. by real time polymerase chain reaction = 743 vs. 1.4; uterine serous papillary carcinoma vs. endometrioid carcinoma: P < .02).  In vitro kallikrein 10 secretion was detected in all primary uterine serous papillary carcinoma cell lines tested (mean = 2.7 μg/L), and the secretion levels were not significantly different to those found in primary ovarian serous papillary tumor cultures (mean 4.2 μg/L).  In contrast, no kallikrein 10 secretion was detectable in primary endometrioid carcinomas.  Kallikrein 10 serum and plasma concns. (μg/L; mean ± SEM) among normal healthy females (0.6 ± 0.04), patients with benign diseases (0.6 ± 0.06), and patients with endometrioid carcinomas (0.7 ± 0.06) were not significantly different.  In contrast, serum and plasma kallikrein 10 values in uterine serous papillary carcinoma patients (1.2 ± 0.1) were significantly higher than those in the non-cancer group (P = .002), benign group (P = .002), and endometrioid carcinoma patients (P = .005).  Conclusion: Kallikrein 10 is highly expressed in uterine serous papillary carcinoma, and it is released in the plasma and serum of uterine serous papillary carcinoma patients.  Kallikrein 10 may represent a novel biomarker for uterine serous papillary carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRLrgNcqMUbVg90H21EOLACvtfcHk0liJGjwxQ7JBDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVGhtLc%253D&md5=57da003d49d7bb7f692d74a9d479061a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ajog.2005.10.794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajog.2005.10.794%26sid%3Dliteratum%253Aachs%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DBellone%26aufirst%3DS.%26aulast%3DMarizzoni%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DE.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DPapasakelariou%26aufirst%3DC.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DPecorelli%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520kallikrein%252010%2520%2528hK10%2529%2520in%2520uterine%2520serous%2520papillary%2520carcinomas%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D2006%26volume%3D194%26spage%3D1296%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Darling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Boeters, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human kallikrein 6 expression in salivary gland tumors</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1369%2Fjhc.5A6803.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16286664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFWmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=337-342&author=M.+R.+Darlingauthor=L.+Jackson-Boetersauthor=T.+D.+Daleyauthor=E.+P.+Diamandis&title=Human+kallikrein+6+expression+in+salivary+gland+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Human kallikrein 6 expression in salivary gland tumors</span></div><div class="casAuthors">Darling, M. R.; Jackson-Boeters, L.; Daley, T. D.; Diamandis, E. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-342</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Human kallikrein 6 (hK6), also known as zyme/protease M/neurosin, is expressed in many normal glandular tissues.  The aim of this study was to det. whether hK6 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), using an immunohistochem. method.  Pleomorphic adenomas (PA), adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, acinic cell carcinomas, mucoepidermoid carcinomas, and adenocarcinomas not otherwise specified of both minor and major salivary glands were examd.  Cells lining duct-like structures and non-duct-like cells were scored.  Only in PA of minor salivary gland origin was overall staining higher in duct-like than in non-duct-like cells.  In all other tumors exhibiting both types of cells, hK6 staining was similar in both duct-like and non-duct-like cells.  Tumors that exhibited non-duct-like cells only also exhibited cytoplasmic staining.  Results of this study show that salivary gland tumors express hK6, apparently downregulated in comparison with normal salivary gland tissue, and that this expression is not specific for any of the tumors studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhoPmDh7yzwrVg90H21EOLACvtfcHk0liJ-LecXyj7ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFWmu7k%253D&md5=4d2611e1243adc6f4ece5ee0d295cbc6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1369%2Fjhc.5A6803.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.5A6803.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDarling%26aufirst%3DM.%2BR.%26aulast%3DJackson-Boeters%26aufirst%3DL.%26aulast%3DDaley%26aufirst%3DT.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520kallikrein%25206%2520expression%2520in%2520salivary%2520gland%2520tumors%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2006%26volume%3D54%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Darling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Boeters, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human kallikrein 13 expression in salivary gland tumors</span> <span class="citation_source-journal">Int. J. Biol. Markers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16847813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFWktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=106-110&author=M.+R.+Darlingauthor=L.+Jackson-Boetersauthor=T.+D.+Daleyauthor=E.+P.+Diamandis&title=Human+kallikrein+13+expression+in+salivary+gland+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Human kallikrein 13 expression in salivary gland tumors</span></div><div class="casAuthors">Darling, M. R.; Jackson-Boeters, L.; Daley, T. D.; Diamandis, E. P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Markers</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-110</span>CODEN:
                <span class="NLM_cas:coden">IBMAEP</span>;
        ISSN:<span class="NLM_cas:issn">0393-6155</span>.
    
            (<span class="NLM_cas:orgname">Wichtig Editore</span>)
        </div><div class="casAbstract">The human kallikrein 13 protein (hK13) is expressed in many normal tissues.  Petraki, C.D.; et al. (2003) have previously described presence of hK13 in salivary gland tissue, localized to duct epithelia and some acinar cells.  The aim of this study was to det. whether hK13 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), in order to compare normal with tumor tissues.  Pleomorphic adenomas (PA), adenoid cystic carcinomas (ACC), polymorphous low grade adenocarcinomas (PLGA), acinic cell carcinomas (ACI), mucoepidermoid carcinomas (MEC) and adenocarcinomas not otherwise specified (ANOS) of both minor and major salivary glands were examd.  The results of this study indicate that most salivary gland tumors show high levels of expression of hK13.  Overall, staining in PA was significantly less than that seen in normal salivary gland tissue.  PLGA, ACC and ANOS each stained significantly more than normal salivary gland tissue while MEC and ACI did not.  Ductal cells and cells lining duct-like structures showed a higher intensity of staining than non-ductal cells in most tumors.  Tumors which exhibited only non-ductal cells also exhibited cytoplasmic staining.  In conclusion, we demonstrate the high expression of hK13 in several common salivary gland tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwsR2czwWnVLVg90H21EOLACvtfcHk0liJ-LecXyj7ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFWktLY%253D&md5=b3263bf458f87d3524751eff04c83bb2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarling%26aufirst%3DM.%2BR.%26aulast%3DJackson-Boeters%26aufirst%3DL.%26aulast%3DDaley%26aufirst%3DT.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520kallikrein%252013%2520expression%2520in%2520salivary%2520gland%2520tumors%26jtitle%3DInt.%2520J.%2520Biol.%2520Markers%26date%3D2006%26volume%3D21%26spage%3D106%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Klucky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teurich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuhahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flechtenmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J.</span><span> </span><span class="NLM_article-title">Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">8198</span><span class="NLM_x">–</span> <span class="NLM_lpage">8206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=8198-8206&author=B.+Kluckyauthor=R.+Muellerauthor=I.+Vogtauthor=S.+Teurichauthor=B.+Hartensteinauthor=K.+Breuhahnauthor=C.+Flechtenmacherauthor=P.+Angelauthor=J.+Hess&title=Kallikrein+6+induces+E-cadherin+shedding+and+promotes+cell+proliferation%2C+migration%2C+and+invasion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlucky%26aufirst%3DB.%26aulast%3DMueller%26aufirst%3DR.%26aulast%3DVogt%26aufirst%3DI.%26aulast%3DTeurich%26aufirst%3DS.%26aulast%3DHartenstein%26aufirst%3DB.%26aulast%3DBreuhahn%26aufirst%3DK.%26aulast%3DFlechtenmacher%26aufirst%3DC.%26aulast%3DAngel%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DJ.%26atitle%3DKallikrein%25206%2520induces%2520E-cadherin%2520shedding%2520and%2520promotes%2520cell%2520proliferation%252C%2520migration%252C%2520and%2520invasion%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D8198%26epage%3D8206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Clements, J. A.</span><span> </span><span class="NLM_article-title">The Molecular Biology of the Kallikreins and Their Roles in Inflammation</span>. In  <span class="citation_source-book">The Kinin System</span>; <span class="NLM_contrib-group">Farmer, S. G.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">5</span>, pp  <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2FB978-012249340-9%2F50007-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=71-97&author=J.+A.+Clementsauthor=S.+G.+Farmer&title=The+Kinin+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FB978-012249340-9%2F50007-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012249340-9%252F50007-3%26sid%3Dliteratum%253Aachs%26aulast%3DClements%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Molecular%2520Biology%2520of%2520the%2520Kallikreins%2520and%2520Their%2520Roles%2520in%2520Inflammation%26btitle%3DThe%2520Kinin%2520System%26aulast%3DFarmer%26aufirst%3DS.%2BG.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D5%26spage%3D71%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bhoola, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K.</span><span> </span><span class="NLM_article-title">Bioregulation of kinins: kallikreins, kininogens, and kininases</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=1-80&author=K.+D.+Bhoolaauthor=C.+D.+Figueroaauthor=K.+Worthy&title=Bioregulation+of+kinins%3A+kallikreins%2C+kininogens%2C+and+kininases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhoola%26aufirst%3DK.%2BD.%26aulast%3DFigueroa%26aufirst%3DC.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%26atitle%3DBioregulation%2520of%2520kinins%253A%2520kallikreins%252C%2520kininogens%252C%2520and%2520kininases%26jtitle%3DPharmacol.%2520Rev.%26date%3D1992%26volume%3D44%26spage%3D1%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarisbrick, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnett, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptors, targets for kallikrein signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">32095</span><span class="NLM_x">–</span> <span class="NLM_lpage">32112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=32095-32112&author=K.+Oikonomopoulouauthor=K.+K.+Hansenauthor=M.+Saifeddineauthor=I.+Teaauthor=M.+Blaberauthor=S.+I.+Blaberauthor=I.+Scarisbrickauthor=P.+Andrade-Gordonauthor=G.+S.+Cottrellauthor=N.+W.+Bunnettauthor=E.+P.+Diamandisauthor=M.+D.+Hollenberg&title=Proteinase-activated+receptors%2C+targets+for+kallikrein+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DTea%26aufirst%3DI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DScarisbrick%26aufirst%3DI.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DCottrell%26aufirst%3DG.%2BS.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DProteinase-activated%2520receptors%252C%2520targets%2520for%2520kallikrein%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D32095%26epage%3D32112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Kallikrein-mediated activation of PARs in inflammation and nociception</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">S499</span><span class="NLM_x">–</span> <span class="NLM_lpage">S502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=S499-S502&author=K.+Oikonomopoulouauthor=K.+K.+Hansenauthor=K.+Chapmanauthor=N.+Vergnolleauthor=E.+P.+Diamandisauthor=M.+D.+Hollenberg&title=Kallikrein-mediated+activation+of+PARs+in+inflammation+and+nociception"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DKallikrein-mediated%2520activation%2520of%2520PARs%2520in%2520inflammation%2520and%2520nociception%26jtitle%3DInflammation%2520Res.%26date%3D2007%26volume%3D56%26spage%3DS499%26epage%3DS502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Protease-activated receptors in hemostasis, thrombosis and vascular biology</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1538-7836.2005.01377.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16102047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1800-1814&author=S.+R.+Coughlin&title=Protease-activated+receptors+in+hemostasis%2C+thrombosis+and+vascular+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptors in hemostasis, thrombosis and vascular biology</span></div><div class="casAuthors">Coughlin, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1800-1814</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The coagulation cascade and protease-activated receptors (PARs) together provide an elegant mechanism that links mech. information in the form of tissue injury to cellular responses.  These receptors appear to largely account for the cellular effects of thrombin and can mediate signaling to other trypsin-like proteases.  An important role for PARs in hemostasis and thrombosis is established in animal models, and studies in knockout mice and nonhuman primates raise the question of whether PAR inhibition might offer an appealing new approach to the prevention and treatment of thrombosis.  PARs may also trigger inflammatory responses to tissue injury.  For example, PAR activation on endothelial cells and perhaps sensory afferents can trigger local accumulation of leukocytes and platelets and transudation of plasma.  However, panoply of signaling systems and cell types orchestrates inflammatory responses, and efforts to define the relative importance and roles of PARs in various inflammatory processes are just beginning.  Lastly, roles for PARs in blood vessel formation and other processes during embryonic development are emerging, and whether these reflect new roles for the coagulation cascade and/or PAR signaling to other proteases remains to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4G5RcogxRO7Vg90H21EOLACvtfcHk0ljXH5FUupJVqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7w%253D&md5=efa79fca6eca2abc02ea011cf0fc071f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2005.01377.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2005.01377.x%26sid%3Dliteratum%253Aachs%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DProtease-activated%2520receptors%2520in%2520hemostasis%252C%2520thrombosis%2520and%2520vascular%2520biology%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2005%26volume%3D3%26spage%3D1800%26epage%3D1814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Steinhoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buddenkotte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpacovitch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattenholl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moormann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptors: transducers of proteinase mediated signaling in inflammation and immune response</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1210%2Fer.2003-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15689571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFyktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1-43&author=M.+Steinhoffauthor=J.+Buddenkotteauthor=V.+Shpacovitchauthor=A.+Rattenhollauthor=C.+Moormannauthor=N.+Vergnolleauthor=T.+A.+Lugerauthor=M.+D.+Hollenberg&title=Proteinase-activated+receptors%3A+transducers+of+proteinase+mediated+signaling+in+inflammation+and+immune+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response</span></div><div class="casAuthors">Steinhoff, Martin; Buddenkotte, Joerg; Shpacovitch, Victoria; Rattenholl, Anke; Moormann, Corinna; Vergnolle, Nathalie; Luger, Thomas A.; Hollenberg, Morley D.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-43</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Serine proteinases such as thrombin, mast cell tryptase, trypsin, or cathepsin G, for example, are highly active mediators with diverse biol. activities.  So far, proteinases have been considered to act primarily as degradative enzymes in the extracellular space.  However, their biol. actions in tissues and cells suggest important roles as a part of the body's hormonal communication system during inflammation and immune response.  These effects can be attributed to the activation of a new subfamily of G protein-coupled receptors, termed proteinase-activated receptors (PARs).  Four members of the PAR family have been cloned so far.  Thus, certain proteinases act as signaling mols. that specifically regulate cells by activating PARs.  After stimulation, PARs couple to various G proteins and activate signal transduction pathways resulting in the rapid transcription of genes that are involved in inflammation.  For example, PARs are widely expressed by cells involved in immune responses and inflammation, regulate endothelial-leukocyte interactions, and modulate the secretion of inflammatory mediators or neuropeptides.  Together, the PAR family necessitates a paradigm shift in thinking about hormone action, to include proteinases as key modulators of biol. function.  Novel compds. that can modulate PAR function may be potent candidates for the treatment of inflammatory or immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPH5a21zi4NrVg90H21EOLACvtfcHk0ljXH5FUupJVqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFyktrc%253D&md5=c26dcb121cc6ef26b479aaf5ff5a2796</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1210%2Fer.2003-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2003-0025%26sid%3Dliteratum%253Aachs%26aulast%3DSteinhoff%26aufirst%3DM.%26aulast%3DBuddenkotte%26aufirst%3DJ.%26aulast%3DShpacovitch%26aufirst%3DV.%26aulast%3DRattenholl%26aufirst%3DA.%26aulast%3DMoormann%26aufirst%3DC.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DLuger%26aufirst%3DT.%2BA.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DProteinase-activated%2520receptors%253A%2520transducers%2520of%2520proteinase%2520mediated%2520signaling%2520in%2520inflammation%2520and%2520immune%2520response%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D1%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Ramachandran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">S263</span><span class="NLM_x">–</span> <span class="NLM_lpage">S282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=S263-S282&author=R.+Ramachandranauthor=M.+D.+Hollenberg&title=Proteinases+and+signalling%3A+pathophysiological+and+therapeutic+implications+via+PARs+and+more"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DR.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DProteinases%2520and%2520signalling%253A%2520pathophysiological%2520and%2520therapeutic%2520implications%2520via%2520PARs%2520and%2520more%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3DS263%26epage%3DS282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Vu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheaton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=1057-1068&author=T.+Vuauthor=D.+Hungauthor=V.+Wheatonauthor=S.+R.+Coughlin&title=Molecular+cloning+of+a+functional+thrombin+receptor+reveals+a+novel+proteolytic+mechanism+of+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DT.%26aulast%3DHung%26aufirst%3DD.%26aulast%3DWheaton%26aufirst%3DV.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520functional%2520thrombin%2520receptor%2520reveals%2520a%2520novel%2520proteolytic%2520mechanism%2520of%2520receptor%2520activation%26jtitle%3DCell%26date%3D1991%26volume%3D64%26spage%3D1057%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Bohm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khitin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnett, N.</span><span> </span><span class="NLM_article-title">Mechanisms of desensitization and resensitization of proteinase-activated receptor-2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">22003</span><span class="NLM_x">–</span> <span class="NLM_lpage">22016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22003-22016&author=S.+Bohmauthor=L.+Khitinauthor=E.+Gradyauthor=G.+Aponteauthor=D.+Payanauthor=N.+Bunnett&title=Mechanisms+of+desensitization+and+resensitization+of+proteinase-activated+receptor-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DS.%26aulast%3DKhitin%26aufirst%3DL.%26aulast%3DGrady%26aufirst%3DE.%26aulast%3DAponte%26aufirst%3DG.%26aulast%3DPayan%26aufirst%3DD.%26aulast%3DBunnett%26aufirst%3DN.%26atitle%3DMechanisms%2520of%2520desensitization%2520and%2520resensitization%2520of%2520proteinase-activated%2520receptor-2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22003%26epage%3D22016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Boire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherifi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.cell.2004.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15707890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Krtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=303-313&author=A.+Boireauthor=L.+Covicauthor=A.+Agarwalauthor=S.+Jacquesauthor=S.+Sherifiauthor=A.+Kuliopulos&title=PAR1+is+a+matrix+metalloprotease-1+receptor+that+promotes+invasion+and+tumorigenesis+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells</span></div><div class="casAuthors">Boire, Adrienne; Covic, Lidija; Agarwal, Anika; Jacques, Suzanne; Sherifi, Sheida; Kuliopulos, Athan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-313</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that play crit. roles in thrombosis, inflammation, and vascular biol.  PAR1 is proposed to be involved in the invasive and metastatic processes of various cancers.  However, the protease responsible for activating the pro-invasive functions of PAR1 remains to be identified.  Here, the authors show that expression of PAR1 is both required and sufficient to promote growth and invasion of breast carcinoma cells in a xenograft model.  Further, the authors show that the matrix metalloprotease, MMP-1, functions as a protease agonist of PAR1 cleaving the receptor at the proper site to generate PAR1-dependent Ca2+ signals and migration.  MMP-1 activity is derived from fibroblasts and is absent from the breast cancer cells.  These results demonstrate that MMP-1 in the stromal-tumor microenvironment can alter the behavior of cancer cells through PAR1 to promote cell migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhFjuIKgkP3bVg90H21EOLACvtfcHk0liAoUAxhNGsQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Krtrk%253D&md5=307e55f39fe2ac464197625485175e52</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DBoire%26aufirst%3DA.%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DS.%26aulast%3DSherifi%26aufirst%3DS.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DPAR1%2520is%2520a%2520matrix%2520metalloprotease-1%2520receptor%2520that%2520promotes%2520invasion%2520and%2520tumorigenesis%2520of%2520breast%2520cancer%2520cells%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D303%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=643-651&author=M.+D.+Hollenbergauthor=K.+Oikonomopoulouauthor=K.+K.+Hansenauthor=M.+Saifeddineauthor=R.+Ramachandranauthor=E.+P.+Diamandis&title=Kallikreins+and+proteinase-mediated+signaling%3A+proteinase-activated+receptors+%28PARs%29+and+the+pathophysiology+of+inflammatory+diseases+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DR.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DKallikreins%2520and%2520proteinase-mediated%2520signaling%253A%2520proteinase-activated%2520receptors%2520%2528PARs%2529%2520and%2520the%2520pathophysiology%2520of%2520inflammatory%2520diseases%2520and%2520cancer%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Chackalamannil, S.</span><span> </span><span class="NLM_article-title">Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">5389</span><span class="NLM_x">–</span> <span class="NLM_lpage">5403</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603670" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5389-5403&issue=18&author=S.+Chackalamannil&title=Thrombin+receptor+%28protease+activated+receptor-1%29+antagonists+as+potent+antithrombotic+agents+with+strong+antiplatelet+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm0603670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603670%26sid%3Dliteratum%253Aachs%26aulast%3DChackalamannil%26aufirst%3DS.%26atitle%3DThrombin%2520receptor%2520%2528protease%2520activated%2520receptor-1%2529%2520antagonists%2520as%2520potent%2520antithrombotic%2520agents%2520with%2520strong%2520antiplatelet%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D18%26spage%3D5389%26epage%3D5403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Recent advances in synthesis of PAR ligands as therapeutic strategy for inflammatory diseases</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=653-663&author=B.+Severinoauthor=V.+Santagadaauthor=E.+Perissuttiauthor=F.+Fiorinoauthor=F.+Frecenteseauthor=F.+De+Angelisauthor=A.+Espositoauthor=G.+Caliendo&title=Recent+advances+in+synthesis+of+PAR+ligands+as+therapeutic+strategy+for+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DA.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520synthesis%2520of%2520PAR%2520ligands%2520as%2520therapeutic%2520strategy%2520for%2520inflammatory%2520diseases%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D653%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Ramachandran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Targeting proteinase-activated receptors: therapeutic potential and challenges</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=69-86&author=R.+Ramachandranauthor=F.+Noorbakhshauthor=K.+DeFeaauthor=M.+D.+Hollenberg&title=Targeting+proteinase-activated+receptors%3A+therapeutic+potential+and+challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DR.%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DDeFea%26aufirst%3DK.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DTargeting%2520proteinase-activated%2520receptors%253A%2520therapeutic%2520potential%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D69%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Landis, R. C.</span><span> </span><span class="NLM_article-title">Protease activated receptors: clinical relevance to hemostasis and inflammation</span> <span class="citation_source-journal">Hematol. Oncol. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.hoc.2006.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17258121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FlsVKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=103-113&author=R.+C.+Landis&title=Protease+activated+receptors%3A+clinical+relevance+to+hemostasis+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Protease activated receptors: clinical relevance to hemostasis and inflammation</span></div><div class="casAuthors">Landis R Clive</div><div class="citationInfo"><span class="NLM_cas:title">Hematology/oncology clinics of North America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-13</span>
        ISSN:<span class="NLM_cas:issn">0889-8588</span>.
    </div><div class="casAbstract">The protease-activated receptors (PARs) are a unique family of vascular receptors that confer on cells an ability to sense, and respond to, local changes in the proteolytic environment.  They are activated by serine proteases of the blood coagulation cascade, notably thrombin, and are linked to thrombotic and inflammatory effector pathways.  In surgery with cardiopulmonary bypass (CPB), thrombin is generated in large quantities in the extracorporeal circuit and can exert systemic effects by way of platelet and endothelial PAR1.  Aprotinin (Trasylol), a serine protease inhibitor used in cardiac surgery, preserves platelet function, and attenuates the inflammatory response by protecting the PAR 1 receptor on platelets and endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmvB0WSiLH30mhnSqMnvzDfW6udTcc2eZjRKlvd-1OPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FlsVKltA%253D%253D&md5=f2f5dfc88478b8963ae7e10c0eaa64f6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.hoc.2006.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hoc.2006.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DR.%2BC.%26atitle%3DProtease%2520activated%2520receptors%253A%2520clinical%2520relevance%2520to%2520hemostasis%2520and%2520inflammation%26jtitle%3DHematol.%2520Oncol.%2520Clin.%2520North%2520Am.%26date%3D2007%26volume%3D21%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Martorell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-González, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvayrac, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badimon, L.</span><span> </span><span class="NLM_article-title">Thrombin and protease-activated receptors (PARs) in atherothrombosis</span> <span class="citation_source-journal">Thromb Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18278179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=305-315&author=L.+Martorellauthor=J.+Mart%C3%ADnez-Gonz%C3%A1lezauthor=C.+Rodr%C3%ADguezauthor=M.+Gentileauthor=O.+Calvayracauthor=L.+Badimon&title=Thrombin+and+protease-activated+receptors+%28PARs%29+in+atherothrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin and protease-activated receptors (PARs) in atherothrombosis</span></div><div class="casAuthors">Martorell, Lluis; Martinez-Gonzalez, Jose; Rodriguez, Cristina; Gentile, Maurizio; Calvayrac, Olivier; Badimon, Lina</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-315</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  Thrombin is a multifunctional serine protease generated at the site of vascular injury that transforms fibrinogen into fibrin, activates blood platelets and elicits multiple effects on a variety of cell types including endothelial cells, vascular smooth muscle cells (VSMC), monocytes, T lymphocytes and fibroblasts.  Cellular effects of thrombin are mediated by protease-activated receptors (PARs), members of the G protein-coupled receptors that carry their own ligand which remains cryptic until unmasked by proteolytic cleavage.  Thrombin signalling in platelets contributes to haemostasis and thrombosis.  In normal arteries PARs are mainly expressed in endothelial cells, while their expression in VSMC is limited.  Endothelial PARs participate in the regulation of vascular tone, vascular permeability and endothelial secretory activity while in VSMC they mediate contraction, migration, proliferation, hypertrophy and prodn. of extracellular matrix.  PARs contribute to the pro-inflammatory phenotype obsd. in endothelial dysfunction and their up-regulation in VSMC seems to be a key element in the pathogenesis of atherosclerosis and restenosis.  In the last years a myriad of studies have emphasized the crit. role of PAR signalling in thrombin mediated effects in haemostasis, inflammation, cancer and embryonic development.  Lately, PARs have become a therapeutic target to inhibit platelet aggregation and thrombosis.  Early data from a clin. trial (TRA-PCI) to evaluate safety and efficacy of a potent new oral thrombin receptor antagonist (TRA) have promisingly indicated that overall TRA treatment reduces adverse event rates without an increase in bleeding risk.  In this paper we review cellular responses triggered by thrombin and their implication in vascular pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDhN6kbwyVgbVg90H21EOLACvtfcHk0ljQylJF8raEjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFKmtro%253D&md5=e6e3fb23271c1a38cb35595120773666</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartorell%26aufirst%3DL.%26aulast%3DMart%25C3%25ADnez-Gonz%25C3%25A1lez%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DGentile%26aufirst%3DM.%26aulast%3DCalvayrac%26aufirst%3DO.%26aulast%3DBadimon%26aufirst%3DL.%26atitle%3DThrombin%2520and%2520protease-activated%2520receptors%2520%2528PARs%2529%2520in%2520atherothrombosis%26jtitle%3DThromb%2520Haemostasis%26date%3D2008%26volume%3D99%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Napoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Nigris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franconi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignarro, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span> </span><span class="NLM_article-title">Protease-activated receptor-2 modulates myocardial ischemia reperfusion injury in the rat heart</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">3678</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3678-3683&author=C.+Napoliauthor=C.+Cicalaauthor=J.+L.+Wallaceauthor=F.+de+Nigrisauthor=V.+Santagadaauthor=G.+Caliendoauthor=F.+Franconiauthor=L.+J.+Ignarroauthor=G.+Cirino&title=Protease-activated+receptor-2+modulates+myocardial+ischemia+reperfusion+injury+in+the+rat+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNapoli%26aufirst%3DC.%26aulast%3DCicala%26aufirst%3DC.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3Dde%2BNigris%26aufirst%3DF.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DFranconi%26aufirst%3DF.%26aulast%3DIgnarro%26aufirst%3DL.%2BJ.%26aulast%3DCirino%26aufirst%3DG.%26atitle%3DProtease-activated%2520receptor-2%2520modulates%2520myocardial%2520ischemia%2520reperfusion%2520injury%2520in%2520the%2520rat%2520heart%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D3678%26epage%3D3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span> </span><span class="NLM_article-title">Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=1467-1473&author=N.+Vergnolleauthor=C.+K.+Derianauthor=M.+R.+D%E2%80%99Andreaauthor=M.+Steinhoffauthor=P.+Andrade-Gordon&title=Characterization+of+thrombin-induced+leukocyte+rolling+and+adherence%3A+a+potential+proinflammatory+role+for+proteinase-activated+receptor-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DM.%2BR.%26aulast%3DSteinhoff%26aufirst%3DM.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520thrombin-induced%2520leukocyte%2520rolling%2520and%2520adherence%253A%2520a%2520potential%2520proinflammatory%2520role%2520for%2520proteinase-activated%2520receptor-4%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D1467%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J .C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodjgani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">7320</span><span class="NLM_x">–</span> <span class="NLM_lpage">7329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=7320-7329&author=F.+Noorbakhshauthor=N.+Vergnolleauthor=J+.C.+McArthurauthor=C.+Silvaauthor=M.+Vodjganiauthor=P.+Andrade-Gordonauthor=M.+D.+Hollenbergauthor=C.+Power&title=Proteinase-activated+receptor-2+induction+by+neuroinflammation+prevents+neuronal+death+during+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DMcArthur%26aufirst%3DJ%2B.C.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DVodjgani%26aufirst%3DM.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DProteinase-activated%2520receptor-2%2520induction%2520by%2520neuroinflammation%2520prevents%2520neuronal%2520death%2520during%2520HIV%2520infection%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D7320%26epage%3D7329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boven, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shariat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodjgani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=425-435&author=F.+Noorbakhshauthor=S.+Tsutsuiauthor=N.+Vergnolleauthor=L.+A.+Bovenauthor=N.+Shariatauthor=M.+Vodjganiauthor=K.+G.+Warrenauthor=P.+Andrade-Gordonauthor=M.+D.+Hollenbergauthor=C.+Power&title=Proteinase-activated+receptor+2+modulates+neuroinflammation+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DTsutsui%26aufirst%3DS.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DBoven%26aufirst%3DL.%2BA.%26aulast%3DShariat%26aufirst%3DN.%26aulast%3DVodjgani%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DK.%2BG.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DProteinase-activated%2520receptor%25202%2520modulates%2520neuroinflammation%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520and%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D425%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span> </span><span class="NLM_article-title">Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1262</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjp.0702408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10205017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK1MXitFGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=1262-1268&author=N.+Vergnolleauthor=M.+D.+Hollenbergauthor=J.+L.+Wallace&title=Pro-+and+anti-inflammatory+actions+of+thrombin%3A+a+distinct+role+for+proteinase-activated+receptor-1+%28PAR1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1)</span></div><div class="casAuthors">Vergnolle, Nathalie; Hollenberg, Morley D.; Wallace, John L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1262-1268</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Thrombin has well characterized pro-inflammatory actions that have recently been suggested to occur via activation of its receptor, proteinase-activated receptor-1 (PAR1).  In the present study, we have compared the effects of thrombin to those of two peptides that selectively activate the PAR1 receptor, in a rat hindpaw edema model.  We have also examd. whether or not thrombin can exert anti-inflammatory activity in this model.  Both thrombin and the two PAR1 activating peptides induced significant edema in the rat hindpaw following subplantar injection.  The edema induced by thrombin was abolished by pre-incubation with hirudin, and was markedly reduced in rats in which mast cells were depleted through treatment with compd. 48/80 and in rats pretreated with indomethacin.  In contrast, administration of the PAR1 activating peptides produced an edema response that was not reduced by indomethacin and was only slightly reduced in rats pretreated with compd. 48/80.  Co-administration of thrombin together with a PAR1 activating receptor resulted in a significantly smaller edema response than that seen with the PAR1 activating peptide alone.  This anti-inflammatory effect of thrombin was abolished by pre-incubation with hirudin.  These results demonstrate that the pro-inflammatory effects of thrombin occur through a mast-cell-dependent mechanism i.e., at least in part, independent of activation of the PAR1 receptor.  Moreover, thrombin is able to exert anti-inflammatory effects that are also unrelated to the activation of PAR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhqGRJG08V_LVg90H21EOLACvtfcHk0ljzyM-LXdD-Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFGhsL4%253D&md5=67f15f0fecf985f703766b4b941559f6</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702408%26sid%3Dliteratum%253Aachs%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26atitle%3DPro-%2520and%2520anti-inflammatory%2520actions%2520of%2520thrombin%253A%2520a%2520distinct%2520role%2520for%2520proteinase-activated%2520receptor-1%2520%2528PAR1%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D126%26spage%3D1262%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span> </span><span class="NLM_article-title">Proteinase activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjp.0705946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15451771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFCnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=443-454&author=M.+D.+Hollenbergauthor=M.+Saifeddineauthor=S.+Sandhuauthor=S.+Houleauthor=N.+Vergnolle&title=Proteinase+activated+receptor-4%3A+evaluation+of+tethered+ligand-derived+peptides+as+probes+for+receptor+function+and+as+inflammatory+agonists+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinase-activated receptor-4: Evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo</span></div><div class="casAuthors">Hollenberg, Morley D.; Saifeddine, Mahmoud; Sandhu, Sabrina; Houle, Steeve; Vergnolle, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-454</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We evaluated the ability of a no. of peptides based on the tethered ligand sequences of human, rat and murine proteinase-activated receptor-4 (PAR4), to serve as receptor-activating probes or antagonists for bioassays carried out in vitro and for in vivo models of inflammation.  In a rat PAR4-dependent platelet aggregation assay, the relative potencies of the active sequences (AYPGKF-NH2 > GYPGKF-NH2 > GYPGFK-NH2 > GFPGKP-NH2) were consistent with an activation of PAR4.  In the aggregation assay, the reverse or partial reverse-sequence peptides (VQGPYG-NH2, YAPGKF-NH2 and FKGPYA-NH2) were inactive, while trans-cinnamoyl (Tc)-YPGKF-NH2, Tc-APGKF-NH2 and N-palmitoyl-SGRRYGHALR-NH2 (pepducin P4pal-10) were antagonists.  However, in an endothelium-dependent NO-mediated rat aorta (RA) relaxation assay and in a gastric longitudinal muscle (LM) contraction assay, these antagonist peptides were agonists as were most other peptides, with distinct orders of potencies that differed for both the RA and LM assays and from the platelet assay.  We conclude that PAR4-derived tethered ligand peptide agonists can act at receptors other than PAR4 and that a judicious choice of ligands is required to probe for PAR4 function in bioassay systems and in particular for in vivo models.  By selecting from these peptides the ones most reliably reflecting PAR4 activation (AYPGKF-NH2 as a std. agonist; YAPGKF-NH2 as a PAR4-inactive std.), we were able to establish an inflammatory role for the PAR4-activating peptides acting via a non-neurogenic mechanism in a rat paw edema model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3AnNtNU8c4bVg90H21EOLACvtfcHk0ljzyM-LXdD-Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFCnsrY%253D&md5=292facb74e34475a392b0c20d19031c3</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705946%26sid%3Dliteratum%253Aachs%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DSandhu%26aufirst%3DS.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DVergnolle%26aufirst%3DN.%26atitle%3DProteinase%2520activated%2520receptor-4%253A%2520evaluation%2520of%2520tethered%2520ligand-derived%2520peptides%2520as%2520probes%2520for%2520receptor%2520function%2520and%2520as%2520inflammatory%2520agonists%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D443%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Kelso, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembrough, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommerhoff, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrell, W. R.</span><span> </span><span class="NLM_article-title">Therapeutic promise of proteinase activated receptor-2 antagonism in joint inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.105.093807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16260582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Shu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=1017-1024&author=E.+B.+Kelsoauthor=J.+C.+Lockhartauthor=T.+Hembroughauthor=L.+Dunningauthor=R.+Plevinauthor=M.+D.+Hollenbergauthor=C.+P.+Sommerhoffauthor=J.+S.+McLeanauthor=W.+R.+Ferrell&title=Therapeutic+promise+of+proteinase+activated+receptor-2+antagonism+in+joint+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation</span></div><div class="casAuthors">Kelso, Elizabeth B.; Lockhart, John C.; Hembrough, Todd; Dunning, Lynette; Plevin, Robin; Hollenberg, Morley D.; Sommerhoff, Christian P.; McLean, John S.; Ferrell, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1017-1024</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Biol. therapies such as tumor necrosis factor-α inhibitors have advanced the treatment of rheumatoid arthritis, but one-third of patients do not respond to such therapy.  Furthermore, these inhibitors are now usually administered in combination with conventional disease-modifying antirheumatic drugs, suggesting they have not achieved their early promise.  This study investigates a novel therapeutic target, proteinase-activated receptor (PAR)-2, in joint inflammation.  Intra-articular carrageenan/kaolin (C/K) injection in mice resulted in joint swelling that was assocd. with synovial PAR2 up-regulation.  Inhibiting receptor up-regulation using small interfering RNA technol., as confirmed by immunoblotting, substantially reduced the inflammatory response in the joint.  Serine proteinase-induced joint swelling was mediated primarily via PAR2 activation, since the response to exogenous application of trypsin and tryptase was absent in PAR2 knockout mice.  Furthermore, serine proteinase inhibitors were effective anti-inflammatory agents in this model.  Disrupting proteolytic activation of PAR2 using antiserum (B5) directed to the receptor cleavage/activation site also attenuated C/K-induced inflammation, as did the similarly targeted PAR2 monoclonal antibody SAM-11.  Finally, we report the activity of a novel small mol. PAR2 antagonist, N1-3-methylbutyryl-N4-6-aminohexanoylpiperazine (ENMD-1068), that dose dependently attenuated joint inflammation.  Our findings represent a major advance in collectively identifying PAR2 as a novel target for the future treatment of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxa3LNtZEPe7Vg90H21EOLACvtfcHk0ljZVXQdQs-rEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Shu7w%253D&md5=dabbf47d3591419299a339ab24d778d0</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.093807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.093807%26sid%3Dliteratum%253Aachs%26aulast%3DKelso%26aufirst%3DE.%2BB.%26aulast%3DLockhart%26aufirst%3DJ.%2BC.%26aulast%3DHembrough%26aufirst%3DT.%26aulast%3DDunning%26aufirst%3DL.%26aulast%3DPlevin%26aufirst%3DR.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DSommerhoff%26aufirst%3DC.%2BP.%26aulast%3DMcLean%26aufirst%3DJ.%2BS.%26aulast%3DFerrell%26aufirst%3DW.%2BR.%26atitle%3DTherapeutic%2520promise%2520of%2520proteinase%2520activated%2520receptor-2%2520antagonism%2520in%2520joint%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D1017%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevigny, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneider, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarides, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azabdaftari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharifi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">Targeting a metalloprotease-PAR-1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2746</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1535-7163.MCT-08-0177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18790755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2746-2757&author=A.+Agarwalauthor=L.+Covicauthor=L.+M.+Sevignyauthor=N.+C.+Kaneiderauthor=K.+Lazaridesauthor=G.+Azabdaftariauthor=S.+Sharifiauthor=A.+Kuliopulos&title=Targeting+a+metalloprotease-PAR-1+signaling+system+with+cell-penetrating+pepducins+inhibits+angiogenesis%2C+ascites%2C+and+progression+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer</span></div><div class="casAuthors">Agarwal, Anika; Covic, Lidija; Sevigny, Leila M.; Kaneider, Nicole C.; Lazarides, Katherine; Azabdaftari, Gissou; Sharifi, Sheida; Kuliopulos, Athan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2746-2757</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Gene chip and proteomic analyses of tumors and stromal tissue has led to the identification of dozens of candidate tumor and host components potentially involved in tumor-stromal interactions, angiogenesis, and progression of invasive disease.  In particular, matrix metalloproteases (MMP) have emerged as important biomarkers and prognostic factors for invasive and metastatic cancers.  From an initial screen of benign vs. malignant patient fluids, we delineated a metalloprotease cascade comprising MMP-14, MMP-9, and MMP-1 that culminates in activation of PAR1, a G protein-coupled protease-activated receptor up-regulated in diverse cancers.  In xenograft models of advanced peritoneal ovarian cancer, PAR1-dependent angiogenesis, ascites formation, and metastasis were effectively inhibited by i.p. administration of cell-penetrating pepducins based on the intracellular loops of PAR1.  These data provide an in vivo proof-of-concept that targeting the metalloprotease-PAR1 signaling system may be a novel therapeutic approach in the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFfkPZNYyQbVg90H21EOLACvtfcHk0ljZVXQdQs-rEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7bM&md5=7766a51d60034e7812f05407f6a2427a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0177%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DSevigny%26aufirst%3DL.%2BM.%26aulast%3DKaneider%26aufirst%3DN.%2BC.%26aulast%3DLazarides%26aufirst%3DK.%26aulast%3DAzabdaftari%26aufirst%3DG.%26aulast%3DSharifi%26aufirst%3DS.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DTargeting%2520a%2520metalloprotease-PAR-1%2520signaling%2520system%2520with%2520cell-penetrating%2520pepducins%2520inhibits%2520angiogenesis%252C%2520ascites%252C%2520and%2520progression%2520of%2520ovarian%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2746%26epage%3D2757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Zigler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brantley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villares, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Eli, M.</span><span> </span><span class="NLM_article-title">PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6561</span><span class="NLM_x">–</span> <span class="NLM_lpage">6566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=6561-6566&issue=21&author=M.+Ziglerauthor=T.+Kamiyaauthor=E.+C.+Brantleyauthor=G.+J.+Villaresauthor=M.+Bar-Eli&title=PAR-1+and+thrombin%3A+the+ties+that+bind+the+microenvironment+to+melanoma+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZigler%26aufirst%3DM.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DBrantley%26aufirst%3DE.%2BC.%26aulast%3DVillares%26aufirst%3DG.%2BJ.%26aulast%3DBar-Eli%26aufirst%3DM.%26atitle%3DPAR-1%2520and%2520thrombin%253A%2520the%2520ties%2520that%2520bind%2520the%2520microenvironment%2520to%2520melanoma%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D21%26spage%3D6561%26epage%3D6566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, K. H.</span><span> </span><span class="NLM_article-title">Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1(MMP-1)</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e25103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25103&issue=9&author=S.+J.+Kimauthor=J.+Y.+Shinauthor=K.+D.+Leeauthor=Y.+K.+Baeauthor=I.+J.+Choiauthor=S.+H.+Parkauthor=K.+H.+Chun&title=Galectin-3+facilitates+cell+motility+in+gastric+cancer+by+up-regulating+protease-activated+receptor-1+%28PAR-1%29+and+matrix+metalloproteinase-1%28MMP-1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DShin%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DK.%2BD.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DChoi%26aufirst%3DI.%2BJ.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DChun%26aufirst%3DK.%2BH.%26atitle%3DGalectin-3%2520facilitates%2520cell%2520motility%2520in%2520gastric%2520cancer%2520by%2520up-regulating%2520protease-activated%2520receptor-1%2520%2528PAR-1%2529%2520and%2520matrix%2520metalloproteinase-1%2528MMP-1%2529%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D9%26spage%3De25103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Cisowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tressel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinckerhoff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, L.</span><span> </span><span class="NLM_article-title">Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ajpath.2011.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21703428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVKktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=513-523&issue=1&author=J.+Cisowskiauthor=K.+O%E2%80%99Callaghanauthor=A.+Kuliopulosauthor=J.+Yangauthor=N.+Nguyenauthor=Q.+Dengauthor=E.+Yangauthor=M.+Fogelauthor=S.+Tresselauthor=C.+Foleyauthor=A.+Agarwalauthor=S.+W.+Huntauthor=T.+McMurryauthor=L.+Brinckerhoffauthor=L.+Covic&title=Targeting+protease-activated+receptor-1+with+cell-penetrating+pepducins+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer</span></div><div class="casAuthors">Cisowski, Jaroslaw; O'Callaghan, Katie; Kuliopulos, Athan; Yang, John; Nguyen, Nga; Deng, Qing; Yang, Eric; Fogel, Michael; Tressel, Sarah; Foley, Caitlin; Agarwal, Anika; Hunt, Stephen W., III; McMurry, Tom; Brinckerhoff, Larry; Covic, Lidija</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">513-523</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Protease-activated receptors (PARs) are G-protein-coupled receptors that are activated by proteolytic cleavage and generation of a tethered ligand.  High PAR1 expression has been documented in a variety of invasive cancers of epithelial origin.  In the present study, we investigated the contribution of the four PAR family members to motility of lung carcinomas and primary tumor samples from patients.  We found that of the four PARs, only PAR1 expression was highly increased in the lung cancer cell lines.  Primary lung cancer cells isolated from patient lung tumors migrated at a 10- to 40-fold higher rate than epithelial cells isolated from nonmalignant lung tissue.  Cell-penetrating pepducin inhibitors were generated against the first (i1) and third (i3) intracellular loops of PAR1 and tested for their ability to inhibit PAR1-driven migration and extracellular regulated kinase (ERK)1/2 activity.  The PAR1 pepducins showed significant inhibition of cell migration in both primary and established cell lines similar to silencing of PAR1 expression with short hairpin RNA (shRNA).  Unlike i1 pepducins, the i3 loop pepducins were effective inhibitors of PAR1-mediated ERK activation and tumor growth.  Comparable in efficacy with Bevacizumab, monotherapy with the PAR1 i3 loop pepducin P1pa1-7 provided significant 75% inhibition of lung tumor growth in nude mice.  We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1oxSBEqnr5rVg90H21EOLACvtfcHk0lie4cCv3QFvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVKktrk%253D&md5=9dd40b86b086d47f65ed279f1768711b</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DCisowski%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DK.%26aulast%3DKuliopulos%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DFogel%26aufirst%3DM.%26aulast%3DTressel%26aufirst%3DS.%26aulast%3DFoley%26aufirst%3DC.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DHunt%26aufirst%3DS.%2BW.%26aulast%3DMcMurry%26aufirst%3DT.%26aulast%3DBrinckerhoff%26aufirst%3DL.%26aulast%3DCovic%26aufirst%3DL.%26atitle%3DTargeting%2520protease-activated%2520receptor-1%2520with%2520cell-penetrating%2520pepducins%2520in%2520lung%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26issue%3D1%26spage%3D513%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obiezu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues and is hormonally regulated</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4252</span><span class="NLM_x">–</span> <span class="NLM_lpage">4256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4252-4256&author=G.+M.+Yousefauthor=C.+V.+Obiezuauthor=L.+Y.+Luoauthor=M.+H.+Blackauthor=E.+P.+Diamandis&title=Prostase%2FKLK-L1+is+a+new+member+of+the+human+kallikrein+gene+family%2C+is+expressed+in+prostate+and+breast+tissues+and+is+hormonally+regulated"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DObiezu%26aufirst%3DC.%2BV.%26aulast%3DLuo%26aufirst%3DL.%2BY.%26aulast%3DBlack%26aufirst%3DM.%2BH.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DProstase%252FKLK-L1%2520is%2520a%2520new%2520member%2520of%2520the%2520human%2520kallikrein%2520gene%2520family%252C%2520is%2520expressed%2520in%2520prostate%2520and%2520breast%2520tissues%2520and%2520is%2520hormonally%2520regulated%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4252%26epage%3D4256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Mize, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T. K.</span><span> </span><span class="NLM_article-title">Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1043</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1541-7786.MCR-08-0096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18567807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1043-1051&author=G.+J.+Mizeauthor=W.+Wangauthor=T.+K.+Takayama&title=Prostate-specific+kallikreins-2+and+-4+enhance+the+proliferation+of+DU-145+prostate+cancer+cells+through+protease-activated+receptors-1+and+-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-Specific Kallikreins-2 and -4 Enhance the Proliferation of DU-145 Prostate Cancer Cells through Protease-Activated Receptors-1 and -2</span></div><div class="casAuthors">Mize, Gregory J.; Wang, Wenbin; Takayama, Thomas K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1043-1051</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A major characteristic of prostate cancer is the elevation of serum levels of prostate-specific antigen (hK3) and hK2, which are tumor markers that correlate with advancing stages of disease.  Including hK4, these three kallikrein serine proteases are almost exclusively produced by the prostate.  Prostate cancer cells have been recently shown to overexpress protease-activated receptors (PAR), which can be potentially activated by kallikreins and can regulate tumor growth.  Here, we show that recombinant hK2 and hK4 activate ERK1/2 signaling of DU-145, PC-3, and LNCaP prostate cancer cells, which express both PAR1 and PAR2.  These kallikreins also stimulate the proliferation of DU-145 cells.  Pretreatment of hK2 and hK4 with the serine protease inhibitor, aprotinin, blocks the responses in DU-145 cells, and small interfering RNA against PAR1 and PAR2 also inhibits ERK1/2 signaling.  To det. which PAR is activated by hK2 and hK4, a cell line that expresses a single PAR, a PAR1 knockout mouse lung fibroblast cell line transfected with PAR1 (KOLF-PAR1) or PAR2 (KOLF-PAR2) was used. hK4 activates both PAR1 and PAR2, whereas hK2 activates PAR2. hK4 generates more phosphorylated ERK1/2 than hK2.  These data indicate that prostatic kallikreins (hK2 and hK4) directly stimulate prostate cancer cell proliferation through PAR1 and/or PAR2 and may be potentially important targets for future drug therapy for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhzPUtKP2xHbVg90H21EOLACvtfcHk0lie4cCv3QFvJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVKhtbY%253D&md5=3281e3fa43234123747455183a6c00d9</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0096%26sid%3Dliteratum%253Aachs%26aulast%3DMize%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DTakayama%26aufirst%3DT.%2BK.%26atitle%3DProstate-specific%2520kallikreins-2%2520and%2520-4%2520enhance%2520the%2520proliferation%2520of%2520DU-145%2520prostate%2520cancer%2520cells%2520through%2520protease-activated%2520receptors-1%2520and%2520-2%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D1043%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mize, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T. K.</span><span> </span><span class="NLM_article-title">Kallikrein- related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1002%2Fijc.24904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19795418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGjs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=599-610&author=W.+Wangauthor=G.+J.+Mizeauthor=X.+Zhangauthor=T.+K.+Takayama&title=Kallikrein-+related+peptidase-4+initiates+tumor-stroma+interactions+in+prostate+cancer+through+protease-activated+receptor-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1</span></div><div class="casAuthors">Wang, Wenbin; Mize, Gregory J.; Zhang, Xiaotun; Takayama, Thomas K.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">599-610</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In prostate cancer, the mechanism by which the stromal cells surrounding the cancer epithelium become reactive and overproduce growth factors is unclear.  Furthermore, the precise process of how these stromal cells stimulate the cancer epithelium is not fully understood.  We recently found that protease-activated receptor-1 (PAR-1) in these reactive stromal cells is upregulated.  To investigate the role of PAR-1 in the stromal-epithelial interaction, WPMY-1 stromal myofibroblasts were stimulated with PAR-1 agonists including thrombin and PAR-1 activating peptide.  We show that WPMY-1 cells have functional PAR-1 by signaling through ERK1/2.  Conditioned media (CM) from PAR-1 agonists-treated WPMY-1 cells stimulate the epithelial LNCaP cells leading to ERK1/2 activation and cell proliferation.  Cytokine array anal. of the CM demonstrates that PAR-1 induces stromal cells to release numerous cytokines, of which interleukin 6 (IL-6) is the major factor responsible for mitogenic signaling in LNCaP cells.  CM further induces expression of prostate-specific kallikrein-related peptidase-3 (KLK3/PSA) and KLK4 in LNCaP cells via the IL-6 pathway.  Moreover, KLK4 functions as a potent agonist of PAR-1 by cleaving the receptor at the proper site on cell surface.  KLK4 triggers transmembrane signaling and upregulates IL-6 in WPMY-1 cells through PAR-1.  Immunohistochem. anal. indicates that PAR-1 is predominantly expressed in peritumoral stroma while KLK4 is produced exclusively by the epithelial cancer cells.  These data provide evidence for a novel double-paracrine mechanism whereby cancer epithelium produces KLK4 to activate PAR-1 in the surrounding stroma, which in-turn releases cytokines (IL-6) that stimulate cancer cells to proliferate and increase prodn. of KLKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfpjkSe_hWrVg90H21EOLACvtfcHk0ljww59N5WEIPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGjs7nL&md5=58c1a145e0e219982123dfde005f0a92</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2Fijc.24904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24904%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMize%26aufirst%3DG.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTakayama%26aufirst%3DT.%2BK.%26atitle%3DKallikrein-%2520related%2520peptidase-4%2520initiates%2520tumor-stroma%2520interactions%2520in%2520prostate%2520cancer%2520through%2520protease-activated%2520receptor-1%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D126%26spage%3D599%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Krenzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterziel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J.</span><span> </span><span class="NLM_article-title">Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2281</span><span class="NLM_x">–</span> <span class="NLM_lpage">2288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2011&pages=2281-2288&issue=11&author=S.+Krenzerauthor=H.+Peterzielauthor=C.+Mauchauthor=S.+I.+Blaberauthor=M.+Blaberauthor=P.+Angelauthor=J.+Hess&title=Expression+and+function+of+the+kallikrein-related+peptidase+6+in+the+human+melanoma+microenvironment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrenzer%26aufirst%3DS.%26aulast%3DPeterziel%26aufirst%3DH.%26aulast%3DMauch%26aufirst%3DC.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DAngel%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DJ.%26atitle%3DExpression%2520and%2520function%2520of%2520the%2520kallikrein-related%2520peptidase%25206%2520in%2520the%2520human%2520melanoma%2520microenvironment%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2011%26volume%3D131%26issue%3D11%26spage%3D2281%26epage%3D2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Gratio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaufort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virca, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grebenchtchikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmoul, D.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.2353%2Fajpath.2010.090523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=20056842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=1452-1461&issue=3&author=V.+Gratioauthor=N.+Beaufortauthor=L.+Seizauthor=J.+Maierauthor=G.+D.+Vircaauthor=M.+Debelaauthor=N.+Grebenchtchikovauthor=V.+Magdolenauthor=D.+Darmoul&title=Kallikrein-related+peptidase+4%3A+a+new+activator+of+the+aberrantly+expressed+protease-activated+receptor+1+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells</span></div><div class="casAuthors">Gratio, Valerie; Beaufort, Nathalie; Seiz, Lina; Maier, Josefine; Virca, G. Duke; Debela, Mekdes; Grebenchtchikov, Nicolai; Magdolen, Viktor; Darmoul, Dalila</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1452-1461</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Certain serine proteases are considered to be signaling mols. that act through protease-activated receptors (PARs).  Our recent studies have implicated PAR1 and PAR4 (thrombin receptors) and PAR2 (trypsin receptor) in human colon cancer growth.  Here we analyzed the expression of KLK4, a member of the kallikrein-related peptidase (KLK) family of serine proteases and explored whether this member can activate PAR1 and PAR2 in human colon cancer cells.  Immunohistochem. showed KLK4 expression in human colon adenocarcinomas and its absence in normal epithelia.  KLK4 (1 μmol/L) initiated loss of PAR1 and PAR2 from the HT29 cell surface as well as increased intracellular calcium transients in HT29 cells.  This KLK4-induced Ca2+ flux was abrogated after an initial challenge of the cells with TRAP (SFLLR-NH2; 100 μmol/L), which is known to desensitize PAR1 and PAR2.  Interestingly, PAR1 blocking antibody, which inhibits cleavage and activation by thrombin, dramatically reduced KLK4-induced Ca2+ influx, but blocking cleavage of PAR2 failed to attenuate the KLK4-induced Ca2+ flux.  Consistently, desensitization with AP1 (TFFLR-NH2), targeting PAR1, attenuated most of the Ca2+ flux induced by KLK4.  KLK4 also induced a rapid and significant ERK1/2 phosphorylation in HT29 cells.  Our results demonstrate, for the first time, that KLK4 is aberrantly expressed in colon cancer and capable of inducing PAR1 signaling in cancer cells.  These data suggest that KLK4 signaling via PAR1 may represent a novel pathway in colon tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvASmgGrZPf7Vg90H21EOLACvtfcHk0ljww59N5WEIPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOisbg%253D&md5=226315d2b7f5b15e91ac60cbdbd012da</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.090523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.090523%26sid%3Dliteratum%253Aachs%26aulast%3DGratio%26aufirst%3DV.%26aulast%3DBeaufort%26aufirst%3DN.%26aulast%3DSeiz%26aufirst%3DL.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DVirca%26aufirst%3DG.%2BD.%26aulast%3DDebela%26aufirst%3DM.%26aulast%3DGrebenchtchikov%26aufirst%3DN.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DDarmoul%26aufirst%3DD.%26atitle%3DKallikrein-related%2520peptidase%25204%253A%2520a%2520new%2520activator%2520of%2520the%2520aberrantly%2520expressed%2520protease-activated%2520receptor%25201%2520in%2520colon%2520cancer%2520cells%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26issue%3D3%26spage%3D1452%26epage%3D1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Gratio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virca, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmoul, D.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2625</span><span class="NLM_x">–</span> <span class="NLM_lpage">2636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ajpath.2011.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21907696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCmu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=2625-2636&issue=5&author=V.+Gratioauthor=C.+Loriotauthor=G.+D.+Vircaauthor=K.+Oikonomopoulouauthor=F.+Walkerauthor=E.+P.+Diamandisauthor=M.+D.+Hollenbergauthor=D.+Darmoul&title=Kallikrein-related+peptidase+14+acts+on+proteinase-activated+receptor+2+to+induce+signaling+pathway+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells</span></div><div class="casAuthors">Gratio, Valerie; Loriot, Celine; Virca, G. Duke; Oikonomopoulou, Katerina; Walker, Francine; Diamandis, Eleftherios P.; Hollenberg, Morley D.; Darmoul, Dalila</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2625-2636</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Serine proteinases participate in tumor growth and invasion by cleaving and activating proteinase-activated receptors (PARs).  Recent studies have implicated PAR-1 and PAR-4 (activated by thrombin) and PAR-2 (activated by trypsin but not by thrombin) in human colon cancer growth.  The endogenous activators of PARs in colon tumors, however, are still unknown.  We hypothesize that the kallikrein-related peptidase (KLK) family member KLK14, a known tumor biomarker, is produced by colonic tumors and signals to human colon cancer cells by activating PARs.  We found that i) KLK14 mRNA was present in 16 human colon cancer cell lines, ii) KLK14 protein was expressed and secreted in colon cancer cell lines, and iii) KLK14 (0.1 μmol/L) induced increases in intracellular calcium in HT29, a human colon cancer-derived cell line.  KLK14-induced calcium flux was assocd. with internalization of KLK14-mediated activation of PAR-2.  Furthermore, KLK14 induced significant extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation and HT29 cell proliferation, presumably by activating PAR-2.  A PAR-2 cleavage and activation-blocking antibody dramatically reduced KLK14-induced ERK1/2 signaling.  Finally, ectopic expression of KLK14 in human colon adenocarcinomas and its absence in normal epithelia was demonstrated by IHC anal.  These results demonstrate, for the first time, the aberrant expression of KLK14 in colon cancer and its involvement in PAR-2 receptor signaling.  Thus, KLK14 and its receptor, PAR-2, may represent therapeutic targets for colon tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLbVtuUUj7_bVg90H21EOLACvtfcHk0lhIboQtk8BeTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCmu7nP&md5=c30354bf0eb77b82b99cc764500e8742</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DGratio%26aufirst%3DV.%26aulast%3DLoriot%26aufirst%3DC.%26aulast%3DVirca%26aufirst%3DG.%2BD.%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DF.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DDarmoul%26aufirst%3DD.%26atitle%3DKallikrein-related%2520peptidase%252014%2520acts%2520on%2520proteinase-activated%2520receptor%25202%2520to%2520induce%2520signaling%2520pathway%2520in%2520colon%2520cancer%2520cells%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26issue%3D5%26spage%3D2625%26epage%3D2636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haasum, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span> </span><span class="NLM_article-title">A proteolytic cascade of kallikreins in the stratum corneum</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2005&pages=198-203&author=M.+Brattsandauthor=K.+Stefanssonauthor=C.+Lundhauthor=Y.+Haasumauthor=T.+Egelrud&title=A+proteolytic+cascade+of+kallikreins+in+the+stratum+corneum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DStefansson%26aufirst%3DK.%26aulast%3DLundh%26aufirst%3DC.%26aulast%3DHaasum%26aufirst%3DY.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DA%2520proteolytic%2520cascade%2520of%2520kallikreins%2520in%2520the%2520stratum%2520corneum%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2005%26volume%3D124%26spage%3D198%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Stefansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=761-768&author=K.+Stefanssonauthor=M.+Brattsandauthor=A.+Nyauthor=B.+Glasauthor=T.+Egelrud&title=Kallikrein-related+peptidase+14+may+be+a+major+contributor+to+trypsin-like+proteolytic+activity+in+human+stratum+corneum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DK.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DNy%26aufirst%3DA.%26aulast%3DGlas%26aufirst%3DB.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DKallikrein-related%2520peptidase%252014%2520may%2520be%2520a%2520major%2520contributor%2520to%2520trypsin-like%2520proteolytic%2520activity%2520in%2520human%2520stratum%2520corneum%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D761%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Komatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saijoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidiropoulos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takehara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2005&pages=1182-1189&author=N.+Komatsuauthor=K.+Saijohauthor=M.+Sidiropoulosauthor=B.+Tsaiauthor=M.+A.+Levesqueauthor=M.+B.+Elliottauthor=K.+Takeharaauthor=E.+P.+Diamandis&title=Quantification+of+human+tissue+kallikreins+in+the+stratum+corneum%3A+dependence+on+age+and+gender"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DN.%26aulast%3DSaijoh%26aufirst%3DK.%26aulast%3DSidiropoulos%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DB.%26aulast%3DLevesque%26aufirst%3DM.%2BA.%26aulast%3DElliott%26aufirst%3DM.%2BB.%26aulast%3DTakehara%26aufirst%3DK.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DQuantification%2520of%2520human%2520tissue%2520kallikreins%2520in%2520the%2520stratum%2520corneum%253A%2520dependence%2520on%2520age%2520and%2520gender%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2005%26volume%3D125%26spage%3D1182%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Caubet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonca, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serre, G.</span><span> </span><span class="NLM_article-title">Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/ hK7</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2004&pages=1235-1244&author=C.+Caubetauthor=N.+Joncaauthor=M.+Brattsandauthor=M.+Guerrinauthor=D.+Bernardauthor=R.+Schmidtauthor=T.+Egelrudauthor=M.+Simonauthor=G.+Serre&title=Degradation+of+corneodesmosome+proteins+by+two+serine+proteases+of+the+kallikrein+family%2C+SCTE%2FKLK5%2FhK5+and+SCCE%2FKLK7%2F+hK7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaubet%26aufirst%3DC.%26aulast%3DJonca%26aufirst%3DN.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DGuerrin%26aufirst%3DM.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DEgelrud%26aufirst%3DT.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DSerre%26aufirst%3DG.%26atitle%3DDegradation%2520of%2520corneodesmosome%2520proteins%2520by%2520two%2520serine%2520proteases%2520of%2520the%2520kallikrein%2520family%252C%2520SCTE%252FKLK5%252FhK5%2520and%2520SCCE%252FKLK7%252F%2520hK7%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2004%26volume%3D122%26spage%3D1235%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Stefansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosterman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempkes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocheva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span> </span><span class="NLM_article-title">Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2008&pages=18-25&author=K.+Stefanssonauthor=M.+Brattsandauthor=D.+Roostermanauthor=C.+Kempkesauthor=G.+Bochevaauthor=M.+Steinhoffauthor=T.+Egelrud&title=Activation+of+proteinase-activated+receptor-2+by+human+kallikrein-related+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DK.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DRoosterman%26aufirst%3DD.%26aulast%3DKempkes%26aufirst%3DC.%26aulast%3DBocheva%26aufirst%3DG.%26aulast%3DSteinhoff%26aufirst%3DM.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DActivation%2520of%2520proteinase-activated%2520receptor-2%2520by%2520human%2520kallikrein-related%2520peptidases%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2008%26volume%3D128%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Hovnanian, A.</span><span> </span><span class="NLM_article-title">Netherton syndrome: new advances in the clinic, disease mechanism and treatment</span> <span class="citation_source-journal">Exp. Rev. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1586%2Fedm.11.85" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=81-92&issue=1&author=A.+Hovnanian&title=Netherton+syndrome%3A+new+advances+in+the+clinic%2C+disease+mechanism+and+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1586%2Fedm.11.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fedm.11.85%26sid%3Dliteratum%253Aachs%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DNetherton%2520syndrome%253A%2520new%2520advances%2520in%2520the%2520clinic%252C%2520disease%2520mechanism%2520and%2520treatment%26jtitle%3DExp.%2520Rev.%2520Dermatol.%26date%3D2012%26volume%3D7%26issue%3D1%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Briot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deraison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacroix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovnanian, A.</span><span> </span><span class="NLM_article-title">Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=1135-1147&author=A.+Briotauthor=C.+Deraisonauthor=M.+Lacroixauthor=C.+Bonnartauthor=A.+Robinauthor=C.+Bessonauthor=P.+Dubusauthor=A.+Hovnanian&title=Kallikrein+5+induces+atopic+dermatitis-like+lesions+through+PAR2-mediated+thymic+stromal+lymphopoietin+expression+in+Netherton+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBriot%26aufirst%3DA.%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DLacroix%26aufirst%3DM.%26aulast%3DBonnart%26aufirst%3DC.%26aulast%3DRobin%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DC.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DKallikrein%25205%2520induces%2520atopic%2520dermatitis-like%2520lesions%2520through%2520PAR2-mediated%2520thymic%2520stromal%2520lymphopoietin%2520expression%2520in%2520Netherton%2520syndrome%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2009%26volume%3D206%26spage%3D1135%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span> </span><span class="NLM_article-title">A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.yexcr.2009.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19879874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WgtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2010&pages=376-389&issue=3&author=L.+Gaoauthor=L.+Chaoauthor=J.+Chao&title=A+novel+signaling+pathway+of+tissue+kallikrein+in+promoting+keratinocyte+migration%3A+activation+of+proteinase-activated+receptor+1+and+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: Activation of proteinase-activated receptor 1 and epidermal growth factor receptor</span></div><div class="casAuthors">Gao, Lin; Chao, Lee; Chao, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-389</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Biol. functions of tissue kallikrein (TK, KLK1) are mainly mediated by kinin generation and subsequent kinin B2 receptor activation.  In this study, we investigated the potential role of TK and its signaling pathways in cultured human keratinocyte migration and in a rat skin wound healing model.  Herein, we show that TK promoted cell migration and proliferation in a concn.- and time-dependent manner.  Inactive TK or kinin had no significant effect on cell migration.  Interestingly, cell migration induced by active TK was not blocked by icatibant or L-NAME, indicating an event independent of kinin B2 receptor and nitric oxide formation.  TK's stimulatory effect on cell migration was inhibited by small interfering RNA for proteinase-activated receptor 1 (PAR1), and by PAR1 inhibitor.  TK-induced migration was assocd. with increased phosphorylation of epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase (ERK), which was blocked by inhibition of protein kinase C (PKC), Src, EGFR and ERK.  TK-induced cell migration and EGFR phosphorylation were blocked by metalloproteinase (MMP) inhibitor, heparin, and antibodies against EGFR external domain, heparin-binding EGF-like growth factor (HB-EGF) and amphiregulin (AR).  Local application of TK promoted skin wound healing in rats, whereas icatibant and EGFR inhibitor blocked TK's effect.  Skin wound healing was further delayed by aprotinin and neutralizing TK antibody.  This study demonstrates a novel role of TK in skin wound healing and uncovers new signaling pathways mediated by TK in promoting keratinocyte migration through activation of the PAR1-PKC-Src-MMP pathway and HB-EGF/AR shedding-dependent EGFR transactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV44XUVCZ_pLVg90H21EOLACvtfcHk0ljqvg2EGCozzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WgtbvK&md5=b82e78fe7d7e9655c99c1ebb355d1969</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2009.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2009.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DJ.%26atitle%3DA%2520novel%2520signaling%2520pathway%2520of%2520tissue%2520kallikrein%2520in%2520promoting%2520keratinocyte%2520migration%253A%2520activation%2520of%2520proteinase-activated%2520receptor%25201%2520and%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2010%26volume%3D316%26issue%3D3%26spage%3D376%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petraki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soosaipillai, A. R.</span><span> </span><span class="NLM_article-title">Human kallikrein 6 as a biomarker of Alzheimer’s disease</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2FS0009-9120%2800%2900185-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=11166014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsl2ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=663-667&author=E.+P.+Diamandisauthor=G.+M.+Yousefauthor=C.+Petrakiauthor=A.+R.+Soosaipillai&title=Human+kallikrein+6+as+a+biomarker+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Human kallikrein 6 as a biomarker of Alzheimer's disease</span></div><div class="casAuthors">Diamandis, Eleftherios P.; Yousef, George M.; Petraki, Constantina; Soosaipillai, Antoninus R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a major cause of dementia in the elderly.  It is generally difficult to diagnose accurately early AD.  A few biomarkers, including τ protein and amyloid β-42, are now used as aids for diagnosis and monitoring of AD.  The aim was to examine the possible use of cerebrospinal fluid, blood and tissue, and human kallikrein 6 (hK6) concn. as a marker of AD.  We have used a highly sensitive and specific immunofluorometric procedure for measuring hK6.  We measured hK6 in tissue exts. from AD brain or normal individuals, in cerebrospinal fluids of AD patients or normals and in whole blood of AD patients and normals and compared the findings.  We have used 10 pairs of AD/normal controls in all cases.  We found that hK6 concn. is tissue exts. from AD brain were approx. 2-fold lower than exts. from normal controls.  Further, the authors found that cerebrospinal fluid hK6 concn. is approx. a 3-fold increase, in comparison to cerebrospinal fluid controls (p = 0.001).  We have also found that the whole blood hK6 concn. in AD patients is about 10 times higher than hK6 concn. in normal controls (p = 0.002).  We have immunohistochem. localized the expression of hK6 in epithelial cells of the chorioid plexus.  This is the first report describing significant elevations of cerebrospinal fluid and plasma and whole blood hK6 concn. in AD patients, in comparison to controls.  These data suggest that hK6 may constitute a new biomarker for diagnosis and monitoring of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCEJVrXNeIbVg90H21EOLACvtfcHk0lhjmX0T6WdCEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsl2ju7Y%253D&md5=217b93c357737490ae8eb590cd8df449</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2FS0009-9120%2800%2900185-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-9120%252800%252900185-5%26sid%3Dliteratum%253Aachs%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DPetraki%26aufirst%3DC.%26aulast%3DSoosaipillai%26aufirst%3DA.%2BR.%26atitle%3DHuman%2520kallikrein%25206%2520as%2520a%2520biomarker%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Biochem.%26date%3D2000%26volume%3D33%26spage%3D663%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, N.</span><span> </span><span class="NLM_article-title">Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer’s disease and Parkinson’s disease</span> <span class="citation_source-journal">Psychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1046%2Fj.1440-1819.2000.00731.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10997858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvFKmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=419-426&author=K.+Ogawaauthor=T.+Yamadaauthor=Y.+Tsujiokaauthor=J.+Taguchiauthor=M.+Takahashiauthor=Y.+Tsuboiauthor=Y.+Fujinoauthor=M.+Nakajimaauthor=T.+Yamamotoauthor=H.+Akatsuauthor=S.+Mitsuiauthor=N.+Yamaguchi&title=Localization+of+a+novel+type+trypsin-like+serine+protease%2C+neurosin%2C+in+brain+tissues+of+Alzheimer%E2%80%99s+disease+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease</span></div><div class="casAuthors">Ogawa, Kenichi; Yamada, Tatsuo; Tsujioka, Yasumi; Taguchi, Junichi; Takahashi, Mitsuo; Tsuboi, Yoshio; Fujino, Yasuhiro; Nakajima, Masashi; Yamamoto, Takashi; Akatsu, Hiroyasu; Mitsui, Sinichi; Yamaguchi, Nozomi</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry and Clinical Neurosciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-426</span>CODEN:
                <span class="NLM_cas:coden">PCNEFP</span>;
        ISSN:<span class="NLM_cas:issn">1323-1316</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Neurosin, a novel type of trypsin-like serine protease, was shown to be preferentially expressed in human brain by Northern blotting.  The authors examd. neurosin immunolabeling in the brains of neurol. normal persons and patients with Alzheimer's disease (AD) and with Parkinson's disease.  The authors also identified the expression of the mRNA for neurosin by in situ hybridization histochem. and reverse transcription-PCR (RT-PCR).  The neurosin antibody stained all of the nuclei of various cell types.  In neurons, there was also staining of neuronal cytoplasm, nucleoli and their processes.  In AD, staining of neurons with processes was rare in the damaged areas.  Some senile plaques, extracellular tangles and Lewy bodies were also pos. for neurosin.  Expression of the mRNA for neurosin was seen in neurons in the gray matter, and in microglial cells in the white matter.  In AD, the intensity of the signal for neurosin mRNA in the gray matter was decreased compared with normal control brains.  The relative levels of neurosin mRNA in AD brains, measured by RT-PCR, were lower than those in controls.  These results suggest that in human brain neurosin plays various physiol. roles, and that in AD this mol., like other serine proteases, may have a role in the degrdn. of such substances as β-amyloid protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnPi-K4fSrcrVg90H21EOLACvtfcHk0lgr-klE8nutCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvFKmurw%253D&md5=a6402198b2623ed700f47108c1c647bc</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1046%2Fj.1440-1819.2000.00731.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1440-1819.2000.00731.x%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DTsujioka%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTsuboi%26aufirst%3DY.%26aulast%3DFujino%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DMitsui%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DN.%26atitle%3DLocalization%2520of%2520a%2520novel%2520type%2520trypsin-like%2520serine%2520protease%252C%2520neurosin%252C%2520in%2520brain%2520tissues%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPsychiatry%2520Clin.%2520Neurosci.%26date%3D2000%26volume%3D54%26spage%3D419%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linbo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneve, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucchinetti, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=739-745&author=I.+A.+Scarisbrickauthor=R.+Linboauthor=A.+G.+Vandellauthor=M.+Keeganauthor=S.+I.+Blaberauthor=M.+Blaberauthor=D.+Sneveauthor=C.+F.+Lucchinettiauthor=M.+Rodriguezauthor=E.+P.+Diamandis&title=Kallikreins+are+associated+with+secondary+progressive+multiple+sclerosis+and+promote+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DLinbo%26aufirst%3DR.%26aulast%3DVandell%26aufirst%3DA.%2BG.%26aulast%3DKeegan%26aufirst%3DM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DSneve%26aufirst%3DD.%26aulast%3DLucchinetti%26aufirst%3DC.%2BF.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DKallikreins%2520are%2520associated%2520with%2520secondary%2520progressive%2520multiple%2520sclerosis%2520and%2520promote%2520neurodegeneration%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boven, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shariat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodjgani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=425-435&author=F.+Noorbakhshauthor=S.+Tsutsuiauthor=N.+Vergnolleauthor=L.+A.+Bovenauthor=N.+Shariatauthor=M.+Vodjganiauthor=K.+G.+Warrenauthor=P.+Andrade-Gordonauthor=M.+D.+Hollenbergauthor=C.+Power&title=Proteinase-activated+receptor+2+modulates+neuroinflammation+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DTsutsui%26aufirst%3DS.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DBoven%26aufirst%3DL.%2BA.%26aulast%3DShariat%26aufirst%3DN.%26aulast%3DVodjgani%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DK.%2BG.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DProteinase-activated%2520receptor%25202%2520modulates%2520neuroinflammation%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520and%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D425%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Vandell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laxmikanthan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span> </span><span class="NLM_article-title">Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1471-4159.2008.05658.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18778305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSisbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=855-870&author=A.+G.+Vandellauthor=N.+Larsonauthor=G.+Laxmikanthanauthor=M.+Panosauthor=S.+I.+Blaberauthor=M.+Blaberauthor=I.+A.+Scarisbrick&title=Protease-activated+receptor+dependent+and+independent+signaling+by+kallikreins+1+and+6+in+CNS+neuron+and+astroglial+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines</span></div><div class="casAuthors">Vandell, Alexander G.; Larson, Nadya; Laxmikanthan, Gurunathan; Panos, Michael; Blaber, Sachiko I.; Blaber, Michael; Scarisbrick, Isobel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">855-870</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">While protease-activated receptors (PARs) are known to mediate signaling events in CNS, contributing both to normal function and pathogenesis, the endogenous activators of CNS PARs are poorly characterized.  In this study, we test the hypothesis that kallikreins (KLKs) represent an important pool of endogenous activators of CNS PARs.  Specifically, KLK1 and KLK6 were examd. for their ability to evoke intracellular Ca2+ flux in a PAR-dependent fashion in NSC34 neurons and Neu7 astrocytes.  Both KLKs were also examd. for their ability to activate mitogen-activated protein kinases (extracellular signal-regulated kinases, C-Jun N-terminal kinases, and p38) and protein kinase B (AKT) intracellular signaling cascades.  Cumulatively, these studies show that KLK6, but not KLK1, signals through PARs.  KLK6 evoked intracellular Ca2+ flux was mediated by PAR1 in neurons and both PAR1 and PAR2 in astrocytes.  Importantly, both KLK1 and KLK6 altered the activation state of mitogen-activated protein kinases and AKT, suggestive of important roles for each in CNS neuron and glial differentiation, and survival.  The cellular specificity of CNS-KLK activity was underscored by observations that both proteases promoted AKT activation in astrocytes, but inhibited such signaling in neurons.  PAR1 and bradykinin receptor inhibitors were used to demonstrate that KLK1-mediated activation of extracellular signal-regulated kinases in neurons occurred in a non-PAR, bradykinin 2 (B2) receptor-dependent fashion, while similar signaling by KLK6 was mediated by the combined activation of PAR1 and B2.  Cumulatively results indicate KLK6, but not KLK1 is an activator of CNS PARs, and that both KLKs are poised to signal in a B2 receptor-dependent fashion to regulate multiple signal transduction pathways relevant to CNS physiol. function and dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAaF5hUJBz7Vg90H21EOLACvtfcHk0lhb6Nhtg0hZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSisbvI&md5=73ad6573138b0118aa6718f11b1a0a15</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05658.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05658.x%26sid%3Dliteratum%253Aachs%26aulast%3DVandell%26aufirst%3DA.%2BG.%26aulast%3DLarson%26aufirst%3DN.%26aulast%3DLaxmikanthan%26aufirst%3DG.%26aulast%3DPanos%26aufirst%3DM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26atitle%3DProtease-activated%2520receptor%2520dependent%2520and%2520independent%2520signaling%2520by%2520kallikreins%25201%2520and%25206%2520in%2520CNS%2520neuron%2520and%2520astroglial%2520cell%2520lines%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D107%26spage%3D855%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloud, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, A. L.</span><span> </span><span class="NLM_article-title">Functional role of kallikrein 6 in regulating immune cell survival</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">e18376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18376&issue=3&author=I.+A.+Scarisbrickauthor=B.+Epsteinauthor=B.+A.+Cloudauthor=H.+Yoonauthor=J.+Wuauthor=D.+N.+Rennerauthor=S.+I.+Blaberauthor=M.+Blaberauthor=A.+G.+Vandellauthor=A.+L.+Bryson&title=Functional+role+of+kallikrein+6+in+regulating+immune+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DEpstein%26aufirst%3DB.%26aulast%3DCloud%26aufirst%3DB.%2BA.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRenner%26aufirst%3DD.%2BN.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DVandell%26aufirst%3DA.%2BG.%26aulast%3DBryson%26aufirst%3DA.%2BL.%26atitle%3DFunctional%2520role%2520of%2520kallikrein%25206%2520in%2520regulating%2520immune%2520cell%2520survival%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3De18376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Goettig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span> </span><span class="NLM_article-title">Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">–</span> <span class="NLM_lpage">1567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1546-1567&author=P.+Goettigauthor=V.+Magdolenauthor=H.+Brandstetter&title=Natural+and+synthetic+inhibitors+of+kallikrein-related+peptidases+%28KLKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoettig%26aufirst%3DP.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DNatural%2520and%2520synthetic%2520inhibitors%2520of%2520kallikrein-related%2520peptidases%2520%2528KLKs%2529%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26spage%3D1546%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span> </span><span class="NLM_article-title">Natural protein proteinase inhibitors and their interaction with proteinases</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1432-1033.1992.tb16654.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=1541261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK38XhsVKnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=1992&pages=433-451&author=W.+Bodeauthor=R.+Huber&title=Natural+protein+proteinase+inhibitors+and+their+interaction+with+proteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Natural protein proteinase inhibitors and their interaction with proteinases</span></div><div class="casAuthors">Bode, Wolfram; Huber, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">433-51</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A review with 152 refs.  The substrate-like canonical inhibition by the small serine proteinase inhibitors and the product-like inhibition by the carboxypeptidase inhibitor have provided the only at. models of protein inhibitor-proteinase interactions for about 15 yr.  The recently published structures of cystatin/stefin-papain complexes and of hirudin-thrombin complexes reveal novel non-substrate-like interactions.  In addn., the structure of pro-carboxypeptidase shows a mode of inactivation which bears resemblance to proteinase/protein inhibitor systems.  Considerable progress in understanding the transition between native and cleaved states of the serpins has also been made by several recent structural studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OxE7oX-XobVg90H21EOLACvtfcHk0ljPqxZ8xh7HiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVKnu7c%253D&md5=0b095f8107fd15ea19c77e227e85f716</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1992.tb16654.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1992.tb16654.x%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26aulast%3DHuber%26aufirst%3DR.%26atitle%3DNatural%2520protein%2520proteinase%2520inhibitors%2520and%2520their%2520interaction%2520with%2520proteinases%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1992%26volume%3D204%26spage%3D433%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Fritz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Förg-Brey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppe, S. Z.</span><span> </span><span class="NLM_article-title">Leupeptin and antipain. Strong competitive inhibitors of sperm acrosomal proteinase (boar acrosin) and kallikreins from porcine organs (pancreas, submand. glands, urine)</span> <span class="citation_source-journal">Physiol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1515%2Fbchm2.1973.354.2.1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=4807834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaE2cXnvFGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=1973&pages=1304-1306&author=H.+Fritzauthor=B.+F%C3%B6rg-Breyauthor=H.+Umezawaauthor=S.+Z.+Hoppe&title=Leupeptin+and+antipain.+Strong+competitive+inhibitors+of+sperm+acrosomal+proteinase+%28boar+acrosin%29+and+kallikreins+from+porcine+organs+%28pancreas%2C+submand.+glands%2C+urine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Leupeptin and antipain.  Strong competitive inhibitors of sperm acrosomal proteinase (boar acrosin) and kallikreins from porcine organs (pancreas, submandibular glands, urine)</span></div><div class="casAuthors">Fritz, Hans; Foerg-Brey, Bruni; Umezawa, Hamao</div><div class="citationInfo"><span class="NLM_cas:title">Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">10-11</span>),
    <span class="NLM_cas:pages">1304-6</span>CODEN:
                <span class="NLM_cas:coden">HSZPAZ</span>;
        ISSN:<span class="NLM_cas:issn">0018-4888</span>.
    </div><div class="casAbstract">The microbial peptides, leupeptin and antipain, were strong competitive inhibitors of boar acrosin (Ki: 5.9 × 10-8M to 7.1 × 10-8M) and porcine pancreatic (Ki: 4.1 × 10-6M and 1.6 × 10-5M), submandibular (Ki: 1.0 × 10-5M and 3.9 × 10-5M), and urinary kallikrein (Ki: 1.3 × 10-5M and 9.5 × 10-5M).  Dixon plots were used for evaluation of the type of inhibition and the Ki-values.  Chymostatin and pepstatin did not inhibit acrosin, the porcine kallikreins, or the chymotrypsin-like proteinase from human sperm plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFjdJhVHKBO7Vg90H21EOLACvtfcHk0ljPqxZ8xh7HiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXnvFGitw%253D%253D&md5=3c0ba6b13a25bb08755f5f443c3bc392</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1515%2Fbchm2.1973.354.2.1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbchm2.1973.354.2.1304%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DH.%26aulast%3DF%25C3%25B6rg-Brey%26aufirst%3DB.%26aulast%3DUmezawa%26aufirst%3DH.%26aulast%3DHoppe%26aufirst%3DS.%2BZ.%26atitle%3DLeupeptin%2520and%2520antipain.%2520Strong%2520competitive%2520inhibitors%2520of%2520sperm%2520acrosomal%2520proteinase%2520%2528boar%2520acrosin%2529%2520and%2520kallikreins%2520from%2520porcine%2520organs%2520%2528pancreas%252C%2520submand.%2520glands%252C%2520urine%2529%26jtitle%3DPhysiol.%2520Chem.%26date%3D1973%26volume%3D354%26spage%3D1304%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloutier, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kündig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deperthes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Activation and enzymatic characterization of recombinant human kallikrein 8</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=723-731&author=T.+Kishiauthor=S.+M.+Cloutierauthor=C.+K%C3%BCndigauthor=D.+Deperthesauthor=E.+P.+Diamandis&title=Activation+and+enzymatic+characterization+of+recombinant+human+kallikrein+8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DCloutier%26aufirst%3DS.%2BM.%26aulast%3DK%25C3%25BCndig%26aufirst%3DC.%26aulast%3DDeperthes%26aufirst%3DD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DActivation%2520and%2520enzymatic%2520characterization%2520of%2520recombinant%2520human%2520kallikrein%25208%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D723%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Lovgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Airas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn<sup>2+</sup> and extracellular protease inhibitors</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1046%2Fj.1432-1327.1999.00433.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10411640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1yruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1999&pages=781-789&author=J.+Lovgrenauthor=K.+Airasauthor=H.+Lilja&title=Enzymatic+action+of+human+glandular+kallikrein+2+%28hK2%29.+Substrate+specificity+and+regulation+by+Zn2%2B+and+extracellular+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors</span></div><div class="casAuthors">Lovgren, Janita; Airas, Kalervo; Lilja, Hans</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Human glandular kallikrein 2 (hK2) is a serine protease expressed by the prostate gland with 80% identity in primary structure to prostate-specific antigen (PSA).  Recently, hK2 was shown to activate the zymogen form of PSA (proPSA) in vitro and is likely to be the physiol. activator of PSA in the prostate.  HK2 is also able to activate urokinase and effectively cleave fibronectin.  We studied the substrate specificity of hK2 and regulation of its activity by zinc and extracellular protease inhibitors present in the prostate and seminal plasma.  The enzymic activity and substrate specificity was studied by detg. hK2 cleavage sites in the major gel proteins in semen, semenogelin I and II, and by measuring hydrolysis of various tripeptide aminomethylcoumarin substrates.  HK2 cleaves substrates C-terminal of single or double arginines.  Basic amino acids were also occasionally found at several other positions N-terminal of the cleavage site.  Therefore, the substrate specificity of hK2 fits in well with that of a processor of protein precursors.  Possible regulation mechanisms were studied by testing the ability of Zn2+ and different protease inhibitors to inhibit hK2 by kinetic measurements.  Inhibitory consts. were detd. for the most effective inhibitors PCI and Zn2+.  The high affinity of PCI for hK2 (kass = 2.0 × 105 M-1·s-1) and the high concns. of PCI (4 μM) and hK2 (0.2 μM) in seminal plasma make hK2 a very likely physiol. target protease for PCI.  HK2 is inhibited by Zn2+ at micromolar concns. well below the 9 mM zinc concn. found in the prostate.  The enzymic activity of hK2 is likely to be reversibly regulated by Zn2+ in prostatic fluid.  This regulation may be impaired in CAP and advanced metastatic cancer resulting in lack of control of the hK2 activity and a need for other means of control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3msB1e5HBZrVg90H21EOLACvtfcHk0liHxxVbdzQIyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1yruro%253D&md5=de1babff1807d8180021c0e7c81c7da6</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00433.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00433.x%26sid%3Dliteratum%253Aachs%26aulast%3DLovgren%26aufirst%3DJ.%26aulast%3DAiras%26aufirst%3DK.%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DEnzymatic%2520action%2520of%2520human%2520glandular%2520kallikrein%25202%2520%2528hK2%2529.%2520Substrate%2520specificity%2520and%2520regulation%2520by%2520Zn2%252B%2520and%2520extracellular%2520protease%2520inhibitors%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D262%26spage%3D781%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Debela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettig, P.</span><span> </span><span class="NLM_article-title">Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">16086</span><span class="NLM_x">–</span> <span class="NLM_lpage">16091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=16086-16091&author=M.+Debelaauthor=P.+Hessauthor=V.+Magdolenauthor=N.+M.+Schechterauthor=T.+Steinerauthor=R.+Huberauthor=W.+Bodeauthor=P.+Goettig&title=Chymotryptic+specificity+determinants+in+the+1.0+%C3%85+structure+of+the+zinc-inhibited+human+tissue+kallikrein+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebela%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DSchechter%26aufirst%3DN.%2BM.%26aulast%3DSteiner%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBode%26aufirst%3DW.%26aulast%3DGoettig%26aufirst%3DP.%26atitle%3DChymotryptic%2520specificity%2520determinants%2520in%2520the%25201.0%2520%25C3%2585%2520structure%2520of%2520the%2520zinc-inhibited%2520human%2520tissue%2520kallikrein%25207%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D16086%26epage%3D16091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Swedberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Veer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. M.</span><span> </span><span class="NLM_article-title">Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2010&pages=357-374&author=J.+E.+Swedbergauthor=S.+J.+de+Veerauthor=J.+M.+Harris&title=Natural+and+engineered+kallikrein+inhibitors%3A+an+emerging+pharmacopoeia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwedberg%26aufirst%3DJ.%2BE.%26aulast%3Dde%2BVeer%26aufirst%3DS.%2BJ.%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26atitle%3DNatural%2520and%2520engineered%2520kallikrein%2520inhibitors%253A%2520an%2520emerging%2520pharmacopoeia%26jtitle%3DBiol.%2520Chem.%26date%3D2010%26volume%3D391%26spage%3D357%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Pimenta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Nucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Design of inhibitors for human tissue kallikrein using nonnatural aromatic and basic amino acids</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2002&pages=853-857&author=D.+Pimentaauthor=R.+L.+Meloauthor=G.+Caliendoauthor=V.+Santagadaauthor=F.+Fiorinoauthor=B.+Severinoauthor=G.+de+Nucciauthor=L.+Julianoauthor=M.+A.+Juliano&title=Design+of+inhibitors+for+human+tissue+kallikrein+using+nonnatural+aromatic+and+basic+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPimenta%26aufirst%3DD.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3Dde%2BNucci%26aufirst%3DG.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DDesign%2520of%2520inhibitors%2520for%2520human%2520tissue%2520kallikrein%2520using%2520nonnatural%2520aromatic%2520and%2520basic%2520amino%2520acids%26jtitle%3DBiol.%2520Chem.%26date%3D2002%26volume%3D383%26spage%3D853%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogac, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Specificity of S′1 and S′2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P′1 and P′2 positions in design of inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=1021-1025&author=D.+C.+Pimentaauthor=S.+E.+Fogacauthor=R.+L.+Meloauthor=L.+Julianoauthor=M.+A.+Juliano&title=Specificity+of+S%E2%80%B21+and+S%E2%80%B22+subsites+of+human+tissue+kallikrein+using+the+reactive-centre+loop+of+kallistatin%3A+the+importance+of+P%E2%80%B21+and+P%E2%80%B22+positions+in+design+of+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DFogac%26aufirst%3DS.%2BE.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DSpecificity%2520of%2520S%25E2%2580%25B21%2520and%2520S%25E2%2580%25B22%2520subsites%2520of%2520human%2520tissue%2520kallikrein%2520using%2520the%2520reactive-centre%2520loop%2520of%2520kallistatin%253A%2520the%2520importance%2520of%2520P%25E2%2580%25B21%2520and%2520P%25E2%2580%25B22%2520positions%2520in%2520design%2520of%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D1021%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Hekim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narvanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivunen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisanen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span> </span><span class="NLM_article-title">Novel peptide inhibitors of human kallikrein 2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">12555</span><span class="NLM_x">–</span> <span class="NLM_lpage">12560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12555-12560&author=C.+Hekimauthor=J.+Leinonenauthor=A.+Narvanenauthor=H.+Koistinenauthor=L.+Zhuauthor=E.+Koivunenauthor=V.+Vaisanenauthor=U.+H.+Stenman&title=Novel+peptide+inhibitors+of+human+kallikrein+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHekim%26aufirst%3DC.%26aulast%3DLeinonen%26aufirst%3DJ.%26aulast%3DNarvanen%26aufirst%3DA.%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DKoivunen%26aufirst%3DE.%26aulast%3DVaisanen%26aufirst%3DV.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26atitle%3DNovel%2520peptide%2520inhibitors%2520of%2520human%2520kallikrein%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D12555%26epage%3D12560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Pakkala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hekim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vepsäläinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Närvänen, A.</span><span> </span><span class="NLM_article-title">Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1002%2Fpsc.849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17436344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1eisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=348-353&author=M.+Pakkalaauthor=C.+Hekimauthor=P.+Soininenauthor=J.+Leinonenauthor=H.+Koistinenauthor=J.+Weisellauthor=U.+H.+Stenmanauthor=J.+Veps%C3%A4l%C3%A4inenauthor=A.+N%C3%A4rv%C3%A4nen&title=Activity+and+stability+of+human+kallikrein-2-specific+linear+and+cyclic+peptide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors</span></div><div class="casAuthors">Pakkala, Miikka; Hekim, Can; Soininen, Pasi; Leinonen, Jari; Koistinen, Hannu; Weisell, Janne; Stenman, Ulf-Hakan; Vepsalainen, Jouko; Narvanen, Ale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-353</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Human glandular kallikrein (KLK2) is a highly prostate-specific serine protease, which is mainly excreted into the seminal fluid, but part of which is also secreted into circulation from prostatic tumors.  Since the expression level of KLK2 is elevated in aggressive tumors and it has been suggested to mediate the metastasis of prostate cancer, inhibition of the proteolytic activity of KLK2 is of potential therapeutic value.  We have previously identified several KLK2-specific linear peptides by phage display technol.  Two of its synthetic analogs, ARRPAPAPG (KLK2a) and GAARFKVWWAAG (KLK2b), show specific inhibition of KLK2 but their sensitivity to proteolysis in vivo may restrict their potential use as therapeutic agents.  In order to improve the stability of the linear peptides for in vivo use, we have prepd. cyclic analogs and compared their biol. activity and their structural stability.  A series of cyclic variants with cysteine bridges were synthesized.  Cyclization inactivated one peptide (KLK2a) and its derivs., while the other peptide (KLK2b) and its derivs. remained active.  Furthermore, backbone cyclization of KLK2b improved significantly the resistance against proteolysis by trypsin and human plasma.  NMR studies showed that cyclization of the KLK2b peptides does not make the structures more rigid.  In conclusion, we have shown that backbone cyclization of KLK2 inhibitory peptides can be used to increase stability without losing biol. activity.  This should render the peptides more useful for in vivo applications, such as tumor imaging and prostate cancer targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBY_32coktHbVg90H21EOLACvtfcHk0lji8QAE9KiyrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1eisLs%253D&md5=fcf73152da918217b350e990256e4434</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1002%2Fpsc.849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.849%26sid%3Dliteratum%253Aachs%26aulast%3DPakkala%26aufirst%3DM.%26aulast%3DHekim%26aufirst%3DC.%26aulast%3DSoininen%26aufirst%3DP.%26aulast%3DLeinonen%26aufirst%3DJ.%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DWeisell%26aufirst%3DJ.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26aulast%3DVeps%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%26aulast%3DN%25C3%25A4rv%25C3%25A4nen%26aufirst%3DA.%26atitle%3DActivity%2520and%2520stability%2520of%2520human%2520kallikrein-2-specific%2520linear%2520and%2520cyclic%2520peptide%2520inhibitors%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26spage%3D348%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Hassan, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somvanshi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, S.</span><span> </span><span class="NLM_article-title">Structure-guided design of peptidic ligand for human prostate specific antigen</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1002%2Fpsc.911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17890654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=849-855&author=M.+I.+Hassanauthor=V.+Kumarauthor=R.+K.+Somvanshiauthor=S.+Deyauthor=T.+P.+Singhauthor=S.+Yadav&title=Structure-guided+design+of+peptidic+ligand+for+human+prostate+specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of peptidic ligand for human prostate specific antigen</span></div><div class="casAuthors">Hassan, Md Imtaiyaz; Kumar, Vijay; Somvanshi, Rishi K.; Dey, Sharmistha; Singh, Tej P.; Yadav, Savita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">849-855</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Prostate specific antigen (PSA) is a member of kallikrein family having serine protease-like activity and acts as a prognostic marker of prostate carcinoma.  Various studies have been performed on inhibition of PSA and such targeting requires the identification of highly selective peptide inhibitors.  PSA was purified from human seminal plasma by rapid and efficient methods, and binding studies for various peptides were carried out by fluorescence spectroscopy and SPR.  The 'S' of PSA is predominated by hydrophobic residues, and hence many hydrophobic residues, and hence many hydrophobic peptides were used to det. their binding affinity to PSA by fluorescence spectroscopy.  We obsd. that LLFW, FFKW, and KFW binds strongly to PSA, among them LLFW showed strong binding.  SPR also showed strong binding affinity of PSA toward peptides with hydrophobic and basic residues.  Among the peptides used, FWYS showed dramatic increase in binding affinity (10-10 M).  The peptides analyzed for binding studies, suggests that peptide with Trp residue along with basic or hydrophobic amino acids may be useful for designing specific inhibitors for PSA.  The strong affinities of designed peptides for PSA can be a valuable tool for designing therapeutic agents for prostate carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrM3mFX8cHabVg90H21EOLACvtfcHk0lhyPw0CH9I0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslyltQ%253D%253D&md5=ff3bcadfd1b180a5d74e39b238f098c9</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1002%2Fpsc.911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.911%26sid%3Dliteratum%253Aachs%26aulast%3DHassan%26aufirst%3DM.%2BI.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DSomvanshi%26aufirst%3DR.%2BK.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DT.%2BP.%26aulast%3DYadav%26aufirst%3DS.%26atitle%3DStructure-guided%2520design%2520of%2520peptidic%2520ligand%2520for%2520human%2520prostate%2520specific%2520antigen%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26spage%3D849%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.chembiol.2008.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18635003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=665-674&author=A.+M.+LeBeauauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Potent+and+selective+peptidyl+boronic+acid+inhibitors+of+the+serine+protease+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span></div><div class="casAuthors">LeBeau, Aaron M.; Singh, Pratap; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">665-674</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Prostate cancer cells produce high (microgram to milligram/mL) levels of the serine protease Prostate-Specific Antigen (PSA).  PSA is enzymically active in the extracellular fluid surrounding prostate cancers but is found at 1,000- to 10,000-fold lower concns. in the circulation, where it is inactivated due to binding to abundant serum protease inhibitors.  The exclusive presence of high levels of active PSA within prostate cancer sites makes PSA an attractive candidate for targeted imaging and therapeutics.  A synthetic approach based on a peptide substrate identified first peptide aldehyde and then boronic acid inhibitors of PSA.  The best of these had the sequence Cbz-Ser-Ser-Lys-Leu-(boro)Leu, with a Ki for PSA of 65 nM.  The inhibitor had a 60-fold higher Ki for chymotrypsin.  A validated model of PSA's catalytic site confirmed the crit. interactions between the inhibitor and residues within the PSA enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EWg1W1qwXbVg90H21EOLACvtfcHk0lhyPw0CH9I0OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D&md5=ff449d09c36c2f8c6402d571c4baeec7</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DPotent%2520and%2520selective%2520peptidyl%2520boronic%2520acid%2520inhibitors%2520of%2520the%2520serine%2520protease%2520prostate-specific%2520antigen%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D665%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4888</span><span class="NLM_x">–</span> <span class="NLM_lpage">4893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=4888-4893&author=A.+M.+LeBeauauthor=S.+R.+Banerjeeauthor=M.+G.+Pomperauthor=R.+C.+Measeauthor=S.+R.+Denmeade&title=Optimization+of+peptide-based+inhibitors+of+prostate-specific+antigen+%28PSA%29+as+targeted+imaging+agents+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DBanerjee%26aufirst%3DS.%2BR.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DOptimization%2520of%2520peptide-based%2520inhibitors%2520of%2520prostate-specific%2520antigen%2520%2528PSA%2529%2520as%2520targeted%2520imaging%2520agents%2520for%2520prostate%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D4888%26epage%3D4893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Molecular insights into substrate specificity of prostate specific antigen through structural modeling</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=984-993&author=P.+Singhauthor=A.+M.+LeBeauauthor=H.+Liljaauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacs&title=Molecular+insights+into+substrate+specificity+of+prostate+specific+antigen+through+structural+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DMolecular%2520insights%2520into%2520substrate%2520specificity%2520of%2520prostate%2520specific%2520antigen%2520through%2520structural%2520modeling%26jtitle%3DProteins%26date%3D2009%26volume%3D77%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Swedberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigon, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Veer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. M.</span><span> </span><span class="NLM_article-title">Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.chembiol.2009.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19549601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFamurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=633-643&author=J.+E.+Swedbergauthor=L.+V.+Nigonauthor=J.+C.+Reidauthor=S.+J.+de+Veerauthor=C.+M.+Walpoleauthor=C.+R.+Stephensauthor=T.+P.+Walshauthor=T.+K.+Takayamaauthor=J.+D.+Hooperauthor=J.+A.+Clementsauthor=A.+M.+Buckleauthor=J.+M.+Harris&title=Substrate-guided+design+of+a+potent+and+selective+kallikrein-related+peptidase+inhibitor+for+kallikrein+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-Guided Design of a Potent and Selective Kallikrein-Related Peptidase Inhibitor for Kallikrein 4</span></div><div class="casAuthors">Swedberg, Joakim E.; Nigon, Laura V.; Reid, Janet C.; de Veer, Simon J.; Walpole, Carina M.; Stephens, Carson R.; Walsh, Terry P.; Takayama, Thomas K.; Hooper, John D.; Clements, Judith A.; Buckle, Ashley M.; Harris, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-643</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Human kallikrein-related peptidase 4 (KLK4/prostase), a trypsin-like serine protease, is a potential target for prostate cancer treatment because of its proteolytic ability to activate many tumorigenic and metastatic pathways including the protease activated receptors (PARs).  Currently there are no KLK4-specific small-mol. inhibitors available for therapeutic development.  Here the authors re-engineer the naturally occurring sunflower trypsin inhibitor to selectively block the proteolytic activity of KLK4 and prevent stimulation of PAR activity in a cell-based system.  The re-engineered inhibitor was designed using a combination of mol. modeling and sparse matrix substrate screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPJTq4KsQ4vrVg90H21EOLACvtfcHk0lgWOMiTydZY1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFamurw%253D&md5=8ac6f81cbfbc1dc4bd469cfa73857608</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DSwedberg%26aufirst%3DJ.%2BE.%26aulast%3DNigon%26aufirst%3DL.%2BV.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3Dde%2BVeer%26aufirst%3DS.%2BJ.%26aulast%3DWalpole%26aufirst%3DC.%2BM.%26aulast%3DStephens%26aufirst%3DC.%2BR.%26aulast%3DWalsh%26aufirst%3DT.%2BP.%26aulast%3DTakayama%26aufirst%3DT.%2BK.%26aulast%3DHooper%26aufirst%3DJ.%2BD.%26aulast%3DClements%26aufirst%3DJ.%2BA.%26aulast%3DBuckle%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26atitle%3DSubstrate-guided%2520design%2520of%2520a%2520potent%2520and%2520selective%2520kallikrein-related%2520peptidase%2520inhibitor%2520for%2520kallikrein%25204%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Deraison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayakumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachem, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovnanian, A.</span><span> </span><span class="NLM_article-title">LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3607</span><span class="NLM_x">–</span> <span class="NLM_lpage">3619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1091%2Fmbc.E07-02-0124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17596512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=3607-3619&author=C.+Deraisonauthor=C.+Bonnartauthor=F.+Lopezauthor=C.+Bessonauthor=R.+Robinsonauthor=A.+Jayakumarauthor=F.+Wagbergauthor=M.+Brattsandauthor=J.+P.+Hachemauthor=G.+Leonardssonauthor=A.+Hovnanian&title=LEKTI+fragments+specifically+inhibit+KLK5%2C+KLK7%2C+and+KLK14+and+control+desquamation+through+a+pH-dependent+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction</span></div><div class="casAuthors">Deraison, Celine; Bonnart, Chrystelle; Lopez, Frederic; Besson, Celine; Robinson, Ross; Jayakumar, Arumugam; Wagberg, Fredrik; Brattsand, Maria; Hachem, Jean Pierre; Leonardsson, Goran; Hovnanian, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3607-3619</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">LEKTI is a 15-domain serine proteinase inhibitor whose defective expression underlies the severe autosomal recessive ichthyosiform skin disease, Netherton syndrome.  Here, the authors show that LEKTI is produced as a precursor rapidly cleaved by furin, generating a variety of single or multidomain LEKTI fragments secreted in cultured keratinocytes and in the epidermis.  The identity of these biol. fragments (D1, D5, D6, D8-D11, and D9-D15) was inferred from biochem. anal., using a panel of LEKTI antibodies.  The functional inhibitory capacity of each fragment was tested on a panel of serine proteases.  All LEKTI fragments, except D1, showed specific and differential inhibition of human kallikreins 5, 7, and 14.  The strongest inhibition was obsd. with D8-D11, toward KLK5.  Kinetics anal. revealed that this interaction is rapid and irreversible, reflecting an extremely tight binding complex.  The authors demonstrated that pH variations govern this interaction, leading to the release of active KLK5 from the complex at acidic pH.  These results identify KLK5, a key actor of the desquamation process, as the major target of LEKTI.  They disclose a new mechanism of skin homeostasis by which the epidermal pH gradient allows precisely regulated KLK5 activity and corneodesmosomal cleavage in the most superficial layers of the stratum corneum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_pZiNJq9L7Vg90H21EOLACvtfcHk0liEJb4MOuqCUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7fJ&md5=2d7e7326d29135f35d319f552744bd8d</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E07-02-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E07-02-0124%26sid%3Dliteratum%253Aachs%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DBonnart%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DF.%26aulast%3DBesson%26aufirst%3DC.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DJayakumar%26aufirst%3DA.%26aulast%3DWagberg%26aufirst%3DF.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DHachem%26aufirst%3DJ.%2BP.%26aulast%3DLeonardsson%26aufirst%3DG.%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DLEKTI%2520fragments%2520specifically%2520inhibit%2520KLK5%252C%2520KLK7%252C%2520and%2520KLK14%2520and%2520control%2520desquamation%2520through%2520a%2520pH-dependent%2520interaction%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2007%26volume%3D18%26spage%3D3607%26epage%3D3619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Vasileiou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlos, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deraison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlos, K.</span><span> </span><span class="NLM_article-title">Synthesis of the proteinase inhibitor LEKTI domain 6 by the fragment condensation method and regioselective disulfide bond formation</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=339-349&author=Z.+Vasileiouauthor=K.+K.+Barlosauthor=D.+Gatosauthor=K.+Adermannauthor=C.+Deraisonauthor=K.+Barlos&title=Synthesis+of+the+proteinase+inhibitor+LEKTI+domain+6+by+the+fragment+condensation+method+and+regioselective+disulfide+bond+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVasileiou%26aufirst%3DZ.%26aulast%3DBarlos%26aufirst%3DK.%2BK.%26aulast%3DGatos%26aufirst%3DD.%26aulast%3DAdermann%26aufirst%3DK.%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DBarlos%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520the%2520proteinase%2520inhibitor%2520LEKTI%2520domain%25206%2520by%2520the%2520fragment%2520condensation%2520method%2520and%2520regioselective%2520disulfide%2520bond%2520formation%26jtitle%3DBiopolymers%26date%3D2010%26volume%3D94%26spage%3D339%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Evans, D. M.</span><span> </span><span class="NLM_article-title">Preparation of Aminothiazoles, Including Dipeptide [(2-Aminothiazol-5-yl)methyl]amide Derivatives, as Kallikrein 1 Inhibitors</span>. Patent Appl. WO 2011051673,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+M.+Evans&title=Preparation+of+Aminothiazoles%2C+Including+Dipeptide+%5B%282-Aminothiazol-5-yl%29methyl%5Damide+Derivatives%2C+as+Kallikrein+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DPreparation%2520of%2520Aminothiazoles%252C%2520Including%2520Dipeptide%2520%255B%25282-Aminothiazol-5-yl%2529methyl%255Damide%2520Derivatives%252C%2520as%2520Kallikrein%25201%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Evans, D. M.; Allan, C. E.</span><span> </span><span class="NLM_article-title">Preparation of Azaindoles, Including Dipeptide [(1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-5-yl)methyl]amide Derivatives, as Kallikrein 1 Inhibitors</span>. Patent Appl. WO2011051672,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+M.+Evans&author=C.+E.+Allan&title=Preparation+of+Azaindoles%2C+Including+Dipeptide+%5B%281H-Pyrrolo%5B2%2C3-b%5Dpyridin-5-yl%29methyl%5Damide+Derivatives%2C+as+Kallikrein+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DPreparation%2520of%2520Azaindoles%252C%2520Including%2520Dipeptide%2520%255B%25281H-Pyrrolo%255B2%252C3-b%255Dpyridin-5-yl%2529methyl%255Damide%2520Derivatives%252C%2520as%2520Kallikrein%25201%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Evans, D. M.; Allan, C. E.; Horton, J.; Rooker, D. P.</span><span> </span><span class="NLM_article-title">Preparation of Dipeptide [(6-Aminopyridin-3-yl)methyl]amide Derivatives as Kallikrein 1 Inhibitors</span>. Patent. Appl. WO2009133348,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+M.+Evans&author=C.+E.+Allan&author=J.+Horton&author=D.+P.+Rooker&title=Preparation+of+Dipeptide+%5B%286-Aminopyridin-3-yl%29methyl%5Damide+Derivatives+as+Kallikrein+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DPreparation%2520of%2520Dipeptide%2520%255B%25286-Aminopyridin-3-yl%2529methyl%255Damide%2520Derivatives%2520as%2520Kallikrein%25201%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfahrt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattsson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahdenperä, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span> </span><span class="NLM_article-title">Novel small molecule inhibitors for prostate-specific antigen</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1143-1151&author=H.+Koistinenauthor=G.+Wohlfahrtauthor=J.+M.+Mattssonauthor=P.+Wuauthor=J.+Lahdenper%C3%A4author=U.+H.+Stenman&title=Novel+small+molecule+inhibitors+for+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DWohlfahrt%26aufirst%3DG.%26aulast%3DMattsson%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLahdenper%25C3%25A4%26aufirst%3DJ.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26atitle%3DNovel%2520small%2520molecule%2520inhibitors%2520for%2520prostate-specific%2520antigen%26jtitle%3DProstate%26date%3D2008%26volume%3D68%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Teixeira, T. S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahao, O.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devienne, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzer, L.</span><span> </span><span class="NLM_article-title">Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6112</span><span class="NLM_x">–</span> <span class="NLM_lpage">6115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6112-6115&author=T.+S.+P.+Teixeiraauthor=R.+F.+Freitasauthor=O.+Abrahaoauthor=K.+F.+Devienneauthor=L.+R.+de+Souzaauthor=S.+I.+Blaberauthor=M.+Blaberauthor=M.+Y.+Kondoauthor=M.+A.+Julianoauthor=L.+Julianoauthor=L.+Puzer&title=Biological+evaluation+and+docking+studies+of+natural+isocoumarins+as+inhibitors+for+human+kallikrein+5+and+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeixeira%26aufirst%3DT.%2BS.%2BP.%26aulast%3DFreitas%26aufirst%3DR.%2BF.%26aulast%3DAbrahao%26aufirst%3DO.%26aulast%3DDevienne%26aufirst%3DK.%2BF.%26aulast%3Dde%2BSouza%26aufirst%3DL.%2BR.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DM.%2BY.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DPuzer%26aufirst%3DL.%26atitle%3DBiological%2520evaluation%2520and%2520docking%2520studies%2520of%2520natural%2520isocoumarins%2520as%2520inhibitors%2520for%2520human%2520kallikrein%25205%2520and%25207%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6112%26epage%3D6115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckardt, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santulli, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. B.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">12257</span><span class="NLM_x">–</span> <span class="NLM_lpage">12262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12257-12262&author=P.+Andrade-Gordonauthor=B.+E.+Maryanoffauthor=C.+K.+Derianauthor=H.+C.+Zhangauthor=M.+F.+Addoauthor=A.+L.+Darrowauthor=A.+J.+Eckardtauthor=W.+J.+Hoekstraauthor=D.+F.+McComseyauthor=D.+Oksenbergauthor=E.+E.+Reynoldsauthor=R.+J.+Santulliauthor=R.+M.+Scarboroughauthor=C.+E.+Smithauthor=K.+B.+White&title=Design%2C+synthesis%2C+and+biological+characterization+of+a+peptide-mimetic+antagonist+for+a+tethered-ligand+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DDarrow%26aufirst%3DA.%2BL.%26aulast%3DEckardt%26aufirst%3DA.%2BJ.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DOksenberg%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DE.%2BE.%26aulast%3DSantulli%26aufirst%3DR.%2BJ.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DC.%2BE.%26aulast%3DWhite%26aufirst%3DK.%2BB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520characterization%2520of%2520a%2520peptide-mimetic%2520antagonist%2520for%2520a%2520tethered-ligand%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D12257%26epage%3D12262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">High affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2199-2203&author=H.+C.+Zhangauthor=K.+B.+Whiteauthor=D.+F.+McComseyauthor=M.+F.+Addoauthor=P.+Andrade-Gordonauthor=C.+K.+Derianauthor=D.+Oksenbergauthor=B.+E.+Maryanoff&title=High+affinity+thrombin+receptor+%28PAR-1%29+ligands%3A+a+new+generation+of+indole-based+peptide+mimetic+antagonists+with+a+basic+amine+at+the+C-terminus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DWhite%26aufirst%3DK.%2BB.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DOksenberg%26aufirst%3DD.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DHigh%2520affinity%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520ligands%253A%2520a%2520new%2520generation%2520of%2520indole-based%2520peptide%2520mimetic%2520antagonists%2520with%2520a%2520basic%2520amine%2520at%2520the%2520C-terminus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2199%26epage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulter, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a novel series of thrombin receptor (PAR-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000506s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1021-1024&author=H.+C.+Zhangauthor=C.+K.+Derianauthor=P.+Andrade-Gordonauthor=W.+J.+Hoekstraauthor=D.+F.+McComseyauthor=K.+B.+Whiteauthor=B.+L.+Poulterauthor=M.+F.+Addoauthor=W.+M.+Cheungauthor=B.+P.+Damianoauthor=D.+Oksenbergauthor=E.+E.+Reynoldsauthor=A.+Pandeyauthor=R.+M.+Scarboroughauthor=B.+Maryanoff&title=Discovery+and+optimization+of+a+novel+series+of+thrombin+receptor+%28PAR-1%29+antagonists%3A+potent%2C+selective+peptide+mimetics+based+on+indole+and+indazole+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm000506s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000506s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DWhite%26aufirst%3DK.%2BB.%26aulast%3DPoulter%26aufirst%3DB.%2BL.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DCheung%26aufirst%3DW.%2BM.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DOksenberg%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DE.%2BE.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DMaryanoff%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%253A%2520potent%252C%2520selective%2520peptide%2520mimetics%2520based%2520on%2520indole%2520and%2520indazole%2520templates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1021%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roviezzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6009</span><span class="NLM_x">–</span> <span class="NLM_lpage">6020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=6009-6020&author=B.+Severinoauthor=F.+Fiorinoauthor=E.+Perissuttiauthor=F.+Frecenteseauthor=G.+Cirinoauthor=F.+Roviezzoauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+and+pharmacological+evaluation+of+peptide-mimetic+protease-activated+receptor-1+antagonists+containing+novel+heterocyclic+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DRoviezzo%26aufirst%3DF.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520peptide-mimetic%2520protease-activated%2520receptor-1%2520antagonists%2520containing%2520novel%2520heterocyclic%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D6009%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresser, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talavera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane tethered peptides</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=643-648&author=L.+Covicauthor=A.+L.+Gresserauthor=J.+Talaveraauthor=S.+Swiftauthor=A.+Kuliopulos&title=Activation+and+inhibition+of+G+protein-coupled+receptors+by+cell-penetrating+membrane+tethered+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DGresser%26aufirst%3DA.%2BL.%26aulast%3DTalavera%26aufirst%3DJ.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DActivation%2520and%2520inhibition%2520of%2520G%2520protein-coupled%2520receptors%2520by%2520cell-penetrating%2520membrane%2520tethered%2520peptides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D643%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1161</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnm760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12357249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1161-1165&author=L.+Covicauthor=M.+Misraauthor=J.+Badarauthor=C.+Singhauthor=A.+Kuliopulos&title=Pepducin-based+intervention+of+thrombin-receptor+signaling+and+systemic+platelet+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation</span></div><div class="casAuthors">Covic, Lidija; Misra, Meghna; Badar, Jehangir; Singh, Christopher; Kuliopulos, Athan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1161-1165</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transmembrane signaling through G protein-coupled receptors (GPCRs) controls a diverse array of cellular processes including metab., growth, motility, adhesion, neuronal signaling and blood coagulation.  The numerous GPCRs and their key roles in both normal physiol. and disease have made them the target for more than 50% of all prescribed drugs.  GPCR agonists and antagonists act on the extracellular side of the receptors, whereas the intracellular surface has not yet been exploited for development of new therapeutic agents.  Here, we demonstrate the utility of novel cell-penetrating peptides, termed 'pepducins', that act as intracellular inhibitors of signal transference from receptors to G proteins.  Attachment of a palmitate lipid to peptides based on the third intracellular loop of protease-activated receptor 1 (PAR1) or PAR4 yielded potent inhibitors of thrombin-mediated aggregation of human platelets.  Infusion of the anti-PAR4 pepducin into mice extended bleeding time and protected against systemic platelet activation, consistent with the phenotype of PAR4-deficient mice.  We show that pepducins might be used to ascertain the physiol. roles of GPCRs and rapidly det. the potential therapeutic value of blockade of a particular signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqVW-3ft-YybVg90H21EOLACvtfcHk0lgg1QCWT6TVZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7o%253D&md5=996168b4f762891e4b80e23dc908137d</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fnm760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm760%26sid%3Dliteratum%253Aachs%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DMisra%26aufirst%3DM.%26aulast%3DBadar%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DC.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DPepducin-based%2520intervention%2520of%2520thrombin-receptor%2520signaling%2520and%2520systemic%2520platelet%2520activation%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1161%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of pyrazoloquinazolones as thrombin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2073-2078&author=H.+S.+Ahnauthor=L.+Arikauthor=G.+Boykowauthor=D.+Burnettauthor=M.+A.+Caplenauthor=M.+Czarnieckiauthor=M.+Domalskiauthor=C.+Fosterauthor=M.+Mannaauthor=A.+W.+Stamfordauthor=Y.+Wu&title=Structure%E2%80%93activity+relationships+of+pyrazoloquinazolones+as+thrombin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCaplen%26aufirst%3DM.%2BA.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDomalski%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DManna%26aufirst%3DM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520pyrazoloquinazolones%2520as%2520thrombin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2073%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Strande, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. E.</span><span> </span><span class="NLM_article-title">SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1007%2Fs00395-007-0653-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17468933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1CltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=350-358&author=J.+L.+Strandeauthor=A.+Hsuauthor=J.+Suauthor=X.+Fuauthor=G.+J.+Grossauthor=J.+E.+Baker&title=SCH+79797%2C+a+selective+PAR1+antagonist%2C+limits+myocardial+ischemia%2Freperfusion+injury+in+rat+hearts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts</span></div><div class="casAuthors">Strande, Jennifer I.; Hsu, Anna; Su, Jidong; Fu, Xiangping; Gross, Garrett J.; Baker, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-358</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">Myocardial ischemia/reperfusion (I/R) injury is partly mediated by thrombin.  In support, the functional inhibition of thrombin has been shown to decrease infarct size after I/R.  Several cellular responses to thrombin are mediated by a G-protein coupled protease-activated receptor 1 (PAR1).  However, the role of PAR1 in myocardial I/R injury has not been well characterized.  Therefore, we hypothesized that PAR1 inhibition will reduce the amt. of myocardial I/R injury.  After we detected the presence of PAR1 mRNA and protein in the rat heart by RT-PCR and immunoblot anal., we assessed the potential protective role of SCH 79797, a selective PAR1 antagonist, in two rat models of myocardial I/R injury.  SCH 79797 treatment immediately before or during ischemia reduced myocardial necrosis following I/R in the intact rat heart.  This response was dose-dependent with the optimal dose being 25 μg/kg IV.  Likewise, SCH 79797 treatment before ischemia in the isolated heart model reduced infarct size and increased ventricular recovery following I/R in the isolated heart model with an optimal concn. of 1 μM.  This redn. was abolished by a PAR1 selective agonist.  SCH 79797-induced resistance to myocardial ischemia was abolished by wortmannin, an inhibitor of PI3 kinase; L-NMA, a NOS inhibitor; and glibenclamide, a nonselective KATP channel blocker.  PAR1 activating peptide, wortmannin, L-NMA and glibenclamide alone had no effect on functional recovery or infarct size.  A single treatment of SCH 79797 administered prior to or during ischemia confers immediate cardioprotection suggesting a potential therapeutic role of PAR1 antagonist in the treatment of injury resulting from myocardial ischemia and reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog8djjnYMt3rVg90H21EOLACvtfcHk0lgzjtioHIAmZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1CltLg%253D&md5=351aa6d436aee252bbfe5c20b53692ff</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1007%2Fs00395-007-0653-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-007-0653-4%26sid%3Dliteratum%253Aachs%26aulast%3DStrande%26aufirst%3DJ.%2BL.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26aulast%3DBaker%26aufirst%3DJ.%2BE.%26atitle%3DSCH%252079797%252C%2520a%2520selective%2520PAR1%2520antagonist%252C%2520limits%2520myocardial%2520ischemia%252Freperfusion%2520injury%2520in%2520rat%2520hearts%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2007%26volume%3D102%26spage%3D350%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Zania, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritikou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flordellis, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maragoudakis, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsopanoglou, N. E.</span><span> </span><span class="NLM_article-title">Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.105.099069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16595737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=246-254&author=P.+Zaniaauthor=S.+Kritikouauthor=C.+S.+Flordellisauthor=M.+E.+Maragoudakisauthor=N.+E.+Tsopanoglou&title=Blockade+of+angiogenesis+by+small+molecule+antagonists+to+protease-activated+receptor-1%3A+association+with+endothelial+cell+growth+suppression+and+induction+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis</span></div><div class="casAuthors">Zania, Panagiota; Kritikou, Sosanna; Flordellis, Christodoulos S.; Maragoudakis, Michael E.; Tsopanoglou, Nikos E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">246-254</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Many studies support the notion that protease-activated receptor (PAR)-1 plays a pivotal role in angiogenesis.  However, direct evidence and understanding the mol. mechanisms involved were limited because PAR-1-specific antagonists have been developed only recently.  In the present study, we evaluated the effects of two well characterized PAR-1 antagonists, SCH79797 ((N-3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine)) and RWJ56110 [(αS)-N-[(1S)-3-amino-1-[[(phenylmethyl)amino]carbonyl]propyl]-α-[[[[[1-(2,6-dichlorophenyl)methyl]-3-(1-pyrrolidinylmethyl)-1H-indol-6-yl]amino]carbonyl]amino]-3,4-difluorobenzenepropanamide], in the angiogenic cascade.  These antagonists suppressed both the basic angiogenesis and that stimulated by thrombin in the chick chorioallantoic membrane model in vivo.  PAR-1 antagonists also abrogated tube formation in the in vitro Matrigel system.  These inhibitory effects were dose-dependent and well correlated with the inhibitory effects of SCH79797 and RWJ56110 on primary endothelial cell proliferation and on the initiation of apoptosis.  PAR-1 blockage resulted in inhibition of endothelial cell growth by increasing the sub-G0/G1 fraction and reducing the percentage of cells in the S phase.  Consistent with this, PAR-1 antagonists reduced incorporation of [3H]thymidine in endothelial cells and blocked the phosphorylation of extracellular signal-regulated kinases in a fashion depending specifically on PAR-1 activation.  Anal. by annexin V/propidium iodide staining and poly(ADP-ribose) polymerase cleavage revealed that PAR-1 blockage increased apoptotic cell death by a mechanism involving caspases.  These results provide further evidence that PAR-1 is a key receptor that mediates angiogenesis and suggest PAR-1 as target for developing antiangiogenic agents with potential therapeutic application in cancer and other angiogenesis-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOjzQWhrsMNLVg90H21EOLACvtfcHk0lgzjtioHIAmZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymtrk%253D&md5=e8cc7a22933224b42424dc7c8e7d270b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.099069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.099069%26sid%3Dliteratum%253Aachs%26aulast%3DZania%26aufirst%3DP.%26aulast%3DKritikou%26aufirst%3DS.%26aulast%3DFlordellis%26aufirst%3DC.%2BS.%26aulast%3DMaragoudakis%26aufirst%3DM.%2BE.%26aulast%3DTsopanoglou%26aufirst%3DN.%2BE.%26atitle%3DBlockade%2520of%2520angiogenesis%2520by%2520small%2520molecule%2520antagonists%2520to%2520protease-activated%2520receptor-1%253A%2520association%2520with%2520endothelial%2520cell%2520growth%2520suppression%2520and%2520induction%2520of%2520apoptosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D246%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Di Serio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantucci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geppetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarantini, F.</span><span> </span><span class="NLM_article-title">Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1742-7843.2007.00078.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17577318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFSqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=63-69&author=C.+Di+Serioauthor=S.+Pelleritoauthor=M.+Duarteauthor=D.+Massiauthor=A.+Naldiniauthor=G.+Cirinoauthor=I.+Prudovskyauthor=M.+Cantucciauthor=P.+Geppettiauthor=N.+Marchionniauthor=G.+Casottiauthor=F.+Tarantini&title=Protease-activated+receptor+1-selective+antagonist+SCH79797+inhibits+cell+proliferation+and+induces+apoptosis+by+a+protease-activated+receptor+1-independent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism</span></div><div class="casAuthors">Di Serio, Claudia; Pellerito, Silvia; Duarte, Maria; Massi, Daniela; Naldini, Antonella; Cirino, Giuseppe; Prudovsky, Igor; Santucci, Marco; Geppetti, Pierangelo; Marchionni, Niccolo; Masotti, Giulio; Tarantini, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Thrombin, a key mediator of blood coagulation, exerts a large no. of cellular actions via activation of a specific G-protein-coupled receptor, named protease-activated receptor 1 (PAR1).  Several studies in exptl. animals have demonstrated a therapeutic potential of small mols. with PAR1 antagonistic properties for treatment of diseases such as vascular thrombosis and arterial restenosis.  We have studied the biol. actions of one highly potent, selective PAR1 antagonist, SCH79797 (N 3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine), in vitro, and found that this compd. was able to interfere with the growth of several human and mouse cell lines, in a concn.-dependent manner.  The ED50 for growth inhibition was 75 nM, 81 nM and 116 nM for NIH 3T3, HEK 293 and A375 cells, resp.  Moreover, in NIH 3T3 cells, SCH79797 inhibited serum-stimulated activation of p44/p42 mitogen-activated protein kinases (MAPK) at low concns. and induced apoptosis at higher concns.  However, the antiproliferative and pro-apoptotic effects of SCH79797 are likely not mediated by PAR1 antagonism, as they were also obsd. in embryonic fibroblasts derived from PAR1 null mice.  These data suggest that, in view of the development of PAR1-selective antagonists as therapeutic agents, effects potentially unrelated to PAR1 inhibition should be carefully scrutinized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUVoGHKH7DZrVg90H21EOLACvtfcHk0ljQBE2oJiMd4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFSqs70%253D&md5=17a8df0ae6397d1877a4ed5c944717a7</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2007.00078.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2007.00078.x%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSerio%26aufirst%3DC.%26aulast%3DPellerito%26aufirst%3DS.%26aulast%3DDuarte%26aufirst%3DM.%26aulast%3DMassi%26aufirst%3DD.%26aulast%3DNaldini%26aufirst%3DA.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DPrudovsky%26aufirst%3DI.%26aulast%3DCantucci%26aufirst%3DM.%26aulast%3DGeppetti%26aufirst%3DP.%26aulast%3DMarchionni%26aufirst%3DN.%26aulast%3DCasotti%26aufirst%3DG.%26aulast%3DTarantini%26aufirst%3DF.%26atitle%3DProtease-activated%2520receptor%25201-selective%2520antagonist%2520SCH79797%2520inhibits%2520cell%2520proliferation%2520and%2520induces%2520apoptosis%2520by%2520a%2520protease-activated%2520receptor%25201-independent%2520mechanism%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D101%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">O’Donoghue, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiviott, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolillo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalescot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeymer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aylward, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziecina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contant, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flather, M. D.</span><span> </span><span class="NLM_article-title">Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of thrombin-acute coronary syndromes trial</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=1843-1853&author=M.+L.+O%E2%80%99Donoghueauthor=D.+L.+Bhattauthor=S.+D.+Wiviottauthor=S.+G.+Goodmanauthor=D.+J.+Fitzgeraldauthor=D.+J.+Angiolilloauthor=S.+Gotoauthor=G.+Montalescotauthor=U.+Zeymerauthor=P.+E.+Aylwardauthor=V.+Guettaauthor=D.+Dudekauthor=R.+Ziecinaauthor=C.+F.+Contantauthor=M.+D.+Flather&title=Safety+and+tolerability+of+atopaxar+in+the+treatment+of+patients+with+acute+coronary+syndromes%3A+the+lessons+from+antagonizing+the+cellular+effects+of+thrombin-acute+coronary+syndromes+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DM.%2BL.%26aulast%3DBhatt%26aufirst%3DD.%2BL.%26aulast%3DWiviott%26aufirst%3DS.%2BD.%26aulast%3DGoodman%26aufirst%3DS.%2BG.%26aulast%3DFitzgerald%26aufirst%3DD.%2BJ.%26aulast%3DAngiolillo%26aufirst%3DD.%2BJ.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DMontalescot%26aufirst%3DG.%26aulast%3DZeymer%26aufirst%3DU.%26aulast%3DAylward%26aufirst%3DP.%2BE.%26aulast%3DGuetta%26aufirst%3DV.%26aulast%3DDudek%26aufirst%3DD.%26aulast%3DZiecina%26aufirst%3DR.%26aulast%3DContant%26aufirst%3DC.%2BF.%26aulast%3DFlather%26aufirst%3DM.%2BD.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520atopaxar%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520acute%2520coronary%2520syndromes%253A%2520the%2520lessons%2520from%2520antagonizing%2520the%2520cellular%2520effects%2520of%2520thrombin-acute%2520coronary%2520syndromes%2520trial%26jtitle%3DCirculation%26date%3D2011%26volume%3D123%26spage%3D1843%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Wiviott, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flather, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donoghue, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cura, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aylward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contant, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolillo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, D. L.</span><span> </span><span class="NLM_article-title">Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of thrombin-coronary artery disease trial</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1161%2FCIRCULATIONAHA.110.001404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21502571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVynsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=1854-1863&author=S.+D.+Wiviottauthor=M.+D.+Flatherauthor=M.+L.+O%E2%80%99Donoghueauthor=S.+Gotoauthor=D.+J.+Fitzgeraldauthor=F.+Curaauthor=P.+Aylwardauthor=V.+Guettaauthor=D.+Dudekauthor=C.+F.+Contantauthor=D.+J.+Angiolilloauthor=D.+L.+Bhatt&title=Randomized+trial+of+atopaxar+in+the+treatment+of+patients+with+coronary+artery+disease%3A+the+lessons+from+antagonizing+the+cellular+effect+of+thrombin-coronary+artery+disease+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease Trial</span></div><div class="casAuthors">Wiviott, Stephen D.; Flather, Marcus D.; O'Donoghue, Michelle L.; Goto, Shinya; Fitzgerald, Desmond J.; Cura, Fernando; Aylward, Philip; Guetta, Victor; Dudek, Dariusz; Contant, Charles F.; Angiolillo, Dominick J.; Bhatt, Deepak L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1854-1863</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Thrombin is a key mediator of platelet activation.  Atopaxar is a reversible protease-activated receptor-1 antagonist that interferes with thrombin-mediated platelet effects.  The phase II Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease (LANCELOT-CAD) trial examd. the safety and tolerability of prolonged therapy with atopaxar in subjects with CAD.  Subjects with a qualifying history were randomized in a double-blind fashion to 3 dosing regimens of atopaxar (50, 100, or 200 mg daily) or matching placebo for 24 wk and followed up for an addnl. 4 wk.  The key safety end points were bleeding according to the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Thrombolysis in Myocardial Infarction (TIMI) classifications.  Secondary objectives included platelet aggregation and major adverse cardiac events.  720 Subjects were randomized.  Overall bleeding rates tended to be higher with atopaxar compared with placebo by CURE criteria (placebo, 0.6%; atopaxar, 3.9%; relative risk, 6.82, P=0.03; 50 mg, 3.9%; 100 mg, 1.7%; 200 mg, 5.9%; P for trend=0.01) and TIMI criteria (placebo, 6.8%; atopaxar, 10.3%; relative risk, 1.52, P=0.17; 50 mg, 9.9%; 100 mg, 8.1%; 200 mg, 12.9%; P for trend=0.07).  There was no difference in major bleeding.  Major adverse cardiac events were numerically lower in the atopaxar subjects.  All atopaxar regimens achieved high levels of platelet inhibition.  A transient elevation in liver transaminases and dose-dependent QTc prolongation without apparent complications were obsd. in higher-dose atopaxar treatment groups.  In this dose-ranging study of patients with CAD, treatment with atopaxar resulted in platelet inhibition, more minor bleeding, and numerically but not statistically fewer ischemic events.  Larger-scale trials are needed to det. whether these patterns translate into clin. meaningful effects.  Clin. TRIAL REGISTRATION-: URL: http://www.ClinicalTrials.gov.  Unique identifier: NCT00312052.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9dgWqGgNN8LVg90H21EOLACvtfcHk0lgEMvUAd-CO6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVynsbw%253D&md5=4e7fec4a660ef09121e0f6090cfcf86c</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.110.001404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.110.001404%26sid%3Dliteratum%253Aachs%26aulast%3DWiviott%26aufirst%3DS.%2BD.%26aulast%3DFlather%26aufirst%3DM.%2BD.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DM.%2BL.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DD.%2BJ.%26aulast%3DCura%26aufirst%3DF.%26aulast%3DAylward%26aufirst%3DP.%26aulast%3DGuetta%26aufirst%3DV.%26aulast%3DDudek%26aufirst%3DD.%26aulast%3DContant%26aufirst%3DC.%2BF.%26aulast%3DAngiolillo%26aufirst%3DD.%2BJ.%26aulast%3DBhatt%26aufirst%3DD.%2BL.%26atitle%3DRandomized%2520trial%2520of%2520atopaxar%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520coronary%2520artery%2520disease%253A%2520the%2520lessons%2520from%2520antagonizing%2520the%2520cellular%2520effect%2520of%2520thrombin-coronary%2520artery%2520disease%2520trial%26jtitle%3DCirculation%26date%3D2011%26volume%3D123%26spage%3D1854%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5884</span><span class="NLM_x">–</span> <span class="NLM_lpage">5887</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5884-5887&author=S.+Chackalamannilauthor=Y.+Xiaauthor=W.+J.+Greenleeauthor=M.+Clasbyauthor=D.+Dollerauthor=H.+Tsaiauthor=T.+Asberomauthor=M.+Czarnieckiauthor=H.+S.+Ahnauthor=G.+Boykowauthor=C.+Fosterauthor=J.+Agans-Fantuzziauthor=M.+Bryantauthor=J.+Lauauthor=M.+Chintala&title=Discovery+of+potent+orally+active+thrombin+receptor+%28protease+activated+receptor+1%29+antagonists+as+novel+antithrombotic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents</span></div><div class="casAuthors">Chackalamannil, Samuel; Xia, Yan; Greenlee, William J.; Clasby, Martin; Doller, Dario; Tsai, Hsingan; Asberom, Theodros; Czarniecki, Michael; Ahn, Ho-Sam; Boykow, George; Foster, Carolyn; Agans-Fantuzzi, Jacqueline; Bryant, Matthew; Lau, Janice; Chintala, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5884-5887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structurally novel thrombin receptor (protease activated receptor 1, PAR-1) antagonists based on the natural product himbacine are described.  The prototypical PAR-1 antagonist 55 showed a Ki of 2.7 nM in the binding assay, making it the most potent PAR-1 antagonist reported.  55 Was highly active in several functional assays, showed excellent oral bioavailability in rat and monkey models, and showed complete inhibition of agonist-induced ex vivo platelet aggregation in cynomolgus monkeys after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBkDEp-8JKu7Vg90H21EOLACvtfcHk0lgEMvUAd-CO6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wiurs%253D&md5=5fd450717cefc13b24daef89cd52054c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm0502236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502236%26sid%3Dliteratum%253Aachs%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DClasby%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520potent%2520orally%2520active%2520thrombin%2520receptor%2520%2528protease%2520activated%2520receptor%25201%2529%2520antagonists%2520as%2520novel%2520antithrombotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5884%26epage%3D5887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span> </span><span class="NLM_article-title">Himbacine derived thrombin receptor (PAR-1) antagonists: structure–activity relationship of the lactone ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4969</span><span class="NLM_x">–</span> <span class="NLM_lpage">4972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4969-4972&author=Y.+Xiaauthor=S.+Chackalamannilauthor=T.+M.+Chanauthor=M.+Czarnieckiauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=H.+Tsaiauthor=Y.+Wangauthor=H.+S.+Ahnauthor=G.+C.+Boykowauthor=A.+T.+McPhail&title=Himbacine+derived+thrombin+receptor+%28PAR-1%29+antagonists%3A+structure%E2%80%93activity+relationship+of+the+lactone+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%2BC.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26atitle%3DHimbacine%2520derived%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%253A%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520the%2520lactone%2520ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4969%26epage%3D4972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4509</span><span class="NLM_x">–</span> <span class="NLM_lpage">4513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4509-4513&author=Y.+Xiaauthor=S.+Chackalamannilauthor=M.+Clasbyauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=H.+Tsaiauthor=J.+Agans-Fantuzziauthor=H.+S.+Ahnauthor=G.+C.+Boykowauthor=Y.+Hsiehauthor=C.+A.+Lunnauthor=M.+Chintala&title=Himbacine+derived+thrombin+receptor+%28PAR-1%29+antagonists%3A+SAR+of+the+pyridine+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DClasby%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%2BC.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DLunn%26aufirst%3DC.%2BA.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DHimbacine%2520derived%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%253A%2520SAR%2520of%2520the%2520pyridine%2520ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4509%26epage%3D4513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Clasby, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, J.</span><span> </span><span class="NLM_article-title">Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1544</span><span class="NLM_x">–</span> <span class="NLM_lpage">1548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1544-1548&author=M.+C.+Clasbyauthor=S.+Chackalamannilauthor=M.+Czarnieckiauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=Y.+Linauthor=H.+Tsaiauthor=Y.+Xiaauthor=H.+S.+Ahnauthor=J.+Agans-Fantuzziauthor=G.+Boykowauthor=M.+Chintalaauthor=C.+Fosterauthor=M.+Bryantauthor=J.+Lau&title=Discovery+and+synthesis+of+a+novel+series+of+quinoline-based+thrombin+receptor+%28PAR-1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClasby%26aufirst%3DM.%2BC.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DChintala%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520quinoline-based%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1544%26epage%3D1548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Clasby, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span> </span><span class="NLM_article-title">Himbacine derived thrombin receptor antagonists: discovery of a new tricyclic core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3647</span><span class="NLM_x">–</span> <span class="NLM_lpage">3651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3647-3651&author=M.+C.+Clasbyauthor=S.+Chackalamannilauthor=M.+Czarnieckiauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=Y.+Linauthor=J.+R.+Tagatauthor=H.+Tsaiauthor=Y.+Xiaauthor=H.+S.+Ahnauthor=J.+Agans-Fantuzziauthor=G.+Boykowauthor=M.+Chintalaauthor=Y.+Hsiehauthor=A.+T.+McPhail&title=Himbacine+derived+thrombin+receptor+antagonists%3A+discovery+of+a+new+tricyclic+core"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClasby%26aufirst%3DM.%2BC.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DChintala%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26atitle%3DHimbacine%2520derived%2520thrombin%2520receptor%2520antagonists%253A%2520discovery%2520of%2520a%2520new%2520tricyclic%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3647%26epage%3D3651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Chelliah, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasby, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palamanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5147</span><span class="NLM_x">–</span> <span class="NLM_lpage">5160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070704k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5147-5160&author=M.+V.+Chelliahauthor=S.+Chackalamannilauthor=Y.+Xiaauthor=K.+Eagenauthor=M.+C.+Clasbyauthor=X.+Gaoauthor=W.+J.+Greenleeauthor=H.+S.+Ahnauthor=J.+Agans-Fantuzziauthor=G.+Boykowauthor=Y.+Hsiehauthor=M.+Bryantauthor=J.+Palamandaauthor=T.+M.+Chanauthor=D.+Heskauthor=M.+Chintala&title=Heterotricyclic+himbacine+analogs+as+potent%2C+orally+active+thrombin+receptor+%28protease+activated+receptor-1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm070704k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070704k%26sid%3Dliteratum%253Aachs%26aulast%3DChelliah%26aufirst%3DM.%2BV.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DClasby%26aufirst%3DM.%2BC.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DHeterotricyclic%2520himbacine%2520analogs%2520as%2520potent%252C%2520orally%2520active%2520thrombin%2520receptor%2520%2528protease%2520activated%2520receptor-1%2529%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5147%26epage%3D5160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palamanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3061</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800180e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ghu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3061-3064&author=S.+Chackalamannilauthor=Y.+Wangauthor=W.+J.+Greenleeauthor=Z.+Huauthor=Y.+Xiaauthor=H.+S.+Ahnauthor=G.+Boykowauthor=Y.+Hsiehauthor=J.+Palamandaauthor=J.+Agans-Fantuzziauthor=S.+Kurowskiauthor=M.+Grazianoauthor=M.+Chintala&title=Discovery+of+a+novel%2C+orally+active+himbacine-based+thrombin+receptor+antagonist+%28SCH+530348%29+with+potent+antiplatelet+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity</span></div><div class="casAuthors">Chackalamannil, Samuel; Wang, Yuguang; Greenlee, William J.; Hu, Zhiyong; Xia, Yan; Ahn, Ho-Sam; Boykow, George; Hsieh, Yunsheng; Palamanda, Jairam; Agans-Fantuzzi, Jacqueline; Kurowski, Stan; Graziano, Michael; Chintala, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3061-3064</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of an exceptionally potent series of thrombin receptor (PAR-1) antagonists based on the natural product himbacine is described.  Optimization of this series has led to the discovery of 4 (SCH 530348), a potent, oral antiplatelet agent that is currently undergoing Phase-III clin. trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKpr_OJqfuEbVg90H21EOLACvtfcHk0lg3502NHUFDjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ghu70%253D&md5=228c224e173cdb77b448943bdbec6838</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm800180e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800180e%26sid%3Dliteratum%253Aachs%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DKurowski%26aufirst%3DS.%26aulast%3DGraziano%26aufirst%3DM.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%252C%2520orally%2520active%2520himbacine-based%2520thrombin%2520receptor%2520antagonist%2520%2528SCH%2520530348%2529%2520with%2520potent%2520antiplatelet%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3061%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Becker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterno, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziada, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaffey, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Werf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veltri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. A.</span><span> </span><span class="NLM_article-title">Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=919-928&author=R.+C.+Beckerauthor=D.+J.+Moliternoauthor=L.+K.+Jenningsauthor=K.+S.+Pieperauthor=J.+Peiauthor=A.+Niedermanauthor=K.+M.+Ziadaauthor=G.+Bermanauthor=J.+Stronyauthor=D.+Josephauthor=K.+W.+Mahaffeyauthor=F.+Van+de+Werfauthor=E.+Veltriauthor=R.+A.+Harrington&title=Safety+and+tolerability+of+SCH+530348+in+patients+undergoing+non-urgent+percutaneous+coronary+intervention%3A+a+randomised%2C+double-blind%2C+placebo-controlled+phase+II+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DR.%2BC.%26aulast%3DMoliterno%26aufirst%3DD.%2BJ.%26aulast%3DJennings%26aufirst%3DL.%2BK.%26aulast%3DPieper%26aufirst%3DK.%2BS.%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DNiederman%26aufirst%3DA.%26aulast%3DZiada%26aufirst%3DK.%2BM.%26aulast%3DBerman%26aufirst%3DG.%26aulast%3DStrony%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DMahaffey%26aufirst%3DK.%2BW.%26aulast%3DVan%2Bde%2BWerf%26aufirst%3DF.%26aulast%3DVeltri%26aufirst%3DE.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520SCH%2520530348%2520in%2520patients%2520undergoing%2520non-urgent%2520percutaneous%2520coronary%2520intervention%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520phase%2520II%2520study%26jtitle%3DLancet%26date%3D2009%26volume%3D14%26spage%3D919%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">The TRA·CER Executive and Steering Committees.</span><span> </span><span class="NLM_article-title"> The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA·CER) trial: study design and rationale</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=327-334&author=The+TRA%C2%B7CER+Executive+and+Steering+Committees.&title=+The+Thrombin+Receptor+Antagonist+for+Clinical+Event+Reduction+in+Acute+Coronary+Syndrome+%28TRA%C2%B7CER%29+trial%3A+study+design+and+rationale"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D%2520The%2520Thrombin%2520Receptor%2520Antagonist%2520for%2520Clinical%2520Event%2520Reduction%2520in%2520Acute%2520Coronary%2520Syndrome%2520%2528TRA%25C2%25B7CER%2529%2520trial%253A%2520study%2520design%2520and%2520rationale%26jtitle%3DAm.%2520Heart%2520J.%26date%3D2009%26volume%3D158%26spage%3D327%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Morrow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scirica, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, K. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veltri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaca, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunwald, E.</span><span> </span><span class="NLM_article-title">Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the thrombin-receptor antagonist in secondary prevention of atherothrombotic ischemic events (TRA 2°P)-TIMI 50 trial</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=335-341&author=D.+Morrowauthor=B.+Sciricaauthor=K.+A.+A.+Foxauthor=G.+Bermanauthor=J.+Stronyauthor=E.+Veltriauthor=M.+P.+Bonacaauthor=P.+Fishauthor=C.+H.+McCabeauthor=E.+Braunwald&title=Evaluation+of+a+novel+antiplatelet+agent+for+secondary+prevention+in+patients+with+a+history+of+atherosclerotic+disease%3A+design+and+rationale+for+the+thrombin-receptor+antagonist+in+secondary+prevention+of+atherothrombotic+ischemic+events+%28TRA+2%C2%B0P%29-TIMI+50+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorrow%26aufirst%3DD.%26aulast%3DScirica%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DK.%2BA.%2BA.%26aulast%3DBerman%26aufirst%3DG.%26aulast%3DStrony%26aufirst%3DJ.%26aulast%3DVeltri%26aufirst%3DE.%26aulast%3DBonaca%26aufirst%3DM.%2BP.%26aulast%3DFish%26aufirst%3DP.%26aulast%3DMcCabe%26aufirst%3DC.%2BH.%26aulast%3DBraunwald%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520a%2520novel%2520antiplatelet%2520agent%2520for%2520secondary%2520prevention%2520in%2520patients%2520with%2520a%2520history%2520of%2520atherosclerotic%2520disease%253A%2520design%2520and%2520rationale%2520for%2520the%2520thrombin-receptor%2520antagonist%2520in%2520secondary%2520prevention%2520of%2520atherothrombotic%2520ischemic%2520events%2520%2528TRA%25202%25C2%25B0P%2529-TIMI%252050%2520trial%26jtitle%3DAm.%2520Heart%2520J.%26date%3D2009%26volume%3D158%26spage%3D335%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Discovery of a vorapaxar analog with increased aqueous solubility</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6676</span><span class="NLM_x">–</span> <span class="NLM_lpage">6679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6676-6679&author=Y.+Xiaauthor=S.+Chackalamannilauthor=W.+J.+Greenleeauthor=Y.+Wangauthor=Z.+Huauthor=Y.+Rootauthor=J.+Wongauthor=J.+Kongauthor=H.+S.+Ahnauthor=G.+Boykowauthor=Y.+Hsiehauthor=S.+Kurowskiauthor=M.+Chintala&title=Discovery+of+a+vorapaxar+analog+with+increased+aqueous+solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DRoot%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DKurowski%26aufirst%3DS.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520vorapaxar%2520analog%2520with%2520increased%2520aqueous%2520solubility%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6676%26epage%3D6679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraval, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirabel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loubat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignier, C. B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal-Wollbold, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cussac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span> </span><span class="NLM_article-title">Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5826</span><span class="NLM_x">–</span> <span class="NLM_lpage">5836</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900553j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5826-5836&author=M.+Perezauthor=M.+Lamotheauthor=C.+Maravalauthor=E.+Mirabelauthor=C.+Loubatauthor=B.+Plantyauthor=C.+Hornauthor=J.+Michauxauthor=R.+Letienneauthor=C.+B.+A.+Pignierauthor=F.+Nadal-Wollboldauthor=D.+Cussacauthor=L.+De+Vriesauthor=B.+Le+Grand&title=Discovery+of+novel+protease+activated+receptors+1+antagonists+with+potent+antithrombotic+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Protease Activated Receptors 1 Antagonists with Potent Antithrombotic Activity in Vivo</span></div><div class="casAuthors">Perez, Michel; Lamothe, Marie; Maraval, Catherine; Mirabel, Etienne; Loubat, Chantal; Planty, Bruno; Horn, Clemens; Michaux, Julien; Marrot, Sebastien; Letienne, Robert; Pignier, Christophe; Bocquet, Arnaud; Nadal-Wollbold, Florence; Cussac, Didier; de Vries, Luc; Le Grand, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5826-5836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protease activated receptors (PARs) or thrombin receptors constitute a class of G-protein-coupled receptors (GPCRs) implicated in the activation of many physiol. mechanisms.  Thus, thrombin activates many cell types such as vascular smooth muscle cells, leukocytes, endothelial cells, and platelets via activation of these receptors.  In humans, thrombin-induced platelet aggregation is mediated by one subtype of these receptors, termed PAR1.  This article describes the discovery of new antagonists of these receptors and more specifically two compds.: 2-[5-oxo-5-(4-pyridin-2-ylpiperazin-1-yl)penta-1,3-dienyl]benzonitrile 36 (F 16618) and 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone 39 (F 16357), obtained after optimization.  Both compds. are able to inhibit SFLLR-induced human platelet aggregation and display antithrombotic activity in an arteriovenous shunt model in the rat after iv or oral administration.  Furthermore, these compds. are devoid of bleeding side effects often obsd. with other types of antiplatelet drugs, which constitutes a promising advantage for this new class of antithrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP7LSnzu0p9bVg90H21EOLACvtfcHk0liKPDdAl9DblA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vK&md5=c288af1cc48500c62138f6cb7b833e76</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm900553j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900553j%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DLamothe%26aufirst%3DM.%26aulast%3DMaraval%26aufirst%3DC.%26aulast%3DMirabel%26aufirst%3DE.%26aulast%3DLoubat%26aufirst%3DC.%26aulast%3DPlanty%26aufirst%3DB.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DPignier%26aufirst%3DC.%2BB.%2BA.%26aulast%3DNadal-Wollbold%26aufirst%3DF.%26aulast%3DCussac%26aufirst%3DD.%26aulast%3DDe%2BVries%26aufirst%3DL.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520novel%2520protease%2520activated%2520receptors%25201%2520antagonists%2520with%2520potent%2520antithrombotic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5826%26epage%3D5836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leparq-Panissie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmettes, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal-Wollbold, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span> </span><span class="NLM_article-title">Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1616-1621&author=R.+Letienneauthor=A.+Leparq-Panissieauthor=Y.+Calmettesauthor=F.+Nadal-Wollboldauthor=M.+Perezauthor=B.+Le+Grand&title=Antithrombotic+activity+of+F+16618%2C+a+new+PAR1+antagonist+evaluated+in+extracorporeal+arterio-venous+shunt+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DLeparq-Panissie%26aufirst%3DA.%26aulast%3DCalmettes%26aufirst%3DY.%26aulast%3DNadal-Wollbold%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26atitle%3DAntithrombotic%2520activity%2520of%2520F%252016618%252C%2520a%2520new%2520PAR1%2520antagonist%2520evaluated%2520in%2520extracorporeal%2520arterio-venous%2520shunt%2520in%2520the%2520rat%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1616%26epage%3D1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Chieng-Yane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablayrolles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatem, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lompre, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Dufilho, M.</span><span> </span><span class="NLM_article-title">Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.110.175182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21139058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=643-651&author=P.+Chieng-Yaneauthor=A.+Bocquetauthor=R.+Letienneauthor=T.+Bourbonauthor=S.+Sablayrollesauthor=M.+Perezauthor=S.+N.+Hatemauthor=A.+M.+Lompreauthor=B.+Le+Grandauthor=M.+David-Dufilho&title=Protease-activated+receptor-1+antagonist+F+16618+reduces+arterial+restenosis+by+down-regulation+of+tumor+necrosis+factor+%CE%B1+and+matrix+metalloproteinase+7+expression%2C+migration%2C+and+proliferation+of+vascular+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells</span></div><div class="casAuthors">Chieng-Yane, Pauline; Bocquet, Arnaud; Letienne, Robert; Bourbon, Thierry; Sablayrolles, Sylvie; Perez, Michel; Hatem, Stephane Nicolas; Lompre, Anne-Marie; Le Grand, Bruno; David-Dufilho, Monique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">643-651</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Wound healing after angioplasty or stenting is assocd. with increased prodn. of thrombin and the activation of protease-activated receptor 1 (PAR1).  The aim of the present study was to examine the effects of a new selective PAR1 antagonist, 2-[5-oxo-5-(4-pyridin-2-ylpiperazin-1-yl)-penta-1,3-dienyl]-benzonitrile (F 16618), in restenosis and vascular smooth muscle cell (SMC) proliferation and migration using both in vivo and in vitro approaches.  Daily oral administration of F 16618 inhibited the restenosis induced by balloon angioplasty on rat carotid artery in a dose-dependent manner.  Furthermore, single i.v. administration of F 16618 during the angioplasty procedure was sufficient to protect the carotid artery against restenosis.  In vitro, F 16618 inhibited the growth of human aortic SMCs in a concn.-dependent manner with maximal effects at 10 μM.  At that concn., F 16618 also prevented thrombin-mediated SMC migration.  In vivo, oral and i.v. F 16618 treatments reduced by 30 and 50% the expression of the inflammatory cytokine tumor necrosis factor α (TNFα) 24 h after angioplasty.  However, only acute i.v. administration prevented the induction of matrix metalloproteinase 7 expression.  In contrast, F 16618 treatments had no effect on early SMC de-differentiation and transcription of monocyte chemoattractant protein-1 and interleukin-6 and late re-endothelialization of injured arteries.  Furthermore, F 16618 compensated for the carotid endothelium loss by inhibiting PAR1-mediated contraction.  Altogether, these data demonstrate that PAR1 antagonists such as F 16618 are a highly effective treatment of restenosis after vascular injury, by inhibition of TNFα, matrix metalloproteinase 7, and SMC migration and proliferation in addn. to an antithrombotic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopXB-r0SGYHrVg90H21EOLACvtfcHk0lhCah2oy98ZiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqsbs%253D&md5=878d7114d1b114a6a4ee4ed492d8ac69</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.175182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.175182%26sid%3Dliteratum%253Aachs%26aulast%3DChieng-Yane%26aufirst%3DP.%26aulast%3DBocquet%26aufirst%3DA.%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DBourbon%26aufirst%3DT.%26aulast%3DSablayrolles%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DHatem%26aufirst%3DS.%2BN.%26aulast%3DLompre%26aufirst%3DA.%2BM.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DDavid-Dufilho%26aufirst%3DM.%26atitle%3DProtease-activated%2520receptor-1%2520antagonist%2520F%252016618%2520reduces%2520arterial%2520restenosis%2520by%2520down-regulation%2520of%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520and%2520matrix%2520metalloproteinase%25207%2520expression%252C%2520migration%252C%2520and%2520proliferation%2520of%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Rilatt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirabel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span> </span><span class="NLM_article-title">Discovery and SAR of small molecule PAR1 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=903-906&author=I.+Rilattauthor=E.+Mirabelauthor=B.+Le+Grandauthor=M.+Perez&title=Discovery+and+SAR+of+small+molecule+PAR1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRilatt%26aufirst%3DI.%26aulast%3DMirabel%26aufirst%3DE.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPerez%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520small%2520molecule%2520PAR1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D903%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Planty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraval, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span> </span><span class="NLM_article-title">Exploration of a new series of PAR1 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1735-1739&author=B.+Plantyauthor=C.+Pujolauthor=M.+Lamotheauthor=C.+Maravalauthor=C.+Hornauthor=B.+Le+Grandauthor=M.+Perez&title=Exploration+of+a+new+series+of+PAR1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanty%26aufirst%3DB.%26aulast%3DPujol%26aufirst%3DC.%26aulast%3DLamothe%26aufirst%3DM.%26aulast%3DMaraval%26aufirst%3DC.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPerez%26aufirst%3DM.%26atitle%3DExploration%2520of%2520a%2520new%2520series%2520of%2520PAR1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1735%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellars, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baruch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span> </span><span class="NLM_article-title">A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8363</span><span class="NLM_x">–</span> <span class="NLM_lpage">8368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8363-8368&author=K.+K.+Hansenauthor=P.+M.+Shermanauthor=L.+Cellarsauthor=P.+Andrade-Gordonauthor=Z.+Panauthor=A.+Baruchauthor=J.+L.+Wallaceauthor=M.+D.+Hollenbergauthor=N.+Vergnolle&title=A+major+role+for+proteolytic+activity+and+proteinase-activated+receptor-2+in+the+pathogenesis+of+infectious+colitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DSherman%26aufirst%3DP.%2BM.%26aulast%3DCellars%26aufirst%3DL.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DBaruch%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DVergnolle%26aufirst%3DN.%26atitle%3DA%2520major%2520role%2520for%2520proteolytic%2520activity%2520and%2520proteinase-activated%2520receptor-2%2520in%2520the%2520pathogenesis%2520of%2520infectious%2520colitis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D8363%26epage%3D8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Kanke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15655521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2005&pages=212-219&issue=2&author=T.+Kankeauthor=H.+Ishiwataauthor=M.+Kabeyaauthor=M.+Sakaauthor=T.+Doiauthor=Y.+Hattoriauthor=A.+Kawabataauthor=R.+Plevin&title=2-Furoyl-LIGRL-NH2%2C+a+potent+agonist+for+proteinase-activated+receptor-2%2C+as+a+gastric+mucosal+cytoprotective+agent+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice</span></div><div class="casAuthors">Kawabata, Atsufumi; Oono, Yuko; Yonezawa, Daiki; Hiramatsu, Kaori; Inoi, Naoki; Sekiguchi, Fumiko; Honjo, Masami; Hirofuchi, Michiko; Kanke, Toru; Ishiwata, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-219</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Proteinase-activated receptor-2 (PAR2), expressed in capsaicin-sensitive sensory neurons, plays a protective role in gastric mucosa.  The present study evaluated gastric mucosal cytoprotective effect of 2-furoyl-LIGRL-NH2, a novel highly potent PAR2 agonist, in ddY mice and in wild-type and PAR2-knockout mice of C57BL/6 background.  2 Gastric mucosal injury was created by oral administration of HCl/ethanol soln. in the mice.  The native PAR2-activating peptide SLIGRL-NH2, administered i.p. at 0.3-1 μmol kg-1 in combination with amastatin, an aminopeptidase inhibitor, but not alone, revealed gastric mucosal protection in ddY mice, which was abolished by ablation of capsaicin-sensitive sensory neurons.  3 I.p. administration of 2-furoyl-LIGRL-NH2 at 0.1 μmol kg-1, without combined treatment with amastatin, exhibited gastric mucosal cytoprotective activity in ddY mice, the potency being much greater than SLIGRL-NH2 in combination with amastatin.  This effect was also inhibited by capsaicin pretreatment.  4 Oral administration of 2-furoyl-LIGRL-NH2 at 0.003-0.03 μmol kg-1 also protected against gastric mucosal lesion in a capsaicin-reversible manner in ddY mice.  5 I.p. 2-furoyl-LIGRL-NH2 at 0.1-0.3 μmol kg-1 caused prompt salivation in anesthetized mice, whereas its oral administration at 0.003-1 μmol kg-1 was incapable of eliciting salivation.  6 In wild-type, but not PAR2-knockout, mice of C57BL/6 background, i.p. administration of 2-furoyl-LIGRL-NH2 caused gastric mucosal protection.  7 Thus, 2-furoyl-LIGRL-NH2 is considered a potent and orally available gastric mucosal protective agent.  Our data also substantiate a role for PAR2 in gastric mucosal protection and the selective nature of 2-furoyl-LIGRL-NH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJJ4uwdPOe_bVg90H21EOLACvtfcHk0liy3xZieYplOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlKrtA%253D%253D&md5=5648b534ea47c179c4976bb31287f111</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DIshiwata%26aufirst%3DH.%26aulast%3DKabeya%26aufirst%3DM.%26aulast%3DSaka%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DKawabata%26aufirst%3DA.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3D2-Furoyl-LIGRL-NH2%252C%2520a%2520potent%2520agonist%2520for%2520proteinase-activated%2520receptor-2%252C%2520as%2520a%2520gastric%2520mucosal%2520cytoprotective%2520agent%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D144%26issue%3D2%26spage%3D212%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">McGuire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triggle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">2-Furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.103.064584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=14976230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=1124-1131&author=J.+J.+McGuireauthor=M.+Saifeddineauthor=C.+R.+Triggleauthor=K.+Sunauthor=M.+D.+Hollenberg&title=2-Furoyl-LIGRLO-amide%3A+a+potent+and+selective+proteinase-activated+receptor+2+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">2-Furoyl-LIGRLO-amide: A potent and selective proteinase-activated receptor 2 agonist</span></div><div class="casAuthors">McGuire, John J.; Saifeddine, Mahmoud; Triggle, Chris R.; Sun, Kimberly; Hollenberg, Morley D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-1131</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A peptide corresponding to a proteinase-activated receptor 2 (PAR2)-activating peptide with an N-terminal furoyl group modification, 2-furoyl-LIGRLO-NH2, was assessed for PAR2-dependent and -independent biol. activities.  2-Furoyl-LIGRLO-NH2 was equally effective to and 10 to 25 times more potent than SLIGRL-NH2 for increasing intracellular calcium in cultured human and rat PAR2-expressing cells, resp.  In bioassays of tissue PAR2 activity, measured as arterial vasodilation and hyperpolarization, 2-furoyl-LIGRLO-NH2 was 10 to 300 times more potent than SLIGRL-NH2.  Unlike trans-cinnamoyl-LIGRLO-NH2, 2-furoyl-LIGRLO-NH2 did not cause a prominent non-PAR2-mediated contraction of murine femoral arteries.  In conclusion, 2-furoyl-LIGRLO-NH2 represents the most potent and selective activator of PAR2 in biol. systems described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh-GCZZfqQLLVg90H21EOLACvtfcHk0liy3xZieYplOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCnt7s%253D&md5=c25d1d3335bce33b0081e2fa9f72bb93</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.064584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.064584%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DTriggle%26aufirst%3DC.%2BR.%26aulast%3DSun%26aufirst%3DK.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3D2-Furoyl-LIGRLO-amide%253A%2520a%2520potent%2520and%2520selective%2520proteinase-activated%2520receptor%25202%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D1124%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Barry, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotterell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Novel agonists and antagonists for human protease activated receptor 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7428</span><span class="NLM_x">–</span> <span class="NLM_lpage">7440</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100984y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7428-7440&author=G.+D.+Barryauthor=J.+Y.+Suenauthor=G.+T.+Leauthor=A.+Cotterellauthor=R.+C.+Reidauthor=D.+P.+Fairlie&title=Novel+agonists+and+antagonists+for+human+protease+activated+receptor+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm100984y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100984y%26sid%3Dliteratum%253Aachs%26aulast%3DBarry%26aufirst%3DG.%2BD.%26aulast%3DSuen%26aufirst%3DJ.%2BY.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DCotterell%26aufirst%3DA.%26aulast%3DReid%26aufirst%3DR.%2BC.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DNovel%2520agonists%2520and%2520antagonists%2520for%2520human%2520protease%2520activated%2520receptor%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7428%26epage%3D7440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Boitano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagner, J.</span><span> </span><span class="NLM_article-title">Potent agonists of the protease activated receptor 2 (PAR2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1308-1313&author=S.+Boitanoauthor=A.+N.+Flynnauthor=S.+M.+Schulzauthor=J.+Hoffmanauthor=T.+J.+Priceauthor=J.+Vagner&title=Potent+agonists+of+the+protease+activated+receptor+2+%28PAR2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fjm1013049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013049%26sid%3Dliteratum%253Aachs%26aulast%3DBoitano%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DA.%2BN.%26aulast%3DSchulz%26aufirst%3DS.%2BM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DVagner%26aufirst%3DJ.%26atitle%3DPotent%2520agonists%2520of%2520the%2520protease%2520activated%2520receptor%25202%2520%2528PAR2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1308%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Flynn, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillu, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asiedu, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boitano, S.</span><span> </span><span class="NLM_article-title">The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH<sub>2</sub> and 6-aminonicotinyl-LIGRL-NH<sub>2</sub> stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">19076</span><span class="NLM_x">–</span> <span class="NLM_lpage">190788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=19076-190788&issue=21&author=A.+N.+Flynnauthor=D.+V.+Tilluauthor=M.+N.+Asieduauthor=J.+Hoffmanauthor=J.+Vagnerauthor=T.+J.+Priceauthor=S.+Boitano&title=The+protease-activated+receptor-2-specific+agonists+2-aminothiazol-4-yl-LIGRL-NH2+and+6-aminonicotinyl-LIGRL-NH2+stimulate+multiple+signaling+pathways+to+induce+physiological+responses+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DA.%2BN.%26aulast%3DTillu%26aufirst%3DD.%2BV.%26aulast%3DAsiedu%26aufirst%3DM.%2BN.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DVagner%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DBoitano%26aufirst%3DS.%26atitle%3DThe%2520protease-activated%2520receptor-2-specific%2520agonists%25202-aminothiazol-4-yl-LIGRL-NH2%2520and%25206-aminonicotinyl-LIGRL-NH2%2520stimulate%2520multiple%2520signaling%2520pathways%2520to%2520induce%2520physiological%2520responses%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D21%26spage%3D19076%26epage%3D190788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Kanke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1476-5381.2009.00342.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19719785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKlsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=361-371&author=T.+Kankeauthor=M.+Kabeyaauthor=S.+Kuboauthor=S.+Kondoauthor=K.+Yasuokaauthor=J.+Tagashiraauthor=H.+Ishiwataauthor=M.+Sakaauthor=T.+Furuyamaauthor=T.+Nishiyamaauthor=T.+Doiauthor=Y.+Hattoriauthor=A.+Kawabataauthor=M.+R.+Cunninghamauthor=R.+Plevin&title=Novel+antagonists+for+proteinase-activated+receptor+2%3A+inhibition+of+cellular+and+vascular+responses+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo</span></div><div class="casAuthors">Kanke, T.; Kabeya, M.; Kubo, S.; Kondo, S.; Yasuoka, K.; Tagashira, J.; Ishiwata, H.; Saka, M.; Furuyama, T.; Nishiyama, T.; Doi, T.; Hattori, Y.; Kawabata, A.; Cunningham, M. R.; Plevin, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">361-371</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Proteinase-activated receptor 2 (PAR2) is a G-protein coupled receptor assocd. with many pathophysiol. functions.  To date, the development of PAR2 antagonists has been limited.  Here, we identify a no. of novel peptide-mimetic PAR2 antagonists and demonstrate inhibitory effects on PAR2-mediated intracellular signalling pathways and vascular responses.  The peptide-mimetic compd. library based on the structures of PAR2 agonist peptides were screened for inhibition of PAR2-induced calcium mobilisation in human keratinocytes.  Representative compds. were further evaluated by radioligand binding and inhibition of NFκB transcriptional activity and IL-8 prodn.  The vascular effects of the antagonists were assessed using in vitro and in vivo models.  Key results: Two compds., K-12940 and K-14585, significantly reduced SLIGKV-induced Ca2+ mobilisation in primary human keratinocytes.  Both K-12940 and K-14585 exhibited competitive inhibition for the binding of a high-affinity radiolabeled PAR2-ligand, [3H]-2-furoyl-LIGRL-NH2, to human PAR2 with Ki values of 1.94 and 0.627 μM resp.  NFκB reporter activity and IL-8 prodn. were also significantly reduced.  Furthermore, relaxation of rat-isolated aorta induced by SLIGRL-NH2 was inhibited competitively by K-14585.  K-14585 also significantly lowered plasma extravasation in the dorsal skin of guinea pigs and reduced salivation in mice.  K-12940 and K-14585 antagonized PAR2 competitively, resulting in inhibition of PAR2-mediated signalling and physiol. responses both in vitro and in vivo.  These peptide-mimetic PAR2 antagonists could be useful in evaluating PAR2-mediated biol. events and might lead to a new generation of therapeutically useful antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkxA51-GthUrVg90H21EOLACvtfcHk0ljUEqpRtjKf-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKlsr3P&md5=3ab8f0b7fb2c36e7989ed217f82f95df</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00342.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00342.x%26sid%3Dliteratum%253Aachs%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DKabeya%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DYasuoka%26aufirst%3DK.%26aulast%3DTagashira%26aufirst%3DJ.%26aulast%3DIshiwata%26aufirst%3DH.%26aulast%3DSaka%26aufirst%3DM.%26aulast%3DFuruyama%26aufirst%3DT.%26aulast%3DNishiyama%26aufirst%3DT.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DKawabata%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DM.%2BR.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3DNovel%2520antagonists%2520for%2520proteinase-activated%2520receptor%25202%253A%2520inhibition%2520of%2520cellular%2520and%2520vascular%2520responses%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Goh, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1476-5381.2009.00415.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19917067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Whtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1695-1704&author=F.+G.+Gohauthor=P.+Y.+Ngauthor=M.+Nilssonauthor=T.+Kankeauthor=R.+Plevin&title=Dual+effect+of+the+novel+peptide+antagonist+K-14585+on+proteinase-activated+receptor-2-mediated+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling</span></div><div class="casAuthors">Goh, Fui Goon; Ng, Pei Yuen; Nilsson, Mary; Kanke, Toru; Plevin, Robin</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1695-1704</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Here we have examd. the effects of the novel peptide antagonist K-14585 on proteinase-activated receptor (PAR)2-mediated intracellular signalling events.  Exptl. approach: Using NCTC2544 cells expressing PAR2, we assessed the effects of K-14585 on PAR2-mediated [3H] inositol phosphate accumulation, MAP kinase activation, p65 NFκB phosphorylation and DNA binding and IL-8 prodn.  Key results: Pretreatment with K-14585 (5 μM) inhibited [3H] inositol phosphate levels stimulated by PAR2-activating peptide Ser-Leu-Ile-Gly-Lys-Val (SLIGKV-OH) in PAR2-expressing NCTC2544 cells.  K-14585 pretreatment did not influence PAR2-mediated extracellular regulated kinase activation but inhibited p38 MAP kinase phosphorylation.  At a higher concn. (30 μM), K-14585 alone stimulated p38 MAP kinase activation.  These effects were replicated in EAhy926 cells, endogenously expressing PAR2, but not in parental or PAR4-expressing NCTC2544 cells, suggesting these effects were PAR2-dependent.  SLIGKV-mediated stimulation of p38 MAP kinase phosphorylation was substantially reduced by the Gq/11 inhibitor YM-254890, without affecting K-14585-mediated phosphorylation.  Pretreatment with K-14585 inhibited PAR2-mediated p65 NF-κB phosphorylation and NFκB-DNA binding.  K-14585 (30 μM) alone stimulated comparable NFβB reporter activity to SLIGKV-OH.  K-14585 inhibited SLIGKV-stimulated IL-8 prodn., but given alone increased IL-8.  While SLIGKV-induced IL-8 formation was reduced by both SB203580 and YM-254890, the response to K-14585 was sensitive to SB203580 but not YM-254890.  Conclusions and implications: These data reveal that K-14585 has a duality of action functioning both as an antagonist and agonist due to either partial agonist actions or possible agonist-directed signalling.  The data also suggest two modes of p38 MAP kinase activation emanating from PAR2, one Gq/11-dependent and the other Gq/11-independent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru7YeTp95Mq7Vg90H21EOLACvtfcHk0ljUEqpRtjKf-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Whtr%252FM&md5=d6301cb6ad0a18fe58c7425a9c6bee8a</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00415.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00415.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoh%26aufirst%3DF.%2BG.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3DDual%2520effect%2520of%2520the%2520novel%2520peptide%2520antagonist%2520K-14585%2520on%2520proteinase-activated%2520receptor-2-mediated%2520signalling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1695%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Suen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halili, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotterell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1476-5381.2011.01610.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21806599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Ohurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1413-1423&issue=5&author=J.+Y.+Suenauthor=G.+D.+Barryauthor=R.+J.+Lohmanauthor=M.+A.+Haliliauthor=A.+J.+Cotterellauthor=G.+T.+Leauthor=D.+P.+Fairlie&title=Modulating+human+proteinase+activated+receptor+2+with+a+novel+antagonist+%28GB88%29+and+agonist+%28GB110%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)</span></div><div class="casAuthors">Suen, J. Y.; Barry, G. D.; Lohman, R. J.; Halili, M. A.; Cotterell, A. J.; Le, G. T.; Fairlie, D. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1413-1423</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Many cells express proteinase activated receptor 2 (PAR2) on their plasma membrane.  PAR2 is activated by proteolytic enzymes, such as trypsin and tryptase that cleave the receptor N-terminus, inititating signalling to intracellular G proteins.  Studies on PAR2 have relied heavily upon activating effects of proteases and peptide agonists that lack stability and bioavailability in vivo.  Exptl. Approach: A novel small mol. agonist GB110 and an antagonist GB88 were characterized in vitro against trypsin, peptide agonists, PAR2 antibody, PAR1 agonists and flow cytometry, in seven cell lines using intracellular Ca2+ mobilization and examd. in vivo against PAR2- and PAR1-induced rat paw edema.  Key Results: GB110 is a potent non-peptidic agonist activating PAR2-mediated Ca2+ release in HT29 cells (EC50 ∼200 nM) and six other human cell lines, inducing PAR2 internalization.  GB88 is a unique PAR2 antagonist, inhibiting PAR2 activated Ca2+ release (IC50 ∼2 μM) induced by native (trypsin) or synthetic peptide and non-peptide agonists.  GB88 was a competitive and surmountable antagonist of agonist 2f-LIGRLO-NH2, a competitive but insurmountable antagonist of agonist GB110, and a non-competitive insurmountable antagonist of trypsin.  GB88 was orally active and anti-inflammatory in vivo, inhibiting acute rat paw edema elicited by agonist GB110 and proteolytic or peptide agonists of PAR2 but not by corresponding agonists of PAR1 or PAR4.  Conclusions and Implications: The novel PAR2 agonist and antagonist modulate intracellular Ca2+ and rat paw edema, providing novel mol. tools for examg. PAR2-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQGZvYtKqS_7Vg90H21EOLACvtfcHk0liJXk9_rnm-aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Ohurw%253D&md5=d9c85910ce574bd19350258b8724d809</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01610.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01610.x%26sid%3Dliteratum%253Aachs%26aulast%3DSuen%26aufirst%3DJ.%2BY.%26aulast%3DBarry%26aufirst%3DG.%2BD.%26aulast%3DLohman%26aufirst%3DR.%2BJ.%26aulast%3DHalili%26aufirst%3DM.%2BA.%26aulast%3DCotterell%26aufirst%3DA.%2BJ.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DModulating%2520human%2520proteinase%2520activated%2520receptor%25202%2520with%2520a%2520novel%2520antagonist%2520%2528GB88%2529%2520and%2520agonist%2520%2528GB110%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26issue%3D5%26spage%3D1413%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Lohman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotterell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Antagonism of protease activated receptor 2 protects against experimental colitis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.111.187062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=22028393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2012&pages=256-265&author=R.+J.+Lohmanauthor=A.+J.+Cotterellauthor=J.+Suenauthor=L.+Liuauthor=T.+A.+Doauthor=D.+A.+Veseyauthor=D.+P.+Fairlie&title=Antagonism+of+protease+activated+receptor+2+protects+against+experimental+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of protease-activated receptor 2 protects against experimental colitis</span></div><div class="casAuthors">Lohman, Rink-Jan; Cotterell, Adam J.; Suen, Jacky; Liu, Ligong; Do, Anh T.; Vesey, David A.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-265</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Many trypsin-like serine proteases such as β-tryptase are involved in the pathogenesis of colitis and inflammatory bowel diseases.  Inhibitors of individual proteases show limited efficacy in treating such conditions, but also probably disrupt digestive and defensive functions of proteases.  Here, we investigate whether masking their common target, protease-activated receptor 2 (PAR2), is an effective therapeutic strategy for treating acute and chronic exptl. colitis in rats.  A novel PAR2 antagonist (5-isoxazoyl-Cha-Ile-spiro[indene-1,4'-piperidine]; GB88) was evaluated for the blockade of intracellular calcium release in colonocytes and anti-inflammatory activity in acute (PAR2 agonist-induced) vs. chronic [2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced] models of colitis in Wistar rats.  Disease progression (disease activity index, wt. loss, and mortality) and postmortem colonic histopathol. (inflammation, bowel wall thickness, and myeloperoxidase) were measured.  PAR2 and tryptase colocalization were investigated by using immunohistochem.  GB88 was a more potent antagonist of PAR2 activation in colonocytes than another reported compd., N1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine (ENMD-1068) (IC50 8 μM vs. 5 mM).  Acute colonic inflammation induced in rats by the PAR2 agonist SLIGRL-NH2 was inhibited by oral administration of GB88 (10 mg/kg) with markedly reduced edema, mucin depletion, PAR2 receptor internalization, and mastocytosis.  Chronic TNBS-induced colitis in rats was ameliorated by GB88 (10 mg/kg/day p.o.), which reduced mortality and pathol. (including colon obstruction, ulceration, wall thickness, and myeloperoxidase release) more effectively than the clin. used drug sulfasalazine (100 mg/kg/day p.o.).  These disease-modifying properties for the PAR2 antagonist in both acute and chronic exptl. colitis strongly support a pathogenic role for PAR2 and PAR2-activating proteases and therapeutic potential for PAR2 antagonism in inflammatory diseases of the colon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUq443e9Ln5rVg90H21EOLACvtfcHk0liJXk9_rnm-aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSltLs%253D&md5=7624171941696f6796965801ca6cd3d6</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.187062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.187062%26sid%3Dliteratum%253Aachs%26aulast%3DLohman%26aufirst%3DR.%2BJ.%26aulast%3DCotterell%26aufirst%3DA.%2BJ.%26aulast%3DSuen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDo%26aufirst%3DT.%2BA.%26aulast%3DVesey%26aufirst%3DD.%2BA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DAntagonism%2520of%2520protease%2520activated%2520receptor%25202%2520protects%2520against%2520experimental%2520colitis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D340%26spage%3D256%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Seitzberg, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winther Lund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandrup Bertozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherbukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective small-molecule PAR-2 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5490</span><span class="NLM_x">–</span> <span class="NLM_lpage">5493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800754r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5490-5493&author=J.+G.+Seitzbergauthor=A.+E.+Knappauthor=B.+Winther+Lundauthor=S.+Mandrup+Bertozziauthor=E.+A.+Currierauthor=J.+Maauthor=V.+Sherbukhinauthor=E.+S.+Bursteinauthor=R.+Olsson&title=Discovery+of+potent+and+selective+small-molecule+PAR-2+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fjm800754r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800754r%26sid%3Dliteratum%253Aachs%26aulast%3DSeitzberg%26aufirst%3DJ.%2BG.%26aulast%3DKnapp%26aufirst%3DA.%2BE.%26aulast%3DWinther%2BLund%26aufirst%3DB.%26aulast%3DMandrup%2BBertozzi%26aufirst%3DS.%26aulast%3DCurrier%26aufirst%3DE.%2BA.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DSherbukhin%26aufirst%3DV.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DOlsson%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520small-molecule%2520PAR-2%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5490%26epage%3D5493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Gardell, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitzberg, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabatabaei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lameh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelzer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span> </span><span class="NLM_article-title">Identification and characterization of novel small-molecule protease-activated receptor 2 agonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.108.142570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18768780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=799-808&author=L.+R.+Gardellauthor=J.+N.+Maauthor=J.+G.+Seitzbergauthor=A.+E.+Knappauthor=H.+H.+Schifferauthor=A.+Tabatabaeiauthor=C.+Davisauthor=K.+K.+Wongauthor=B.+W.+Lundauthor=N.+R.+Nashauthor=Y.+Gaoauthor=J.+Lamehauthor=K.+Schmelzerauthor=R.+Olssonauthor=E.+S.+Burstein&title=Identification+and+characterization+of+novel+small-molecule+protease-activated+receptor+2+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of novel small-molecule protease-activated receptor 2 agonists</span></div><div class="casAuthors">Gardell, Luis R.; Ma, Jian-Nong; Seitzberg, Jimmi Gerner; Knapp, Anne E.; Schiffer, Hans H.; Tabatabaei, Ali; Davis, Christopher N.; Owens, Michelle; Clemons, Bryan; Wong, Kenneth K.; Lund, Birgitte; Nash, Norman R.; Gao, Yan; Lameh, Jelveh; Schmelzer, Kara; Olsson, Roger; Burstein, Ethan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We report the first small-mol. protease-activated receptor (PAR) 2 agonists, AC-55541 [N-[[1-(3-bromo-phenyl)-eth-(E)-ylidene-hydrazinocarbonyl]-(4-oxo-3,4-dihydro-phthalazin-1-yl)-methyl]-benzamide] and AC-264613 [2-oxo-4-phenyl-pyrrolidine-3-carboxylic acid [1-(3-bromo-phenyl)-(E/Z)-ethylidene]-hydrazide], each representing a distinct chem. series.  AC-55541 and AC-264613 each activated PAR2 signaling in cellular proliferation assays, phosphatidylinositol hydrolysis assays, and Ca2+ mobilization assays, with potencies ranging from 200 to 1000 nM for AC-55541 and 30 to 100 nM for AC-264613.  In comparison, the PAR2-activating peptide 2-furoyl-LIGRLO-NH2 had similar potency, whereas SLIGRL-NH2 was 30 to 300 times less potent.  Neither AC-55541 nor AC-264613 had activity at any of the other PAR receptor subtypes, nor did they have any significant affinity for over 30 other mol. targets involved in nociception.  Visualization of EYFP-tagged PAR2 receptors showed that each compd. stimulated internalization of PAR2 receptors.  AC-55541 and AC-264613 were well absorbed when administered i.p. to rats, each reaching micromolar peak plasma concns.  AC-55541 and AC-264613 were each stable to metab. by liver microsomes and maintained sustained exposure in rats, with elimination half-lives of 6.1 and 2.5 h, resp.  Intra-paw administration of AC-55541 or AC-264613 elicited robust and persistent thermal hyperalgesia and edema.  Co-administration of either a tachykinin 1 (neurokinin 1) receptor antagonist or a transient receptor potential vanilloid (TRPV) 1 antagonist completely blocked these effects.  Systemic administration of either AC-55541 or AC-264613 produced a similar degree of hyperalgesia as was obsd. when the compds. were administered locally.  These compds. represent novel small-mol. PAR2 agonists that will be useful in probing the physiol. functions of PAR2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocBrndF1NxnLVg90H21EOLACvtfcHk0liZ-M4Bn1cYqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvE&md5=4d4117820181e1664c97dec51e43660f</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.142570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.142570%26sid%3Dliteratum%253Aachs%26aulast%3DGardell%26aufirst%3DL.%2BR.%26aulast%3DMa%26aufirst%3DJ.%2BN.%26aulast%3DSeitzberg%26aufirst%3DJ.%2BG.%26aulast%3DKnapp%26aufirst%3DA.%2BE.%26aulast%3DSchiffer%26aufirst%3DH.%2BH.%26aulast%3DTabatabaei%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DLund%26aufirst%3DB.%2BW.%26aulast%3DNash%26aufirst%3DN.%2BR.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLameh%26aufirst%3DJ.%26aulast%3DSchmelzer%26aufirst%3DK.%26aulast%3DOlsson%26aufirst%3DR.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520novel%2520small-molecule%2520protease-activated%2520receptor%25202%2520agonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Wu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C. M.</span><span> </span><span class="NLM_article-title">YD-3, a novel inhibitor of protease-induced platelet activation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjp.0703437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10903968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFOnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1289-1296&author=C.+C.+Wuauthor=S.+W.+Huangauthor=T.+L.+Hwangauthor=S.+C.+Kuoauthor=F.+Y.+Leeauthor=C.+M.+Teng&title=YD-3%2C+a+novel+inhibitor+of+protease-induced+platelet+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">YD-3, a novel inhibitor of protease-induced platelet activation</span></div><div class="casAuthors">Wu, Chin-Chung; Huang, Shiow-Wen; Hwang, Tsong-Long; Kuo, Sheng-Chu; Lee, Fang-Yu; Teng, Che-Ming</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1289-1296</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 In the present study, the antiplatelet effects and mechanisms of a new synthetic compd. YD-3 [1-benzyl-3(ethoxycarbonylphenyl)-indazole] were examd.  2 YD-3 inhibited the aggregation of washed rabbit platelets caused by thrombin (IC50 = 28.3 μM), but had no or little inhibitory effect on that induced by arachidonic acid, collagen, platelet-activating factor (PAF) or U46619.  YD-3 also suppressed generation of inositol phosphates caused by thrombin.  On the other hand, thrombin-induced fibrin formation was not affected by YD-3, indicating YD-3 does not inhibit the proteolytic activity of thrombin.  3 In washed human platelets, however, YD-3 had only mild inhibitory effect on the low concn. (0.05 u ml-1) of thrombin-induced human platelet aggregation, and did not affect that induced by higher concns. (≥ 0.1 u ml-1) of thrombin or SFLLRN, the protease-activated receptor 1 (PAR1) agonist peptide.  By contrast, YD-3 inhibited both human and rabbit platelet aggregation elicited by trypsin with IC50 values of 38.1 μM and 5.7 μM, resp.  4 YD-3, at 100 μM, had no effect on ristocetin-induced glycoprotein Ib (GPIb)-dependent aggregation of human platelets.  In addn., platelets treated with chymotrypsin, which cleaves GPIb, enhanced rather than attenuated the inhibition of YD-3 on thrombin-induced human platelet aggregation.  These data indicate that GPIb plays no role in the antiplatelet effect of YD-3.  5 In SFLLRN-desensitized human platelets, high concn. of thrombin (1 u ml-1) could still elicit intracellular Ca2+ mobilization, and the rise of [Ca2+]i was prevented by either leupeptin or YD-3.  6 Our results suggest that YD-3 inhibits a non-PAR1 thrombin receptor which mediates the major effect of thrombin in rabbit platelets, but in human platelets, this receptor function becomes significant only when the function of PAR1 has been blocked or attenuated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow5TqMmsXlxLVg90H21EOLACvtfcHk0ljAvNzHt5Ruqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFOnsLo%253D&md5=6e0d63eb4540a7395bba15167018a30d</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703437%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BC.%26aulast%3DHuang%26aufirst%3DS.%2BW.%26aulast%3DHwang%26aufirst%3DT.%2BL.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DTeng%26aufirst%3DC.%2BM.%26atitle%3DYD-3%252C%2520a%2520novel%2520inhibitor%2520of%2520protease-induced%2520platelet%2520activation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D1289%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Wielders, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaghmouch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reutelingsperger, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhout, T.</span><span> </span><span class="NLM_article-title">Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1538-7836.2007.02364.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17166251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFCisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=571-576&author=S.+J.+Wieldersauthor=A.+Bennaghmouchauthor=C.+P.+Reutelingspergerauthor=E.+M.+Beversauthor=T.+Lindhout&title=Anticoagulant+and+antithrombotic+properties+of+intracellular+protease-activated+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists</span></div><div class="casAuthors">Wielders, S. J. H.; Bennaghmouch, A.; Reutelingsperger, C. P. M.; Bevers, E. M.; Lindhout, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">571-576</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Background: Blockade of the thrombin receptors protease-activated receptor (PAR)1 and PAR4 with pepducins, cell-penetrating lipopeptides based on the third intracellular loop of PAR1 and PAR4, effectively inhibits platelet aggregation.  We have previously shown that PAR1 pepducin also exerts an anticoagulant activity by partial inhibition of the thrombin plus collagen-induced externalization of phosphatidylserine (PS) at the platelet plasma membrane.  Objective: In the present study we examd. the effects of PAR1 and PAR4 pepducins on tissue factor (TF)-initiated thrombin generation in platelet-rich plasma (PRP) and the interaction between PAR4 pepducin-loaded mouse platelets and a growing thrombus to confirm the relevance of the in vitro data.  Results: Localization of pepducins at the inner leaflet of the plasma membrane was confirmed with a fluorescence resonance energy transfer assay.  Both the PAR1 pepducin, P1Pal12, and the PAR4 pepducin, P4pal10, inhibited TF-initiated thrombin generation in PRP.  Concns. of P1pal12 and P4pal10, which blocked the thrombin-induced influx of extracellular calcium ions and inhibited platelet aggregation, reduced the rate of thrombin generation during the propagation phase by 38% and 36%, resp.  Whether this anticoagulant effect is relevant in inhibiting in vivo arterial thrombin growth is uncertain because P4pal10 prevented the incorporation of platelets in a growing thrombus.  Conclusions: Our findings suggest that in spite of their potential anticoagulant activities the in vivo antithrombotic effect of intracellular PAR pepducins is mainly based on inhibiting platelet-platelet interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5pIkYfalvnbVg90H21EOLACvtfcHk0ljAvNzHt5Ruqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFCisrw%253D&md5=09e6fd68dd6ed0b256168dd8cd8bd604</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02364.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02364.x%26sid%3Dliteratum%253Aachs%26aulast%3DWielders%26aufirst%3DS.%2BJ.%26aulast%3DBennaghmouch%26aufirst%3DA.%26aulast%3DReutelingsperger%26aufirst%3DC.%2BP.%26aulast%3DBevers%26aufirst%3DE.%2BM.%26aulast%3DLindhout%26aufirst%3DT.%26atitle%3DAnticoagulant%2520and%2520antithrombotic%2520properties%2520of%2520intracellular%2520protease-activated%2520receptor%2520antagonists%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2007%26volume%3D5%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Strande, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. E.</span><span> </span><span class="NLM_article-title">Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signalling</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1054</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.107.133595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18055876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=1045-1054&issue=3&author=J.+L.+Strandeauthor=A.+Hsuauthor=J.+Suauthor=X.+Fuauthor=G.+J.+Grossauthor=J.+E.+Baker&title=Inhibiting+protease-activated+receptor+4+limits+myocardial+ischemia%2Freperfusion+injury+in+rat+hearts+by+unmasking+adenosine+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling</span></div><div class="casAuthors">Strande, Jennifer L.; Hsu, Anna; Su, Jidong; Fu, Xiangping; Gross, Garrett J.; Baker, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1045-1054</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Harnessing endogenous cardioprotectants is a novel therapeutic strategy to combat ischemia/reperfusion (I/R) injury.  Thrombin causes I/R injury, whereas exogenous adenosine prevents I/R injury.  We hypothesized that blocking thrombin receptor activation with a protease-activated receptor (PAR) 4 antagonist would unmask the cardioprotective effects of endogenous adenosine.  The protective role of two structurally unrelated PAR4 antagonists, trans-cinnamoyl-YPGKF-amide (tc-Y-NH2) and palmitoyl-SGRRYGHALR-amide (P4pal10), were evaluated in two rat models of myocardial I/R injury.  P4pal10 (10 μg/kg) treatment before ischemia significantly decreased infarct size (IS) by 31, 21, and 19% when given before, during, and after ischemia in the in vivo model.  Tc-Y-NH2 (5 μM) treatment before ischemia decreased IS by 51% in the in vitro model and increased recovery of ventricular function by 26%.  To assess whether the cardioprotective effects of PAR4 blockade were due to endogenous adenosine, isolated hearts were treated with a nonselective adenosine receptor blocker, 8-sulfaphenyltheophylline (8-SPT), and tc-Y-NH2 before ischemia.  8-SPT abolished the protective effects of tc-Y-NH2 but did not affect IS when given alone.  Adenosine-mediated survival pathways were then explored.  The cardioprotective effects of tc-Y-NH2 were abolished by inhibition of Akt (wortmannin), extracellular signal-regulated kinase 1/2 [PD98059 (2'-amino-3'-methoxyflavone)], nitric-oxide synthase [NG-monomethyl-L-arginine (L-NMA)], and KATP channels (glibenclamide).  PD98059, L-NMA, and glibenclamide alone had no effect on cardioprotection in vitro.  Furthermore, inhibition of mitochondrial KATP channels [5-hydroxydecanoic acid (5-HD)] and sarcolemmal KATP channels (sodium (5-(2-(5-chloro-2-methoxybenzamido)ethyl)-2-methoxyphenylsulfonyl)(methylcarbamothioyl)amide; HMR 1098) abolished P4pal10-induced cardioprotection in vivo.  Thrombin receptor blockade by PAR4 inhibition provides protection against injury from myocardial I/R by unmasking adenosine receptor signaling and supports the hypothesis of a coupling between thrombin receptors and adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Uuu5KE0fObVg90H21EOLACvtfcHk0ljAvNzHt5Ruqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVajsL8%253D&md5=e83c6b4d639ed63493f07305bfe9ccb2</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133595%26sid%3Dliteratum%253Aachs%26aulast%3DStrande%26aufirst%3DJ.%2BL.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26aulast%3DBaker%26aufirst%3DJ.%2BE.%26atitle%3DInhibiting%2520protease-activated%2520receptor%25204%2520limits%2520myocardial%2520ischemia%252Freperfusion%2520injury%2520in%2520rat%2520hearts%2520by%2520unmasking%2520adenosine%2520signalling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26issue%3D3%26spage%3D1045%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Slofstra, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijlsma, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitsma, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cate, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spek, C. A.</span><span> </span><span class="NLM_article-title">Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3176</span><span class="NLM_x">–</span> <span class="NLM_lpage">3182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2007&pages=3176-3182&issue=9&author=S.+H.+Slofstraauthor=M.+F.+Bijlsmaauthor=A.+P.+Grootauthor=P.+H.+Reitsmaauthor=T.+Lindhoutauthor=H.+Cateauthor=C.+A.+Spek&title=Protease-activated+receptor-4+inhibition+protects+from+multiorgan+failure+in+a+murine+model+of+systemic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlofstra%26aufirst%3DS.%2BH.%26aulast%3DBijlsma%26aufirst%3DM.%2BF.%26aulast%3DGroot%26aufirst%3DA.%2BP.%26aulast%3DReitsma%26aufirst%3DP.%2BH.%26aulast%3DLindhout%26aufirst%3DT.%26aulast%3DCate%26aufirst%3DH.%26aulast%3DSpek%26aufirst%3DC.%2BA.%26atitle%3DProtease-activated%2520receptor-4%2520inhibition%2520protects%2520from%2520multiorgan%2520failure%2520in%2520a%2520murine%2520model%2520of%2520systemic%2520inflammation%26jtitle%3DBlood%26date%3D2007%26volume%3D110%26issue%3D9%26spage%3D3176%26epage%3D3182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elena De Vita, Peter Schüler, Scott Lovell, Jasmin Lohbeck, Sven Kullmann, Eitan Rabinovich, Amiram Sananes, Bernd Heßling, Veronique Hamon, Niv Papo, Jochen Hess, Edward W. Tate, Nikolas Gunkel, <span class="NLM_string-name hlFld-ContribAuthor">Aubry K. Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Depsipeptides Featuring a Neutral P1 Are Potent Inhibitors of Kallikrein-Related Peptidase 6 with On-Target Cellular Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8859-8874. <a href="https://doi.org/10.1021/acs.jmedchem.8b01106" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01106%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDepsipeptides%252BFeaturing%252Ba%252BNeutral%252BP1%252BAre%252BPotent%252BInhibitors%252Bof%252BKallikrein-Related%252BPeptidase%252B6%252Bwith%252BOn-Target%252BCellular%252BActivity%26aulast%3DDe%2BVita%26aufirst%3DElena%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13072018%26date%3D28092018%26date%3D13092018%26volume%3D61%26issue%3D19%26spage%3D8859%26epage%3D8874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiliang  Peng</span>, <span class="hlFld-ContribAuthor ">Yi  Shen</span>, <span class="hlFld-ContribAuthor ">Peifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Ming  Cheng</span>, <span class="hlFld-ContribAuthor ">Yongyou  Wu</span>, <span class="hlFld-ContribAuthor ">Yaqun  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell International</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12935-020-01350-4" title="DOI URL">https://doi.org/10.1186/s12935-020-01350-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12935-020-01350-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12935-020-01350-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%2520International%26atitle%3DBiomarker%252Bimplication%252Bof%252Bkallikrein-related%252Bpeptidases%252Bas%252Bprognostic%252Btissue%252Bsubstrates%252Bof%252Bpoor%252Bsurvival%252Bin%252Bcolorectal%252Bcancer%26aulast%3DPeng%26aufirst%3DQiliang%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorothea M.  Heuberger</span>, <span class="hlFld-ContribAuthor ">Reto A.  Schuepbach</span>. </span><span class="cited-content_cbyCitation_article-title">Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Thrombosis Journal</span><span> <strong>2019,</strong> <em>17 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12959-019-0194-8" title="DOI URL">https://doi.org/10.1186/s12959-019-0194-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12959-019-0194-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12959-019-0194-8%26sid%3Dliteratum%253Aachs%26jtitle%3DThrombosis%2520Journal%26atitle%3DProtease-activated%252Breceptors%252B%252528PARs%252529%25253A%252Bmechanisms%252Bof%252Baction%252Band%252Bpotential%252Btherapeutic%252Bmodulators%252Bin%252BPAR-driven%252Binflammatory%252Bdiseases%26aulast%3DHeuberger%26aufirst%3DDorothea%2BM.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amiram  Sananes</span>, <span class="hlFld-ContribAuthor ">Itay  Cohen</span>, <span class="hlFld-ContribAuthor ">Anat  Shahar</span>, <span class="hlFld-ContribAuthor ">Alexandra  Hockla</span>, <span class="hlFld-ContribAuthor ">Elena  De Vita</span>, <span class="hlFld-ContribAuthor ">Aubry K.  Miller</span>, <span class="hlFld-ContribAuthor ">Evette S.  Radisky</span>, <span class="hlFld-ContribAuthor ">Niv  Papo</span>. </span><span class="cited-content_cbyCitation_article-title">A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (33)
                                     , 12663-12680. <a href="https://doi.org/10.1074/jbc.RA117.000871" title="DOI URL">https://doi.org/10.1074/jbc.RA117.000871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA117.000871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA117.000871%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Bpotent%25252C%252Bproteolysis-resistant%252Binhibitor%252Bof%252Bkallikrein-related%252Bpeptidase%252B6%252B%252528KLK6%252529%252Bfor%252Bcancer%252Btherapy%25252C%252Bdeveloped%252Bby%252Bcombinatorial%252Bengineering%26aulast%3DSananes%26aufirst%3DAmiram%26date%3D2018%26volume%3D293%26issue%3D33%26spage%3D12663%26epage%3D12680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheila Siqueira  Andrade</span>, <span class="hlFld-ContribAuthor ">Iuri Estrada  Gouvea</span>, <span class="hlFld-ContribAuthor ">Mariana Cristina C.  Silva</span>, <span class="hlFld-ContribAuthor ">Eloísa Dognani  Castro</span>, <span class="hlFld-ContribAuthor ">Cláudia A. A.  de Paula</span>, <span class="hlFld-ContribAuthor ">Debora  Okamoto</span>, <span class="hlFld-ContribAuthor ">Lilian  Oliveira</span>, <span class="hlFld-ContribAuthor ">Giovani Bravin  Peres</span>, <span class="hlFld-ContribAuthor ">Tatiana  Ottaiano</span>, <span class="hlFld-ContribAuthor ">Gil  Facina</span>, <span class="hlFld-ContribAuthor ">Afonso Celso Pinto  Nazário</span>, <span class="hlFld-ContribAuthor ">Antonio Hugo J. F. M.  Campos</span>, <span class="hlFld-ContribAuthor ">Edgar Julian  Paredes-Gamero</span>, <span class="hlFld-ContribAuthor ">Maria  Juliano</span>, <span class="hlFld-ContribAuthor ">Ismael D. C. G.  da Silva</span>, <span class="hlFld-ContribAuthor ">Maria Luiza V.  Oliva</span>, <span class="hlFld-ContribAuthor ">Manoel J. B. C.  Girão</span>. </span><span class="cited-content_cbyCitation_article-title">Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2016,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-016-2203-7" title="DOI URL">https://doi.org/10.1186/s12885-016-2203-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-016-2203-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-016-2203-7%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DCathepsin%252BK%252Binduces%252Bplatelet%252Bdysfunction%252Band%252Baffects%252Bcell%252Bsignaling%252Bin%252Bbreast%252Bcancer%252B-%252Bmolecularly%252Bdistinct%252Bbehavior%252Bof%252Bcathepsin%252BK%252Bin%252Bbreast%252Bcancer%26aulast%3DAndrade%26aufirst%3DSheila%2BSiqueira%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Krasoudaki</span>, <span class="hlFld-ContribAuthor ">Aggelos  Banos</span>, <span class="hlFld-ContribAuthor ">Elias  Stagakis</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Loupasakis</span>, <span class="hlFld-ContribAuthor ">Elias  Drakos</span>, <span class="hlFld-ContribAuthor ">Vaios  Sinatkas</span>, <span class="hlFld-ContribAuthor ">Amalia  Zampoulaki</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Papagianni</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Iliopoulos</span>, <span class="hlFld-ContribAuthor ">Dimitrios T.  Boumpas</span>, <span class="hlFld-ContribAuthor ">George K.  Bertsias</span>. </span><span class="cited-content_cbyCitation_article-title">Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4. </span><span class="cited-content_cbyCitation_journal-name">Nephrology Dialysis Transplantation</span><span> <strong>2016,</strong> <em>31 </em>
                                    (10)
                                     , 1676-1686. <a href="https://doi.org/10.1093/ndt/gfv374" title="DOI URL">https://doi.org/10.1093/ndt/gfv374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ndt/gfv374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fndt%2Fgfv374%26sid%3Dliteratum%253Aachs%26jtitle%3DNephrology%2520Dialysis%2520Transplantation%26atitle%3DMicro-RNA%252Banalysis%252Bof%252Brenal%252Bbiopsies%252Bin%252Bhuman%252Blupus%252Bnephritis%252Bdemonstrates%252Bup-regulated%252BmiR-422a%252Bdriving%252Breduction%252Bof%252Bkallikrein-related%252Bpeptidase%252B4%26aulast%3DKrasoudaki%26aufirst%3DEleni%26date%3D2016%26date%3D2015%26volume%3D31%26issue%3D10%26spage%3D1676%26epage%3D1686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florian  Guenther</span>, <span class="hlFld-ContribAuthor ">Matthias F.  Melzig</span>. </span><span class="cited-content_cbyCitation_article-title">Protease-activated receptors and their biological role—focused on skin inflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2015,</strong> <em>67 </em>
                                    (12)
                                     , 1623-1633. <a href="https://doi.org/10.1111/jphp.12447" title="DOI URL">https://doi.org/10.1111/jphp.12447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.12447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.12447%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DProtease-activated%252Breceptors%252Band%252Btheir%252Bbiological%252Brole%2525E2%252580%252594focused%252Bon%252Bskin%252Binflammation%26aulast%3DGuenther%26aufirst%3DFlorian%26date%3D2015%26date%3D2015%26volume%3D67%26issue%3D12%26spage%3D1623%26epage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatrice  Severino</span>, <span class="hlFld-ContribAuthor ">Ferdinando  Fiorino</span>, <span class="hlFld-ContribAuthor ">Angela  Corvino</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Caliendo</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Santagada</span>, <span class="hlFld-ContribAuthor ">Diego Magno  Assis</span>, <span class="hlFld-ContribAuthor ">Juliana R.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Luiz  Juliano</span>, <span class="hlFld-ContribAuthor ">Serena  Manganelli</span>, <span class="hlFld-ContribAuthor ">Emilio  Benfenati</span>, <span class="hlFld-ContribAuthor ">Francesco  Frecentese</span>, <span class="hlFld-ContribAuthor ">Elisa  Perissutti</span>, <span class="hlFld-ContribAuthor ">Maria Aparecida  Juliano</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and docking studies of PAR2-AP-derived pseudopeptides as inhibitors of kallikrein 5 and 6. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2015,</strong> <em>396 </em>
                                    (1)
                                     , 45-52. <a href="https://doi.org/10.1515/hsz-2014-0190" title="DOI URL">https://doi.org/10.1515/hsz-2014-0190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2014-0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2014-0190%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bdocking%252Bstudies%252Bof%252BPAR2-AP-derived%252Bpseudopeptides%252Bas%252Binhibitors%252Bof%252Bkallikrein%252B5%252Band%252B6%26aulast%3DSeverino%26aufirst%3DBeatrice%26date%3D2015%26volume%3D396%26issue%3D1%26spage%3D45%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noémie  Michel</span>, <span class="hlFld-ContribAuthor ">Nathalie  Heuzé-Vourc’h</span>, <span class="hlFld-ContribAuthor ">Elise  Lavergne</span>, <span class="hlFld-ContribAuthor ">Christelle  Parent</span>, <span class="hlFld-ContribAuthor ">Marie-Lise  Jourdan</span>, <span class="hlFld-ContribAuthor ">Amandine  Vallet</span>, <span class="hlFld-ContribAuthor ">Sophie  Iochmann</span>, <span class="hlFld-ContribAuthor ">Orlando  Musso</span>, <span class="hlFld-ContribAuthor ">Pascale  Reverdiau</span>, <span class="hlFld-ContribAuthor ">Yves  Courty</span>. </span><span class="cited-content_cbyCitation_article-title">Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2014,</strong> <em>395 </em>
                                    (9)
                                     , 1015-1025. <a href="https://doi.org/10.1515/hsz-2014-0124" title="DOI URL">https://doi.org/10.1515/hsz-2014-0124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2014-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2014-0124%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DGrowth%252Band%252Bsurvival%252Bof%252Blung%252Bcancer%252Bcells%25253A%252Bregulation%252Bby%252Bkallikrein-related%252Bpeptidase%252B6%252Bvia%252Bactivation%252Bof%252Bproteinase-activated%252Breceptor%252B2%252Band%252Bthe%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%26aulast%3DMichel%26aufirst%3DNo%25C3%25A9mie%26date%3D2014%26volume%3D395%26issue%3D9%26spage%3D1015%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yijing  Yu</span>, <span class="hlFld-ContribAuthor ">Ioannis  Prassas</span>, <span class="hlFld-ContribAuthor ">Eleftherios P.  Diamandis</span>. </span><span class="cited-content_cbyCitation_article-title">Putative kallikrein substrates and their (patho)biological functions. </span><span class="cited-content_cbyCitation_journal-name">Biological Chemistry</span><span> <strong>2014,</strong> <em>395 </em>
                                    (9)
                                     , 931-943. <a href="https://doi.org/10.1515/hsz-2014-0129" title="DOI URL">https://doi.org/10.1515/hsz-2014-0129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hsz-2014-0129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhsz-2014-0129%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Chemistry%26atitle%3DPutative%252Bkallikrein%252Bsubstrates%252Band%252Btheir%252B%252528patho%252529biological%252Bfunctions%26aulast%3DYu%26aufirst%3DYijing%26date%3D2014%26volume%3D395%26issue%3D9%26spage%3D931%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos K.  Kontos</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Mavridis</span>, <span class="hlFld-ContribAuthor ">Maroulio  Talieri</span>, <span class="hlFld-ContribAuthor ">Andreas  Scorilas</span>. </span><span class="cited-content_cbyCitation_article-title">Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects. </span><span class="cited-content_cbyCitation_journal-name">Thrombosis and Haemostasis</span><span> <strong>2013,</strong> <em>110 </em>
                                    (09)
                                     , 450-457. <a href="https://doi.org/10.1160/TH12-11-0791" title="DOI URL">https://doi.org/10.1160/TH12-11-0791</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1160/TH12-11-0791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1160%2FTH12-11-0791%26sid%3Dliteratum%253Aachs%26jtitle%3DThrombosis%2520and%2520Haemostasis%26atitle%3DKallikrein-related%252Bpeptidases%252B%252528KLKs%252529%252Bin%252Bgastrointestinal%252Bcancer%25253A%252BMechanistic%252Band%252Bclinical%252Baspects%26aulast%3DKontos%26aufirst%3DChristos%2BK.%26date%3D2013%26date%3D2017%26volume%3D110%26issue%3D09%26spage%3D450%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potential substrates via which KLKs can regulate tissue function. Selected examples are given for each suggested substrate group. MBP stands for myelin basic protein, VIP for vasoactive intestinal peptide, TGF-β for tissue growth factor type β, and pro-uPA for the zymogen of urokinase plasminogen activator. For details about the potential KLK substrates, see refs <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a> and <a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">20</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Low specificity small peptides and small molecule KLK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Peptide and peptide-mimetic KLK1 inhibitors obtained by drug design approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Peptide and peptide-mimetic KLK3/PSA inhibitors obtained by drug design approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Small molecule KLK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Peptide/peptidomimetic PAR1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Small molecules as PAR1 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Peptide-mimetic derivatives as PAR2 agonists and antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/medium/jm-2012-00407t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Small-molecule compounds as PAR2/PAR4 agonists and antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-15/jm300407t/production/images/large/jm-2012-00407t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300407t&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 179 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Travis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potempa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">Are bacterial proteinases pathogenic factors?</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=405-407&author=J.+Travisauthor=J.+Potempaauthor=H.+Maeda&title=Are+bacterial+proteinases+pathogenic+factors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTravis%26aufirst%3DJ.%26aulast%3DPotempa%26aufirst%3DJ.%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DAre%2520bacterial%2520proteinases%2520pathogenic%2520factors%253F%26jtitle%3DTrends%2520Microbiol.%26date%3D1995%26volume%3D3%26spage%3D405%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Klemba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. E.</span><span> </span><span class="NLM_article-title">Biological roles of proteases in parasitic protozoa</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1146%2Fannurev.biochem.71.090501.145453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12045098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1Cltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2002&pages=275-305&author=M.+Klembaauthor=D.+E.+Goldberg&title=Biological+roles+of+proteases+in+parasitic+protozoa"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biological roles of proteases in parasitic protozoa</span></div><div class="casAuthors">Klemba, Michael; Goldberg, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275-305</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Proteases from a variety of protozoan parasites were characterized at the mol. and cellular levels, and the many roles that proteases play in these organisms are coming into focus.  Central roles were proposed for proteases in diverse processes such as host cell invasion and egress, encystation, excystation, catabolism of host proteins, differentiation, cell cycle progression, cytoadherence, and both stimulation and evasion of host immune responses.  Detailed structural and functional characterization of parasite proteases has led to novel insights into the workings of these fascinating catalytic machines.  The possibility of developing selective inhibitors of key proteases of pathogenic parasites into novel chemotherapeutic strategies is being vigorously explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor1gqvbjIuoLVg90H21EOLACvtfcHk0lhssdZoYEadOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1Cltrw%253D&md5=0375e4211b1f5546bcfec5194933f52c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.71.090501.145453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.71.090501.145453%26sid%3Dliteratum%253Aachs%26aulast%3DKlemba%26aufirst%3DM.%26aulast%3DGoldberg%26aufirst%3DD.%2BE.%26atitle%3DBiological%2520roles%2520of%2520proteases%2520in%2520parasitic%2520protozoa%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2002%26volume%3D71%26spage%3D275%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Monod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capoccia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechenne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaugg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holdom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jousson, O.</span><span> </span><span class="NLM_article-title">Secreted proteases from pathogenic fungi</span> <span class="citation_source-journal">Int. J. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1078%2F1438-4221-00223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12452286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Khsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2002&pages=405-419&author=M.+Monodauthor=S.+Capocciaauthor=B.+Lechenneauthor=C.+Zauggauthor=M.+Holdomauthor=O.+Jousson&title=Secreted+proteases+from+pathogenic+fungi"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Secreted proteases from pathogenic fungi</span></div><div class="casAuthors">Monod, Michel; Capoccia, Sabrina; Lechenne, Barbara; Zaugg, Christophe; Holdom, Mary; Jousson, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">405-419</span>CODEN:
                <span class="NLM_cas:coden">IMEMFV</span>;
        ISSN:<span class="NLM_cas:issn">1438-4221</span>.
    
            (<span class="NLM_cas:orgname">Urban & Fischer Verlag GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  Many species of human pathogenic fungi secrete proteases in vitro or during the infection process.  Secreted endoproteases belong to the aspartic proteases of the pepsin family, serine proteases of the subtilisin family, and metalloproteases of two different families.  To these proteases has to be added the non-pepsin-type aspartic protease from Aspergillus niger and a unique chymotrypsin-like protease from Coccidioides immitis.  Pathogenic fungi also secrete aminopeptidases, carboxypeptidases and dipeptidyl-peptidases.  The function of fungal secreted proteases and their importance in infections vary.  It is evident that secreted proteases are important for the virulence of dermatophytes since these fungi grow exclusively in the stratum corneum, nails or hair, which constitutes their sole nitrogen and carbon sources.  The aspartic proteases secreted by Candida albicans are involved in the adherence process and penetration of tissues, and in interactions with the immune system of the infected host.  For Aspergillus fumigatus, the role of proteolytic activity has not yet been proved.  Although the secreted proteases have been intensively investigated as potential virulence factors, knowledge on protease substrate specificities is rather poor and few studies have focused on the research of inhibitors.  Knowledge of substrate specificities will increase our understanding about the action of each protease secreted by pathogenic fungi and will help to det. their contribution to virulence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYRKE3cdYkLVg90H21EOLACvtfcHk0lgAndJUupNt3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Khsr8%253D&md5=9b102f1af1f5ab38f9f4e0c59e81dc5a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1078%2F1438-4221-00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1078%252F1438-4221-00223%26sid%3Dliteratum%253Aachs%26aulast%3DMonod%26aufirst%3DM.%26aulast%3DCapoccia%26aufirst%3DS.%26aulast%3DLechenne%26aufirst%3DB.%26aulast%3DZaugg%26aufirst%3DC.%26aulast%3DHoldom%26aufirst%3DM.%26aulast%3DJousson%26aufirst%3DO.%26atitle%3DSecreted%2520proteases%2520from%2520pathogenic%2520fungi%26jtitle%3DInt.%2520J.%2520Med.%2520Microbiol.%26date%3D2002%26volume%3D292%26spage%3D405%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tong, L.</span><span> </span><span class="NLM_article-title">Viral proteases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4609</span><span class="NLM_x">–</span> <span class="NLM_lpage">4626</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010184f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4609-4626&author=L.+Tong&title=Viral+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fcr010184f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010184f%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26atitle%3DViral%2520proteases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4609%26epage%3D4626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Puente, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overall, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Otin, C.</span><span> </span><span class="NLM_article-title">Human and mouse proteases: a comparative genomic approach</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnrg1111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12838346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVWgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=544-558&author=X.+S.+Puenteauthor=L.+M.+Sanchezauthor=C.+M.+Overallauthor=C.+Lopez-Otin&title=Human+and+mouse+proteases%3A+a+comparative+genomic+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Human and mouse proteases: A comparative genomic approach</span></div><div class="casAuthors">Puente, Xose S.; Sanchez, Luis M.; Overall, Christopher M.; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">544-558</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The availability of the human and mouse genome sequences has allowed the identification and comparison of their resp. degradomes, i.e., the complete repertoire of proteases that are produced by these organisms.  Because of the essential roles of proteolytic enzymes in the control of cell behavior, survival and death, degradome anal. provides a useful framework for the global exploration of these protease-mediated functions in normal and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFfpMsn9HKerVg90H21EOLACvtfcHk0lgAndJUupNt3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVWgu7k%253D&md5=64c4142954441dddc975af7c7117bdf5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrg1111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1111%26sid%3Dliteratum%253Aachs%26aulast%3DPuente%26aufirst%3DX.%2BS.%26aulast%3DSanchez%26aufirst%3DL.%2BM.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DLopez-Otin%26aufirst%3DC.%26atitle%3DHuman%2520and%2520mouse%2520proteases%253A%2520a%2520comparative%2520genomic%2520approach%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2003%26volume%3D4%26spage%3D544%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopolovic, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Genomic overview of serine proteases</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=28-36&author=G.+M.+Yousefauthor=A.+D.+Kopolovicauthor=M.+B.+Elliottauthor=E.+P.+Diamandis&title=Genomic+overview+of+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DKopolovic%26aufirst%3DA.%2BD.%26aulast%3DElliott%26aufirst%3DM.%2BB.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DGenomic%2520overview%2520of%2520serine%2520proteases%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26spage%3D28%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">López-Otín, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matrisian, L. M.</span><span> </span><span class="NLM_article-title">Emerging roles of proteases in tumour suppression</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">800</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnrc2228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17851543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOnsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=800-808&author=C.+L%C3%B3pez-Ot%C3%ADnauthor=L.+M.+Matrisian&title=Emerging+roles+of+proteases+in+tumour+suppression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of proteases in tumor suppression</span></div><div class="casAuthors">Lopez-Otin, Carlos; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">800-808</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Proteases have long been assocd. with cancer progression and metastasis, however studies have also revealed proteases with tumor-suppressive effects.  What are the implications of these findings.  Proteases have long been assocd. with cancer progression because of their ability to degrade extracellular matrixes, which facilitates invasion and metastasis.  However, recent studies have shown that these enzymes target a diversity of substrates and favor all steps of tumor evolution.  Unexpectedly, the post-trial studies have also revealed proteases with tumor-suppressive effects.  These effects are assocd. with more than 30 different enzymes that belong to three distinct protease classes.  What are the clin. implications of these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6806krUkPrVg90H21EOLACvtfcHk0lh1-ixjcDEBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOnsr3I&md5=9ce3f849d58d4760c3d9738909d193fd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc2228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2228%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez-Ot%25C3%25ADn%26aufirst%3DC.%26aulast%3DMatrisian%26aufirst%3DL.%2BM.%26atitle%3DEmerging%2520roles%2520of%2520proteases%2520in%2520tumour%2520suppression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D800%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Barrett, A. J.; Rawlings, N. D.; Woessner, J. F.</span> <span class="citation_source-book">Handbook of Proteolytic Enzymes</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Elsevier Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=A.+J.+Barrett&author=N.+D.+Rawlings&author=J.+F.+Woessner&title=Handbook+of+Proteolytic+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DA.%2BJ.%26btitle%3DHandbook%2520of%2520Proteolytic%2520Enzymes%26pub%3DElsevier%2520Academic%2520Press%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mason, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, R. I.</span><span> </span><span class="NLM_article-title">Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=1983&pages=300-307&author=A.+J.+Masonauthor=B.+A.+Evansauthor=D.+R.+Coxauthor=J.+Shineauthor=R.+I.+Richards&title=Structure+of+mouse+kallikrein+gene+family+suggests+a+role+in+specific+processing+of+biologically+active+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DA.%2BJ.%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DCox%26aufirst%3DD.%2BR.%26aulast%3DShine%26aufirst%3DJ.%26aulast%3DRichards%26aufirst%3DR.%2BI.%26atitle%3DStructure%2520of%2520mouse%2520kallikrein%2520gene%2520family%2520suggests%2520a%2520role%2520in%2520specific%2520processing%2520of%2520biologically%2520active%2520peptides%26jtitle%3DNature%26date%3D1983%26volume%3D303%26spage%3D300%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Fukushima, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span> </span><span class="NLM_article-title">Nucleotide sequence of cloned cDNA for human pancreatic kallikrein</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">8037</span><span class="NLM_x">–</span> <span class="NLM_lpage">8043</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00348a030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1985&pages=8037-8043&author=D.+Fukushimaauthor=N.+Kitamuraauthor=S.+Nakanishi&title=Nucleotide+sequence+of+cloned+cDNA+for+human+pancreatic+kallikrein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbi00348a030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00348a030%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DD.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DNakanishi%26aufirst%3DS.%26atitle%3DNucleotide%2520sequence%2520of%2520cloned%2520cDNA%2520for%2520human%2520pancreatic%2520kallikrein%26jtitle%3DBiochemistry%26date%3D1985%26volume%3D24%26spage%3D8037%26epage%3D8043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Schedlich, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennetts, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, B. J.</span><span> </span><span class="NLM_article-title">Primary structure of a human glandular kallikrein gene</span> <span class="citation_source-journal">DNA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1089%2Fdna.1987.6.429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=2824146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaL1cXhtVOhtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1987&pages=429-437&author=L.+J.+Schedlichauthor=B.+H.+Bennettsauthor=B.+J.+Morris&title=Primary+structure+of+a+human+glandular+kallikrein+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Primary structure of a human glandular kallikrein gene</span></div><div class="casAuthors">Schedlich, Lynette J.; Bennetts, Bruce H.; Morris, Brian J.</div><div class="citationInfo"><span class="NLM_cas:title">DNA</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">429-37</span>CODEN:
                <span class="NLM_cas:coden">DNAADR</span>;
        ISSN:<span class="NLM_cas:issn">0198-0238</span>.
    </div><div class="casAbstract">To isolate a human glandular kallikrein gene, a human genomic library was screened with a probe made from a mouse kallikrein cDNA (pMK-1).  Overlapping clones were obtained, and nucleotide sequence detn. showed that they together contained a human glandular preprokallikrein gene, hGK-1, of 5.2 kb.  The gene encoded a unique preproprotein of 261 amino acids.  The sequences of the mature 237-amino acid protein had 66% homol. with the sequence predicted for human kallikrein synthesized in the pancreas, kidney, and salivary gland.  Moreover, it had even stronger homol. (78%) with human prostate-specific antigen.  The latter lacks an aspartic acid residue essential for kallikrein-specific cleavage, whereas the sequences of this new protein had all of the attributes needed to confer kallikrein-like specificity.  Southern blotting indicated that the no. of glandular kallikrein genes in man could be limited to 3, a situation very different from mouse and rat, which each have a large multigene family.  Furthermore, unlike kallikrein genes in the mouse, hGK-1 was not closely linked to other human kallikrein genes.  In other respects, the structure of the human kallikrein gene resembled that in mouse; coding sequences in the 5 exons were organized similarly, homol. was higher with other members of the kallikrein gene family in the same species, and the 3 key amino acid residues required by serine proteases for their catalytic activity, together with the residue that confers kallikrein-specific cleavage, were conserved and located on different exons.  Thus, if hGK-1 is expressed, its product represents a new, and possibly the only other, enzyme with true kallikrein-like specificity in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIssE1CkCISLVg90H21EOLACvtfcHk0lh1-ixjcDEBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXhtVOhtLk%253D&md5=6362b55bfae275b0904972d2773c7e04</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1089%2Fdna.1987.6.429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdna.1987.6.429%26sid%3Dliteratum%253Aachs%26aulast%3DSchedlich%26aufirst%3DL.%2BJ.%26aulast%3DBennetts%26aufirst%3DB.%2BH.%26aulast%3DMorris%26aufirst%3DB.%2BJ.%26atitle%3DPrimary%2520structure%2520of%2520a%2520human%2520glandular%2520kallikrein%2520gene%26jtitle%3DDNA%26date%3D1987%26volume%3D6%26spage%3D429%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lundwall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">Molecular cloning of human prostate specific antigen cDNA</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1987&pages=317-322&author=A.+Lundwallauthor=H.+Lilja&title=Molecular+cloning+of+human+prostate+specific+antigen+cDNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLundwall%26aufirst%3DA.%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520of%2520human%2520prostate%2520specific%2520antigen%2520cDNA%26jtitle%3DFEBS%2520Lett.%26date%3D1987%26volume%3D214%26spage%3D317%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argonza-Barrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCuaig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paeper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span> </span><span class="NLM_article-title">Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2000&pages=119-130&author=L.+Ganauthor=I.+Leeauthor=R.+Smithauthor=R.+Argonza-Barrettauthor=H.+Leiauthor=J.+McCuaigauthor=P.+Mossauthor=B.+Paeperauthor=K.+Wang&title=Sequencing+and+expression+analysis+of+the+serine+protease+gene+cluster+located+in+chromosome+19q13+region"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DI.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DArgonza-Barrett%26aufirst%3DR.%26aulast%3DLei%26aufirst%3DH.%26aulast%3DMcCuaig%26aufirst%3DJ.%26aulast%3DMoss%26aufirst%3DP.%26aulast%3DPaeper%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DSequencing%2520and%2520expression%2520analysis%2520of%2520the%2520serine%2520protease%2520gene%2520cluster%2520located%2520in%2520chromosome%252019q13%2520region%26jtitle%3DGene%26date%3D2000%26volume%3D257%26spage%3D119%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Harvey, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. A.</span><span> </span><span class="NLM_article-title">Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">37397</span><span class="NLM_x">–</span> <span class="NLM_lpage">37406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=37397-37406&author=T.+J.+Harveyauthor=J.+D.+Hooperauthor=S.+A.+Myersauthor=S.+A.+Stephensonauthor=L.+K.+Ashworthauthor=J.+A.+Clements&title=Tissue-specific+expression+patterns+and+fine+mapping+of+the+human+kallikrein+%28KLK%29+locus+on+proximal+19q13.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DT.%2BJ.%26aulast%3DHooper%26aufirst%3DJ.%2BD.%26aulast%3DMyers%26aufirst%3DS.%2BA.%26aulast%3DStephenson%26aufirst%3DS.%2BA.%26aulast%3DAshworth%26aufirst%3DL.%2BK.%26aulast%3DClements%26aufirst%3DJ.%2BA.%26atitle%3DTissue-specific%2520expression%2520patterns%2520and%2520fine%2520mapping%2520of%2520the%2520human%2520kallikrein%2520%2528KLK%2529%2520locus%2520on%2520proximal%252019q13.4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D37397%26epage%3D37406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2000&pages=125-133&author=G.+M.+Yousefauthor=A.+Changauthor=A.+Scorilasauthor=E.+P.+Diamandis&title=Genomic+organization+of+the+human+kallikrein+gene+family+on+chromosome+19q13.3-q13.4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DGenomic%2520organization%2520of%2520the%2520human%2520kallikrein%2520gene%2520family%2520on%2520chromosome%252019q13.3-q13.4%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D276%26spage%3D125%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2000&pages=251-259&author=G.+M.+Yousefauthor=L.+Y.+Luoauthor=S.+W.+Schererauthor=G.+Sotiropoulouauthor=E.+P.+Diamandis&title=Molecular+characterization+of+zyme%2Fprotease+M%2Fneurosin+%28PRSS9%29%2C+a+hormonally+regulated+kallikrein-like+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DLuo%26aufirst%3DL.%2BY.%26aulast%3DScherer%26aufirst%3DS.%2BW.%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DMolecular%2520characterization%2520of%2520zyme%252Fprotease%2520M%252Fneurosin%2520%2528PRSS9%2529%252C%2520a%2520hormonally%2520regulated%2520kallikrein-like%2520serine%2520protease%26jtitle%3DGenomics%26date%3D2000%26volume%3D62%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Borgono, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">The emerging roles of human tissue kallikreins in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnrc1474" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15516960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=876-890&author=C.+A.+Borgonoauthor=E.+P.+Diamandis&title=The+emerging+roles+of+human+tissue+kallikreins+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging roles of human tissue kallikreins in cancer</span></div><div class="casAuthors">Borgono, Carla A.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-890</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikreins (hKs), which are encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiol. roles.  Although primarily known for their clin. applicability as cancer biomarkers, recent evidence implicates hKs in many cancer-related processes, including cell-growth regulation, angiogenesis, invasion and metastasis.  They have been shown to promote or inhibit neoplastic progression, acting individually and/or in cascades with other hKs and proteases, and might represent attractive targets for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVQTk6Djzi7LVg90H21EOLACvtfcHk0liFiyRH_DVO9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFegtrY%253D&md5=a5bd96fc35210ea97a97703942827d0d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrc1474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1474%26sid%3Dliteratum%253Aachs%26aulast%3DBorgono%26aufirst%3DC.%2BA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520emerging%2520roles%2520of%2520human%2520tissue%2520kallikreins%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D876%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">The new human tissue kallikrein gene family: structure, function, and association to disease</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1210%2Fer.22.2.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=11294823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=184-204&author=G.+M.+Yousefauthor=E.+P.+Diamandis&title=The+new+human+tissue+kallikrein+gene+family%3A+structure%2C+function%2C+and+association+to+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The new human tissue kallikrein gene family: Structure, function, and association to disease</span></div><div class="casAuthors">Yousef, George M.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-204</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  The human tissue kallikrein gene family was, until recently, thought to consist of only three genes.  Two of these human kallikreins, prostate-specific antigen and human glandular kallikrein 2, are currently used as valuable biomarkers of prostatic carcinoma.  More recently, new kallikrein-like genes have been discovered.  It is now clear that the human tissue kallikrein gene family contains at least 15 genes.  All genes share important similarities, including mapping at the same chromosomal locus (19q13.4), significant homol. at both the nucleotide and protein level, and similar genomic organization.  All genes encode for putative serine proteases and most of them are regulated by steroid hormones.  Recent data suggest that at least a few of these kallikrein genes are connected to malignancy.  In this review, we summarize the recently accumulated knowledge on the human tissue kallikrein gene family, including gene and protein structure, predicted enzymic activities, tissue expression, hormonal regulation, and alternative splicing.  We further describe the reported assocns. of the human kallikreins with various human diseases and identify future avenues for research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0QpkM-LBKh7Vg90H21EOLACvtfcHk0ljNQWJQsmtEBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsFSntL8%253D&md5=ca1b47cc183643d953e8abecd25cc730</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fer.22.2.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.22.2.184%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DThe%2520new%2520human%2520tissue%2520kallikrein%2520gene%2520family%253A%2520structure%252C%2520function%252C%2520and%2520association%2520to%2520disease%26jtitle%3DEndocr.%2520Rev.%26date%3D2001%26volume%3D22%26spage%3D184%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lundwall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Band, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petraki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span> </span><span class="NLM_article-title">A comprehensive nomenclature for serine proteases with homology to tissue kallikreins</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=637-641&author=A.+Lundwallauthor=V.+Bandauthor=M.+Blaberauthor=J.+A.+Clementsauthor=Y.+Courtyauthor=E.+P.+Diamandisauthor=H.+Fritzauthor=H.+Liljaauthor=J.+Malmauthor=L.+J.+Maltaisauthor=A.+Y.+Olssonauthor=C.+Petrakiauthor=A.+Scorilasauthor=G.+Sotiropoulouauthor=U.+H.+Stenmanauthor=C.+Stephanauthor=M.+Talieriauthor=G.+M.+Yousef&title=A+comprehensive+nomenclature+for+serine+proteases+with+homology+to+tissue+kallikreins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLundwall%26aufirst%3DA.%26aulast%3DBand%26aufirst%3DV.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DClements%26aufirst%3DJ.%2BA.%26aulast%3DCourty%26aufirst%3DY.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DFritz%26aufirst%3DH.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DMalm%26aufirst%3DJ.%26aulast%3DMaltais%26aufirst%3DL.%2BJ.%26aulast%3DOlsson%26aufirst%3DA.%2BY.%26aulast%3DPetraki%26aufirst%3DC.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26atitle%3DA%2520comprehensive%2520nomenclature%2520for%2520serine%2520proteases%2520with%2520homology%2520to%2520tissue%2520kallikreins%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D637%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Borgono, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human tissue kallikreins: physiologic roles and applications in cancer</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15192120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslajtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2004&pages=257-280&author=C.+A.+Borgonoauthor=I.+P.+Michaelauthor=E.+P.+Diamandis&title=Human+tissue+kallikreins%3A+physiologic+roles+and+applications+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer</span></div><div class="casAuthors">Borgono, Carla A.; Michael, Iacovos P.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">257-280</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Tissue kallikreins are members of the S1 family (clan SA) of trypsin-like serine proteases and are present in at least six mammalian orders.  In humans, tissue kallikreins (hK) are encoded by 15 structurally similar, steroid hormone-regulated genes (KLK) that colocalize to chromosome 19q13.4, representing the largest cluster of contiguous protease genes in the entire genome.  HKs are widely expressed in diverse tissues and implicated in a range of normal physiol. functions from the regulation of blood pressure and electrolyte balance to tissue remodeling, prohormone processing, neural plasticity, and skin desquamation.  Several lines of evidence suggest that hKs may be involved in cascade reactions and that cross-talk may exist with proteases of other catalytic classes.  The proteolytic activity of hKs is regulated in several ways including zymogen activation, endogenous inhibitors, such as serpins, and via internal (auto)cleavage leading to inactivation.  Dysregulated hK expression is assocd. with multiple diseases, primarily cancer.  As a consequence, many kallikreins, in addn. to hK3/PSA, have been identified as promising diagnostic and/or prognostic biomarkers for several cancer types, including ovarian, breast, and prostate.  Recent data also suggest that hKs may be causally involved in carcinogenesis, particularly in tumor metastasis and invasion, and, thus, may represent attractive drug targets to consider for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3PIYdWcNnhrVg90H21EOLACvtfcHk0ljNQWJQsmtEBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslajtr0%253D&md5=4f6d5f54a20dca35e8d96a8c67edd6c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorgono%26aufirst%3DC.%2BA.%26aulast%3DMichael%26aufirst%3DI.%2BP.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520tissue%2520kallikreins%253A%2520physiologic%2520roles%2520and%2520applications%2520in%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2004%26volume%3D2%26spage%3D257%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Evans, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkwater, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, R. I.</span><span> </span><span class="NLM_article-title">Mouse glandular kallikrein genes. Structure and partial sequence analysis of the kallikrein gene locus</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">8027</span><span class="NLM_x">–</span> <span class="NLM_lpage">8034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1987&pages=8027-8034&author=B.+A.+Evansauthor=C.+C.+Drinkwaterauthor=R.+I.+Richards&title=Mouse+glandular+kallikrein+genes.+Structure+and+partial+sequence+analysis+of+the+kallikrein+gene+locus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BA.%26aulast%3DDrinkwater%26aufirst%3DC.%2BC.%26aulast%3DRichards%26aufirst%3DR.%2BI.%26atitle%3DMouse%2520glandular%2520kallikrein%2520genes.%2520Structure%2520and%2520partial%2520sequence%2520analysis%2520of%2520the%2520kallikrein%2520gene%2520locus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1987%26volume%3D262%26spage%3D8027%26epage%3D8034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wines, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southard, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, R. J.</span><span> </span><span class="NLM_article-title">Evolution of the rat kallikrein gene family: gene conversion leads to functional diversity</span> <span class="citation_source-journal">J. Mol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">–</span> <span class="NLM_lpage">492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=476-492&author=D.+R.+Winesauthor=J.+M.+Bradyauthor=E.+M.+Southardauthor=R.+J.+MacDonald&title=Evolution+of+the+rat+kallikrein+gene+family%3A+gene+conversion+leads+to+functional+diversity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWines%26aufirst%3DD.%2BR.%26aulast%3DBrady%26aufirst%3DJ.%2BM.%26aulast%3DSouthard%26aufirst%3DE.%2BM.%26aulast%3DMacDonald%26aufirst%3DR.%2BJ.%26atitle%3DEvolution%2520of%2520the%2520rat%2520kallikrein%2520gene%2520family%253A%2520gene%2520conversion%2520leads%2520to%2520functional%2520diversity%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D1999%26volume%3D32%26spage%3D476%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kurlender, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obiezu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis., E. P.</span><span> </span><span class="NLM_article-title">A survey of alternative transcripts of human tissue kallikrein genes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1755</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1755&publication_year=2005&pages=1-14&author=L.+Kurlenderauthor=C.+Borgonoauthor=I.+P.+Michaelauthor=C.+Obiezuauthor=M.+B.+Elliottauthor=G.+M.+Yousefauthor=E.+P.+Diamandis.&title=A+survey+of+alternative+transcripts+of+human+tissue+kallikrein+genes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurlender%26aufirst%3DL.%26aulast%3DBorgono%26aufirst%3DC.%26aulast%3DMichael%26aufirst%3DI.%2BP.%26aulast%3DObiezu%26aufirst%3DC.%26aulast%3DElliott%26aufirst%3DM.%2BB.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis.%26aufirst%3DE.%2BP.%26atitle%3DA%2520survey%2520of%2520alternative%2520transcripts%2520of%2520human%2520tissue%2520kallikrein%2520genes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1755%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span> </span><span class="NLM_article-title">Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">4969</span><span class="NLM_x">–</span> <span class="NLM_lpage">4974</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00136a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=4969-4974&author=J.+R.+Chagasauthor=I.+Y.+Hirataauthor=M.+A.+Julianoauthor=W.+Xiongauthor=C.+Wangauthor=J.+Chaoauthor=L.+Julianoauthor=E.+S.+Prado&title=Substrate+specificities+of+tissue+kallikrein+and+T-kininogenase%3A+their+possible+role+in+kininogen+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fbi00136a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00136a008%26sid%3Dliteratum%253Aachs%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DHirata%26aufirst%3DI.%2BY.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26atitle%3DSubstrate%2520specificities%2520of%2520tissue%2520kallikrein%2520and%2520T-kininogenase%253A%2520their%2520possible%2520role%2520in%2520kininogen%2520processing%26jtitle%3DBiochemistry%26date%3D1992%26volume%3D31%26spage%3D4969%26epage%3D4974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazure, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span> </span><span class="NLM_article-title">Purification and characterization of active recombinant rat kallikrein rK9</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1547</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1547&publication_year=2001&pages=387-396&author=M.+Zaniauthor=M.+Brillard-Bourdetauthor=C.+Lazureauthor=L.+Julianoauthor=Y.+Courtyauthor=F.+Gauthierauthor=T.+Moreau&title=Purification+and+characterization+of+active+recombinant+rat+kallikrein+rK9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZani%26aufirst%3DM.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DLazure%26aufirst%3DC.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DCourty%26aufirst%3DY.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DT.%26atitle%3DPurification%2520and%2520characterization%2520of%2520active%2520recombinant%2520rat%2520kallikrein%2520rK9%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2001%26volume%3D1547%26spage%3D387%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">El Moujahed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span> </span><span class="NLM_article-title">Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins. Identification of a T-kinin-releasing rat kallikrein</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">247</span><span class="NLM_x">, </span> <span class="NLM_fpage">652</span><span class="NLM_x">–</span> <span class="NLM_lpage">658</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1432-1033.1997.00652.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=9266709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVCmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=247&publication_year=1997&pages=652-658&author=A.+El+Moujahedauthor=M.+Brillard-Bourdetauthor=M.+A.+Julianoauthor=T.+Moreauauthor=J.+R.+Chagasauthor=N.+Gutmanauthor=E.+S.+Pradoauthor=F.+Gauthier&title=Kininogen-derived+fluorogenic+substrates+for+investigating+the+vasoactive+properties+of+rat+tissue+kallikreins.+Identification+of+a+T-kinin-releasing+rat+kallikrein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins. Identification of a T-kinin-releasing rat kallikrein</span></div><div class="casAuthors">El Moujahed, Abderrahman; Brillard-Bourdet, Michele; Juliano, Maria A.; Moreau, Thierry; Chagas, Jair R.; Gutman, Ninette; Prado, Eline S.; Gauthier, Francis</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">247</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">652-658</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Peptide substrates with intramolecularly quenched fluorescence that reproduce the rat kininogen sequences at both ends of the bradykinin moiety were synthesized and used to investigate the kinin-releasing properties of five rat tissue kallikreins (rK1, rK2, rK7, rK9, rK10).  Substrates derived from rat H- and L-kininogen were cleaved best by rK1, esp. that including the N-terminal insertion site of bradykinin, Abz-TSVIRRPQ-EDDnp(Abz = O-aminobenzoyl, EDDnp = ethylenediamine 2,4-dinitrophenyl), which was cleaved at the R-R bond with a kcat/Km of 12400 mM-1 s-1.  Replacement of the P2' residue Pro by Val in Abz-TSVIRRPQ-EDDnp gave a far less specific substrate that was rapidly hydrolyzed by all five rat kallikreins and human kallikrein hK1.  Peptidyl-N-Me coumarylamide substrates, which lack prime residues, also had low specificities.  The importance of the P2' residue for rK1 specificity was further demonstrated using a human-kininogen-derived substrate that included the N-terminal insertion site of bradykinin (Abz-LMKRP-EDDnp).  This was cleaved at the M-K bond by hK1 (kallidin-releasing site), but at the K-R bond (bradykinin-releasing site) by rK1.  Competition expts. with Abz-TSVIRRPQ-EDDnp, which is resistant to most kallikreins, and Abz-TSVIRRVQ-EDDnp, a general kallikrein substrate, demonstrated that the former competitively inhibited hydrolysis by rK9 and hK1, with Ki values similar to the Km values for the substrate.  Thus Pro in P2' does not prevent the peptide binding to the enzyme active site, but impairs cleavage of the scissile bond.  The T-kininogen-derived substrate with the T-kinin C-terminal sequence (Abz-FRLVR-EDDnp) was cleaved by rK10 (Kcat/Km = 2310 mM-1 s-1) and less rapidly by rK1, rK7 and hK1, at the R-L bond, while that corresponding to the N-terminal (Abz-ALDMMISRP-EDDnp) of T-kinin was resistant to all five kallikreins used, suggesting that none has T-kininogenase activity.  But this substrate was hydrolyzed by a semi-purified sample of submandibular gland ext.  Another kallikrein, identified as kallikrein rK3, was isolated from this fraction and shown to hydrolyze Abz-ALDMMISRP-EDDnp; rK3 also specifically released T-kinin from purified T1/T2-kininogen after HPLC fractionation.  Injection of purified rK3 and of Abz-ALDMMISRP-EDDnp-cleaving fractions into the circulation of anesthetized rats caused transient falls in blood pressure, as did purified rK1 but none of the other purified rat or human kallikreins.  This effect occurred via activation of the kinin system since it was blocked by Hoe140, a kinin receptor antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvsoH18aMxEbVg90H21EOLACvtfcHk0lgSJ29LvoX5oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVCmsrw%253D&md5=6725c0e64c6ede8bc84e70b9a65893d9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.00652.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.00652.x%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BMoujahed%26aufirst%3DA.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DMoreau%26aufirst%3DT.%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DGutman%26aufirst%3DN.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26aulast%3DGauthier%26aufirst%3DF.%26atitle%3DKininogen-derived%2520fluorogenic%2520substrates%2520for%2520investigating%2520the%2520vasoactive%2520properties%2520of%2520rat%2520tissue%2520kallikreins.%2520Identification%2520of%2520a%2520T-kinin-releasing%2520rat%2520kallikrein%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D247%26spage%3D652%26epage%3D658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fogaca, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">380</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=380&publication_year=2004&pages=775-781&author=S.+E.+Fogacaauthor=R.+L.+Meloauthor=D.+C.+Pimentaauthor=K.+Hosoiauthor=L.+Julianoauthor=M.+A.+Juliano&title=Differences+in+substrate+and+inhibitor+sequence+specificity+of+human%2C+mouse+and+rat+tissue+kallikreins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFogaca%26aufirst%3DS.%2BE.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DHosoi%26aufirst%3DK.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DDifferences%2520in%2520substrate%2520and%2520inhibitor%2520sequence%2520specificity%2520of%2520human%252C%2520mouse%2520and%2520rat%2520tissue%2520kallikreins%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D380%26spage%3D775%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lundwall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2019</span><span class="NLM_x">–</span> <span class="NLM_lpage">2038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1007%2Fs00018-008-8024-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18344018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVykt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=2019-2038&author=A.+Lundwallauthor=M.+Brattsand&title=Kallikrein-related+peptidases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidases</span></div><div class="casAuthors">Lundwall, A.; Brattsand, M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2019-2038</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Kallikrein 1 (KLK1), a key component of the kallikrein-kinin system, originates from a locus on the long arm of chromosome 19 that contains several related serine endopeptidases.  The biol. role of these kallikrein-related peptidases is not clear, but emerging evidence suggests that they might be important in several physiol. systems, e.g., in male reprodn., skin homeostasis, tooth enamel formation, and neural development and plasticity.  The kallikrein locus has undergone some major evolutionary events.  Most spectacular are relatively recent duplications of KLK1 that have created 13 and 9 functional genes that are unique to the mouse and the rat, resp.  Human paralogs are KLK2 and KLK3: the latter encoding the cancer biomarker prostate-specific antigen.  Here, the authors focus on the evolution of kallikrein-related peptidases, their role in skin homeostasis and semen liquefaction, and their utility as cancer biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqVQsvj2Xj-7Vg90H21EOLACvtfcHk0likdDNo2d-QcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVykt78%253D&md5=bc10a0ab2a2c2d4005c8e0cb76d3c06d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-8024-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-8024-3%26sid%3Dliteratum%253Aachs%26aulast%3DLundwall%26aufirst%3DA.%26aulast%3DBrattsand%26aufirst%3DM.%26atitle%3DKallikrein-related%2520peptidases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D2019%26epage%3D2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Sotiropoulou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pampalakis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Functional roles of human kallikrein-related peptidases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">32989</span><span class="NLM_x">–</span> <span class="NLM_lpage">32994</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=32989-32994&author=G.+Sotiropoulouauthor=G.+Pampalakisauthor=E.+P.+Diamandis&title=Functional+roles+of+human+kallikrein-related+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSotiropoulou%26aufirst%3DG.%26aulast%3DPampalakis%26aufirst%3DG.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DFunctional%2520roles%2520of%2520human%2520kallikrein-related%2520peptidases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D32989%26epage%3D32994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Angelo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Substrate specificity of human kallikrein 6: salt and glycosaminoglycan effects</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">3116</span><span class="NLM_x">–</span> <span class="NLM_lpage">3126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=3116-3126&author=P.+F.+Angeloauthor=A.+R.+Limaauthor=F.+M.+Alvesauthor=S.+I.+Blaberauthor=I.+A.+Scarisbrickauthor=M.+Blaberauthor=L.+Julianoauthor=M.+A.+Juliano&title=Substrate+specificity+of+human+kallikrein+6%3A+salt+and+glycosaminoglycan+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngelo%26aufirst%3DP.%2BF.%26aulast%3DLima%26aufirst%3DA.%2BR.%26aulast%3DAlves%26aufirst%3DF.%2BM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DSubstrate%2520specificity%2520of%2520human%2520kallikrein%25206%253A%2520salt%2520and%2520glycosaminoglycan%2520effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D3116%26epage%3D3126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Andrade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, J. A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1709</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=1701-1709&author=D.+Andradeauthor=D.+M.+Assisauthor=J.+A.+N.+Santosauthor=F.+M.+Alvesauthor=Y.+I.+Hirataauthor=M.+S.+Araujoauthor=S.+I.+Blaberauthor=M.+Blaberauthor=M.+A.+Julianoauthor=L.+Juliano&title=Substrate+specificity+of+kallikrein-related+peptidase+13+activated+by+salts+or+glycosaminoglycans+and+a+search+for+natural+substrate+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrade%26aufirst%3DD.%26aulast%3DAssis%26aufirst%3DD.%2BM.%26aulast%3DSantos%26aufirst%3DJ.%2BA.%2BN.%26aulast%3DAlves%26aufirst%3DF.%2BM.%26aulast%3DHirata%26aufirst%3DY.%2BI.%26aulast%3DAraujo%26aufirst%3DM.%2BS.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DSubstrate%2520specificity%2520of%2520kallikrein-related%2520peptidase%252013%2520activated%2520by%2520salts%2520or%2520glycosaminoglycans%2520and%2520a%2520search%2520for%2520natural%2520substrate%2520candidates%26jtitle%3DBiochimie%26date%3D2011%26volume%3D93%26spage%3D1701%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Andrade, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2010&pages=74-82&author=D.+Andradeauthor=D.+M.+Assisauthor=A.+R.+Limaauthor=J.+R.+Oliveiraauthor=M.+S.+Araujoauthor=S.+I.+Blaberauthor=M.+Blaberauthor=M.+A.+Julianoauthor=L.+Juliano&title=Substrate+specificity+and+inhibition+of+human+kallikrein-related+peptidase+3+%28KLK3+or+PSA%29+activated+with+sodium+citrate+and+glycosaminoglycans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrade%26aufirst%3DD.%26aulast%3DAssis%26aufirst%3DD.%2BM.%26aulast%3DLima%26aufirst%3DA.%2BR.%26aulast%3DOliveira%26aufirst%3DJ.%2BR.%26aulast%3DAraujo%26aufirst%3DM.%2BS.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DSubstrate%2520specificity%2520and%2520inhibition%2520of%2520human%2520kallikrein-related%2520peptidase%25203%2520%2528KLK3%2520or%2520PSA%2529%2520activated%2520with%2520sodium%2520citrate%2520and%2520glycosaminoglycans%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D498%26spage%3D74%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fiedler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leysath, G.</span><span> </span><span class="NLM_article-title">Substrate specificity of porcine pancreatic kallikrein</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1979&pages=261-271&author=F.+Fiedlerauthor=G.+Leysath&title=Substrate+specificity+of+porcine+pancreatic+kallikrein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiedler%26aufirst%3DF.%26aulast%3DLeysath%26aufirst%3DG.%26atitle%3DSubstrate%2520specificity%2520of%2520porcine%2520pancreatic%2520kallikrein%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1979%26volume%3D120%26spage%3D261%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Axen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkop, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, M. E.</span><span> </span><span class="NLM_article-title">Release of kinin activity from human kininogens and fresh plasma by cyanogen bromide</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1966&pages=353-357&author=R.+Axenauthor=E.+Grossauthor=B.+Witkopauthor=J.+V.+Pierceauthor=M.+E.+Webster&title=Release+of+kinin+activity+from+human+kininogens+and+fresh+plasma+by+cyanogen+bromide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAxen%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DE.%26aulast%3DWitkop%26aufirst%3DB.%26aulast%3DPierce%26aufirst%3DJ.%2BV.%26aulast%3DWebster%26aufirst%3DM.%2BE.%26atitle%3DRelease%2520of%2520kinin%2520activity%2520from%2520human%2520kininogens%2520and%2520fresh%2520plasma%2520by%2520cyanogen%2520bromide%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1966%26volume%3D5%26spage%3D353%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portaro, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span> </span><span class="NLM_article-title">Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1995&pages=63-69&author=J.+R.+Chagasauthor=F.+C.+Portaroauthor=I.+Y.+Hirataauthor=P.+C.+Almeidaauthor=M.+A.+Julianoauthor=L.+Julianoauthor=E.+S.+Prado&title=Determinants+of+the+unusual+cleavage+specificity+of+lysyl-bradykinin-releasing+kallikreins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DPortaro%26aufirst%3DF.%2BC.%26aulast%3DHirata%26aufirst%3DI.%2BY.%26aulast%3DAlmeida%26aufirst%3DP.%2BC.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26atitle%3DDeterminants%2520of%2520the%2520unusual%2520cleavage%2520specificity%2520of%2520lysyl-bradykinin-releasing%2520kallikreins%26jtitle%3DBiochem.%2520J.%26date%3D1995%26volume%3D306%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Del Nery, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chagas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prado, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=1995&pages=233-238&author=E.+Del+Neryauthor=J.+R.+Chagasauthor=M.+A.+Julianoauthor=E.+S.+Pradoauthor=L.+Juliano&title=Evaluation+of+the+extent+of+the+binding+site+in+human+tissue+kallikrein+by+synthetic+substrates+with+sequences+of+human+kininogen+fragments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BNery%26aufirst%3DE.%26aulast%3DChagas%26aufirst%3DJ.%2BR.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DPrado%26aufirst%3DE.%2BS.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DEvaluation%2520of%2520the%2520extent%2520of%2520the%2520binding%2520site%2520in%2520human%2520tissue%2520kallikrein%2520by%2520synthetic%2520substrates%2520with%2520sequences%2520of%2520human%2520kininogen%2520fragments%26jtitle%3DBiochem.%2520J.%26date%3D1995%26volume%3D312%26spage%3D233%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span> </span><span class="NLM_article-title">Specificity of human tissue kallikrein towards substrates containing Phe–Phe pair of amino acids</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1999&pages=473-479&author=D.+C.+Pimentaauthor=J.+Chaoauthor=L.+Chaoauthor=M.+A.+Julianoauthor=L.+Juliano&title=Specificity+of+human+tissue+kallikrein+towards+substrates+containing+Phe%E2%80%93Phe+pair+of+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DChao%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26atitle%3DSpecificity%2520of%2520human%2520tissue%2520kallikrein%2520towards%2520substrates%2520containing%2520Phe%25E2%2580%2593Phe%2520pair%2520of%2520amino%2520acids%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D339%26spage%3D473%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa Pozzo, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">5226</span><span class="NLM_x">–</span> <span class="NLM_lpage">5232</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi002003u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=5226-5232&author=R.+L.+Meloauthor=R.+C.+Barbosa+Pozzoauthor=D.+C.+Pimentaauthor=E.+Perissuttiauthor=G.+Caliendoauthor=V.+Santagadaauthor=L.+Julianoauthor=M.+A.+Juliano&title=Human+tissue+kallikrein+S1+subsite+recognition+of+non-natural+basic+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi002003u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi002003u%26sid%3Dliteratum%253Aachs%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DBarbosa%2BPozzo%26aufirst%3DR.%2BC.%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DHuman%2520tissue%2520kallikrein%2520S1%2520subsite%2520recognition%2520of%2520non-natural%2520basic%2520amino%2520acids%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D5226%26epage%3D5232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Bourgeois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deperthes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dube, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span> </span><span class="NLM_article-title">Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">29590</span><span class="NLM_x">–</span> <span class="NLM_lpage">29595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=29590-29595&author=L.+Bourgeoisauthor=M.+Brillard-Bourdetauthor=D.+Deperthesauthor=M.+A.+Julianoauthor=L.+Julianoauthor=R.+R.+Tremblayauthor=J.+Y.+Dubeauthor=F.+Gauthier&title=Potential+involvement+of+kallikrein+hK2+in+the+hydrolysis+of+the+human+seminal+vesicle+proteins+after+ejaculation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBourgeois%26aufirst%3DL.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DDeperthes%26aufirst%3DD.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DTremblay%26aufirst%3DR.%2BR.%26aulast%3DDube%26aufirst%3DJ.%2BY.%26aulast%3DGauthier%26aufirst%3DF.%26atitle%3DPotential%2520involvement%2520of%2520kallikrein%2520hK2%2520in%2520the%2520hydrolysis%2520of%2520the%2520human%2520seminal%2520vesicle%2520proteins%2520after%2520ejaculation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D29590%26epage%3D29595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Rehault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brillard-Bourdet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span> </span><span class="NLM_article-title">Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1596</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1596&publication_year=2002&pages=55-62&author=S.+Rehaultauthor=M.+Brillard-Bourdetauthor=L.+Bourgeoisauthor=G.+Frenetteauthor=L.+Julianoauthor=F.+Gauthierauthor=T.+Moreau&title=Design+of+new+and+sensitive+fluorogenic+substrates+for+human+kallikrein+hK3+%28prostate-specific+antigen%29+derived+from+semenogelin+sequences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRehault%26aufirst%3DS.%26aulast%3DBrillard-Bourdet%26aufirst%3DM.%26aulast%3DBourgeois%26aufirst%3DL.%26aulast%3DFrenette%26aufirst%3DG.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DT.%26atitle%3DDesign%2520of%2520new%2520and%2520sensitive%2520fluorogenic%2520substrates%2520for%2520human%2520kallikrein%2520hK3%2520%2528prostate-specific%2520antigen%2529%2520derived%2520from%2520semenogelin%2520sequences%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1596%26spage%3D55%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoell, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazegh-Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashjian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeles, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timasheff, S. N.</span><span> </span><span class="NLM_article-title">Modulation of recombinant human prostate-specific antigen: activation by hofmeister salts and inhibition by azapeptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">11734</span><span class="NLM_x">–</span> <span class="NLM_lpage">11741</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi010364j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=11734-11741&author=X.+Huangauthor=C.+T.+Knoellauthor=G.+Freyauthor=M.+Hazegh-Azamauthor=A.+H.+Tashjianauthor=L.+Hedstromauthor=R.+H.+Abelesauthor=S.+N.+Timasheff&title=Modulation+of+recombinant+human+prostate-specific+antigen%3A+activation+by+hofmeister+salts+and+inhibition+by+azapeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi010364j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi010364j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKnoell%26aufirst%3DC.%2BT.%26aulast%3DFrey%26aufirst%3DG.%26aulast%3DHazegh-Azam%26aufirst%3DM.%26aulast%3DTashjian%26aufirst%3DA.%2BH.%26aulast%3DHedstrom%26aufirst%3DL.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26aulast%3DTimasheff%26aufirst%3DS.%2BN.%26atitle%3DModulation%2520of%2520recombinant%2520human%2520prostate-specific%2520antigen%253A%2520activation%2520by%2520hofmeister%2520salts%2520and%2520inhibition%2520by%2520azapeptides%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D11734%26epage%3D11741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Rehault, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monget, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazerbourg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, T.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">2960</span><span class="NLM_x">–</span> <span class="NLM_lpage">2968</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1046%2Fj.1432-1327.2001.02185.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=11358513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=2960-2968&author=S.+Rehaultauthor=P.+Mongetauthor=S.+Mazerbourgauthor=R.+Tremblayauthor=N.+Gutmanauthor=F.+Gauthierauthor=T.+Moreau&title=Insulin-like+growth+factor+binding+proteins+%28IGFBPs%29+as+potential+physiological+substrates+for+human+kallikreins+hK2+and+hK3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3</span></div><div class="casAuthors">Rehault, Sophie; Monget, Philippe; Mazerbourg, Sabine; Tremblay, Roland; Gutman, Ninette; Gauthier, Francis; Moreau, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2960-2968</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Insulin-like growth factors (IGFs) are important growth regulators of both normal and malignant prostate cells.  Their action is regulated by six insulin-like growth factor binding proteins (IGFBPs).  The proteolytic cleavage of IGFBPs by various proteases decreases dramatically their affinity for their ligands and therefore enhances the bioavailability of IGFs.  To elucidate the putative biol. role of prostatic kallikreins hK2 and hK3 (prostate-specific antigen) in tumor progression, the authors analyzed the degrdn. of IGFBP-2, -3, -4 and -5 by these two tissue kallikreins.  The authors found that hK3, already characterized as an IGFBP-3 degrading protease, cleaved IGFBP-4 but not IGFBP-2 and -5, whereas hK2 cleaved all of the IGFBPs much more effectively, and at concns. far lower than those reported for other IGFBP-degrading proteases.  The proteolytic patterns after cleavage of IGFBPs by hK2 and hK3 were similar and were not modified in the presence of IGF-1.  Heparin, but not other glycosaminoglycans, enhanced dramatically the ability of hK3 but not hK2 to degrade IGFBP-3 and IGFBP-4.  More importantly, the IGFBP fragments generated by hK2 and hK3 had no IGF-binding capacity, as assessed by Western ligand blotting.  The authors' results suggest that the prostatic kallikreins hK2 and hK3 may influence specifically the tumoral growth of prostate cells through the degrdn. of IGFBPs, to increase IGF bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAqAzviXJyDLVg90H21EOLACvtfcHk0lhTIrmDMNkVKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSktLo%253D&md5=617645c37afd1276a2a905f4dcf0f458</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02185.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02185.x%26sid%3Dliteratum%253Aachs%26aulast%3DRehault%26aufirst%3DS.%26aulast%3DMonget%26aufirst%3DP.%26aulast%3DMazerbourg%26aufirst%3DS.%26aulast%3DTremblay%26aufirst%3DR.%26aulast%3DGutman%26aufirst%3DN.%26aulast%3DGauthier%26aufirst%3DF.%26aulast%3DMoreau%26aufirst%3DT.%26atitle%3DInsulin-like%2520growth%2520factor%2520binding%2520proteins%2520%2528IGFBPs%2529%2520as%2520potential%2520physiological%2520substrates%2520for%2520human%2520kallikreins%2520hK2%2520and%2520hK3%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D2960%26epage%3D2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Debela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaufort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettig, P.</span><span> </span><span class="NLM_article-title">Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=623-632&issue=6&author=M.+Debelaauthor=N.+Beaufortauthor=V.+Magdolenauthor=N.+M.+Schechterauthor=C.+S.+Craikauthor=M.+Schmittauthor=W.+Bodeauthor=P.+Goettig&title=Structures+and+specificity+of+the+human+kallikrein-related+peptidases+KLK+4%2C+5%2C+6%2C+and+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebela%26aufirst%3DM.%26aulast%3DBeaufort%26aufirst%3DN.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DSchechter%26aufirst%3DN.%2BM.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DBode%26aufirst%3DW.%26aulast%3DGoettig%26aufirst%3DP.%26atitle%3DStructures%2520and%2520specificity%2520of%2520the%2520human%2520kallikrein-related%2520peptidases%2520KLK%25204%252C%25205%252C%25206%252C%2520and%25207%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26issue%3D6%26spage%3D623%26epage%3D632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Luo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span> </span><span class="NLM_article-title">Inhibition profiles of human tissue kallikreins by serine protease inhibitors</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=813-816&author=L.+Y.+Luoauthor=W.+Jiang&title=Inhibition+profiles+of+human+tissue+kallikreins+by+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DL.%2BY.%26aulast%3DJiang%26aufirst%3DW.%26atitle%3DInhibition%2520profiles%2520of%2520human%2520tissue%2520kallikreins%2520by%2520serine%2520protease%2520inhibitors%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D813%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Zhou, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span> </span><span class="NLM_article-title">Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">25873</span><span class="NLM_x">–</span> <span class="NLM_lpage">25880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=25873-25880&author=G.+X.+Zhouauthor=L.+Chaoauthor=J.+Chao&title=Kallistatin%3A+a+novel+human+tissue+kallikrein+inhibitor.+Purification%2C+characterization%2C+and+reactive+center+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%2BX.%26aulast%3DChao%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DJ.%26atitle%3DKallistatin%253A%2520a%2520novel%2520human%2520tissue%2520kallikrein%2520inhibitor.%2520Purification%252C%2520characterization%252C%2520and%2520reactive%2520center%2520sequence%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D25873%26epage%3D25880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Obiezu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human tissue kallikrein gene family: applications in cancer</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.canlet.2004.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15911097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2005&pages=1-22&author=C.+V.+Obiezuauthor=E.+P.+Diamandis&title=Human+tissue+kallikrein+gene+family%3A+applications+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Human tissue kallikrein gene family: applications in cancer</span></div><div class="casAuthors">Obiezu, Christina V.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes.  Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes.  These genes, and their protein products, share a high degree of homol. and are expressed in a wide array of tissues, mainly those that are under steroid hormone control.  PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker.  In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been assocd. with several types of cancer.  For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer.  New evidence raises the possibility that some kallikreins are directly involved with cancer progression.  We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdVQ3Ly8oHCbVg90H21EOLACvtfcHk0lirp-7xgZ6VJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1aksbY%253D&md5=837a7e70ff67c0e7d17986f0b833ddc7</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2004.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2004.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DObiezu%26aufirst%3DC.%2BV.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520tissue%2520kallikrein%2520gene%2520family%253A%2520applications%2520in%2520cancer%26jtitle%3DCancer%2520Lett.%26date%3D2005%26volume%3D224%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=312-329&author=S.+A.+Williamsauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Does+PSA+play+a+role+as+a+promoting+agent+during+the+initiation+and%2For+progression+of+prostate+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DDoes%2520PSA%2520play%2520a%2520role%2520as%2520a%2520promoting%2520agent%2520during%2520the%2520initiation%2520and%252For%2520progression%2520of%2520prostate%2520cancer%253F%26jtitle%3DProstate%26date%3D2007%26volume%3D67%26spage%3D312%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fritzsche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gansukh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgono, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayordomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzer, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span> </span><span class="NLM_article-title">Expression of human kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjc.6602956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16434994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ersrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=540-547&author=F.+Fritzscheauthor=T.+Gansukhauthor=C.+A.+Borgonoauthor=M.+Burkhardtauthor=S.+Pahlauthor=E.+Mayordomoauthor=K.+J.+Winzerauthor=W.+Weichertauthor=C.+Denkertauthor=K.+Jungauthor=C.+Stephanauthor=M.+Dietelauthor=E.+P.+Diamandisauthor=E.+Dahlauthor=G.+Kristiansen&title=Expression+of+human+kallikrein+14+%28KLK14%29+in+breast+cancer+is+associated+with+higher+tumour+grades+and+positive+nodal+status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status</span></div><div class="casAuthors">Fritzsche, F.; Gansukh, T.; Borgono, C. A.; Burkhardt, M.; Pahl, S.; Mayordomo, E.; Winzer, K-J.; Weichert, W.; Denkert, C.; Jung, K.; Stephan, C.; Dietel, M.; Diamandis, E. P.; Dahl, E.; Kristiansen, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">540-547</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human kallikrein 14 (KLK14) is a steroid hormone-regulated member of the tissue kallikrein family of serine proteases, for which a prognostic and diagnostic value in breast cancer has been suggested.  To further characterize the value of KLK14 as a breast tumor marker, we have carefully analyzed KLK14 expression in normal breast tissue and breast cancer both on the RNA level by real-time RT-PCR (n=39), and on the protein level (n=127) using a KLK14-specific antibody for immunohistochem.  We correlated KLK14 protein expression data with available clinico-pathol. parameters (mean follow-up time was 55 mo) including patient prognosis.  KLK14 RNA expression as quantified by real-time RT-PCR was significantly more abundant in breast tumors compared to normal breast tissue (P=0.027), an issue that had not been clarified recently.  Concordantly with the RNA data, cytoplasmic KLK14 protein expression was significantly higher in invasive breast carcinomas compared to normal breast tissues (P=0.003).  Furthermore, KLK14 protein expression was assocd. with higher tumor grade (P=0.041) and pos. nodal status (P=0.045) but was not significantly assocd. with shortened disease-free or overall patient survival time in univariate analyses.  We conclude that KLK14 is clearly overexpressed in breast cancer in comparison to normal breast tissues and is pos. assocd. with conventional parameters of tumor aggressiveness, but due to a missing assocn. with survival times, the use of KLK14 immunohistochem. as a prognostic marker in breast cancer is questionable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2dz15isTbrVg90H21EOLACvtfcHk0lg7_7_GT4gWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ersrs%253D&md5=4d1a1725e38fe4136dab08870583df0a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602956%26sid%3Dliteratum%253Aachs%26aulast%3DFritzsche%26aufirst%3DF.%26aulast%3DGansukh%26aufirst%3DT.%26aulast%3DBorgono%26aufirst%3DC.%2BA.%26aulast%3DBurkhardt%26aufirst%3DM.%26aulast%3DPahl%26aufirst%3DS.%26aulast%3DMayordomo%26aufirst%3DE.%26aulast%3DWinzer%26aufirst%3DK.%2BJ.%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DDahl%26aufirst%3DE.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DExpression%2520of%2520human%2520kallikrein%252014%2520%2528KLK14%2529%2520in%2520breast%2520cancer%2520is%2520associated%2520with%2520higher%2520tumour%2520grades%2520and%2520positive%2520nodal%2520status%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D540%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Xi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaern, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klokk, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risberg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saatcioglu, F.</span><span> </span><span class="NLM_article-title">Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer</span> <span class="citation_source-journal">Gynecol Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ygyno.2004.03.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15262123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslOqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=80-85&author=Z.+Xiauthor=J.+Kaernauthor=B.+Davidsonauthor=T.+I.+Klokkauthor=B.+Risbergauthor=C.+Trop%C3%A9author=F.+Saatcioglu&title=Kallikrein+4+is+associated+with+paclitaxel+resistance+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer</span></div><div class="casAuthors">Xi, Zhijun; Kaern, Janne; Davidson, Ben; Klokk, Tove Irene; Risberg, Bjorn; Trope, Claes; Saatcioglu, Fahri</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-85</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Carcinoma of the ovary is the most fatal malignancy of the female genital tract in western countries.  The effectiveness of chemotherapy is limited by the acquisition of drug resistance.  Several members of the kallikrein (KLK) family were recently shown to be expressed in ovarian cancer and implicated in disease prognosis.  One of these is KLK4, whose increased mRNA expression was identified as a poor prognostic marker in ovarian cancer.  The goal of this study was to investigate if KLK4 protein (hK4) is expressed in ovarian carcinoma lesions and if it is assocd. with paclitaxel resistance.  Immunohistochem. was used to assess hK4 expression.  The 126 lesions were from a cohort of 46 patients with platinum-resistant tumors, which were treated with weekly paclitaxel for recurrent disease.  The overall response rate to weekly paclitaxel was 52% (24 of 46) and for patients with tumors resistant to std. three weekly paclitaxel treatment 48% (16 of 33).  Immunohistochem. indicated that 85% (79 of 93) of lesions from paclitaxel-resistant patients expressed hK4, while only 61% (20 of 33) of lesions were pos. for hK4 from paclitaxel sensitive patients.  Statistical anal. showed that the intensity of hK4 staining was significantly assocd. with paclitaxel resistance (P = 0.005), whereas hK4 staining extent showed marginal significance (P = 0.05), but was significantly correlated with higher histol. grade (P < 0.001).  These data show that hK4 is expressed in ovarian cancer and suggest that hK4 expression might be a predictive marker for paclitaxel resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHYjkAoBtDs7Vg90H21EOLACvtfcHk0lg7_7_GT4gWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslOqsbs%253D&md5=880f456417c4354792146406b9c829e2</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2004.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2004.03.044%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%26aulast%3DKaern%26aufirst%3DJ.%26aulast%3DDavidson%26aufirst%3DB.%26aulast%3DKlokk%26aufirst%3DT.%2BI.%26aulast%3DRisberg%26aufirst%3DB.%26aulast%3DTrop%25C3%25A9%26aufirst%3DC.%26aulast%3DSaatcioglu%26aufirst%3DF.%26atitle%3DKallikrein%25204%2520is%2520associated%2520with%2520paclitaxel%2520resistance%2520in%2520ovarian%2520cancer%26jtitle%3DGynecol%2520Oncol.%26date%3D2004%26volume%3D94%26spage%3D80%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Talieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourgiotis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathioudaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span> </span><span class="NLM_article-title">Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=14691584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=180-186&author=M.+Talieriauthor=E.+P.+Diamandisauthor=D.+Gourgiotisauthor=K.+Mathioudakiauthor=A.+Scorilas&title=Expression+analysis+of+the+human+kallikrein+7+%28KLK7%29+in+breast+tumors%3A+a+new+potential+biomarker+for+prognosis+of+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: A new potential biomarker for prognosis of breast carcinoma</span></div><div class="casAuthors">Talieri, Maroulio; Diamandis, Eleftherios P.; Gourgiotis, Dimitrios; Mathioudaki, Kostandina; Scorilas, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">180-186</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Kallikreins are a subgroup of serine proteases that are involved in the post-translational processing of polypeptide precursors.  Growing evidence suggests that many kallikreins are implicated in carcinogenesis.  Human kallikrein gene 7 (KLK7; HSCCE) is a new member of the human kallikrein gene family.  KLK7 is expressed in normal breast tissue and is up-regulated in breast cancer cells by estrogens and glucocorticoids.  In the present study, expression of the KLK7 gene in 92 breast cancer tissues was analyzed by reverse transcription-PCR (RT-PCR) and direct sequencing of several samples.  The results were correlated with other clinicopathol. variables and patient outcome.  KLK7 gene expression was significantly lower in breast cancer patients of low stage (I/II) (p = 0.011) and patients with pos. progesterone receptors (p = 0.022).  Survival anal. showed that breast cancer patients with KLK7 pos. tumors have relatively shorter disease-free survival (DFS) and overall survival (OS) than patients with KLK7 neg. tumors.  These data suggest that KLK7 gene expression may be used as a marker of unfavorable prognosis for breast cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreLtnwQi8jl7Vg90H21EOLACvtfcHk0lg7_7_GT4gWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVWgsg%253D%253D&md5=23134f1e50c39714b7998f39b2942263</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DGourgiotis%26aufirst%3DD.%26aulast%3DMathioudaki%26aufirst%3DK.%26aulast%3DScorilas%26aufirst%3DA.%26atitle%3DExpression%2520analysis%2520of%2520the%2520human%2520kallikrein%25207%2520%2528KLK7%2529%2520in%2520breast%2520tumors%253A%2520a%2520new%2520potential%2520biomarker%2520for%2520prognosis%2520of%2520breast%2520carcinoma%26jtitle%3DThromb.%2520Haemostasis%26date%3D2004%26volume%3D91%26spage%3D180%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Holzscheiter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biermann, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotzsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farthmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baretton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjan-Heijnen, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Span, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span> </span><span class="NLM_article-title">Quantitative reverse transcription-PCR assay for detection of mRNA encoding full length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer</span> <span class="citation_source-journal">Clin. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1373%2Fclinchem.2005.065599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16627559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlSrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=1070-1079&author=L.+Holzscheiterauthor=J.+C.+Biermannauthor=M.+Kotzschauthor=P.+Prezasauthor=J.+Farthmannauthor=G.+Barettonauthor=T.+Lutherauthor=V.+C.+Tjan-Heijnenauthor=M.+Talieriauthor=M.+Schmittauthor=F.+C.+Sweepauthor=P.+N.+Spanauthor=V.+Magdolen&title=Quantitative+reverse+transcription-PCR+assay+for+detection+of+mRNA+encoding+full+length+human+tissue+kallikrein+7%3A+prognostic+relevance+of+KLK7+mRNA+expression+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer</span></div><div class="casAuthors">Holzscheiter, Leon; Biermann, Julia C.; Kotzsch, Matthias; Prezas, Panagiotis; Farthmann, Juliane; Baretton, Gustavo; Luther, Thomas; Tjan-Heijnen, Vivianne C. G.; Talieri, Maroulio; Schmitt, Manfred; Sweep, Fred C. G. J.; Span, Paul N.; Magdolen, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1070-1079</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    
            (<span class="NLM_cas:orgname">American Association for Clinical Chemistry</span>)
        </div><div class="casAbstract">Background: The human tissue kallikrein gene family (KLK1 to KLK15) encodes a group of 15 serine proteases (hK1 to hK15), several of which have been implicated in cancer-related processes.  Methods: We established a specific quant. reverse transcription-PCR assay for full-length KLK7 mRNA that excluded amplification of the exon 2 deletion splice variant (the latter does not encode a functional protease), and evaluated full-length KLK7 mRNA expression [normalized to human glucose-6-phosphate dehydrogenase (h-G6PDH)] in tumor tissue specimens from 155 breast cancer patients.  Results: High KLK7 mRNA expression (continuous) was significantly assocd. with a better patient out-come according to both univariate (P = 0.005) and multivariate (P = 0.046) Cox survival anal.  Sepn. of patients by optimized dichotomization revealed a significantly better prognosis for patients with high KLK7 mRNA status (n = 89) compared with patients with low KLK7 mRNA status (n = 66) [univariate hazard ratio (HR) = 0.45 (P = 0.001); multivariate HR = 0.50 (P = 0.005)].  In the subgroup of patients not receiving adjuvant treatment (n = 69), KLK7 mRNA status was a significant prognosticator [univariate HR = 0.29 (P = 0.002); multivariate HR = 0.40 (P = 0.034)].  This subgroup was least influenced by postoperative treatment and thus best showed the impact of KLK7 expression on the natural course of breast cancer disease.  Conclusion: Expression of full-length KLK7 mRNA may represent a new prognostic marker in breast cancer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMKw2XfLV5h7Vg90H21EOLACvtfcHk0lineo5FutthjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlSrtb0%253D&md5=f55950880d34f6f31bf1130b92093bc8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1373%2Fclinchem.2005.065599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1373%252Fclinchem.2005.065599%26sid%3Dliteratum%253Aachs%26aulast%3DHolzscheiter%26aufirst%3DL.%26aulast%3DBiermann%26aufirst%3DJ.%2BC.%26aulast%3DKotzsch%26aufirst%3DM.%26aulast%3DPrezas%26aufirst%3DP.%26aulast%3DFarthmann%26aufirst%3DJ.%26aulast%3DBaretton%26aufirst%3DG.%26aulast%3DLuther%26aufirst%3DT.%26aulast%3DTjan-Heijnen%26aufirst%3DV.%2BC.%26aulast%3DTalieri%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DSweep%26aufirst%3DF.%2BC.%26aulast%3DSpan%26aufirst%3DP.%2BN.%26aulast%3DMagdolen%26aufirst%3DV.%26atitle%3DQuantitative%2520reverse%2520transcription-PCR%2520assay%2520for%2520detection%2520of%2520mRNA%2520encoding%2520full%2520length%2520human%2520tissue%2520kallikrein%25207%253A%2520prognostic%2520relevance%2520of%2520KLK7%2520mRNA%2520expression%2520in%2520breast%2520cancer%26jtitle%3DClin.%2520Chem.%26date%3D2006%26volume%3D52%26spage%3D1070%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Shvartsman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deavers, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bast, R. C.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershenson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span> </span><span class="NLM_article-title">Overexpression of kallikrein 10 in epithelial ovarian carcinomas</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2FS0090-8258%2803%2900257-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12821340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVaqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2003&pages=44-50&author=H.+S.+Shvartsmanauthor=K.+H.+Luauthor=J.+Leeauthor=J.+Lillieauthor=M.+T.+Deaversauthor=S.+Cliffordauthor=J.+K.+Wolfauthor=G.+B.+Millsauthor=R.+C.+Bastauthor=D.+M.+Gershensonauthor=R.+Schmandt&title=Overexpression+of+kallikrein+10+in+epithelial+ovarian+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of kallikrein 10 in epithelial ovarian carcinomas</span></div><div class="casAuthors">Shvartsman, Hyun S.; Lu, Karen H.; Lee, John; Lillie, Jim; Deavers, Michael T.; Clifford, Stephanie; Wolf, Judith K.; Mills, Gordon B.; Bast, Robert C.; Gershenson, David M.; Schmandt, Rosemarie</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-50</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Objective.  The authors wanted to identify genes up-regulated in ovarian tumors that might serve as early markers for ovarian cancer.  One promising focus is the family of genes that encode secreted proteases, which play essential roles in tumor invasion and metastasis.  Kallikrein 10 (KLK10) is a member of the kallikrein family of serine proteases which include 15 proteins, including the prostate-specific antigen (PSA), also known as hK3.  The authors investigated whether KLK10 and its related protein, hK10, might serve as equally accurate markers for ovarian carcinoma.  Methods. Transcriptional profiling was performed using RNA isolated from normal ovarian epithelium, ovarian cancer cell lines, and primary ovarian tumors.  Microarray data were confirmed by Northern blot anal. of 66 ovarian tumor samples and 6 ovarian cancer cell lines.  In situ hybridization and Western blot anal. confirmed the Northern blot findings.  Results. KLK10 was more highly expressed by primary ovarian tumors than by NOE.  Thirty-two of 35 primary serous ovarian carcinoma samples (91.4%) expressed higher levels of KLK10 than NOE did.  Eleven of 15 nonserous epithelial ovarian carcinoma samples (73.3%) and 8 of 11 primary peritoneal carcinoma samples (72.7%) also expressed KLK10.  Overall, 84.8% of all epithelial ovarian and peritoneal carcinoma tumor samples showed elevated expression of KLK10.  Similarly, Western blot anal. demonstrated that levels of the KLK10-related protein, designated hK10, are elevated in primary ovarian tissue lysates, but the protein is undetectable in immortalized ovarian epithelium.  Finally, in situ hybridization established that KLK10 mRNA is much more highly expressed by tumor tissue than by normal epithelium and stromal tissues.  Conclusions.  The authors' data support recent immunoassay findings of elevated levels of hK10 in the tumor tissue and serum of ovarian cancer patients.  Thus, it is likely that KLK10 and other kallikreins will serve as useful diagnostic and prognostic markers in patients with ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc1dqVut07crVg90H21EOLACvtfcHk0lineo5FutthjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVaqs7s%253D&md5=55c62b69a73ce2e9495c2a78601f831f</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0090-8258%2803%2900257-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0090-8258%252803%252900257-9%26sid%3Dliteratum%253Aachs%26aulast%3DShvartsman%26aufirst%3DH.%2BS.%26aulast%3DLu%26aufirst%3DK.%2BH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLillie%26aufirst%3DJ.%26aulast%3DDeavers%26aufirst%3DM.%2BT.%26aulast%3DClifford%26aufirst%3DS.%26aulast%3DWolf%26aufirst%3DJ.%2BK.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DBast%26aufirst%3DR.%2BC.%26aulast%3DGershenson%26aufirst%3DD.%2BM.%26aulast%3DSchmandt%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520kallikrein%252010%2520in%2520epithelial%2520ovarian%2520carcinomas%26jtitle%3DGynecol.%2520Oncol.%26date%3D2003%26volume%3D90%26spage%3D44%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">McIntosh, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drescher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4422</span><span class="NLM_x">–</span> <span class="NLM_lpage">4428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1078-0432.CCR-06-2224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17671125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlGqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=4422-4428&author=M.+W.+McIntoshauthor=Y.+Liuauthor=C.+Drescherauthor=N.+Urbanauthor=E.+P.+Diamandis&title=Validation+and+characterization+of+human+kallikrein+11+as+a+serum+marker+for+diagnosis+of+ovarian+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma</span></div><div class="casAuthors">McIntosh, Martin W.; Liu, Yan; Drescher, Charles; Urban, Nicole; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15, Pt. 1</span>),
    <span class="NLM_cas:pages">4422-4428</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The serum tumor marker CA 125 is elevated in most clin. advanced ovarian carcinomas, and currently, one of the most promising early detection strategies for ovarian cancer uses CA 125 level in conjunction with imaging.  However, CA 125 is elevated in only 50% of early-stage ovarian cancer and is often elevated in women with benign ovarian tumors and other gynecol. diseases.  Addnl. markers may improve on its individual performance if they increase sensitivity and specificity and are less sensitive to other gynecol. conditions.  The human kallikrein 11 (hK11) marker has been reported to have favorable predictive value for ovarian cancer, although, by itself, it may be inferior to CA 125.  Exptl. Design: We here validate the performance of hK11 on an independent data set and further characterize its behavior in multiple types of controls.  We also investigate its behavior when combined with CA 125 to form a composite marker. hK11 had not previously been evaluated on these serum samples.  CA 125, hK11, and the composite marker were evaluated for their performance in identifying ovarian cancer and for temporal stability.  RESULTS: hK11 significantly distinguished ovarian cancer cases from healthy controls and is less sensitive to benign ovarian disease than is CA 125.  CONCLUSION: We conclude that hK11 is a valuable new biomarker for ovarian cancer and its temporal stability implies that it may do even better when used in a longitudinal screening program for early detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwkX4sCMggzLVg90H21EOLACvtfcHk0lineo5FutthjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlGqt70%253D&md5=2962348f5d716667b62a988e4708e1ac</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2224%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntosh%26aufirst%3DM.%2BW.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDrescher%26aufirst%3DC.%26aulast%3DUrban%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DValidation%2520and%2520characterization%2520of%2520human%2520kallikrein%252011%2520as%2520a%2520serum%2520marker%2520for%2520diagnosis%2520of%2520ovarian%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D4422%26epage%3D4428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Monte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyetant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmazes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemarié, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span> </span><span class="NLM_article-title">KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2005&pages=1260-1266&author=C.+Planqueauthor=M.+de+Monteauthor=S.+Guyetantauthor=J.+Rollinauthor=C.+Desmazesauthor=V.+Panelauthor=E.+Lemari%C3%A9author=Y.+Courty&title=KLK5+and+KLK7%2C+two+members+of+the+human+tissue+kallikrein+family%2C+are+differentially+expressed+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3Dde%2BMonte%26aufirst%3DM.%26aulast%3DGuyetant%26aufirst%3DS.%26aulast%3DRollin%26aufirst%3DJ.%26aulast%3DDesmazes%26aufirst%3DC.%26aulast%3DPanel%26aufirst%3DV.%26aulast%3DLemari%25C3%25A9%26aufirst%3DE.%26aulast%3DCourty%26aufirst%3DY.%26atitle%3DKLK5%2520and%2520KLK7%252C%2520two%2520members%2520of%2520the%2520human%2520tissue%2520kallikrein%2520family%252C%2520are%2520differentially%2520expressed%2520in%2520lung%2520cancer%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D329%26spage%3D1260%26epage%3D1266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sher, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peck, K.</span><span> </span><span class="NLM_article-title">Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">11763</span><span class="NLM_x">–</span> <span class="NLM_lpage">11770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11763-11770&author=Y.+P.+Sherauthor=C.+C.+Chouauthor=R.+H.+Chouauthor=H.+M.+Wuauthor=W.+S.+Changauthor=C.+H.+Chenauthor=P.+C.+Yangauthor=C.+W.+Wuauthor=C.+L.+Yuauthor=K.+Peck&title=Human+kallikrein+8+protease+confers+a+favorable+clinical+outcome+in+non-small+cell+lung+cancer+by+suppressing+tumor+cell+invasiveness"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSher%26aufirst%3DY.%2BP.%26aulast%3DChou%26aufirst%3DC.%2BC.%26aulast%3DChou%26aufirst%3DR.%2BH.%26aulast%3DWu%26aufirst%3DH.%2BM.%26aulast%3DChang%26aufirst%3DW.%2BS.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DYang%26aufirst%3DP.%2BC.%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3DYu%26aufirst%3DC.%2BL.%26aulast%3DPeck%26aufirst%3DK.%26atitle%3DHuman%2520kallikrein%25208%2520protease%2520confers%2520a%2520favorable%2520clinical%2520outcome%2520in%2520non-small%2520cell%2520lung%2520cancer%2520by%2520suppressing%2520tumor%2520cell%2520invasiveness%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11763%26epage%3D11770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aïnciburu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuzé-Vourc’h, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Régina, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Monte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span> </span><span class="NLM_article-title">Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues</span> <span class="citation_source-journal">Biol Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=783-788&author=C.+Planqueauthor=M.+A%C3%AFnciburuauthor=N.+Heuz%C3%A9-Vourc%E2%80%99hauthor=S.+R%C3%A9ginaauthor=M.+de+Monteauthor=Y.+Courty&title=Expression+of+the+human+kallikrein+genes+10+%28KLK10%29+and+11+%28KLK11%29+in+cancerous+and+non-cancerous+lung+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3DA%25C3%25AFnciburu%26aufirst%3DM.%26aulast%3DHeuz%25C3%25A9-Vourc%25E2%2580%2599h%26aufirst%3DN.%26aulast%3DR%25C3%25A9gina%26aufirst%3DS.%26aulast%3Dde%2BMonte%26aufirst%3DM.%26aulast%3DCourty%26aufirst%3DY.%26atitle%3DExpression%2520of%2520the%2520human%2520kallikrein%2520genes%252010%2520%2528KLK10%2529%2520and%252011%2520%2528KLK11%2529%2520in%2520cancerous%2520and%2520non-cancerous%2520lung%2520tissues%26jtitle%3DBiol%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D783%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bléchet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayadi-Kaddour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuzé-Vourc’h, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyétant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Mezni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courty, Y.</span><span> </span><span class="NLM_article-title">Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=781-786&author=C.+Planqueauthor=C.+Bl%C3%A9chetauthor=A.+Ayadi-Kaddourauthor=N.+Heuz%C3%A9-Vourc%E2%80%99hauthor=P.+Dumontauthor=S.+Guy%C3%A9tantauthor=E.+P.+Diamandisauthor=F.+El+Mezniauthor=Y.+Courty&title=Quantitative+RT-PCR+analysis+and+immunohistochemical+localization+of+the+kallikrein-related+peptidases+13+and+14+in+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3DBl%25C3%25A9chet%26aufirst%3DC.%26aulast%3DAyadi-Kaddour%26aufirst%3DA.%26aulast%3DHeuz%25C3%25A9-Vourc%25E2%2580%2599h%26aufirst%3DN.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DGuy%25C3%25A9tant%26aufirst%3DS.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DEl%2BMezni%26aufirst%3DF.%26aulast%3DCourty%26aufirst%3DY.%26atitle%3DQuantitative%2520RT-PCR%2520analysis%2520and%2520immunohistochemical%2520localization%2520of%2520the%2520kallikrein-related%2520peptidases%252013%2520and%252014%2520in%2520lung%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D781%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Petraki, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregorakis, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaslamatzis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papanastasiou, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1159%2F000090150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16340244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCks7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1-7&author=C.+D.+Petrakiauthor=A.+K.+Gregorakisauthor=M.+M.+Vaslamatzisauthor=P.+A.+Papanastasiouauthor=G.+M.+Yousefauthor=M.+A.+Levesqueauthor=E.+P.+Diamandis&title=Prognostic+implications+of+the+immunohistochemical+expression+of+human+kallikreins+5%2C+6%2C+10+and+11+in+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma</span></div><div class="casAuthors">Petraki, Constantina D.; Gregorakis, Alkiviadis K.; Vaslamatzis, Michael M.; Papanastasiou, Panagiotis A.; Yousef, George M.; Levesque, Michael A.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Human kallikreins 5, 6, 10 and 11 (hK5, 6, 10 and 11) are expressed by many normal tissues, and it has been suggested that they may represent candidate tumor-diagnostic or -prognostic markers.  In patients with renal cell carcinoma (RCC), outcome is unpredictable despite the use of conventional prognostic factors.  The aim of this study is to evaluate the immunohistochem. expression and the prognostic value of the above kallikreins in RCC.  The study comprised 95 patients who underwent radical nephrectomy for RCC.  The median follow-up period was 60 mo (range 1-180 mo).  Fifty-seven RCC cases were immunostained for hK5, 70 for hK6, 70 for hK10 and 69 for hK11.  The streptavidin-biotin-peroxidase method of immunostaining was performed using anti-hK5, anti-hK6, anti-hK10 and anti-hK11 monoclonal and polyclonal antibodies.  The immunohistochem. expression of these kallikreins was correlated with tumor size, histol. type, histol. malignancy according to the Fuhrman four-grade scale, mitotic index, pathol. stage and disease survival.  For the statistical anal., four grades were collapsed into two by which RCC cases were categorized as low malignant (LM) and high malignant (HM).  In the normal renal parenchyma adjacent to the tumors, the renal tubular epithelium showed a cytoplasmic expression of all four kallikreins.  In RCC, immunohistochem. expression was decreased: 33 of 57 cases (58%) were pos. for hK5, 27 of 70 (39%) for hK6, 46 of 70 (66%) for hK10 and 32 of 69 (46%) for hK11.  A statistically significant pos. correlation was obsd. among the immunohistochem. expression of all kallikreins.  HM-RCC expressed all kallikreins in a higher percentage of cases than LM-RCC, but statistically significant differences were only obsd. for hK6 and hK10 (55 vs. 27%, p = 0.016, and 79 vs. 56%, p = 0.044, resp.). hK6 and hK11 expression showed a pos. correlation to pathol. stage: hK6 with both Robson and TNM 2002 staging systems (p = 0.010 and p = 0.017, resp.), and hK11 only with the Robson staging system (p = 0.045).  In both the Kaplan-Meier and the univariate Cox regression analyses, hK6 expression was neg. correlated with disease-specific survival (p = 0.05 and p = 0.038, resp.).  In univariate anal., nuclear grade, Robson stage and TNM stage also correlated with disease-specific survival.  However, in the multivariate anal., TNM stage was the only independent prognostic factor.  In conclusion, although the immunohistochem. expression of hK5, hK6, hK10 and hK11 was downregulated in RCC, tumors of high grade and late stage expressed one or more of the above kallikreins in a higher percentage of cases, and hK6 may predict a poor disease outcome in RCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIPqhnEbMxrVg90H21EOLACvtfcHk0lhWefjNEfj_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCks7jJ&md5=fb718f3d5187df366e4576792625b447</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1159%2F000090150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000090150%26sid%3Dliteratum%253Aachs%26aulast%3DPetraki%26aufirst%3DC.%2BD.%26aulast%3DGregorakis%26aufirst%3DA.%2BK.%26aulast%3DVaslamatzis%26aufirst%3DM.%2BM.%26aulast%3DPapanastasiou%26aufirst%3DP.%2BA.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DLevesque%26aufirst%3DM.%2BA.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DPrognostic%2520implications%2520of%2520the%2520immunohistochemical%2520expression%2520of%2520human%2520kallikreins%25205%252C%25206%252C%252010%2520and%252011%2520in%2520renal%2520cell%2520carcinoma%26jtitle%3DTumor%2520Biol.%26date%3D2006%26volume%3D27%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Prezas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scorilas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yfanti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viktorov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnanti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talieri, M.</span><span> </span><span class="NLM_article-title">The role of human tissue kallikreins 7 and 8 in intracranial malignancies</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">1607</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=1607-1612&author=P.+Prezasauthor=A.+Scorilasauthor=C.+Yfantiauthor=P.+Viktorovauthor=N.+Agnantiauthor=E.+P.+Diamandisauthor=M.+Talieri&title=The+role+of+human+tissue+kallikreins+7+and+8+in+intracranial+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrezas%26aufirst%3DP.%26aulast%3DScorilas%26aufirst%3DA.%26aulast%3DYfanti%26aufirst%3DC.%26aulast%3DViktorov%26aufirst%3DP.%26aulast%3DAgnanti%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DTalieri%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520human%2520tissue%2520kallikreins%25207%2520and%25208%2520in%2520intracranial%2520malignancies%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D1607%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Santin, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soosaipillai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecorelli, S.</span><span> </span><span class="NLM_article-title">Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3320</span><span class="NLM_x">–</span> <span class="NLM_lpage">3325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1078-0432.CCR-04-2528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15867230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslOqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3320-3325&author=A.+D.+Santinauthor=E.+P.+Diamandisauthor=S.+Belloneauthor=A.+Soosaipillaiauthor=S.+Caneauthor=M.+Palmieriauthor=A.+Burnettauthor=J.+J.+Romanauthor=S.+Pecorelli&title=Human+kallikrein+6%3A+a+new+potential+serum+biomarker+for+uterine+serous+papillary+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer</span></div><div class="casAuthors">Santin, Alessandro D.; Diamandis, Eleftherios P.; Bellone, Stefania; Soosaipillai, Antoninus; Cane, Stefania; Palmieri, Michela; Burnett, Alexander; Roman, Juan J.; Pecorelli, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3320-3325</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The discovery of novel biomarkers might greatly contribute to improve clin. management and outcomes in uterine serous papillary carcinoma (USPC), a highly aggressive variant of endometrial cancer.  Exptl. Design: Human kallikrein 6 (hK6) gene expression levels were evaluated in 29 snap-frozen endometrial biopsies, including 13 USPC, 13 endometrioid carcinomas, and 3 normal endometrial cells by real-time PCR.  Secretion of hK6 protein by 14 tumor cultures, including 3 USPC, 3 endometrioid carcinoma, 5 ovarian serous papillary carcinoma, and 3 cervical cancers, was measured using a sensitive ELISA.  Finally, hK6 concn. in 79 serum and plasma samples from 22 healthy women, 20 women with benign diseases, 20 women with endometrioid carcinoma, and 17 USPC patients was studied.  RESULTS: hK6 gene expression levels were significantly higher in USPC when compared with endometrioid carcinoma (mean copy no. by real-time PCR, 1,927 vs. 239, USPC vs. endometrioid carcinoma; P < 0.01).  In vitro hK6 secretion was detected in all primary USPC cell lines tested (mean, 11.5 μg/L) and the secretion levels were similar to those found in primary ovarian serous papillary carcinoma cultures (mean, 9.6 μg/L).  In contrast, no hK6 secretion was detectable in primary endometrioid carcinoma and cervical cancer cultures. hK6 serum and plasma concns. (mean ± SE) among normal healthy females (2.7 ± 0.2 μg/L), patients with benign diseases (2.4 ± 0.2 μg/L), and patients with endometrioid carcinoma (2.6 ± 0.2 μg/L) were not significantly different.  In contrast, serum and plasma hK6 values in USPC patients (6.1 ± 1.1) were significantly higher than those in the noncancer group (P = 0.006), benign group (P = 0.003), and endometrioid carcinoma patients (P = 0.005).  CONCLUSIONS: hK6 is highly expressed in USPC and is released in the plasma and serum of USPC patients. hK6 may represent a novel biomarker for USPC for monitoring early disease recurrence and response to therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4iXfKMgCC7Vg90H21EOLACvtfcHk0lhWefjNEfj_rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslOqtrs%253D&md5=d2fdd22cca30214aa3e5fe5f01d55fe1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2528%26sid%3Dliteratum%253Aachs%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DBellone%26aufirst%3DS.%26aulast%3DSoosaipillai%26aufirst%3DA.%26aulast%3DCane%26aufirst%3DS.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DRoman%26aufirst%3DJ.%2BJ.%26aulast%3DPecorelli%26aufirst%3DS.%26atitle%3DHuman%2520kallikrein%25206%253A%2520a%2520new%2520potential%2520serum%2520biomarker%2520for%2520uterine%2520serous%2520papillary%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D3320%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemasa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yunokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T. J.</span><span> </span><span class="NLM_article-title">Expression of tumor-associated differentially expressed gene-14 (TADG-14/KLK8) and its protein hK8 in uterine endometria and endometrial carcinomas</span> <span class="citation_source-journal">Tumor Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">274</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1159%2F000094741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16888409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlaitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=274-282&author=H.+Jinauthor=N.+Nagaiauthor=K.+Shigemasaauthor=L.+Guauthor=H.+Tanimotoauthor=M.+Yunokawaauthor=K.+Ohamaauthor=Y.+Kudoauthor=T.+J.+O%E2%80%99Brien&title=Expression+of+tumor-associated+differentially+expressed+gene-14+%28TADG-14%2FKLK8%29+and+its+protein+hK8+in+uterine+endometria+and+endometrial+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of Tumor-Associated Differentially Expressed Gene-14 (TADG-14/KLK8) and Its Protein hK8 in Uterine Endometria and Endometrial Carcinomas</span></div><div class="casAuthors">Jin, Honghua; Nagai, Nobutaka; Shigemasa, Kazushi; Gu, Lijun; Tanimoto, Hirotoshi; Yunokawa, Mayu; Ohama, Koso; Kudo, Yoshiki; O'Brien, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">274-282</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">To clarify the biol. behavior of TADG-14/KLK8, we investigated TADG-14/KLK8 mRNA by semiquant. RT-PCR and hK8 expression by immunohistochem. using 37 normal endometria and 44 endometrial carcinoma tissues.  TADG-14/KLK8 mRNA expression levels were significantly higher in proliferative compared to secretory phase endometria (p = 0.0143).  Levels of TADG-14/KLK8 mRNA expression correlated with hK8 protein levels. hK8 was detected in 73.3% (11/15) of endometria with a significantly higher detection rate in the proliferative compared to secretory and atrophic phase endometria (p = 0.0002).  High expression of hK8 was found in 61.4% of endometrial carcinomas compared to 35.1% of endometrial tissue samples (p = 0.0187). hK8 expression was significantly higher in stage I (p = 0.0433, 0.0038) and grade 1/2 (G1/2) of the tumors (p = 0.0195, 0.0044).  We suggest that expression of TADG-14/KLK8 may be regulated by sex steroid hormones in endometria.  Our results indicate that elevated TADG-14/KLK8 expression is an early event in endometrial carcinogenesis, and may potentially serve as a useful early biomarker for the detection of endometrial carcinomas in menopausal women.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGgWOFl0U1jbVg90H21EOLACvtfcHk0lhR8B5JReBAAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlaitLg%253D&md5=045ebd080afe53aa1e2825d974ba18fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1159%2F000094741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000094741%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DN.%26aulast%3DShigemasa%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DTanimoto%26aufirst%3DH.%26aulast%3DYunokawa%26aufirst%3DM.%26aulast%3DOhama%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%2BJ.%26atitle%3DExpression%2520of%2520tumor-associated%2520differentially%2520expressed%2520gene-14%2520%2528TADG-14%252FKLK8%2529%2520and%2520its%2520protein%2520hK8%2520in%2520uterine%2520endometria%2520and%2520endometrial%2520carcinomas%26jtitle%3DTumor%2520Biol.%26date%3D2006%26volume%3D27%26spage%3D274%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Santin, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marizzoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papasakelariou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsaros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecorelli, S.</span><span> </span><span class="NLM_article-title">Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas</span> <span class="citation_source-journal">Am. J. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ajog.2005.10.794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16647913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVGhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2006&pages=1296-1302&author=A.+D.+Santinauthor=E.+P.+Diamandisauthor=S.+Belloneauthor=M.+Marizzoniauthor=E.+Bandieraauthor=M.+Palmieriauthor=C.+Papasakelariouauthor=D.+Katsarosauthor=A.+Burnettauthor=S.+Pecorelli&title=Overexpression+of+kallikrein+10+%28hK10%29+in+uterine+serous+papillary+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas</span></div><div class="casAuthors">Santin, Alessandro D.; Diamandis, Eleftherios P.; Bellone, Stefania; Marizzoni, Moira; Bandiera, Elisabetta; Palmieri, Michela; Papasakelariou, Catherine; Katsaros, Dionyssios; Burnett, Alexander; Pecorelli, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Obstetrics and Gynecology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">AJOGAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9378</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Objective: Kallikrein 10 is a secreted serine protease recently implicated in the growth and invasion of several human tumors.  The goal of this study was to investigate the expression and secretion levels in vitro and in vivo of kallikrein 10 in uterine serous papillary carcinoma, a highly aggressive variant of endometrial tumor.  Study design: Human kallikrein 10 gene expression levels were evaluated in 11 snap-frozen uterine serous papillary carcinoma biopsies and 6 normal endometrial cell biopsies by real-time polymerase chain reaction.  Secretion of kallikrein 10 protein by 10 primary tumor cultures including 3 uterine serous papillary carcinomas, 2 endometrioid carcinomas, and 5 ovarian serous papillary tumors was measured using a sensitive ELISA.  Finally, kallikrein 10 concn. in 75 serum and plasma samples from 22 healthy women, 20 women with benign diseases, 21 women with endometrioid carcinomas, and 12 uterine serous papillary carcinoma patients was studied.  Results: Kallikrein 10 gene expression levels were significantly higher in uterine serous papillary carcinoma when compared with normal endometrial cell biopsies (mean copy no. by real time polymerase chain reaction = 743 vs. 1.4; uterine serous papillary carcinoma vs. endometrioid carcinoma: P < .02).  In vitro kallikrein 10 secretion was detected in all primary uterine serous papillary carcinoma cell lines tested (mean = 2.7 μg/L), and the secretion levels were not significantly different to those found in primary ovarian serous papillary tumor cultures (mean 4.2 μg/L).  In contrast, no kallikrein 10 secretion was detectable in primary endometrioid carcinomas.  Kallikrein 10 serum and plasma concns. (μg/L; mean ± SEM) among normal healthy females (0.6 ± 0.04), patients with benign diseases (0.6 ± 0.06), and patients with endometrioid carcinomas (0.7 ± 0.06) were not significantly different.  In contrast, serum and plasma kallikrein 10 values in uterine serous papillary carcinoma patients (1.2 ± 0.1) were significantly higher than those in the non-cancer group (P = .002), benign group (P = .002), and endometrioid carcinoma patients (P = .005).  Conclusion: Kallikrein 10 is highly expressed in uterine serous papillary carcinoma, and it is released in the plasma and serum of uterine serous papillary carcinoma patients.  Kallikrein 10 may represent a novel biomarker for uterine serous papillary carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjRLrgNcqMUbVg90H21EOLACvtfcHk0lhR8B5JReBAAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVGhtLc%253D&md5=57da003d49d7bb7f692d74a9d479061a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ajog.2005.10.794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajog.2005.10.794%26sid%3Dliteratum%253Aachs%26aulast%3DSantin%26aufirst%3DA.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DBellone%26aufirst%3DS.%26aulast%3DMarizzoni%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DE.%26aulast%3DPalmieri%26aufirst%3DM.%26aulast%3DPapasakelariou%26aufirst%3DC.%26aulast%3DKatsaros%26aufirst%3DD.%26aulast%3DBurnett%26aufirst%3DA.%26aulast%3DPecorelli%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520kallikrein%252010%2520%2528hK10%2529%2520in%2520uterine%2520serous%2520papillary%2520carcinomas%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D2006%26volume%3D194%26spage%3D1296%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Darling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Boeters, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human kallikrein 6 expression in salivary gland tumors</span> <span class="citation_source-journal">J. Histochem. Cytochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1369%2Fjhc.5A6803.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16286664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFWmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=337-342&author=M.+R.+Darlingauthor=L.+Jackson-Boetersauthor=T.+D.+Daleyauthor=E.+P.+Diamandis&title=Human+kallikrein+6+expression+in+salivary+gland+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Human kallikrein 6 expression in salivary gland tumors</span></div><div class="casAuthors">Darling, M. R.; Jackson-Boeters, L.; Daley, T. D.; Diamandis, E. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">337-342</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">Human kallikrein 6 (hK6), also known as zyme/protease M/neurosin, is expressed in many normal glandular tissues.  The aim of this study was to det. whether hK6 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), using an immunohistochem. method.  Pleomorphic adenomas (PA), adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, acinic cell carcinomas, mucoepidermoid carcinomas, and adenocarcinomas not otherwise specified of both minor and major salivary glands were examd.  Cells lining duct-like structures and non-duct-like cells were scored.  Only in PA of minor salivary gland origin was overall staining higher in duct-like than in non-duct-like cells.  In all other tumors exhibiting both types of cells, hK6 staining was similar in both duct-like and non-duct-like cells.  Tumors that exhibited non-duct-like cells only also exhibited cytoplasmic staining.  Results of this study show that salivary gland tumors express hK6, apparently downregulated in comparison with normal salivary gland tissue, and that this expression is not specific for any of the tumors studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhoPmDh7yzwrVg90H21EOLACvtfcHk0lhR8B5JReBAAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFWmu7k%253D&md5=4d2611e1243adc6f4ece5ee0d295cbc6</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1369%2Fjhc.5A6803.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.5A6803.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDarling%26aufirst%3DM.%2BR.%26aulast%3DJackson-Boeters%26aufirst%3DL.%26aulast%3DDaley%26aufirst%3DT.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520kallikrein%25206%2520expression%2520in%2520salivary%2520gland%2520tumors%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2006%26volume%3D54%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Darling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Boeters, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Human kallikrein 13 expression in salivary gland tumors</span> <span class="citation_source-journal">Int. J. Biol. Markers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16847813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFWktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=106-110&author=M.+R.+Darlingauthor=L.+Jackson-Boetersauthor=T.+D.+Daleyauthor=E.+P.+Diamandis&title=Human+kallikrein+13+expression+in+salivary+gland+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Human kallikrein 13 expression in salivary gland tumors</span></div><div class="casAuthors">Darling, M. R.; Jackson-Boeters, L.; Daley, T. D.; Diamandis, E. P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Markers</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-110</span>CODEN:
                <span class="NLM_cas:coden">IBMAEP</span>;
        ISSN:<span class="NLM_cas:issn">0393-6155</span>.
    
            (<span class="NLM_cas:orgname">Wichtig Editore</span>)
        </div><div class="casAbstract">The human kallikrein 13 protein (hK13) is expressed in many normal tissues.  Petraki, C.D.; et al. (2003) have previously described presence of hK13 in salivary gland tissue, localized to duct epithelia and some acinar cells.  The aim of this study was to det. whether hK13 is expressed in salivary gland tissues and salivary gland tumors (both benign and malignant), in order to compare normal with tumor tissues.  Pleomorphic adenomas (PA), adenoid cystic carcinomas (ACC), polymorphous low grade adenocarcinomas (PLGA), acinic cell carcinomas (ACI), mucoepidermoid carcinomas (MEC) and adenocarcinomas not otherwise specified (ANOS) of both minor and major salivary glands were examd.  The results of this study indicate that most salivary gland tumors show high levels of expression of hK13.  Overall, staining in PA was significantly less than that seen in normal salivary gland tissue.  PLGA, ACC and ANOS each stained significantly more than normal salivary gland tissue while MEC and ACI did not.  Ductal cells and cells lining duct-like structures showed a higher intensity of staining than non-ductal cells in most tumors.  Tumors which exhibited only non-ductal cells also exhibited cytoplasmic staining.  In conclusion, we demonstrate the high expression of hK13 in several common salivary gland tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwsR2czwWnVLVg90H21EOLACvtfcHk0li0xdS8Zu-L6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFWktLY%253D&md5=b3263bf458f87d3524751eff04c83bb2</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDarling%26aufirst%3DM.%2BR.%26aulast%3DJackson-Boeters%26aufirst%3DL.%26aulast%3DDaley%26aufirst%3DT.%2BD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DHuman%2520kallikrein%252013%2520expression%2520in%2520salivary%2520gland%2520tumors%26jtitle%3DInt.%2520J.%2520Biol.%2520Markers%26date%3D2006%26volume%3D21%26spage%3D106%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Klucky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teurich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuhahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flechtenmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J.</span><span> </span><span class="NLM_article-title">Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">8198</span><span class="NLM_x">–</span> <span class="NLM_lpage">8206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=8198-8206&author=B.+Kluckyauthor=R.+Muellerauthor=I.+Vogtauthor=S.+Teurichauthor=B.+Hartensteinauthor=K.+Breuhahnauthor=C.+Flechtenmacherauthor=P.+Angelauthor=J.+Hess&title=Kallikrein+6+induces+E-cadherin+shedding+and+promotes+cell+proliferation%2C+migration%2C+and+invasion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlucky%26aufirst%3DB.%26aulast%3DMueller%26aufirst%3DR.%26aulast%3DVogt%26aufirst%3DI.%26aulast%3DTeurich%26aufirst%3DS.%26aulast%3DHartenstein%26aufirst%3DB.%26aulast%3DBreuhahn%26aufirst%3DK.%26aulast%3DFlechtenmacher%26aufirst%3DC.%26aulast%3DAngel%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DJ.%26atitle%3DKallikrein%25206%2520induces%2520E-cadherin%2520shedding%2520and%2520promotes%2520cell%2520proliferation%252C%2520migration%252C%2520and%2520invasion%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D8198%26epage%3D8206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Clements, J. A.</span><span> </span><span class="NLM_article-title">The Molecular Biology of the Kallikreins and Their Roles in Inflammation</span>. In  <span class="citation_source-book">The Kinin System</span>; <span class="NLM_contrib-group">Farmer, S. G.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">5</span>, pp  <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2FB978-012249340-9%2F50007-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=71-97&author=J.+A.+Clementsauthor=S.+G.+Farmer&title=The+Kinin+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FB978-012249340-9%2F50007-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012249340-9%252F50007-3%26sid%3Dliteratum%253Aachs%26aulast%3DClements%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520Molecular%2520Biology%2520of%2520the%2520Kallikreins%2520and%2520Their%2520Roles%2520in%2520Inflammation%26btitle%3DThe%2520Kinin%2520System%26aulast%3DFarmer%26aufirst%3DS.%2BG.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D5%26spage%3D71%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bhoola, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthy, K.</span><span> </span><span class="NLM_article-title">Bioregulation of kinins: kallikreins, kininogens, and kininases</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=1-80&author=K.+D.+Bhoolaauthor=C.+D.+Figueroaauthor=K.+Worthy&title=Bioregulation+of+kinins%3A+kallikreins%2C+kininogens%2C+and+kininases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhoola%26aufirst%3DK.%2BD.%26aulast%3DFigueroa%26aufirst%3DC.%2BD.%26aulast%3DWorthy%26aufirst%3DK.%26atitle%3DBioregulation%2520of%2520kinins%253A%2520kallikreins%252C%2520kininogens%252C%2520and%2520kininases%26jtitle%3DPharmacol.%2520Rev.%26date%3D1992%26volume%3D44%26spage%3D1%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarisbrick, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnett, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptors, targets for kallikrein signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">32095</span><span class="NLM_x">–</span> <span class="NLM_lpage">32112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=32095-32112&author=K.+Oikonomopoulouauthor=K.+K.+Hansenauthor=M.+Saifeddineauthor=I.+Teaauthor=M.+Blaberauthor=S.+I.+Blaberauthor=I.+Scarisbrickauthor=P.+Andrade-Gordonauthor=G.+S.+Cottrellauthor=N.+W.+Bunnettauthor=E.+P.+Diamandisauthor=M.+D.+Hollenberg&title=Proteinase-activated+receptors%2C+targets+for+kallikrein+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DTea%26aufirst%3DI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DScarisbrick%26aufirst%3DI.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DCottrell%26aufirst%3DG.%2BS.%26aulast%3DBunnett%26aufirst%3DN.%2BW.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DProteinase-activated%2520receptors%252C%2520targets%2520for%2520kallikrein%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D32095%26epage%3D32112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Kallikrein-mediated activation of PARs in inflammation and nociception</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">S499</span><span class="NLM_x">–</span> <span class="NLM_lpage">S502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=S499-S502&author=K.+Oikonomopoulouauthor=K.+K.+Hansenauthor=K.+Chapmanauthor=N.+Vergnolleauthor=E.+P.+Diamandisauthor=M.+D.+Hollenberg&title=Kallikrein-mediated+activation+of+PARs+in+inflammation+and+nociception"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DKallikrein-mediated%2520activation%2520of%2520PARs%2520in%2520inflammation%2520and%2520nociception%26jtitle%3DInflammation%2520Res.%26date%3D2007%26volume%3D56%26spage%3DS499%26epage%3DS502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Protease-activated receptors in hemostasis, thrombosis and vascular biology</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1800</span><span class="NLM_x">–</span> <span class="NLM_lpage">1814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1538-7836.2005.01377.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16102047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1800-1814&author=S.+R.+Coughlin&title=Protease-activated+receptors+in+hemostasis%2C+thrombosis+and+vascular+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptors in hemostasis, thrombosis and vascular biology</span></div><div class="casAuthors">Coughlin, S. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1800-1814</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The coagulation cascade and protease-activated receptors (PARs) together provide an elegant mechanism that links mech. information in the form of tissue injury to cellular responses.  These receptors appear to largely account for the cellular effects of thrombin and can mediate signaling to other trypsin-like proteases.  An important role for PARs in hemostasis and thrombosis is established in animal models, and studies in knockout mice and nonhuman primates raise the question of whether PAR inhibition might offer an appealing new approach to the prevention and treatment of thrombosis.  PARs may also trigger inflammatory responses to tissue injury.  For example, PAR activation on endothelial cells and perhaps sensory afferents can trigger local accumulation of leukocytes and platelets and transudation of plasma.  However, panoply of signaling systems and cell types orchestrates inflammatory responses, and efforts to define the relative importance and roles of PARs in various inflammatory processes are just beginning.  Lastly, roles for PARs in blood vessel formation and other processes during embryonic development are emerging, and whether these reflect new roles for the coagulation cascade and/or PAR signaling to other proteases remains to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4G5RcogxRO7Vg90H21EOLACvtfcHk0li0xdS8Zu-L6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFKjs7w%253D&md5=efa79fca6eca2abc02ea011cf0fc071f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2005.01377.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2005.01377.x%26sid%3Dliteratum%253Aachs%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DProtease-activated%2520receptors%2520in%2520hemostasis%252C%2520thrombosis%2520and%2520vascular%2520biology%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2005%26volume%3D3%26spage%3D1800%26epage%3D1814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Steinhoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buddenkotte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpacovitch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattenholl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moormann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luger, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptors: transducers of proteinase mediated signaling in inflammation and immune response</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1210%2Fer.2003-0025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15689571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitFyktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1-43&author=M.+Steinhoffauthor=J.+Buddenkotteauthor=V.+Shpacovitchauthor=A.+Rattenhollauthor=C.+Moormannauthor=N.+Vergnolleauthor=T.+A.+Lugerauthor=M.+D.+Hollenberg&title=Proteinase-activated+receptors%3A+transducers+of+proteinase+mediated+signaling+in+inflammation+and+immune+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response</span></div><div class="casAuthors">Steinhoff, Martin; Buddenkotte, Joerg; Shpacovitch, Victoria; Rattenholl, Anke; Moormann, Corinna; Vergnolle, Nathalie; Luger, Thomas A.; Hollenberg, Morley D.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-43</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Serine proteinases such as thrombin, mast cell tryptase, trypsin, or cathepsin G, for example, are highly active mediators with diverse biol. activities.  So far, proteinases have been considered to act primarily as degradative enzymes in the extracellular space.  However, their biol. actions in tissues and cells suggest important roles as a part of the body's hormonal communication system during inflammation and immune response.  These effects can be attributed to the activation of a new subfamily of G protein-coupled receptors, termed proteinase-activated receptors (PARs).  Four members of the PAR family have been cloned so far.  Thus, certain proteinases act as signaling mols. that specifically regulate cells by activating PARs.  After stimulation, PARs couple to various G proteins and activate signal transduction pathways resulting in the rapid transcription of genes that are involved in inflammation.  For example, PARs are widely expressed by cells involved in immune responses and inflammation, regulate endothelial-leukocyte interactions, and modulate the secretion of inflammatory mediators or neuropeptides.  Together, the PAR family necessitates a paradigm shift in thinking about hormone action, to include proteinases as key modulators of biol. function.  Novel compds. that can modulate PAR function may be potent candidates for the treatment of inflammatory or immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPH5a21zi4NrVg90H21EOLACvtfcHk0lhBsa0wK15WxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitFyktrc%253D&md5=c26dcb121cc6ef26b479aaf5ff5a2796</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1210%2Fer.2003-0025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2003-0025%26sid%3Dliteratum%253Aachs%26aulast%3DSteinhoff%26aufirst%3DM.%26aulast%3DBuddenkotte%26aufirst%3DJ.%26aulast%3DShpacovitch%26aufirst%3DV.%26aulast%3DRattenholl%26aufirst%3DA.%26aulast%3DMoormann%26aufirst%3DC.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DLuger%26aufirst%3DT.%2BA.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DProteinase-activated%2520receptors%253A%2520transducers%2520of%2520proteinase%2520mediated%2520signaling%2520in%2520inflammation%2520and%2520immune%2520response%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D1%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Ramachandran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">S263</span><span class="NLM_x">–</span> <span class="NLM_lpage">S282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=S263-S282&author=R.+Ramachandranauthor=M.+D.+Hollenberg&title=Proteinases+and+signalling%3A+pathophysiological+and+therapeutic+implications+via+PARs+and+more"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DR.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DProteinases%2520and%2520signalling%253A%2520pathophysiological%2520and%2520therapeutic%2520implications%2520via%2520PARs%2520and%2520more%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3DS263%26epage%3DS282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Vu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheaton, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coughlin, S. R.</span><span> </span><span class="NLM_article-title">Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1057</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=1057-1068&author=T.+Vuauthor=D.+Hungauthor=V.+Wheatonauthor=S.+R.+Coughlin&title=Molecular+cloning+of+a+functional+thrombin+receptor+reveals+a+novel+proteolytic+mechanism+of+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DT.%26aulast%3DHung%26aufirst%3DD.%26aulast%3DWheaton%26aufirst%3DV.%26aulast%3DCoughlin%26aufirst%3DS.%2BR.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520functional%2520thrombin%2520receptor%2520reveals%2520a%2520novel%2520proteolytic%2520mechanism%2520of%2520receptor%2520activation%26jtitle%3DCell%26date%3D1991%26volume%3D64%26spage%3D1057%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Bohm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khitin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aponte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnett, N.</span><span> </span><span class="NLM_article-title">Mechanisms of desensitization and resensitization of proteinase-activated receptor-2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">22003</span><span class="NLM_x">–</span> <span class="NLM_lpage">22016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22003-22016&author=S.+Bohmauthor=L.+Khitinauthor=E.+Gradyauthor=G.+Aponteauthor=D.+Payanauthor=N.+Bunnett&title=Mechanisms+of+desensitization+and+resensitization+of+proteinase-activated+receptor-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DS.%26aulast%3DKhitin%26aufirst%3DL.%26aulast%3DGrady%26aufirst%3DE.%26aulast%3DAponte%26aufirst%3DG.%26aulast%3DPayan%26aufirst%3DD.%26aulast%3DBunnett%26aufirst%3DN.%26atitle%3DMechanisms%2520of%2520desensitization%2520and%2520resensitization%2520of%2520proteinase-activated%2520receptor-2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22003%26epage%3D22016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Boire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherifi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.cell.2004.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15707890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Krtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=303-313&author=A.+Boireauthor=L.+Covicauthor=A.+Agarwalauthor=S.+Jacquesauthor=S.+Sherifiauthor=A.+Kuliopulos&title=PAR1+is+a+matrix+metalloprotease-1+receptor+that+promotes+invasion+and+tumorigenesis+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells</span></div><div class="casAuthors">Boire, Adrienne; Covic, Lidija; Agarwal, Anika; Jacques, Suzanne; Sherifi, Sheida; Kuliopulos, Athan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">303-313</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Protease-activated receptors (PARs) are a unique class of G protein-coupled receptors that play crit. roles in thrombosis, inflammation, and vascular biol.  PAR1 is proposed to be involved in the invasive and metastatic processes of various cancers.  However, the protease responsible for activating the pro-invasive functions of PAR1 remains to be identified.  Here, the authors show that expression of PAR1 is both required and sufficient to promote growth and invasion of breast carcinoma cells in a xenograft model.  Further, the authors show that the matrix metalloprotease, MMP-1, functions as a protease agonist of PAR1 cleaving the receptor at the proper site to generate PAR1-dependent Ca2+ signals and migration.  MMP-1 activity is derived from fibroblasts and is absent from the breast cancer cells.  These results demonstrate that MMP-1 in the stromal-tumor microenvironment can alter the behavior of cancer cells through PAR1 to promote cell migration and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhFjuIKgkP3bVg90H21EOLACvtfcHk0ljVzYsPUu3JCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Krtrk%253D&md5=307e55f39fe2ac464197625485175e52</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2004.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2004.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DBoire%26aufirst%3DA.%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DS.%26aulast%3DSherifi%26aufirst%3DS.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DPAR1%2520is%2520a%2520matrix%2520metalloprotease-1%2520receptor%2520that%2520promotes%2520invasion%2520and%2520tumorigenesis%2520of%2520breast%2520cancer%2520cells%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D303%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=643-651&author=M.+D.+Hollenbergauthor=K.+Oikonomopoulouauthor=K.+K.+Hansenauthor=M.+Saifeddineauthor=R.+Ramachandranauthor=E.+P.+Diamandis&title=Kallikreins+and+proteinase-mediated+signaling%3A+proteinase-activated+receptors+%28PARs%29+and+the+pathophysiology+of+inflammatory+diseases+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DRamachandran%26aufirst%3DR.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DKallikreins%2520and%2520proteinase-mediated%2520signaling%253A%2520proteinase-activated%2520receptors%2520%2528PARs%2529%2520and%2520the%2520pathophysiology%2520of%2520inflammatory%2520diseases%2520and%2520cancer%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Chackalamannil, S.</span><span> </span><span class="NLM_article-title">Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">5389</span><span class="NLM_x">–</span> <span class="NLM_lpage">5403</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603670" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5389-5403&issue=18&author=S.+Chackalamannil&title=Thrombin+receptor+%28protease+activated+receptor-1%29+antagonists+as+potent+antithrombotic+agents+with+strong+antiplatelet+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm0603670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603670%26sid%3Dliteratum%253Aachs%26aulast%3DChackalamannil%26aufirst%3DS.%26atitle%3DThrombin%2520receptor%2520%2528protease%2520activated%2520receptor-1%2529%2520antagonists%2520as%2520potent%2520antithrombotic%2520agents%2520with%2520strong%2520antiplatelet%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D18%26spage%3D5389%26epage%3D5403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Recent advances in synthesis of PAR ligands as therapeutic strategy for inflammatory diseases</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=653-663&author=B.+Severinoauthor=V.+Santagadaauthor=E.+Perissuttiauthor=F.+Fiorinoauthor=F.+Frecenteseauthor=F.+De+Angelisauthor=A.+Espositoauthor=G.+Caliendo&title=Recent+advances+in+synthesis+of+PAR+ligands+as+therapeutic+strategy+for+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DDe%2BAngelis%26aufirst%3DF.%26aulast%3DEsposito%26aufirst%3DA.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520synthesis%2520of%2520PAR%2520ligands%2520as%2520therapeutic%2520strategy%2520for%2520inflammatory%2520diseases%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D653%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Ramachandran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">Targeting proteinase-activated receptors: therapeutic potential and challenges</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=69-86&author=R.+Ramachandranauthor=F.+Noorbakhshauthor=K.+DeFeaauthor=M.+D.+Hollenberg&title=Targeting+proteinase-activated+receptors%3A+therapeutic+potential+and+challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DR.%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DDeFea%26aufirst%3DK.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3DTargeting%2520proteinase-activated%2520receptors%253A%2520therapeutic%2520potential%2520and%2520challenges%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D69%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Landis, R. C.</span><span> </span><span class="NLM_article-title">Protease activated receptors: clinical relevance to hemostasis and inflammation</span> <span class="citation_source-journal">Hematol. Oncol. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.hoc.2006.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17258121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FlsVKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=103-113&author=R.+C.+Landis&title=Protease+activated+receptors%3A+clinical+relevance+to+hemostasis+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Protease activated receptors: clinical relevance to hemostasis and inflammation</span></div><div class="casAuthors">Landis R Clive</div><div class="citationInfo"><span class="NLM_cas:title">Hematology/oncology clinics of North America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">103-13</span>
        ISSN:<span class="NLM_cas:issn">0889-8588</span>.
    </div><div class="casAbstract">The protease-activated receptors (PARs) are a unique family of vascular receptors that confer on cells an ability to sense, and respond to, local changes in the proteolytic environment.  They are activated by serine proteases of the blood coagulation cascade, notably thrombin, and are linked to thrombotic and inflammatory effector pathways.  In surgery with cardiopulmonary bypass (CPB), thrombin is generated in large quantities in the extracorporeal circuit and can exert systemic effects by way of platelet and endothelial PAR1.  Aprotinin (Trasylol), a serine protease inhibitor used in cardiac surgery, preserves platelet function, and attenuates the inflammatory response by protecting the PAR 1 receptor on platelets and endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmvB0WSiLH30mhnSqMnvzDfW6udTcc2eaqVcp6heqOF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FlsVKltA%253D%253D&md5=f2f5dfc88478b8963ae7e10c0eaa64f6</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.hoc.2006.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hoc.2006.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DLandis%26aufirst%3DR.%2BC.%26atitle%3DProtease%2520activated%2520receptors%253A%2520clinical%2520relevance%2520to%2520hemostasis%2520and%2520inflammation%26jtitle%3DHematol.%2520Oncol.%2520Clin.%2520North%2520Am.%26date%3D2007%26volume%3D21%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Martorell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-González, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvayrac, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badimon, L.</span><span> </span><span class="NLM_article-title">Thrombin and protease-activated receptors (PARs) in atherothrombosis</span> <span class="citation_source-journal">Thromb Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18278179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFKmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=305-315&author=L.+Martorellauthor=J.+Mart%C3%ADnez-Gonz%C3%A1lezauthor=C.+Rodr%C3%ADguezauthor=M.+Gentileauthor=O.+Calvayracauthor=L.+Badimon&title=Thrombin+and+protease-activated+receptors+%28PARs%29+in+atherothrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Thrombin and protease-activated receptors (PARs) in atherothrombosis</span></div><div class="casAuthors">Martorell, Lluis; Martinez-Gonzalez, Jose; Rodriguez, Cristina; Gentile, Maurizio; Calvayrac, Olivier; Badimon, Lina</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">305-315</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">A review.  Thrombin is a multifunctional serine protease generated at the site of vascular injury that transforms fibrinogen into fibrin, activates blood platelets and elicits multiple effects on a variety of cell types including endothelial cells, vascular smooth muscle cells (VSMC), monocytes, T lymphocytes and fibroblasts.  Cellular effects of thrombin are mediated by protease-activated receptors (PARs), members of the G protein-coupled receptors that carry their own ligand which remains cryptic until unmasked by proteolytic cleavage.  Thrombin signalling in platelets contributes to haemostasis and thrombosis.  In normal arteries PARs are mainly expressed in endothelial cells, while their expression in VSMC is limited.  Endothelial PARs participate in the regulation of vascular tone, vascular permeability and endothelial secretory activity while in VSMC they mediate contraction, migration, proliferation, hypertrophy and prodn. of extracellular matrix.  PARs contribute to the pro-inflammatory phenotype obsd. in endothelial dysfunction and their up-regulation in VSMC seems to be a key element in the pathogenesis of atherosclerosis and restenosis.  In the last years a myriad of studies have emphasized the crit. role of PAR signalling in thrombin mediated effects in haemostasis, inflammation, cancer and embryonic development.  Lately, PARs have become a therapeutic target to inhibit platelet aggregation and thrombosis.  Early data from a clin. trial (TRA-PCI) to evaluate safety and efficacy of a potent new oral thrombin receptor antagonist (TRA) have promisingly indicated that overall TRA treatment reduces adverse event rates without an increase in bleeding risk.  In this paper we review cellular responses triggered by thrombin and their implication in vascular pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDhN6kbwyVgbVg90H21EOLACvtfcHk0liNvTXHD1L9gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFKmtro%253D&md5=e6e3fb23271c1a38cb35595120773666</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartorell%26aufirst%3DL.%26aulast%3DMart%25C3%25ADnez-Gonz%25C3%25A1lez%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DGentile%26aufirst%3DM.%26aulast%3DCalvayrac%26aufirst%3DO.%26aulast%3DBadimon%26aufirst%3DL.%26atitle%3DThrombin%2520and%2520protease-activated%2520receptors%2520%2528PARs%2529%2520in%2520atherothrombosis%26jtitle%3DThromb%2520Haemostasis%26date%3D2008%26volume%3D99%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Napoli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Nigris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franconi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignarro, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span> </span><span class="NLM_article-title">Protease-activated receptor-2 modulates myocardial ischemia reperfusion injury in the rat heart</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">3678</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3678-3683&author=C.+Napoliauthor=C.+Cicalaauthor=J.+L.+Wallaceauthor=F.+de+Nigrisauthor=V.+Santagadaauthor=G.+Caliendoauthor=F.+Franconiauthor=L.+J.+Ignarroauthor=G.+Cirino&title=Protease-activated+receptor-2+modulates+myocardial+ischemia+reperfusion+injury+in+the+rat+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNapoli%26aufirst%3DC.%26aulast%3DCicala%26aufirst%3DC.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3Dde%2BNigris%26aufirst%3DF.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DFranconi%26aufirst%3DF.%26aulast%3DIgnarro%26aufirst%3DL.%2BJ.%26aulast%3DCirino%26aufirst%3DG.%26atitle%3DProtease-activated%2520receptor-2%2520modulates%2520myocardial%2520ischemia%2520reperfusion%2520injury%2520in%2520the%2520rat%2520heart%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D3678%26epage%3D3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span> </span><span class="NLM_article-title">Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">1467</span><span class="NLM_x">–</span> <span class="NLM_lpage">1473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=1467-1473&author=N.+Vergnolleauthor=C.+K.+Derianauthor=M.+R.+D%E2%80%99Andreaauthor=M.+Steinhoffauthor=P.+Andrade-Gordon&title=Characterization+of+thrombin-induced+leukocyte+rolling+and+adherence%3A+a+potential+proinflammatory+role+for+proteinase-activated+receptor-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DM.%2BR.%26aulast%3DSteinhoff%26aufirst%3DM.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26atitle%3DCharacterization%2520of%2520thrombin-induced%2520leukocyte%2520rolling%2520and%2520adherence%253A%2520a%2520potential%2520proinflammatory%2520role%2520for%2520proteinase-activated%2520receptor-4%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D1467%26epage%3D1473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J .C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodjgani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">7320</span><span class="NLM_x">–</span> <span class="NLM_lpage">7329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=7320-7329&author=F.+Noorbakhshauthor=N.+Vergnolleauthor=J+.C.+McArthurauthor=C.+Silvaauthor=M.+Vodjganiauthor=P.+Andrade-Gordonauthor=M.+D.+Hollenbergauthor=C.+Power&title=Proteinase-activated+receptor-2+induction+by+neuroinflammation+prevents+neuronal+death+during+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DMcArthur%26aufirst%3DJ%2B.C.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DVodjgani%26aufirst%3DM.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DProteinase-activated%2520receptor-2%2520induction%2520by%2520neuroinflammation%2520prevents%2520neuronal%2520death%2520during%2520HIV%2520infection%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D7320%26epage%3D7329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boven, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shariat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodjgani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=425-435&author=F.+Noorbakhshauthor=S.+Tsutsuiauthor=N.+Vergnolleauthor=L.+A.+Bovenauthor=N.+Shariatauthor=M.+Vodjganiauthor=K.+G.+Warrenauthor=P.+Andrade-Gordonauthor=M.+D.+Hollenbergauthor=C.+Power&title=Proteinase-activated+receptor+2+modulates+neuroinflammation+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DTsutsui%26aufirst%3DS.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DBoven%26aufirst%3DL.%2BA.%26aulast%3DShariat%26aufirst%3DN.%26aulast%3DVodjgani%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DK.%2BG.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DProteinase-activated%2520receptor%25202%2520modulates%2520neuroinflammation%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520and%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D425%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span> </span><span class="NLM_article-title">Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">1262</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjp.0702408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10205017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK1MXitFGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=1999&pages=1262-1268&author=N.+Vergnolleauthor=M.+D.+Hollenbergauthor=J.+L.+Wallace&title=Pro-+and+anti-inflammatory+actions+of+thrombin%3A+a+distinct+role+for+proteinase-activated+receptor-1+%28PAR1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1)</span></div><div class="casAuthors">Vergnolle, Nathalie; Hollenberg, Morley D.; Wallace, John L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1262-1268</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Thrombin has well characterized pro-inflammatory actions that have recently been suggested to occur via activation of its receptor, proteinase-activated receptor-1 (PAR1).  In the present study, we have compared the effects of thrombin to those of two peptides that selectively activate the PAR1 receptor, in a rat hindpaw edema model.  We have also examd. whether or not thrombin can exert anti-inflammatory activity in this model.  Both thrombin and the two PAR1 activating peptides induced significant edema in the rat hindpaw following subplantar injection.  The edema induced by thrombin was abolished by pre-incubation with hirudin, and was markedly reduced in rats in which mast cells were depleted through treatment with compd. 48/80 and in rats pretreated with indomethacin.  In contrast, administration of the PAR1 activating peptides produced an edema response that was not reduced by indomethacin and was only slightly reduced in rats pretreated with compd. 48/80.  Co-administration of thrombin together with a PAR1 activating receptor resulted in a significantly smaller edema response than that seen with the PAR1 activating peptide alone.  This anti-inflammatory effect of thrombin was abolished by pre-incubation with hirudin.  These results demonstrate that the pro-inflammatory effects of thrombin occur through a mast-cell-dependent mechanism i.e., at least in part, independent of activation of the PAR1 receptor.  Moreover, thrombin is able to exert anti-inflammatory effects that are also unrelated to the activation of PAR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhqGRJG08V_LVg90H21EOLACvtfcHk0ljR3GjSjjC6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFGhsL4%253D&md5=67f15f0fecf985f703766b4b941559f6</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0702408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0702408%26sid%3Dliteratum%253Aachs%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26atitle%3DPro-%2520and%2520anti-inflammatory%2520actions%2520of%2520thrombin%253A%2520a%2520distinct%2520role%2520for%2520proteinase-activated%2520receptor-1%2520%2528PAR1%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1999%26volume%3D126%26spage%3D1262%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span> </span><span class="NLM_article-title">Proteinase activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjp.0705946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15451771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsFCnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=443-454&author=M.+D.+Hollenbergauthor=M.+Saifeddineauthor=S.+Sandhuauthor=S.+Houleauthor=N.+Vergnolle&title=Proteinase+activated+receptor-4%3A+evaluation+of+tethered+ligand-derived+peptides+as+probes+for+receptor+function+and+as+inflammatory+agonists+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Proteinase-activated receptor-4: Evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo</span></div><div class="casAuthors">Hollenberg, Morley D.; Saifeddine, Mahmoud; Sandhu, Sabrina; Houle, Steeve; Vergnolle, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-454</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We evaluated the ability of a no. of peptides based on the tethered ligand sequences of human, rat and murine proteinase-activated receptor-4 (PAR4), to serve as receptor-activating probes or antagonists for bioassays carried out in vitro and for in vivo models of inflammation.  In a rat PAR4-dependent platelet aggregation assay, the relative potencies of the active sequences (AYPGKF-NH2 > GYPGKF-NH2 > GYPGFK-NH2 > GFPGKP-NH2) were consistent with an activation of PAR4.  In the aggregation assay, the reverse or partial reverse-sequence peptides (VQGPYG-NH2, YAPGKF-NH2 and FKGPYA-NH2) were inactive, while trans-cinnamoyl (Tc)-YPGKF-NH2, Tc-APGKF-NH2 and N-palmitoyl-SGRRYGHALR-NH2 (pepducin P4pal-10) were antagonists.  However, in an endothelium-dependent NO-mediated rat aorta (RA) relaxation assay and in a gastric longitudinal muscle (LM) contraction assay, these antagonist peptides were agonists as were most other peptides, with distinct orders of potencies that differed for both the RA and LM assays and from the platelet assay.  We conclude that PAR4-derived tethered ligand peptide agonists can act at receptors other than PAR4 and that a judicious choice of ligands is required to probe for PAR4 function in bioassay systems and in particular for in vivo models.  By selecting from these peptides the ones most reliably reflecting PAR4 activation (AYPGKF-NH2 as a std. agonist; YAPGKF-NH2 as a PAR4-inactive std.), we were able to establish an inflammatory role for the PAR4-activating peptides acting via a non-neurogenic mechanism in a rat paw edema model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3AnNtNU8c4bVg90H21EOLACvtfcHk0ljR3GjSjjC6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsFCnsrY%253D&md5=292facb74e34475a392b0c20d19031c3</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705946%26sid%3Dliteratum%253Aachs%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DSandhu%26aufirst%3DS.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DVergnolle%26aufirst%3DN.%26atitle%3DProteinase%2520activated%2520receptor-4%253A%2520evaluation%2520of%2520tethered%2520ligand-derived%2520peptides%2520as%2520probes%2520for%2520receptor%2520function%2520and%2520as%2520inflammatory%2520agonists%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D443%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Kelso, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hembrough, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommerhoff, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrell, W. R.</span><span> </span><span class="NLM_article-title">Therapeutic promise of proteinase activated receptor-2 antagonism in joint inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.105.093807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16260582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Shu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=1017-1024&author=E.+B.+Kelsoauthor=J.+C.+Lockhartauthor=T.+Hembroughauthor=L.+Dunningauthor=R.+Plevinauthor=M.+D.+Hollenbergauthor=C.+P.+Sommerhoffauthor=J.+S.+McLeanauthor=W.+R.+Ferrell&title=Therapeutic+promise+of+proteinase+activated+receptor-2+antagonism+in+joint+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation</span></div><div class="casAuthors">Kelso, Elizabeth B.; Lockhart, John C.; Hembrough, Todd; Dunning, Lynette; Plevin, Robin; Hollenberg, Morley D.; Sommerhoff, Christian P.; McLean, John S.; Ferrell, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1017-1024</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Biol. therapies such as tumor necrosis factor-α inhibitors have advanced the treatment of rheumatoid arthritis, but one-third of patients do not respond to such therapy.  Furthermore, these inhibitors are now usually administered in combination with conventional disease-modifying antirheumatic drugs, suggesting they have not achieved their early promise.  This study investigates a novel therapeutic target, proteinase-activated receptor (PAR)-2, in joint inflammation.  Intra-articular carrageenan/kaolin (C/K) injection in mice resulted in joint swelling that was assocd. with synovial PAR2 up-regulation.  Inhibiting receptor up-regulation using small interfering RNA technol., as confirmed by immunoblotting, substantially reduced the inflammatory response in the joint.  Serine proteinase-induced joint swelling was mediated primarily via PAR2 activation, since the response to exogenous application of trypsin and tryptase was absent in PAR2 knockout mice.  Furthermore, serine proteinase inhibitors were effective anti-inflammatory agents in this model.  Disrupting proteolytic activation of PAR2 using antiserum (B5) directed to the receptor cleavage/activation site also attenuated C/K-induced inflammation, as did the similarly targeted PAR2 monoclonal antibody SAM-11.  Finally, we report the activity of a novel small mol. PAR2 antagonist, N1-3-methylbutyryl-N4-6-aminohexanoylpiperazine (ENMD-1068), that dose dependently attenuated joint inflammation.  Our findings represent a major advance in collectively identifying PAR2 as a novel target for the future treatment of arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxa3LNtZEPe7Vg90H21EOLACvtfcHk0lgGsyJ0qQ4vWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Shu7w%253D&md5=dabbf47d3591419299a339ab24d778d0</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.093807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.093807%26sid%3Dliteratum%253Aachs%26aulast%3DKelso%26aufirst%3DE.%2BB.%26aulast%3DLockhart%26aufirst%3DJ.%2BC.%26aulast%3DHembrough%26aufirst%3DT.%26aulast%3DDunning%26aufirst%3DL.%26aulast%3DPlevin%26aufirst%3DR.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DSommerhoff%26aufirst%3DC.%2BP.%26aulast%3DMcLean%26aufirst%3DJ.%2BS.%26aulast%3DFerrell%26aufirst%3DW.%2BR.%26atitle%3DTherapeutic%2520promise%2520of%2520proteinase%2520activated%2520receptor-2%2520antagonism%2520in%2520joint%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D1017%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevigny, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneider, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarides, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azabdaftari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharifi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">Targeting a metalloprotease-PAR-1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2746</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1535-7163.MCT-08-0177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18790755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2746-2757&author=A.+Agarwalauthor=L.+Covicauthor=L.+M.+Sevignyauthor=N.+C.+Kaneiderauthor=K.+Lazaridesauthor=G.+Azabdaftariauthor=S.+Sharifiauthor=A.+Kuliopulos&title=Targeting+a+metalloprotease-PAR-1+signaling+system+with+cell-penetrating+pepducins+inhibits+angiogenesis%2C+ascites%2C+and+progression+of+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer</span></div><div class="casAuthors">Agarwal, Anika; Covic, Lidija; Sevigny, Leila M.; Kaneider, Nicole C.; Lazarides, Katherine; Azabdaftari, Gissou; Sharifi, Sheida; Kuliopulos, Athan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2746-2757</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Gene chip and proteomic analyses of tumors and stromal tissue has led to the identification of dozens of candidate tumor and host components potentially involved in tumor-stromal interactions, angiogenesis, and progression of invasive disease.  In particular, matrix metalloproteases (MMP) have emerged as important biomarkers and prognostic factors for invasive and metastatic cancers.  From an initial screen of benign vs. malignant patient fluids, we delineated a metalloprotease cascade comprising MMP-14, MMP-9, and MMP-1 that culminates in activation of PAR1, a G protein-coupled protease-activated receptor up-regulated in diverse cancers.  In xenograft models of advanced peritoneal ovarian cancer, PAR1-dependent angiogenesis, ascites formation, and metastasis were effectively inhibited by i.p. administration of cell-penetrating pepducins based on the intracellular loops of PAR1.  These data provide an in vivo proof-of-concept that targeting the metalloprotease-PAR1 signaling system may be a novel therapeutic approach in the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQFfkPZNYyQbVg90H21EOLACvtfcHk0lgGsyJ0qQ4vWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSms7bM&md5=7766a51d60034e7812f05407f6a2427a</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0177%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DSevigny%26aufirst%3DL.%2BM.%26aulast%3DKaneider%26aufirst%3DN.%2BC.%26aulast%3DLazarides%26aufirst%3DK.%26aulast%3DAzabdaftari%26aufirst%3DG.%26aulast%3DSharifi%26aufirst%3DS.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DTargeting%2520a%2520metalloprotease-PAR-1%2520signaling%2520system%2520with%2520cell-penetrating%2520pepducins%2520inhibits%2520angiogenesis%252C%2520ascites%252C%2520and%2520progression%2520of%2520ovarian%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2746%26epage%3D2757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Zigler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brantley, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villares, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Eli, M.</span><span> </span><span class="NLM_article-title">PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6561</span><span class="NLM_x">–</span> <span class="NLM_lpage">6566</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=6561-6566&issue=21&author=M.+Ziglerauthor=T.+Kamiyaauthor=E.+C.+Brantleyauthor=G.+J.+Villaresauthor=M.+Bar-Eli&title=PAR-1+and+thrombin%3A+the+ties+that+bind+the+microenvironment+to+melanoma+metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZigler%26aufirst%3DM.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DBrantley%26aufirst%3DE.%2BC.%26aulast%3DVillares%26aufirst%3DG.%2BJ.%26aulast%3DBar-Eli%26aufirst%3DM.%26atitle%3DPAR-1%2520and%2520thrombin%253A%2520the%2520ties%2520that%2520bind%2520the%2520microenvironment%2520to%2520melanoma%2520metastasis%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D21%26spage%3D6561%26epage%3D6566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, K. H.</span><span> </span><span class="NLM_article-title">Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1(MMP-1)</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e25103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25103&issue=9&author=S.+J.+Kimauthor=J.+Y.+Shinauthor=K.+D.+Leeauthor=Y.+K.+Baeauthor=I.+J.+Choiauthor=S.+H.+Parkauthor=K.+H.+Chun&title=Galectin-3+facilitates+cell+motility+in+gastric+cancer+by+up-regulating+protease-activated+receptor-1+%28PAR-1%29+and+matrix+metalloproteinase-1%28MMP-1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DShin%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DK.%2BD.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DChoi%26aufirst%3DI.%2BJ.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DChun%26aufirst%3DK.%2BH.%26atitle%3DGalectin-3%2520facilitates%2520cell%2520motility%2520in%2520gastric%2520cancer%2520by%2520up-regulating%2520protease-activated%2520receptor-1%2520%2528PAR-1%2529%2520and%2520matrix%2520metalloproteinase-1%2528MMP-1%2529%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D9%26spage%3De25103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Cisowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Callaghan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tressel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, S. W.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMurry, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinckerhoff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covic, L.</span><span> </span><span class="NLM_article-title">Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ajpath.2011.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21703428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVKktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=513-523&issue=1&author=J.+Cisowskiauthor=K.+O%E2%80%99Callaghanauthor=A.+Kuliopulosauthor=J.+Yangauthor=N.+Nguyenauthor=Q.+Dengauthor=E.+Yangauthor=M.+Fogelauthor=S.+Tresselauthor=C.+Foleyauthor=A.+Agarwalauthor=S.+W.+Huntauthor=T.+McMurryauthor=L.+Brinckerhoffauthor=L.+Covic&title=Targeting+protease-activated+receptor-1+with+cell-penetrating+pepducins+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer</span></div><div class="casAuthors">Cisowski, Jaroslaw; O'Callaghan, Katie; Kuliopulos, Athan; Yang, John; Nguyen, Nga; Deng, Qing; Yang, Eric; Fogel, Michael; Tressel, Sarah; Foley, Caitlin; Agarwal, Anika; Hunt, Stephen W., III; McMurry, Tom; Brinckerhoff, Larry; Covic, Lidija</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">513-523</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Protease-activated receptors (PARs) are G-protein-coupled receptors that are activated by proteolytic cleavage and generation of a tethered ligand.  High PAR1 expression has been documented in a variety of invasive cancers of epithelial origin.  In the present study, we investigated the contribution of the four PAR family members to motility of lung carcinomas and primary tumor samples from patients.  We found that of the four PARs, only PAR1 expression was highly increased in the lung cancer cell lines.  Primary lung cancer cells isolated from patient lung tumors migrated at a 10- to 40-fold higher rate than epithelial cells isolated from nonmalignant lung tissue.  Cell-penetrating pepducin inhibitors were generated against the first (i1) and third (i3) intracellular loops of PAR1 and tested for their ability to inhibit PAR1-driven migration and extracellular regulated kinase (ERK)1/2 activity.  The PAR1 pepducins showed significant inhibition of cell migration in both primary and established cell lines similar to silencing of PAR1 expression with short hairpin RNA (shRNA).  Unlike i1 pepducins, the i3 loop pepducins were effective inhibitors of PAR1-mediated ERK activation and tumor growth.  Comparable in efficacy with Bevacizumab, monotherapy with the PAR1 i3 loop pepducin P1pa1-7 provided significant 75% inhibition of lung tumor growth in nude mice.  We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1oxSBEqnr5rVg90H21EOLACvtfcHk0lgEiAFkJsHODA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVKktrk%253D&md5=9dd40b86b086d47f65ed279f1768711b</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DCisowski%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Callaghan%26aufirst%3DK.%26aulast%3DKuliopulos%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DFogel%26aufirst%3DM.%26aulast%3DTressel%26aufirst%3DS.%26aulast%3DFoley%26aufirst%3DC.%26aulast%3DAgarwal%26aufirst%3DA.%26aulast%3DHunt%26aufirst%3DS.%2BW.%26aulast%3DMcMurry%26aufirst%3DT.%26aulast%3DBrinckerhoff%26aufirst%3DL.%26aulast%3DCovic%26aufirst%3DL.%26atitle%3DTargeting%2520protease-activated%2520receptor-1%2520with%2520cell-penetrating%2520pepducins%2520in%2520lung%2520cancer%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26issue%3D1%26spage%3D513%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obiezu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues and is hormonally regulated</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4252</span><span class="NLM_x">–</span> <span class="NLM_lpage">4256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4252-4256&author=G.+M.+Yousefauthor=C.+V.+Obiezuauthor=L.+Y.+Luoauthor=M.+H.+Blackauthor=E.+P.+Diamandis&title=Prostase%2FKLK-L1+is+a+new+member+of+the+human+kallikrein+gene+family%2C+is+expressed+in+prostate+and+breast+tissues+and+is+hormonally+regulated"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DObiezu%26aufirst%3DC.%2BV.%26aulast%3DLuo%26aufirst%3DL.%2BY.%26aulast%3DBlack%26aufirst%3DM.%2BH.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DProstase%252FKLK-L1%2520is%2520a%2520new%2520member%2520of%2520the%2520human%2520kallikrein%2520gene%2520family%252C%2520is%2520expressed%2520in%2520prostate%2520and%2520breast%2520tissues%2520and%2520is%2520hormonally%2520regulated%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4252%26epage%3D4256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Mize, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T. K.</span><span> </span><span class="NLM_article-title">Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1043</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1158%2F1541-7786.MCR-08-0096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18567807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVKhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=1043-1051&author=G.+J.+Mizeauthor=W.+Wangauthor=T.+K.+Takayama&title=Prostate-specific+kallikreins-2+and+-4+enhance+the+proliferation+of+DU-145+prostate+cancer+cells+through+protease-activated+receptors-1+and+-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-Specific Kallikreins-2 and -4 Enhance the Proliferation of DU-145 Prostate Cancer Cells through Protease-Activated Receptors-1 and -2</span></div><div class="casAuthors">Mize, Gregory J.; Wang, Wenbin; Takayama, Thomas K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1043-1051</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A major characteristic of prostate cancer is the elevation of serum levels of prostate-specific antigen (hK3) and hK2, which are tumor markers that correlate with advancing stages of disease.  Including hK4, these three kallikrein serine proteases are almost exclusively produced by the prostate.  Prostate cancer cells have been recently shown to overexpress protease-activated receptors (PAR), which can be potentially activated by kallikreins and can regulate tumor growth.  Here, we show that recombinant hK2 and hK4 activate ERK1/2 signaling of DU-145, PC-3, and LNCaP prostate cancer cells, which express both PAR1 and PAR2.  These kallikreins also stimulate the proliferation of DU-145 cells.  Pretreatment of hK2 and hK4 with the serine protease inhibitor, aprotinin, blocks the responses in DU-145 cells, and small interfering RNA against PAR1 and PAR2 also inhibits ERK1/2 signaling.  To det. which PAR is activated by hK2 and hK4, a cell line that expresses a single PAR, a PAR1 knockout mouse lung fibroblast cell line transfected with PAR1 (KOLF-PAR1) or PAR2 (KOLF-PAR2) was used. hK4 activates both PAR1 and PAR2, whereas hK2 activates PAR2. hK4 generates more phosphorylated ERK1/2 than hK2.  These data indicate that prostatic kallikreins (hK2 and hK4) directly stimulate prostate cancer cell proliferation through PAR1 and/or PAR2 and may be potentially important targets for future drug therapy for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhzPUtKP2xHbVg90H21EOLACvtfcHk0lgEiAFkJsHODA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVKhtbY%253D&md5=3281e3fa43234123747455183a6c00d9</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0096%26sid%3Dliteratum%253Aachs%26aulast%3DMize%26aufirst%3DG.%2BJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DTakayama%26aufirst%3DT.%2BK.%26atitle%3DProstate-specific%2520kallikreins-2%2520and%2520-4%2520enhance%2520the%2520proliferation%2520of%2520DU-145%2520prostate%2520cancer%2520cells%2520through%2520protease-activated%2520receptors-1%2520and%2520-2%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2008%26volume%3D6%26spage%3D1043%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mize, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T. K.</span><span> </span><span class="NLM_article-title">Kallikrein- related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1002%2Fijc.24904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19795418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGjs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2010&pages=599-610&author=W.+Wangauthor=G.+J.+Mizeauthor=X.+Zhangauthor=T.+K.+Takayama&title=Kallikrein-+related+peptidase-4+initiates+tumor-stroma+interactions+in+prostate+cancer+through+protease-activated+receptor-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1</span></div><div class="casAuthors">Wang, Wenbin; Mize, Gregory J.; Zhang, Xiaotun; Takayama, Thomas K.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">599-610</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">In prostate cancer, the mechanism by which the stromal cells surrounding the cancer epithelium become reactive and overproduce growth factors is unclear.  Furthermore, the precise process of how these stromal cells stimulate the cancer epithelium is not fully understood.  We recently found that protease-activated receptor-1 (PAR-1) in these reactive stromal cells is upregulated.  To investigate the role of PAR-1 in the stromal-epithelial interaction, WPMY-1 stromal myofibroblasts were stimulated with PAR-1 agonists including thrombin and PAR-1 activating peptide.  We show that WPMY-1 cells have functional PAR-1 by signaling through ERK1/2.  Conditioned media (CM) from PAR-1 agonists-treated WPMY-1 cells stimulate the epithelial LNCaP cells leading to ERK1/2 activation and cell proliferation.  Cytokine array anal. of the CM demonstrates that PAR-1 induces stromal cells to release numerous cytokines, of which interleukin 6 (IL-6) is the major factor responsible for mitogenic signaling in LNCaP cells.  CM further induces expression of prostate-specific kallikrein-related peptidase-3 (KLK3/PSA) and KLK4 in LNCaP cells via the IL-6 pathway.  Moreover, KLK4 functions as a potent agonist of PAR-1 by cleaving the receptor at the proper site on cell surface.  KLK4 triggers transmembrane signaling and upregulates IL-6 in WPMY-1 cells through PAR-1.  Immunohistochem. anal. indicates that PAR-1 is predominantly expressed in peritumoral stroma while KLK4 is produced exclusively by the epithelial cancer cells.  These data provide evidence for a novel double-paracrine mechanism whereby cancer epithelium produces KLK4 to activate PAR-1 in the surrounding stroma, which in-turn releases cytokines (IL-6) that stimulate cancer cells to proliferate and increase prodn. of KLKs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfpjkSe_hWrVg90H21EOLACvtfcHk0lgEiAFkJsHODA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGjs7nL&md5=58c1a145e0e219982123dfde005f0a92</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2Fijc.24904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24904%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMize%26aufirst%3DG.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTakayama%26aufirst%3DT.%2BK.%26atitle%3DKallikrein-%2520related%2520peptidase-4%2520initiates%2520tumor-stroma%2520interactions%2520in%2520prostate%2520cancer%2520through%2520protease-activated%2520receptor-1%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2010%26volume%3D126%26spage%3D599%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Krenzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterziel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, J.</span><span> </span><span class="NLM_article-title">Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2281</span><span class="NLM_x">–</span> <span class="NLM_lpage">2288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2011&pages=2281-2288&issue=11&author=S.+Krenzerauthor=H.+Peterzielauthor=C.+Mauchauthor=S.+I.+Blaberauthor=M.+Blaberauthor=P.+Angelauthor=J.+Hess&title=Expression+and+function+of+the+kallikrein-related+peptidase+6+in+the+human+melanoma+microenvironment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrenzer%26aufirst%3DS.%26aulast%3DPeterziel%26aufirst%3DH.%26aulast%3DMauch%26aufirst%3DC.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DAngel%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DJ.%26atitle%3DExpression%2520and%2520function%2520of%2520the%2520kallikrein-related%2520peptidase%25206%2520in%2520the%2520human%2520melanoma%2520microenvironment%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2011%26volume%3D131%26issue%3D11%26spage%3D2281%26epage%3D2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Gratio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaufort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virca, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grebenchtchikov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmoul, D.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.2353%2Fajpath.2010.090523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=20056842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=1452-1461&issue=3&author=V.+Gratioauthor=N.+Beaufortauthor=L.+Seizauthor=J.+Maierauthor=G.+D.+Vircaauthor=M.+Debelaauthor=N.+Grebenchtchikovauthor=V.+Magdolenauthor=D.+Darmoul&title=Kallikrein-related+peptidase+4%3A+a+new+activator+of+the+aberrantly+expressed+protease-activated+receptor+1+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells</span></div><div class="casAuthors">Gratio, Valerie; Beaufort, Nathalie; Seiz, Lina; Maier, Josefine; Virca, G. Duke; Debela, Mekdes; Grebenchtchikov, Nicolai; Magdolen, Viktor; Darmoul, Dalila</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1452-1461</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Certain serine proteases are considered to be signaling mols. that act through protease-activated receptors (PARs).  Our recent studies have implicated PAR1 and PAR4 (thrombin receptors) and PAR2 (trypsin receptor) in human colon cancer growth.  Here we analyzed the expression of KLK4, a member of the kallikrein-related peptidase (KLK) family of serine proteases and explored whether this member can activate PAR1 and PAR2 in human colon cancer cells.  Immunohistochem. showed KLK4 expression in human colon adenocarcinomas and its absence in normal epithelia.  KLK4 (1 μmol/L) initiated loss of PAR1 and PAR2 from the HT29 cell surface as well as increased intracellular calcium transients in HT29 cells.  This KLK4-induced Ca2+ flux was abrogated after an initial challenge of the cells with TRAP (SFLLR-NH2; 100 μmol/L), which is known to desensitize PAR1 and PAR2.  Interestingly, PAR1 blocking antibody, which inhibits cleavage and activation by thrombin, dramatically reduced KLK4-induced Ca2+ influx, but blocking cleavage of PAR2 failed to attenuate the KLK4-induced Ca2+ flux.  Consistently, desensitization with AP1 (TFFLR-NH2), targeting PAR1, attenuated most of the Ca2+ flux induced by KLK4.  KLK4 also induced a rapid and significant ERK1/2 phosphorylation in HT29 cells.  Our results demonstrate, for the first time, that KLK4 is aberrantly expressed in colon cancer and capable of inducing PAR1 signaling in cancer cells.  These data suggest that KLK4 signaling via PAR1 may represent a novel pathway in colon tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvASmgGrZPf7Vg90H21EOLACvtfcHk0liHLgWzRvVldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOisbg%253D&md5=226315d2b7f5b15e91ac60cbdbd012da</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.090523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.090523%26sid%3Dliteratum%253Aachs%26aulast%3DGratio%26aufirst%3DV.%26aulast%3DBeaufort%26aufirst%3DN.%26aulast%3DSeiz%26aufirst%3DL.%26aulast%3DMaier%26aufirst%3DJ.%26aulast%3DVirca%26aufirst%3DG.%2BD.%26aulast%3DDebela%26aufirst%3DM.%26aulast%3DGrebenchtchikov%26aufirst%3DN.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DDarmoul%26aufirst%3DD.%26atitle%3DKallikrein-related%2520peptidase%25204%253A%2520a%2520new%2520activator%2520of%2520the%2520aberrantly%2520expressed%2520protease-activated%2520receptor%25201%2520in%2520colon%2520cancer%2520cells%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26issue%3D3%26spage%3D1452%26epage%3D1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Gratio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virca, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikonomopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmoul, D.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2625</span><span class="NLM_x">–</span> <span class="NLM_lpage">2636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.ajpath.2011.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21907696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCmu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2011&pages=2625-2636&issue=5&author=V.+Gratioauthor=C.+Loriotauthor=G.+D.+Vircaauthor=K.+Oikonomopoulouauthor=F.+Walkerauthor=E.+P.+Diamandisauthor=M.+D.+Hollenbergauthor=D.+Darmoul&title=Kallikrein-related+peptidase+14+acts+on+proteinase-activated+receptor+2+to+induce+signaling+pathway+in+colon+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells</span></div><div class="casAuthors">Gratio, Valerie; Loriot, Celine; Virca, G. Duke; Oikonomopoulou, Katerina; Walker, Francine; Diamandis, Eleftherios P.; Hollenberg, Morley D.; Darmoul, Dalila</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2625-2636</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Serine proteinases participate in tumor growth and invasion by cleaving and activating proteinase-activated receptors (PARs).  Recent studies have implicated PAR-1 and PAR-4 (activated by thrombin) and PAR-2 (activated by trypsin but not by thrombin) in human colon cancer growth.  The endogenous activators of PARs in colon tumors, however, are still unknown.  We hypothesize that the kallikrein-related peptidase (KLK) family member KLK14, a known tumor biomarker, is produced by colonic tumors and signals to human colon cancer cells by activating PARs.  We found that i) KLK14 mRNA was present in 16 human colon cancer cell lines, ii) KLK14 protein was expressed and secreted in colon cancer cell lines, and iii) KLK14 (0.1 μmol/L) induced increases in intracellular calcium in HT29, a human colon cancer-derived cell line.  KLK14-induced calcium flux was assocd. with internalization of KLK14-mediated activation of PAR-2.  Furthermore, KLK14 induced significant extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation and HT29 cell proliferation, presumably by activating PAR-2.  A PAR-2 cleavage and activation-blocking antibody dramatically reduced KLK14-induced ERK1/2 signaling.  Finally, ectopic expression of KLK14 in human colon adenocarcinomas and its absence in normal epithelia was demonstrated by IHC anal.  These results demonstrate, for the first time, the aberrant expression of KLK14 in colon cancer and its involvement in PAR-2 receptor signaling.  Thus, KLK14 and its receptor, PAR-2, may represent therapeutic targets for colon tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLbVtuUUj7_bVg90H21EOLACvtfcHk0liHLgWzRvVldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCmu7nP&md5=c30354bf0eb77b82b99cc764500e8742</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2011.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2011.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DGratio%26aufirst%3DV.%26aulast%3DLoriot%26aufirst%3DC.%26aulast%3DVirca%26aufirst%3DG.%2BD.%26aulast%3DOikonomopoulou%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DF.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DDarmoul%26aufirst%3DD.%26atitle%3DKallikrein-related%2520peptidase%252014%2520acts%2520on%2520proteinase-activated%2520receptor%25202%2520to%2520induce%2520signaling%2520pathway%2520in%2520colon%2520cancer%2520cells%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2011%26volume%3D179%26issue%3D5%26spage%3D2625%26epage%3D2636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haasum, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span> </span><span class="NLM_article-title">A proteolytic cascade of kallikreins in the stratum corneum</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2005&pages=198-203&author=M.+Brattsandauthor=K.+Stefanssonauthor=C.+Lundhauthor=Y.+Haasumauthor=T.+Egelrud&title=A+proteolytic+cascade+of+kallikreins+in+the+stratum+corneum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DStefansson%26aufirst%3DK.%26aulast%3DLundh%26aufirst%3DC.%26aulast%3DHaasum%26aufirst%3DY.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DA%2520proteolytic%2520cascade%2520of%2520kallikreins%2520in%2520the%2520stratum%2520corneum%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2005%26volume%3D124%26spage%3D198%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Stefansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span> </span><span class="NLM_article-title">Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=761-768&author=K.+Stefanssonauthor=M.+Brattsandauthor=A.+Nyauthor=B.+Glasauthor=T.+Egelrud&title=Kallikrein-related+peptidase+14+may+be+a+major+contributor+to+trypsin-like+proteolytic+activity+in+human+stratum+corneum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DK.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DNy%26aufirst%3DA.%26aulast%3DGlas%26aufirst%3DB.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DKallikrein-related%2520peptidase%252014%2520may%2520be%2520a%2520major%2520contributor%2520to%2520trypsin-like%2520proteolytic%2520activity%2520in%2520human%2520stratum%2520corneum%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D761%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Komatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saijoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidiropoulos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takehara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1182</span><span class="NLM_x">–</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2005&pages=1182-1189&author=N.+Komatsuauthor=K.+Saijohauthor=M.+Sidiropoulosauthor=B.+Tsaiauthor=M.+A.+Levesqueauthor=M.+B.+Elliottauthor=K.+Takeharaauthor=E.+P.+Diamandis&title=Quantification+of+human+tissue+kallikreins+in+the+stratum+corneum%3A+dependence+on+age+and+gender"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DN.%26aulast%3DSaijoh%26aufirst%3DK.%26aulast%3DSidiropoulos%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DB.%26aulast%3DLevesque%26aufirst%3DM.%2BA.%26aulast%3DElliott%26aufirst%3DM.%2BB.%26aulast%3DTakehara%26aufirst%3DK.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DQuantification%2520of%2520human%2520tissue%2520kallikreins%2520in%2520the%2520stratum%2520corneum%253A%2520dependence%2520on%2520age%2520and%2520gender%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2005%26volume%3D125%26spage%3D1182%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Caubet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonca, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serre, G.</span><span> </span><span class="NLM_article-title">Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/ hK7</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2004&pages=1235-1244&author=C.+Caubetauthor=N.+Joncaauthor=M.+Brattsandauthor=M.+Guerrinauthor=D.+Bernardauthor=R.+Schmidtauthor=T.+Egelrudauthor=M.+Simonauthor=G.+Serre&title=Degradation+of+corneodesmosome+proteins+by+two+serine+proteases+of+the+kallikrein+family%2C+SCTE%2FKLK5%2FhK5+and+SCCE%2FKLK7%2F+hK7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaubet%26aufirst%3DC.%26aulast%3DJonca%26aufirst%3DN.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DGuerrin%26aufirst%3DM.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DEgelrud%26aufirst%3DT.%26aulast%3DSimon%26aufirst%3DM.%26aulast%3DSerre%26aufirst%3DG.%26atitle%3DDegradation%2520of%2520corneodesmosome%2520proteins%2520by%2520two%2520serine%2520proteases%2520of%2520the%2520kallikrein%2520family%252C%2520SCTE%252FKLK5%252FhK5%2520and%2520SCCE%252FKLK7%252F%2520hK7%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2004%26volume%3D122%26spage%3D1235%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Stefansson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosterman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempkes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocheva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelrud, T.</span><span> </span><span class="NLM_article-title">Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2008&pages=18-25&author=K.+Stefanssonauthor=M.+Brattsandauthor=D.+Roostermanauthor=C.+Kempkesauthor=G.+Bochevaauthor=M.+Steinhoffauthor=T.+Egelrud&title=Activation+of+proteinase-activated+receptor-2+by+human+kallikrein-related+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStefansson%26aufirst%3DK.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DRoosterman%26aufirst%3DD.%26aulast%3DKempkes%26aufirst%3DC.%26aulast%3DBocheva%26aufirst%3DG.%26aulast%3DSteinhoff%26aufirst%3DM.%26aulast%3DEgelrud%26aufirst%3DT.%26atitle%3DActivation%2520of%2520proteinase-activated%2520receptor-2%2520by%2520human%2520kallikrein-related%2520peptidases%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2008%26volume%3D128%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Hovnanian, A.</span><span> </span><span class="NLM_article-title">Netherton syndrome: new advances in the clinic, disease mechanism and treatment</span> <span class="citation_source-journal">Exp. Rev. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1586%2Fedm.11.85" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=81-92&issue=1&author=A.+Hovnanian&title=Netherton+syndrome%3A+new+advances+in+the+clinic%2C+disease+mechanism+and+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1586%2Fedm.11.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fedm.11.85%26sid%3Dliteratum%253Aachs%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DNetherton%2520syndrome%253A%2520new%2520advances%2520in%2520the%2520clinic%252C%2520disease%2520mechanism%2520and%2520treatment%26jtitle%3DExp.%2520Rev.%2520Dermatol.%26date%3D2012%26volume%3D7%26issue%3D1%26spage%3D81%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Briot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deraison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacroix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovnanian, A.</span><span> </span><span class="NLM_article-title">Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1147</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=1135-1147&author=A.+Briotauthor=C.+Deraisonauthor=M.+Lacroixauthor=C.+Bonnartauthor=A.+Robinauthor=C.+Bessonauthor=P.+Dubusauthor=A.+Hovnanian&title=Kallikrein+5+induces+atopic+dermatitis-like+lesions+through+PAR2-mediated+thymic+stromal+lymphopoietin+expression+in+Netherton+syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBriot%26aufirst%3DA.%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DLacroix%26aufirst%3DM.%26aulast%3DBonnart%26aufirst%3DC.%26aulast%3DRobin%26aufirst%3DA.%26aulast%3DBesson%26aufirst%3DC.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DKallikrein%25205%2520induces%2520atopic%2520dermatitis-like%2520lesions%2520through%2520PAR2-mediated%2520thymic%2520stromal%2520lymphopoietin%2520expression%2520in%2520Netherton%2520syndrome%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2009%26volume%3D206%26spage%3D1135%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, J.</span><span> </span><span class="NLM_article-title">A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor</span> <span class="citation_source-journal">Exp. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.yexcr.2009.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19879874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1WgtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2010&pages=376-389&issue=3&author=L.+Gaoauthor=L.+Chaoauthor=J.+Chao&title=A+novel+signaling+pathway+of+tissue+kallikrein+in+promoting+keratinocyte+migration%3A+activation+of+proteinase-activated+receptor+1+and+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: Activation of proteinase-activated receptor 1 and epidermal growth factor receptor</span></div><div class="casAuthors">Gao, Lin; Chao, Lee; Chao, Julie</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-389</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Biol. functions of tissue kallikrein (TK, KLK1) are mainly mediated by kinin generation and subsequent kinin B2 receptor activation.  In this study, we investigated the potential role of TK and its signaling pathways in cultured human keratinocyte migration and in a rat skin wound healing model.  Herein, we show that TK promoted cell migration and proliferation in a concn.- and time-dependent manner.  Inactive TK or kinin had no significant effect on cell migration.  Interestingly, cell migration induced by active TK was not blocked by icatibant or L-NAME, indicating an event independent of kinin B2 receptor and nitric oxide formation.  TK's stimulatory effect on cell migration was inhibited by small interfering RNA for proteinase-activated receptor 1 (PAR1), and by PAR1 inhibitor.  TK-induced migration was assocd. with increased phosphorylation of epidermal growth factor receptor (EGFR) and extracellular signal-regulated kinase (ERK), which was blocked by inhibition of protein kinase C (PKC), Src, EGFR and ERK.  TK-induced cell migration and EGFR phosphorylation were blocked by metalloproteinase (MMP) inhibitor, heparin, and antibodies against EGFR external domain, heparin-binding EGF-like growth factor (HB-EGF) and amphiregulin (AR).  Local application of TK promoted skin wound healing in rats, whereas icatibant and EGFR inhibitor blocked TK's effect.  Skin wound healing was further delayed by aprotinin and neutralizing TK antibody.  This study demonstrates a novel role of TK in skin wound healing and uncovers new signaling pathways mediated by TK in promoting keratinocyte migration through activation of the PAR1-PKC-Src-MMP pathway and HB-EGF/AR shedding-dependent EGFR transactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV44XUVCZ_pLVg90H21EOLACvtfcHk0li8-mlg91kU0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1WgtbvK&md5=b82e78fe7d7e9655c99c1ebb355d1969</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2009.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2009.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DL.%26aulast%3DChao%26aufirst%3DJ.%26atitle%3DA%2520novel%2520signaling%2520pathway%2520of%2520tissue%2520kallikrein%2520in%2520promoting%2520keratinocyte%2520migration%253A%2520activation%2520of%2520proteinase-activated%2520receptor%25201%2520and%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2010%26volume%3D316%26issue%3D3%26spage%3D376%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Diamandis, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petraki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soosaipillai, A. R.</span><span> </span><span class="NLM_article-title">Human kallikrein 6 as a biomarker of Alzheimer’s disease</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2FS0009-9120%2800%2900185-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=11166014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsl2ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=663-667&author=E.+P.+Diamandisauthor=G.+M.+Yousefauthor=C.+Petrakiauthor=A.+R.+Soosaipillai&title=Human+kallikrein+6+as+a+biomarker+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Human kallikrein 6 as a biomarker of Alzheimer's disease</span></div><div class="casAuthors">Diamandis, Eleftherios P.; Yousef, George M.; Petraki, Constantina; Soosaipillai, Antoninus R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a major cause of dementia in the elderly.  It is generally difficult to diagnose accurately early AD.  A few biomarkers, including τ protein and amyloid β-42, are now used as aids for diagnosis and monitoring of AD.  The aim was to examine the possible use of cerebrospinal fluid, blood and tissue, and human kallikrein 6 (hK6) concn. as a marker of AD.  We have used a highly sensitive and specific immunofluorometric procedure for measuring hK6.  We measured hK6 in tissue exts. from AD brain or normal individuals, in cerebrospinal fluids of AD patients or normals and in whole blood of AD patients and normals and compared the findings.  We have used 10 pairs of AD/normal controls in all cases.  We found that hK6 concn. is tissue exts. from AD brain were approx. 2-fold lower than exts. from normal controls.  Further, the authors found that cerebrospinal fluid hK6 concn. is approx. a 3-fold increase, in comparison to cerebrospinal fluid controls (p = 0.001).  We have also found that the whole blood hK6 concn. in AD patients is about 10 times higher than hK6 concn. in normal controls (p = 0.002).  We have immunohistochem. localized the expression of hK6 in epithelial cells of the chorioid plexus.  This is the first report describing significant elevations of cerebrospinal fluid and plasma and whole blood hK6 concn. in AD patients, in comparison to controls.  These data suggest that hK6 may constitute a new biomarker for diagnosis and monitoring of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmCEJVrXNeIbVg90H21EOLACvtfcHk0li8-mlg91kU0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsl2ju7Y%253D&md5=217b93c357737490ae8eb590cd8df449</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2FS0009-9120%2800%2900185-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-9120%252800%252900185-5%26sid%3Dliteratum%253Aachs%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DPetraki%26aufirst%3DC.%26aulast%3DSoosaipillai%26aufirst%3DA.%2BR.%26atitle%3DHuman%2520kallikrein%25206%2520as%2520a%2520biomarker%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Biochem.%26date%3D2000%26volume%3D33%26spage%3D663%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, N.</span><span> </span><span class="NLM_article-title">Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer’s disease and Parkinson’s disease</span> <span class="citation_source-journal">Psychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1046%2Fj.1440-1819.2000.00731.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10997858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvFKmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2000&pages=419-426&author=K.+Ogawaauthor=T.+Yamadaauthor=Y.+Tsujiokaauthor=J.+Taguchiauthor=M.+Takahashiauthor=Y.+Tsuboiauthor=Y.+Fujinoauthor=M.+Nakajimaauthor=T.+Yamamotoauthor=H.+Akatsuauthor=S.+Mitsuiauthor=N.+Yamaguchi&title=Localization+of+a+novel+type+trypsin-like+serine+protease%2C+neurosin%2C+in+brain+tissues+of+Alzheimer%E2%80%99s+disease+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease</span></div><div class="casAuthors">Ogawa, Kenichi; Yamada, Tatsuo; Tsujioka, Yasumi; Taguchi, Junichi; Takahashi, Mitsuo; Tsuboi, Yoshio; Fujino, Yasuhiro; Nakajima, Masashi; Yamamoto, Takashi; Akatsu, Hiroyasu; Mitsui, Sinichi; Yamaguchi, Nozomi</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry and Clinical Neurosciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-426</span>CODEN:
                <span class="NLM_cas:coden">PCNEFP</span>;
        ISSN:<span class="NLM_cas:issn">1323-1316</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Neurosin, a novel type of trypsin-like serine protease, was shown to be preferentially expressed in human brain by Northern blotting.  The authors examd. neurosin immunolabeling in the brains of neurol. normal persons and patients with Alzheimer's disease (AD) and with Parkinson's disease.  The authors also identified the expression of the mRNA for neurosin by in situ hybridization histochem. and reverse transcription-PCR (RT-PCR).  The neurosin antibody stained all of the nuclei of various cell types.  In neurons, there was also staining of neuronal cytoplasm, nucleoli and their processes.  In AD, staining of neurons with processes was rare in the damaged areas.  Some senile plaques, extracellular tangles and Lewy bodies were also pos. for neurosin.  Expression of the mRNA for neurosin was seen in neurons in the gray matter, and in microglial cells in the white matter.  In AD, the intensity of the signal for neurosin mRNA in the gray matter was decreased compared with normal control brains.  The relative levels of neurosin mRNA in AD brains, measured by RT-PCR, were lower than those in controls.  These results suggest that in human brain neurosin plays various physiol. roles, and that in AD this mol., like other serine proteases, may have a role in the degrdn. of such substances as β-amyloid protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnPi-K4fSrcrVg90H21EOLACvtfcHk0lierwonBVKrtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvFKmurw%253D&md5=a6402198b2623ed700f47108c1c647bc</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1046%2Fj.1440-1819.2000.00731.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1440-1819.2000.00731.x%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DTsujioka%26aufirst%3DY.%26aulast%3DTaguchi%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTsuboi%26aufirst%3DY.%26aulast%3DFujino%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DMitsui%26aufirst%3DS.%26aulast%3DYamaguchi%26aufirst%3DN.%26atitle%3DLocalization%2520of%2520a%2520novel%2520type%2520trypsin-like%2520serine%2520protease%252C%2520neurosin%252C%2520in%2520brain%2520tissues%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPsychiatry%2520Clin.%2520Neurosci.%26date%3D2000%26volume%3D54%26spage%3D419%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linbo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneve, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucchinetti, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2008&pages=739-745&author=I.+A.+Scarisbrickauthor=R.+Linboauthor=A.+G.+Vandellauthor=M.+Keeganauthor=S.+I.+Blaberauthor=M.+Blaberauthor=D.+Sneveauthor=C.+F.+Lucchinettiauthor=M.+Rodriguezauthor=E.+P.+Diamandis&title=Kallikreins+are+associated+with+secondary+progressive+multiple+sclerosis+and+promote+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DLinbo%26aufirst%3DR.%26aulast%3DVandell%26aufirst%3DA.%2BG.%26aulast%3DKeegan%26aufirst%3DM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DSneve%26aufirst%3DD.%26aulast%3DLucchinetti%26aufirst%3DC.%2BF.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DKallikreins%2520are%2520associated%2520with%2520secondary%2520progressive%2520multiple%2520sclerosis%2520and%2520promote%2520neurodegeneration%26jtitle%3DBiol.%2520Chem.%26date%3D2008%26volume%3D389%26spage%3D739%26epage%3D745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Noorbakhsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boven, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shariat, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vodjgani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span> </span><span class="NLM_article-title">Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=425-435&author=F.+Noorbakhshauthor=S.+Tsutsuiauthor=N.+Vergnolleauthor=L.+A.+Bovenauthor=N.+Shariatauthor=M.+Vodjganiauthor=K.+G.+Warrenauthor=P.+Andrade-Gordonauthor=M.+D.+Hollenbergauthor=C.+Power&title=Proteinase-activated+receptor+2+modulates+neuroinflammation+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoorbakhsh%26aufirst%3DF.%26aulast%3DTsutsui%26aufirst%3DS.%26aulast%3DVergnolle%26aufirst%3DN.%26aulast%3DBoven%26aufirst%3DL.%2BA.%26aulast%3DShariat%26aufirst%3DN.%26aulast%3DVodjgani%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DK.%2BG.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DPower%26aufirst%3DC.%26atitle%3DProteinase-activated%2520receptor%25202%2520modulates%2520neuroinflammation%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520and%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D425%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Vandell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laxmikanthan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span> </span><span class="NLM_article-title">Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1471-4159.2008.05658.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18778305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSisbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=855-870&author=A.+G.+Vandellauthor=N.+Larsonauthor=G.+Laxmikanthanauthor=M.+Panosauthor=S.+I.+Blaberauthor=M.+Blaberauthor=I.+A.+Scarisbrick&title=Protease-activated+receptor+dependent+and+independent+signaling+by+kallikreins+1+and+6+in+CNS+neuron+and+astroglial+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines</span></div><div class="casAuthors">Vandell, Alexander G.; Larson, Nadya; Laxmikanthan, Gurunathan; Panos, Michael; Blaber, Sachiko I.; Blaber, Michael; Scarisbrick, Isobel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">855-870</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">While protease-activated receptors (PARs) are known to mediate signaling events in CNS, contributing both to normal function and pathogenesis, the endogenous activators of CNS PARs are poorly characterized.  In this study, we test the hypothesis that kallikreins (KLKs) represent an important pool of endogenous activators of CNS PARs.  Specifically, KLK1 and KLK6 were examd. for their ability to evoke intracellular Ca2+ flux in a PAR-dependent fashion in NSC34 neurons and Neu7 astrocytes.  Both KLKs were also examd. for their ability to activate mitogen-activated protein kinases (extracellular signal-regulated kinases, C-Jun N-terminal kinases, and p38) and protein kinase B (AKT) intracellular signaling cascades.  Cumulatively, these studies show that KLK6, but not KLK1, signals through PARs.  KLK6 evoked intracellular Ca2+ flux was mediated by PAR1 in neurons and both PAR1 and PAR2 in astrocytes.  Importantly, both KLK1 and KLK6 altered the activation state of mitogen-activated protein kinases and AKT, suggestive of important roles for each in CNS neuron and glial differentiation, and survival.  The cellular specificity of CNS-KLK activity was underscored by observations that both proteases promoted AKT activation in astrocytes, but inhibited such signaling in neurons.  PAR1 and bradykinin receptor inhibitors were used to demonstrate that KLK1-mediated activation of extracellular signal-regulated kinases in neurons occurred in a non-PAR, bradykinin 2 (B2) receptor-dependent fashion, while similar signaling by KLK6 was mediated by the combined activation of PAR1 and B2.  Cumulatively results indicate KLK6, but not KLK1 is an activator of CNS PARs, and that both KLKs are poised to signal in a B2 receptor-dependent fashion to regulate multiple signal transduction pathways relevant to CNS physiol. function and dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAaF5hUJBz7Vg90H21EOLACvtfcHk0lierwonBVKrtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSisbvI&md5=73ad6573138b0118aa6718f11b1a0a15</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2008.05658.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2008.05658.x%26sid%3Dliteratum%253Aachs%26aulast%3DVandell%26aufirst%3DA.%2BG.%26aulast%3DLarson%26aufirst%3DN.%26aulast%3DLaxmikanthan%26aufirst%3DG.%26aulast%3DPanos%26aufirst%3DM.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26atitle%3DProtease-activated%2520receptor%2520dependent%2520and%2520independent%2520signaling%2520by%2520kallikreins%25201%2520and%25206%2520in%2520CNS%2520neuron%2520and%2520astroglial%2520cell%2520lines%26jtitle%3DJ.%2520Neurochem.%26date%3D2008%26volume%3D107%26spage%3D855%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Scarisbrick, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloud, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandell, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryson, A. L.</span><span> </span><span class="NLM_article-title">Functional role of kallikrein 6 in regulating immune cell survival</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">e18376</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18376&issue=3&author=I.+A.+Scarisbrickauthor=B.+Epsteinauthor=B.+A.+Cloudauthor=H.+Yoonauthor=J.+Wuauthor=D.+N.+Rennerauthor=S.+I.+Blaberauthor=M.+Blaberauthor=A.+G.+Vandellauthor=A.+L.+Bryson&title=Functional+role+of+kallikrein+6+in+regulating+immune+cell+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScarisbrick%26aufirst%3DI.%2BA.%26aulast%3DEpstein%26aufirst%3DB.%26aulast%3DCloud%26aufirst%3DB.%2BA.%26aulast%3DYoon%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRenner%26aufirst%3DD.%2BN.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DVandell%26aufirst%3DA.%2BG.%26aulast%3DBryson%26aufirst%3DA.%2BL.%26atitle%3DFunctional%2520role%2520of%2520kallikrein%25206%2520in%2520regulating%2520immune%2520cell%2520survival%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D3%26spage%3De18376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Goettig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span> </span><span class="NLM_article-title">Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">–</span> <span class="NLM_lpage">1567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1546-1567&author=P.+Goettigauthor=V.+Magdolenauthor=H.+Brandstetter&title=Natural+and+synthetic+inhibitors+of+kallikrein-related+peptidases+%28KLKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoettig%26aufirst%3DP.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DNatural%2520and%2520synthetic%2520inhibitors%2520of%2520kallikrein-related%2520peptidases%2520%2528KLKs%2529%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26spage%3D1546%26epage%3D1567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span> </span><span class="NLM_article-title">Natural protein proteinase inhibitors and their interaction with proteinases</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">204</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1432-1033.1992.tb16654.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=1541261" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK38XhsVKnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=1992&pages=433-451&author=W.+Bodeauthor=R.+Huber&title=Natural+protein+proteinase+inhibitors+and+their+interaction+with+proteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Natural protein proteinase inhibitors and their interaction with proteinases</span></div><div class="casAuthors">Bode, Wolfram; Huber, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">433-51</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A review with 152 refs.  The substrate-like canonical inhibition by the small serine proteinase inhibitors and the product-like inhibition by the carboxypeptidase inhibitor have provided the only at. models of protein inhibitor-proteinase interactions for about 15 yr.  The recently published structures of cystatin/stefin-papain complexes and of hirudin-thrombin complexes reveal novel non-substrate-like interactions.  In addn., the structure of pro-carboxypeptidase shows a mode of inactivation which bears resemblance to proteinase/protein inhibitor systems.  Considerable progress in understanding the transition between native and cleaved states of the serpins has also been made by several recent structural studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1OxE7oX-XobVg90H21EOLACvtfcHk0lhaatpgPinh0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVKnu7c%253D&md5=0b095f8107fd15ea19c77e227e85f716</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1992.tb16654.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1992.tb16654.x%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26aulast%3DHuber%26aufirst%3DR.%26atitle%3DNatural%2520protein%2520proteinase%2520inhibitors%2520and%2520their%2520interaction%2520with%2520proteinases%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1992%26volume%3D204%26spage%3D433%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Fritz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Förg-Brey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppe, S. Z.</span><span> </span><span class="NLM_article-title">Leupeptin and antipain. Strong competitive inhibitors of sperm acrosomal proteinase (boar acrosin) and kallikreins from porcine organs (pancreas, submand. glands, urine)</span> <span class="citation_source-journal">Physiol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1515%2Fbchm2.1973.354.2.1304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=4807834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaE2cXnvFGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=1973&pages=1304-1306&author=H.+Fritzauthor=B.+F%C3%B6rg-Breyauthor=H.+Umezawaauthor=S.+Z.+Hoppe&title=Leupeptin+and+antipain.+Strong+competitive+inhibitors+of+sperm+acrosomal+proteinase+%28boar+acrosin%29+and+kallikreins+from+porcine+organs+%28pancreas%2C+submand.+glands%2C+urine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Leupeptin and antipain.  Strong competitive inhibitors of sperm acrosomal proteinase (boar acrosin) and kallikreins from porcine organs (pancreas, submandibular glands, urine)</span></div><div class="casAuthors">Fritz, Hans; Foerg-Brey, Bruni; Umezawa, Hamao</div><div class="citationInfo"><span class="NLM_cas:title">Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">10-11</span>),
    <span class="NLM_cas:pages">1304-6</span>CODEN:
                <span class="NLM_cas:coden">HSZPAZ</span>;
        ISSN:<span class="NLM_cas:issn">0018-4888</span>.
    </div><div class="casAbstract">The microbial peptides, leupeptin and antipain, were strong competitive inhibitors of boar acrosin (Ki: 5.9 × 10-8M to 7.1 × 10-8M) and porcine pancreatic (Ki: 4.1 × 10-6M and 1.6 × 10-5M), submandibular (Ki: 1.0 × 10-5M and 3.9 × 10-5M), and urinary kallikrein (Ki: 1.3 × 10-5M and 9.5 × 10-5M).  Dixon plots were used for evaluation of the type of inhibition and the Ki-values.  Chymostatin and pepstatin did not inhibit acrosin, the porcine kallikreins, or the chymotrypsin-like proteinase from human sperm plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFjdJhVHKBO7Vg90H21EOLACvtfcHk0lhaatpgPinh0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXnvFGitw%253D%253D&md5=3c0ba6b13a25bb08755f5f443c3bc392</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1515%2Fbchm2.1973.354.2.1304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbchm2.1973.354.2.1304%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DH.%26aulast%3DF%25C3%25B6rg-Brey%26aufirst%3DB.%26aulast%3DUmezawa%26aufirst%3DH.%26aulast%3DHoppe%26aufirst%3DS.%2BZ.%26atitle%3DLeupeptin%2520and%2520antipain.%2520Strong%2520competitive%2520inhibitors%2520of%2520sperm%2520acrosomal%2520proteinase%2520%2528boar%2520acrosin%2529%2520and%2520kallikreins%2520from%2520porcine%2520organs%2520%2528pancreas%252C%2520submand.%2520glands%252C%2520urine%2529%26jtitle%3DPhysiol.%2520Chem.%26date%3D1973%26volume%3D354%26spage%3D1304%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloutier, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kündig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deperthes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">Activation and enzymatic characterization of recombinant human kallikrein 8</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2006&pages=723-731&author=T.+Kishiauthor=S.+M.+Cloutierauthor=C.+K%C3%BCndigauthor=D.+Deperthesauthor=E.+P.+Diamandis&title=Activation+and+enzymatic+characterization+of+recombinant+human+kallikrein+8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DCloutier%26aufirst%3DS.%2BM.%26aulast%3DK%25C3%25BCndig%26aufirst%3DC.%26aulast%3DDeperthes%26aufirst%3DD.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DActivation%2520and%2520enzymatic%2520characterization%2520of%2520recombinant%2520human%2520kallikrein%25208%26jtitle%3DBiol.%2520Chem.%26date%3D2006%26volume%3D387%26spage%3D723%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Lovgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Airas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn<sup>2+</sup> and extracellular protease inhibitors</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1046%2Fj.1432-1327.1999.00433.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10411640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1yruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1999&pages=781-789&author=J.+Lovgrenauthor=K.+Airasauthor=H.+Lilja&title=Enzymatic+action+of+human+glandular+kallikrein+2+%28hK2%29.+Substrate+specificity+and+regulation+by+Zn2%2B+and+extracellular+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors</span></div><div class="casAuthors">Lovgren, Janita; Airas, Kalervo; Lilja, Hans</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Human glandular kallikrein 2 (hK2) is a serine protease expressed by the prostate gland with 80% identity in primary structure to prostate-specific antigen (PSA).  Recently, hK2 was shown to activate the zymogen form of PSA (proPSA) in vitro and is likely to be the physiol. activator of PSA in the prostate.  HK2 is also able to activate urokinase and effectively cleave fibronectin.  We studied the substrate specificity of hK2 and regulation of its activity by zinc and extracellular protease inhibitors present in the prostate and seminal plasma.  The enzymic activity and substrate specificity was studied by detg. hK2 cleavage sites in the major gel proteins in semen, semenogelin I and II, and by measuring hydrolysis of various tripeptide aminomethylcoumarin substrates.  HK2 cleaves substrates C-terminal of single or double arginines.  Basic amino acids were also occasionally found at several other positions N-terminal of the cleavage site.  Therefore, the substrate specificity of hK2 fits in well with that of a processor of protein precursors.  Possible regulation mechanisms were studied by testing the ability of Zn2+ and different protease inhibitors to inhibit hK2 by kinetic measurements.  Inhibitory consts. were detd. for the most effective inhibitors PCI and Zn2+.  The high affinity of PCI for hK2 (kass = 2.0 × 105 M-1·s-1) and the high concns. of PCI (4 μM) and hK2 (0.2 μM) in seminal plasma make hK2 a very likely physiol. target protease for PCI.  HK2 is inhibited by Zn2+ at micromolar concns. well below the 9 mM zinc concn. found in the prostate.  The enzymic activity of hK2 is likely to be reversibly regulated by Zn2+ in prostatic fluid.  This regulation may be impaired in CAP and advanced metastatic cancer resulting in lack of control of the hK2 activity and a need for other means of control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3msB1e5HBZrVg90H21EOLACvtfcHk0liRrmnPbcPOaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1yruro%253D&md5=de1babff1807d8180021c0e7c81c7da6</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.1999.00433.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.1999.00433.x%26sid%3Dliteratum%253Aachs%26aulast%3DLovgren%26aufirst%3DJ.%26aulast%3DAiras%26aufirst%3DK.%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DEnzymatic%2520action%2520of%2520human%2520glandular%2520kallikrein%25202%2520%2528hK2%2529.%2520Substrate%2520specificity%2520and%2520regulation%2520by%2520Zn2%252B%2520and%2520extracellular%2520protease%2520inhibitors%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1999%26volume%3D262%26spage%3D781%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Debela, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdolen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goettig, P.</span><span> </span><span class="NLM_article-title">Chymotryptic specificity determinants in the 1.0 Å structure of the zinc-inhibited human tissue kallikrein 7</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">16086</span><span class="NLM_x">–</span> <span class="NLM_lpage">16091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=16086-16091&author=M.+Debelaauthor=P.+Hessauthor=V.+Magdolenauthor=N.+M.+Schechterauthor=T.+Steinerauthor=R.+Huberauthor=W.+Bodeauthor=P.+Goettig&title=Chymotryptic+specificity+determinants+in+the+1.0+%C3%85+structure+of+the+zinc-inhibited+human+tissue+kallikrein+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDebela%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DMagdolen%26aufirst%3DV.%26aulast%3DSchechter%26aufirst%3DN.%2BM.%26aulast%3DSteiner%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBode%26aufirst%3DW.%26aulast%3DGoettig%26aufirst%3DP.%26atitle%3DChymotryptic%2520specificity%2520determinants%2520in%2520the%25201.0%2520%25C3%2585%2520structure%2520of%2520the%2520zinc-inhibited%2520human%2520tissue%2520kallikrein%25207%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D16086%26epage%3D16091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Swedberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Veer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. M.</span><span> </span><span class="NLM_article-title">Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2010&pages=357-374&author=J.+E.+Swedbergauthor=S.+J.+de+Veerauthor=J.+M.+Harris&title=Natural+and+engineered+kallikrein+inhibitors%3A+an+emerging+pharmacopoeia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwedberg%26aufirst%3DJ.%2BE.%26aulast%3Dde%2BVeer%26aufirst%3DS.%2BJ.%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26atitle%3DNatural%2520and%2520engineered%2520kallikrein%2520inhibitors%253A%2520an%2520emerging%2520pharmacopoeia%26jtitle%3DBiol.%2520Chem.%26date%3D2010%26volume%3D391%26spage%3D357%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Pimenta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Nucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Design of inhibitors for human tissue kallikrein using nonnatural aromatic and basic amino acids</span> <span class="citation_source-journal">Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">857</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2002&pages=853-857&author=D.+Pimentaauthor=R.+L.+Meloauthor=G.+Caliendoauthor=V.+Santagadaauthor=F.+Fiorinoauthor=B.+Severinoauthor=G.+de+Nucciauthor=L.+Julianoauthor=M.+A.+Juliano&title=Design+of+inhibitors+for+human+tissue+kallikrein+using+nonnatural+aromatic+and+basic+amino+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPimenta%26aufirst%3DD.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3Dde%2BNucci%26aufirst%3DG.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DDesign%2520of%2520inhibitors%2520for%2520human%2520tissue%2520kallikrein%2520using%2520nonnatural%2520aromatic%2520and%2520basic%2520amino%2520acids%26jtitle%3DBiol.%2520Chem.%26date%3D2002%26volume%3D383%26spage%3D853%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Pimenta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogac, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melo, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span> </span><span class="NLM_article-title">Specificity of S′1 and S′2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P′1 and P′2 positions in design of inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=1021-1025&author=D.+C.+Pimentaauthor=S.+E.+Fogacauthor=R.+L.+Meloauthor=L.+Julianoauthor=M.+A.+Juliano&title=Specificity+of+S%E2%80%B21+and+S%E2%80%B22+subsites+of+human+tissue+kallikrein+using+the+reactive-centre+loop+of+kallistatin%3A+the+importance+of+P%E2%80%B21+and+P%E2%80%B22+positions+in+design+of+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPimenta%26aufirst%3DD.%2BC.%26aulast%3DFogac%26aufirst%3DS.%2BE.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26atitle%3DSpecificity%2520of%2520S%25E2%2580%25B21%2520and%2520S%25E2%2580%25B22%2520subsites%2520of%2520human%2520tissue%2520kallikrein%2520using%2520the%2520reactive-centre%2520loop%2520of%2520kallistatin%253A%2520the%2520importance%2520of%2520P%25E2%2580%25B21%2520and%2520P%25E2%2580%25B22%2520positions%2520in%2520design%2520of%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D1021%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Hekim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narvanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivunen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisanen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span> </span><span class="NLM_article-title">Novel peptide inhibitors of human kallikrein 2</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">12555</span><span class="NLM_x">–</span> <span class="NLM_lpage">12560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=12555-12560&author=C.+Hekimauthor=J.+Leinonenauthor=A.+Narvanenauthor=H.+Koistinenauthor=L.+Zhuauthor=E.+Koivunenauthor=V.+Vaisanenauthor=U.+H.+Stenman&title=Novel+peptide+inhibitors+of+human+kallikrein+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHekim%26aufirst%3DC.%26aulast%3DLeinonen%26aufirst%3DJ.%26aulast%3DNarvanen%26aufirst%3DA.%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DKoivunen%26aufirst%3DE.%26aulast%3DVaisanen%26aufirst%3DV.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26atitle%3DNovel%2520peptide%2520inhibitors%2520of%2520human%2520kallikrein%25202%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D12555%26epage%3D12560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Pakkala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hekim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soininen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vepsäläinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Närvänen, A.</span><span> </span><span class="NLM_article-title">Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1002%2Fpsc.849" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17436344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1eisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=348-353&author=M.+Pakkalaauthor=C.+Hekimauthor=P.+Soininenauthor=J.+Leinonenauthor=H.+Koistinenauthor=J.+Weisellauthor=U.+H.+Stenmanauthor=J.+Veps%C3%A4l%C3%A4inenauthor=A.+N%C3%A4rv%C3%A4nen&title=Activity+and+stability+of+human+kallikrein-2-specific+linear+and+cyclic+peptide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors</span></div><div class="casAuthors">Pakkala, Miikka; Hekim, Can; Soininen, Pasi; Leinonen, Jari; Koistinen, Hannu; Weisell, Janne; Stenman, Ulf-Hakan; Vepsalainen, Jouko; Narvanen, Ale</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-353</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Human glandular kallikrein (KLK2) is a highly prostate-specific serine protease, which is mainly excreted into the seminal fluid, but part of which is also secreted into circulation from prostatic tumors.  Since the expression level of KLK2 is elevated in aggressive tumors and it has been suggested to mediate the metastasis of prostate cancer, inhibition of the proteolytic activity of KLK2 is of potential therapeutic value.  We have previously identified several KLK2-specific linear peptides by phage display technol.  Two of its synthetic analogs, ARRPAPAPG (KLK2a) and GAARFKVWWAAG (KLK2b), show specific inhibition of KLK2 but their sensitivity to proteolysis in vivo may restrict their potential use as therapeutic agents.  In order to improve the stability of the linear peptides for in vivo use, we have prepd. cyclic analogs and compared their biol. activity and their structural stability.  A series of cyclic variants with cysteine bridges were synthesized.  Cyclization inactivated one peptide (KLK2a) and its derivs., while the other peptide (KLK2b) and its derivs. remained active.  Furthermore, backbone cyclization of KLK2b improved significantly the resistance against proteolysis by trypsin and human plasma.  NMR studies showed that cyclization of the KLK2b peptides does not make the structures more rigid.  In conclusion, we have shown that backbone cyclization of KLK2 inhibitory peptides can be used to increase stability without losing biol. activity.  This should render the peptides more useful for in vivo applications, such as tumor imaging and prostate cancer targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBY_32coktHbVg90H21EOLACvtfcHk0li_GV1LY2c7Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1eisLs%253D&md5=fcf73152da918217b350e990256e4434</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1002%2Fpsc.849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.849%26sid%3Dliteratum%253Aachs%26aulast%3DPakkala%26aufirst%3DM.%26aulast%3DHekim%26aufirst%3DC.%26aulast%3DSoininen%26aufirst%3DP.%26aulast%3DLeinonen%26aufirst%3DJ.%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DWeisell%26aufirst%3DJ.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26aulast%3DVeps%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%26aulast%3DN%25C3%25A4rv%25C3%25A4nen%26aufirst%3DA.%26atitle%3DActivity%2520and%2520stability%2520of%2520human%2520kallikrein-2-specific%2520linear%2520and%2520cyclic%2520peptide%2520inhibitors%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26spage%3D348%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Hassan, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somvanshi, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, S.</span><span> </span><span class="NLM_article-title">Structure-guided design of peptidic ligand for human prostate specific antigen</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1002%2Fpsc.911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17890654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=849-855&author=M.+I.+Hassanauthor=V.+Kumarauthor=R.+K.+Somvanshiauthor=S.+Deyauthor=T.+P.+Singhauthor=S.+Yadav&title=Structure-guided+design+of+peptidic+ligand+for+human+prostate+specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of peptidic ligand for human prostate specific antigen</span></div><div class="casAuthors">Hassan, Md Imtaiyaz; Kumar, Vijay; Somvanshi, Rishi K.; Dey, Sharmistha; Singh, Tej P.; Yadav, Savita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Science</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">849-855</span>CODEN:
                <span class="NLM_cas:coden">JPSIEI</span>;
        ISSN:<span class="NLM_cas:issn">1075-2617</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Prostate specific antigen (PSA) is a member of kallikrein family having serine protease-like activity and acts as a prognostic marker of prostate carcinoma.  Various studies have been performed on inhibition of PSA and such targeting requires the identification of highly selective peptide inhibitors.  PSA was purified from human seminal plasma by rapid and efficient methods, and binding studies for various peptides were carried out by fluorescence spectroscopy and SPR.  The 'S' of PSA is predominated by hydrophobic residues, and hence many hydrophobic residues, and hence many hydrophobic peptides were used to det. their binding affinity to PSA by fluorescence spectroscopy.  We obsd. that LLFW, FFKW, and KFW binds strongly to PSA, among them LLFW showed strong binding.  SPR also showed strong binding affinity of PSA toward peptides with hydrophobic and basic residues.  Among the peptides used, FWYS showed dramatic increase in binding affinity (10-10 M).  The peptides analyzed for binding studies, suggests that peptide with Trp residue along with basic or hydrophobic amino acids may be useful for designing specific inhibitors for PSA.  The strong affinities of designed peptides for PSA can be a valuable tool for designing therapeutic agents for prostate carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrM3mFX8cHabVg90H21EOLACvtfcHk0li_GV1LY2c7Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslyltQ%253D%253D&md5=ff3bcadfd1b180a5d74e39b238f098c9</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1002%2Fpsc.911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.911%26sid%3Dliteratum%253Aachs%26aulast%3DHassan%26aufirst%3DM.%2BI.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DSomvanshi%26aufirst%3DR.%2BK.%26aulast%3DDey%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DT.%2BP.%26aulast%3DYadav%26aufirst%3DS.%26atitle%3DStructure-guided%2520design%2520of%2520peptidic%2520ligand%2520for%2520human%2520prostate%2520specific%2520antigen%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26spage%3D849%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.chembiol.2008.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18635003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=665-674&author=A.+M.+LeBeauauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Potent+and+selective+peptidyl+boronic+acid+inhibitors+of+the+serine+protease+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span></div><div class="casAuthors">LeBeau, Aaron M.; Singh, Pratap; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">665-674</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Prostate cancer cells produce high (microgram to milligram/mL) levels of the serine protease Prostate-Specific Antigen (PSA).  PSA is enzymically active in the extracellular fluid surrounding prostate cancers but is found at 1,000- to 10,000-fold lower concns. in the circulation, where it is inactivated due to binding to abundant serum protease inhibitors.  The exclusive presence of high levels of active PSA within prostate cancer sites makes PSA an attractive candidate for targeted imaging and therapeutics.  A synthetic approach based on a peptide substrate identified first peptide aldehyde and then boronic acid inhibitors of PSA.  The best of these had the sequence Cbz-Ser-Ser-Lys-Leu-(boro)Leu, with a Ki for PSA of 65 nM.  The inhibitor had a 60-fold higher Ki for chymotrypsin.  A validated model of PSA's catalytic site confirmed the crit. interactions between the inhibitor and residues within the PSA enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EWg1W1qwXbVg90H21EOLACvtfcHk0li_GV1LY2c7Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D&md5=ff449d09c36c2f8c6402d571c4baeec7</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DPotent%2520and%2520selective%2520peptidyl%2520boronic%2520acid%2520inhibitors%2520of%2520the%2520serine%2520protease%2520prostate-specific%2520antigen%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D665%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4888</span><span class="NLM_x">–</span> <span class="NLM_lpage">4893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=4888-4893&author=A.+M.+LeBeauauthor=S.+R.+Banerjeeauthor=M.+G.+Pomperauthor=R.+C.+Measeauthor=S.+R.+Denmeade&title=Optimization+of+peptide-based+inhibitors+of+prostate-specific+antigen+%28PSA%29+as+targeted+imaging+agents+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DBanerjee%26aufirst%3DS.%2BR.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DOptimization%2520of%2520peptide-based%2520inhibitors%2520of%2520prostate-specific%2520antigen%2520%2528PSA%2529%2520as%2520targeted%2520imaging%2520agents%2520for%2520prostate%2520cancer%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D4888%26epage%3D4893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Molecular insights into substrate specificity of prostate specific antigen through structural modeling</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=984-993&author=P.+Singhauthor=A.+M.+LeBeauauthor=H.+Liljaauthor=S.+R.+Denmeadeauthor=J.+T.+Isaacs&title=Molecular+insights+into+substrate+specificity+of+prostate+specific+antigen+through+structural+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DMolecular%2520insights%2520into%2520substrate%2520specificity%2520of%2520prostate%2520specific%2520antigen%2520through%2520structural%2520modeling%26jtitle%3DProteins%26date%3D2009%26volume%3D77%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Swedberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigon, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Veer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayama, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooper, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J. M.</span><span> </span><span class="NLM_article-title">Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1016%2Fj.chembiol.2009.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19549601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFamurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=633-643&author=J.+E.+Swedbergauthor=L.+V.+Nigonauthor=J.+C.+Reidauthor=S.+J.+de+Veerauthor=C.+M.+Walpoleauthor=C.+R.+Stephensauthor=T.+P.+Walshauthor=T.+K.+Takayamaauthor=J.+D.+Hooperauthor=J.+A.+Clementsauthor=A.+M.+Buckleauthor=J.+M.+Harris&title=Substrate-guided+design+of+a+potent+and+selective+kallikrein-related+peptidase+inhibitor+for+kallikrein+4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate-Guided Design of a Potent and Selective Kallikrein-Related Peptidase Inhibitor for Kallikrein 4</span></div><div class="casAuthors">Swedberg, Joakim E.; Nigon, Laura V.; Reid, Janet C.; de Veer, Simon J.; Walpole, Carina M.; Stephens, Carson R.; Walsh, Terry P.; Takayama, Thomas K.; Hooper, John D.; Clements, Judith A.; Buckle, Ashley M.; Harris, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-643</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Human kallikrein-related peptidase 4 (KLK4/prostase), a trypsin-like serine protease, is a potential target for prostate cancer treatment because of its proteolytic ability to activate many tumorigenic and metastatic pathways including the protease activated receptors (PARs).  Currently there are no KLK4-specific small-mol. inhibitors available for therapeutic development.  Here the authors re-engineer the naturally occurring sunflower trypsin inhibitor to selectively block the proteolytic activity of KLK4 and prevent stimulation of PAR activity in a cell-based system.  The re-engineered inhibitor was designed using a combination of mol. modeling and sparse matrix substrate screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPJTq4KsQ4vrVg90H21EOLACvtfcHk0ljBOFHaBEhXzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFamurw%253D&md5=8ac6f81cbfbc1dc4bd469cfa73857608</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DSwedberg%26aufirst%3DJ.%2BE.%26aulast%3DNigon%26aufirst%3DL.%2BV.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3Dde%2BVeer%26aufirst%3DS.%2BJ.%26aulast%3DWalpole%26aufirst%3DC.%2BM.%26aulast%3DStephens%26aufirst%3DC.%2BR.%26aulast%3DWalsh%26aufirst%3DT.%2BP.%26aulast%3DTakayama%26aufirst%3DT.%2BK.%26aulast%3DHooper%26aufirst%3DJ.%2BD.%26aulast%3DClements%26aufirst%3DJ.%2BA.%26aulast%3DBuckle%26aufirst%3DA.%2BM.%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26atitle%3DSubstrate-guided%2520design%2520of%2520a%2520potent%2520and%2520selective%2520kallikrein-related%2520peptidase%2520inhibitor%2520for%2520kallikrein%25204%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Deraison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayakumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagberg, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brattsand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachem, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovnanian, A.</span><span> </span><span class="NLM_article-title">LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction</span> <span class="citation_source-journal">Mol. Biol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3607</span><span class="NLM_x">–</span> <span class="NLM_lpage">3619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1091%2Fmbc.E07-02-0124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17596512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=3607-3619&author=C.+Deraisonauthor=C.+Bonnartauthor=F.+Lopezauthor=C.+Bessonauthor=R.+Robinsonauthor=A.+Jayakumarauthor=F.+Wagbergauthor=M.+Brattsandauthor=J.+P.+Hachemauthor=G.+Leonardssonauthor=A.+Hovnanian&title=LEKTI+fragments+specifically+inhibit+KLK5%2C+KLK7%2C+and+KLK14+and+control+desquamation+through+a+pH-dependent+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction</span></div><div class="casAuthors">Deraison, Celine; Bonnart, Chrystelle; Lopez, Frederic; Besson, Celine; Robinson, Ross; Jayakumar, Arumugam; Wagberg, Fredrik; Brattsand, Maria; Hachem, Jean Pierre; Leonardsson, Goran; Hovnanian, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology of the Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3607-3619</span>CODEN:
                <span class="NLM_cas:coden">MBCEEV</span>;
        ISSN:<span class="NLM_cas:issn">1059-1524</span>.
    
            (<span class="NLM_cas:orgname">American Society for Cell Biology</span>)
        </div><div class="casAbstract">LEKTI is a 15-domain serine proteinase inhibitor whose defective expression underlies the severe autosomal recessive ichthyosiform skin disease, Netherton syndrome.  Here, the authors show that LEKTI is produced as a precursor rapidly cleaved by furin, generating a variety of single or multidomain LEKTI fragments secreted in cultured keratinocytes and in the epidermis.  The identity of these biol. fragments (D1, D5, D6, D8-D11, and D9-D15) was inferred from biochem. anal., using a panel of LEKTI antibodies.  The functional inhibitory capacity of each fragment was tested on a panel of serine proteases.  All LEKTI fragments, except D1, showed specific and differential inhibition of human kallikreins 5, 7, and 14.  The strongest inhibition was obsd. with D8-D11, toward KLK5.  Kinetics anal. revealed that this interaction is rapid and irreversible, reflecting an extremely tight binding complex.  The authors demonstrated that pH variations govern this interaction, leading to the release of active KLK5 from the complex at acidic pH.  These results identify KLK5, a key actor of the desquamation process, as the major target of LEKTI.  They disclose a new mechanism of skin homeostasis by which the epidermal pH gradient allows precisely regulated KLK5 activity and corneodesmosomal cleavage in the most superficial layers of the stratum corneum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_pZiNJq9L7Vg90H21EOLACvtfcHk0ljBOFHaBEhXzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWnt7fJ&md5=2d7e7326d29135f35d319f552744bd8d</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1091%2Fmbc.E07-02-0124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1091%252Fmbc.E07-02-0124%26sid%3Dliteratum%253Aachs%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DBonnart%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DF.%26aulast%3DBesson%26aufirst%3DC.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DJayakumar%26aufirst%3DA.%26aulast%3DWagberg%26aufirst%3DF.%26aulast%3DBrattsand%26aufirst%3DM.%26aulast%3DHachem%26aufirst%3DJ.%2BP.%26aulast%3DLeonardsson%26aufirst%3DG.%26aulast%3DHovnanian%26aufirst%3DA.%26atitle%3DLEKTI%2520fragments%2520specifically%2520inhibit%2520KLK5%252C%2520KLK7%252C%2520and%2520KLK14%2520and%2520control%2520desquamation%2520through%2520a%2520pH-dependent%2520interaction%26jtitle%3DMol.%2520Biol.%2520Cell%26date%3D2007%26volume%3D18%26spage%3D3607%26epage%3D3619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Vasileiou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlos, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deraison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlos, K.</span><span> </span><span class="NLM_article-title">Synthesis of the proteinase inhibitor LEKTI domain 6 by the fragment condensation method and regioselective disulfide bond formation</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=339-349&author=Z.+Vasileiouauthor=K.+K.+Barlosauthor=D.+Gatosauthor=K.+Adermannauthor=C.+Deraisonauthor=K.+Barlos&title=Synthesis+of+the+proteinase+inhibitor+LEKTI+domain+6+by+the+fragment+condensation+method+and+regioselective+disulfide+bond+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVasileiou%26aufirst%3DZ.%26aulast%3DBarlos%26aufirst%3DK.%2BK.%26aulast%3DGatos%26aufirst%3DD.%26aulast%3DAdermann%26aufirst%3DK.%26aulast%3DDeraison%26aufirst%3DC.%26aulast%3DBarlos%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520the%2520proteinase%2520inhibitor%2520LEKTI%2520domain%25206%2520by%2520the%2520fragment%2520condensation%2520method%2520and%2520regioselective%2520disulfide%2520bond%2520formation%26jtitle%3DBiopolymers%26date%3D2010%26volume%3D94%26spage%3D339%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Evans, D. M.</span><span> </span><span class="NLM_article-title">Preparation of Aminothiazoles, Including Dipeptide [(2-Aminothiazol-5-yl)methyl]amide Derivatives, as Kallikrein 1 Inhibitors</span>. Patent Appl. WO 2011051673,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+M.+Evans&title=Preparation+of+Aminothiazoles%2C+Including+Dipeptide+%5B%282-Aminothiazol-5-yl%29methyl%5Damide+Derivatives%2C+as+Kallikrein+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DPreparation%2520of%2520Aminothiazoles%252C%2520Including%2520Dipeptide%2520%255B%25282-Aminothiazol-5-yl%2529methyl%255Damide%2520Derivatives%252C%2520as%2520Kallikrein%25201%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Evans, D. M.; Allan, C. E.</span><span> </span><span class="NLM_article-title">Preparation of Azaindoles, Including Dipeptide [(1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-5-yl)methyl]amide Derivatives, as Kallikrein 1 Inhibitors</span>. Patent Appl. WO2011051672,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+M.+Evans&author=C.+E.+Allan&title=Preparation+of+Azaindoles%2C+Including+Dipeptide+%5B%281H-Pyrrolo%5B2%2C3-b%5Dpyridin-5-yl%29methyl%5Damide+Derivatives%2C+as+Kallikrein+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DPreparation%2520of%2520Azaindoles%252C%2520Including%2520Dipeptide%2520%255B%25281H-Pyrrolo%255B2%252C3-b%255Dpyridin-5-yl%2529methyl%255Damide%2520Derivatives%252C%2520as%2520Kallikrein%25201%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Evans, D. M.; Allan, C. E.; Horton, J.; Rooker, D. P.</span><span> </span><span class="NLM_article-title">Preparation of Dipeptide [(6-Aminopyridin-3-yl)methyl]amide Derivatives as Kallikrein 1 Inhibitors</span>. Patent. Appl. WO2009133348,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+M.+Evans&author=C.+E.+Allan&author=J.+Horton&author=D.+P.+Rooker&title=Preparation+of+Dipeptide+%5B%286-Aminopyridin-3-yl%29methyl%5Damide+Derivatives+as+Kallikrein+1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DPreparation%2520of%2520Dipeptide%2520%255B%25286-Aminopyridin-3-yl%2529methyl%255Damide%2520Derivatives%2520as%2520Kallikrein%25201%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfahrt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattsson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahdenperä, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span> </span><span class="NLM_article-title">Novel small molecule inhibitors for prostate-specific antigen</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1143-1151&author=H.+Koistinenauthor=G.+Wohlfahrtauthor=J.+M.+Mattssonauthor=P.+Wuauthor=J.+Lahdenper%C3%A4author=U.+H.+Stenman&title=Novel+small+molecule+inhibitors+for+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DWohlfahrt%26aufirst%3DG.%26aulast%3DMattsson%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLahdenper%25C3%25A4%26aufirst%3DJ.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26atitle%3DNovel%2520small%2520molecule%2520inhibitors%2520for%2520prostate-specific%2520antigen%26jtitle%3DProstate%26date%3D2008%26volume%3D68%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Teixeira, T. S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahao, O.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devienne, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juliano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puzer, L.</span><span> </span><span class="NLM_article-title">Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6112</span><span class="NLM_x">–</span> <span class="NLM_lpage">6115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6112-6115&author=T.+S.+P.+Teixeiraauthor=R.+F.+Freitasauthor=O.+Abrahaoauthor=K.+F.+Devienneauthor=L.+R.+de+Souzaauthor=S.+I.+Blaberauthor=M.+Blaberauthor=M.+Y.+Kondoauthor=M.+A.+Julianoauthor=L.+Julianoauthor=L.+Puzer&title=Biological+evaluation+and+docking+studies+of+natural+isocoumarins+as+inhibitors+for+human+kallikrein+5+and+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeixeira%26aufirst%3DT.%2BS.%2BP.%26aulast%3DFreitas%26aufirst%3DR.%2BF.%26aulast%3DAbrahao%26aufirst%3DO.%26aulast%3DDevienne%26aufirst%3DK.%2BF.%26aulast%3Dde%2BSouza%26aufirst%3DL.%2BR.%26aulast%3DBlaber%26aufirst%3DS.%2BI.%26aulast%3DBlaber%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DM.%2BY.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DPuzer%26aufirst%3DL.%26atitle%3DBiological%2520evaluation%2520and%2520docking%2520studies%2520of%2520natural%2520isocoumarins%2520as%2520inhibitors%2520for%2520human%2520kallikrein%25205%2520and%25207%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6112%26epage%3D6115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckardt, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santulli, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. B.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">12257</span><span class="NLM_x">–</span> <span class="NLM_lpage">12262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12257-12262&author=P.+Andrade-Gordonauthor=B.+E.+Maryanoffauthor=C.+K.+Derianauthor=H.+C.+Zhangauthor=M.+F.+Addoauthor=A.+L.+Darrowauthor=A.+J.+Eckardtauthor=W.+J.+Hoekstraauthor=D.+F.+McComseyauthor=D.+Oksenbergauthor=E.+E.+Reynoldsauthor=R.+J.+Santulliauthor=R.+M.+Scarboroughauthor=C.+E.+Smithauthor=K.+B.+White&title=Design%2C+synthesis%2C+and+biological+characterization+of+a+peptide-mimetic+antagonist+for+a+tethered-ligand+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DDarrow%26aufirst%3DA.%2BL.%26aulast%3DEckardt%26aufirst%3DA.%2BJ.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DOksenberg%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DE.%2BE.%26aulast%3DSantulli%26aufirst%3DR.%2BJ.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DSmith%26aufirst%3DC.%2BE.%26aulast%3DWhite%26aufirst%3DK.%2BB.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520characterization%2520of%2520a%2520peptide-mimetic%2520antagonist%2520for%2520a%2520tethered-ligand%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D12257%26epage%3D12262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span> </span><span class="NLM_article-title">High affinity thrombin receptor (PAR-1) ligands: a new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2199-2203&author=H.+C.+Zhangauthor=K.+B.+Whiteauthor=D.+F.+McComseyauthor=M.+F.+Addoauthor=P.+Andrade-Gordonauthor=C.+K.+Derianauthor=D.+Oksenbergauthor=B.+E.+Maryanoff&title=High+affinity+thrombin+receptor+%28PAR-1%29+ligands%3A+a+new+generation+of+indole-based+peptide+mimetic+antagonists+with+a+basic+amine+at+the+C-terminus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DWhite%26aufirst%3DK.%2BB.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DOksenberg%26aufirst%3DD.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DHigh%2520affinity%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520ligands%253A%2520a%2520new%2520generation%2520of%2520indole-based%2520peptide%2520mimetic%2520antagonists%2520with%2520a%2520basic%2520amine%2520at%2520the%2520C-terminus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2199%26epage%3D2203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derian, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McComsey, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulter, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addo, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiano, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a novel series of thrombin receptor (PAR-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000506s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1021-1024&author=H.+C.+Zhangauthor=C.+K.+Derianauthor=P.+Andrade-Gordonauthor=W.+J.+Hoekstraauthor=D.+F.+McComseyauthor=K.+B.+Whiteauthor=B.+L.+Poulterauthor=M.+F.+Addoauthor=W.+M.+Cheungauthor=B.+P.+Damianoauthor=D.+Oksenbergauthor=E.+E.+Reynoldsauthor=A.+Pandeyauthor=R.+M.+Scarboroughauthor=B.+Maryanoff&title=Discovery+and+optimization+of+a+novel+series+of+thrombin+receptor+%28PAR-1%29+antagonists%3A+potent%2C+selective+peptide+mimetics+based+on+indole+and+indazole+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm000506s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000506s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DDerian%26aufirst%3DC.%2BK.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26aulast%3DMcComsey%26aufirst%3DD.%2BF.%26aulast%3DWhite%26aufirst%3DK.%2BB.%26aulast%3DPoulter%26aufirst%3DB.%2BL.%26aulast%3DAddo%26aufirst%3DM.%2BF.%26aulast%3DCheung%26aufirst%3DW.%2BM.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DOksenberg%26aufirst%3DD.%26aulast%3DReynolds%26aufirst%3DE.%2BE.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DScarborough%26aufirst%3DR.%2BM.%26aulast%3DMaryanoff%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%253A%2520potent%252C%2520selective%2520peptide%2520mimetics%2520based%2520on%2520indole%2520and%2520indazole%2520templates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1021%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frecentese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roviezzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6009</span><span class="NLM_x">–</span> <span class="NLM_lpage">6020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=6009-6020&author=B.+Severinoauthor=F.+Fiorinoauthor=E.+Perissuttiauthor=F.+Frecenteseauthor=G.+Cirinoauthor=F.+Roviezzoauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+and+pharmacological+evaluation+of+peptide-mimetic+protease-activated+receptor-1+antagonists+containing+novel+heterocyclic+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFrecentese%26aufirst%3DF.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DRoviezzo%26aufirst%3DF.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacological%2520evaluation%2520of%2520peptide-mimetic%2520protease-activated%2520receptor-1%2520antagonists%2520containing%2520novel%2520heterocyclic%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D6009%26epage%3D6020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresser, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talavera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane tethered peptides</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=643-648&author=L.+Covicauthor=A.+L.+Gresserauthor=J.+Talaveraauthor=S.+Swiftauthor=A.+Kuliopulos&title=Activation+and+inhibition+of+G+protein-coupled+receptors+by+cell-penetrating+membrane+tethered+peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DGresser%26aufirst%3DA.%2BL.%26aulast%3DTalavera%26aufirst%3DJ.%26aulast%3DSwift%26aufirst%3DS.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DActivation%2520and%2520inhibition%2520of%2520G%2520protein-coupled%2520receptors%2520by%2520cell-penetrating%2520membrane%2520tethered%2520peptides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D643%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Covic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuliopulos, A.</span><span> </span><span class="NLM_article-title">Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1161</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fnm760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=12357249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1161-1165&author=L.+Covicauthor=M.+Misraauthor=J.+Badarauthor=C.+Singhauthor=A.+Kuliopulos&title=Pepducin-based+intervention+of+thrombin-receptor+signaling+and+systemic+platelet+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation</span></div><div class="casAuthors">Covic, Lidija; Misra, Meghna; Badar, Jehangir; Singh, Christopher; Kuliopulos, Athan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1161-1165</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transmembrane signaling through G protein-coupled receptors (GPCRs) controls a diverse array of cellular processes including metab., growth, motility, adhesion, neuronal signaling and blood coagulation.  The numerous GPCRs and their key roles in both normal physiol. and disease have made them the target for more than 50% of all prescribed drugs.  GPCR agonists and antagonists act on the extracellular side of the receptors, whereas the intracellular surface has not yet been exploited for development of new therapeutic agents.  Here, we demonstrate the utility of novel cell-penetrating peptides, termed 'pepducins', that act as intracellular inhibitors of signal transference from receptors to G proteins.  Attachment of a palmitate lipid to peptides based on the third intracellular loop of protease-activated receptor 1 (PAR1) or PAR4 yielded potent inhibitors of thrombin-mediated aggregation of human platelets.  Infusion of the anti-PAR4 pepducin into mice extended bleeding time and protected against systemic platelet activation, consistent with the phenotype of PAR4-deficient mice.  We show that pepducins might be used to ascertain the physiol. roles of GPCRs and rapidly det. the potential therapeutic value of blockade of a particular signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqVW-3ft-YybVg90H21EOLACvtfcHk0lh800vHHk860A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVGrt7o%253D&md5=996168b4f762891e4b80e23dc908137d</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1038%2Fnm760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm760%26sid%3Dliteratum%253Aachs%26aulast%3DCovic%26aufirst%3DL.%26aulast%3DMisra%26aufirst%3DM.%26aulast%3DBadar%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DC.%26aulast%3DKuliopulos%26aufirst%3DA.%26atitle%3DPepducin-based%2520intervention%2520of%2520thrombin-receptor%2520signaling%2520and%2520systemic%2520platelet%2520activation%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1161%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caplen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of pyrazoloquinazolones as thrombin receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2073</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=2073-2078&author=H.+S.+Ahnauthor=L.+Arikauthor=G.+Boykowauthor=D.+Burnettauthor=M.+A.+Caplenauthor=M.+Czarnieckiauthor=M.+Domalskiauthor=C.+Fosterauthor=M.+Mannaauthor=A.+W.+Stamfordauthor=Y.+Wu&title=Structure%E2%80%93activity+relationships+of+pyrazoloquinazolones+as+thrombin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DBurnett%26aufirst%3DD.%26aulast%3DCaplen%26aufirst%3DM.%2BA.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDomalski%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DManna%26aufirst%3DM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DWu%26aufirst%3DY.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520pyrazoloquinazolones%2520as%2520thrombin%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D2073%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Strande, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. E.</span><span> </span><span class="NLM_article-title">SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts</span> <span class="citation_source-journal">Basic Res. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1007%2Fs00395-007-0653-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17468933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1CltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=350-358&author=J.+L.+Strandeauthor=A.+Hsuauthor=J.+Suauthor=X.+Fuauthor=G.+J.+Grossauthor=J.+E.+Baker&title=SCH+79797%2C+a+selective+PAR1+antagonist%2C+limits+myocardial+ischemia%2Freperfusion+injury+in+rat+hearts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts</span></div><div class="casAuthors">Strande, Jennifer I.; Hsu, Anna; Su, Jidong; Fu, Xiangping; Gross, Garrett J.; Baker, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-358</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Steinkopff Verlag</span>)
        </div><div class="casAbstract">Myocardial ischemia/reperfusion (I/R) injury is partly mediated by thrombin.  In support, the functional inhibition of thrombin has been shown to decrease infarct size after I/R.  Several cellular responses to thrombin are mediated by a G-protein coupled protease-activated receptor 1 (PAR1).  However, the role of PAR1 in myocardial I/R injury has not been well characterized.  Therefore, we hypothesized that PAR1 inhibition will reduce the amt. of myocardial I/R injury.  After we detected the presence of PAR1 mRNA and protein in the rat heart by RT-PCR and immunoblot anal., we assessed the potential protective role of SCH 79797, a selective PAR1 antagonist, in two rat models of myocardial I/R injury.  SCH 79797 treatment immediately before or during ischemia reduced myocardial necrosis following I/R in the intact rat heart.  This response was dose-dependent with the optimal dose being 25 μg/kg IV.  Likewise, SCH 79797 treatment before ischemia in the isolated heart model reduced infarct size and increased ventricular recovery following I/R in the isolated heart model with an optimal concn. of 1 μM.  This redn. was abolished by a PAR1 selective agonist.  SCH 79797-induced resistance to myocardial ischemia was abolished by wortmannin, an inhibitor of PI3 kinase; L-NMA, a NOS inhibitor; and glibenclamide, a nonselective KATP channel blocker.  PAR1 activating peptide, wortmannin, L-NMA and glibenclamide alone had no effect on functional recovery or infarct size.  A single treatment of SCH 79797 administered prior to or during ischemia confers immediate cardioprotection suggesting a potential therapeutic role of PAR1 antagonist in the treatment of injury resulting from myocardial ischemia and reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog8djjnYMt3rVg90H21EOLACvtfcHk0lgd2LgWE8B5wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1CltLg%253D&md5=351aa6d436aee252bbfe5c20b53692ff</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1007%2Fs00395-007-0653-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-007-0653-4%26sid%3Dliteratum%253Aachs%26aulast%3DStrande%26aufirst%3DJ.%2BL.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26aulast%3DBaker%26aufirst%3DJ.%2BE.%26atitle%3DSCH%252079797%252C%2520a%2520selective%2520PAR1%2520antagonist%252C%2520limits%2520myocardial%2520ischemia%252Freperfusion%2520injury%2520in%2520rat%2520hearts%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2007%26volume%3D102%26spage%3D350%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Zania, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritikou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flordellis, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maragoudakis, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsopanoglou, N. E.</span><span> </span><span class="NLM_article-title">Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.105.099069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=16595737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=246-254&author=P.+Zaniaauthor=S.+Kritikouauthor=C.+S.+Flordellisauthor=M.+E.+Maragoudakisauthor=N.+E.+Tsopanoglou&title=Blockade+of+angiogenesis+by+small+molecule+antagonists+to+protease-activated+receptor-1%3A+association+with+endothelial+cell+growth+suppression+and+induction+of+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis</span></div><div class="casAuthors">Zania, Panagiota; Kritikou, Sosanna; Flordellis, Christodoulos S.; Maragoudakis, Michael E.; Tsopanoglou, Nikos E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">246-254</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Many studies support the notion that protease-activated receptor (PAR)-1 plays a pivotal role in angiogenesis.  However, direct evidence and understanding the mol. mechanisms involved were limited because PAR-1-specific antagonists have been developed only recently.  In the present study, we evaluated the effects of two well characterized PAR-1 antagonists, SCH79797 ((N-3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine)) and RWJ56110 [(αS)-N-[(1S)-3-amino-1-[[(phenylmethyl)amino]carbonyl]propyl]-α-[[[[[1-(2,6-dichlorophenyl)methyl]-3-(1-pyrrolidinylmethyl)-1H-indol-6-yl]amino]carbonyl]amino]-3,4-difluorobenzenepropanamide], in the angiogenic cascade.  These antagonists suppressed both the basic angiogenesis and that stimulated by thrombin in the chick chorioallantoic membrane model in vivo.  PAR-1 antagonists also abrogated tube formation in the in vitro Matrigel system.  These inhibitory effects were dose-dependent and well correlated with the inhibitory effects of SCH79797 and RWJ56110 on primary endothelial cell proliferation and on the initiation of apoptosis.  PAR-1 blockage resulted in inhibition of endothelial cell growth by increasing the sub-G0/G1 fraction and reducing the percentage of cells in the S phase.  Consistent with this, PAR-1 antagonists reduced incorporation of [3H]thymidine in endothelial cells and blocked the phosphorylation of extracellular signal-regulated kinases in a fashion depending specifically on PAR-1 activation.  Anal. by annexin V/propidium iodide staining and poly(ADP-ribose) polymerase cleavage revealed that PAR-1 blockage increased apoptotic cell death by a mechanism involving caspases.  These results provide further evidence that PAR-1 is a key receptor that mediates angiogenesis and suggest PAR-1 as target for developing antiangiogenic agents with potential therapeutic application in cancer and other angiogenesis-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOjzQWhrsMNLVg90H21EOLACvtfcHk0lgd2LgWE8B5wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymtrk%253D&md5=e8cc7a22933224b42424dc7c8e7d270b</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.099069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.099069%26sid%3Dliteratum%253Aachs%26aulast%3DZania%26aufirst%3DP.%26aulast%3DKritikou%26aufirst%3DS.%26aulast%3DFlordellis%26aufirst%3DC.%2BS.%26aulast%3DMaragoudakis%26aufirst%3DM.%2BE.%26aulast%3DTsopanoglou%26aufirst%3DN.%2BE.%26atitle%3DBlockade%2520of%2520angiogenesis%2520by%2520small%2520molecule%2520antagonists%2520to%2520protease-activated%2520receptor-1%253A%2520association%2520with%2520endothelial%2520cell%2520growth%2520suppression%2520and%2520induction%2520of%2520apoptosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D246%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Di Serio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantucci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geppetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarantini, F.</span><span> </span><span class="NLM_article-title">Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1742-7843.2007.00078.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17577318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsFSqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=63-69&author=C.+Di+Serioauthor=S.+Pelleritoauthor=M.+Duarteauthor=D.+Massiauthor=A.+Naldiniauthor=G.+Cirinoauthor=I.+Prudovskyauthor=M.+Cantucciauthor=P.+Geppettiauthor=N.+Marchionniauthor=G.+Casottiauthor=F.+Tarantini&title=Protease-activated+receptor+1-selective+antagonist+SCH79797+inhibits+cell+proliferation+and+induces+apoptosis+by+a+protease-activated+receptor+1-independent+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism</span></div><div class="casAuthors">Di Serio, Claudia; Pellerito, Silvia; Duarte, Maria; Massi, Daniela; Naldini, Antonella; Cirino, Giuseppe; Prudovsky, Igor; Santucci, Marco; Geppetti, Pierangelo; Marchionni, Niccolo; Masotti, Giulio; Tarantini, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Thrombin, a key mediator of blood coagulation, exerts a large no. of cellular actions via activation of a specific G-protein-coupled receptor, named protease-activated receptor 1 (PAR1).  Several studies in exptl. animals have demonstrated a therapeutic potential of small mols. with PAR1 antagonistic properties for treatment of diseases such as vascular thrombosis and arterial restenosis.  We have studied the biol. actions of one highly potent, selective PAR1 antagonist, SCH79797 (N 3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine), in vitro, and found that this compd. was able to interfere with the growth of several human and mouse cell lines, in a concn.-dependent manner.  The ED50 for growth inhibition was 75 nM, 81 nM and 116 nM for NIH 3T3, HEK 293 and A375 cells, resp.  Moreover, in NIH 3T3 cells, SCH79797 inhibited serum-stimulated activation of p44/p42 mitogen-activated protein kinases (MAPK) at low concns. and induced apoptosis at higher concns.  However, the antiproliferative and pro-apoptotic effects of SCH79797 are likely not mediated by PAR1 antagonism, as they were also obsd. in embryonic fibroblasts derived from PAR1 null mice.  These data suggest that, in view of the development of PAR1-selective antagonists as therapeutic agents, effects potentially unrelated to PAR1 inhibition should be carefully scrutinized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUVoGHKH7DZrVg90H21EOLACvtfcHk0lgd2LgWE8B5wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsFSqs70%253D&md5=17a8df0ae6397d1877a4ed5c944717a7</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2007.00078.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2007.00078.x%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BSerio%26aufirst%3DC.%26aulast%3DPellerito%26aufirst%3DS.%26aulast%3DDuarte%26aufirst%3DM.%26aulast%3DMassi%26aufirst%3DD.%26aulast%3DNaldini%26aufirst%3DA.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DPrudovsky%26aufirst%3DI.%26aulast%3DCantucci%26aufirst%3DM.%26aulast%3DGeppetti%26aufirst%3DP.%26aulast%3DMarchionni%26aufirst%3DN.%26aulast%3DCasotti%26aufirst%3DG.%26aulast%3DTarantini%26aufirst%3DF.%26atitle%3DProtease-activated%2520receptor%25201-selective%2520antagonist%2520SCH79797%2520inhibits%2520cell%2520proliferation%2520and%2520induces%2520apoptosis%2520by%2520a%2520protease-activated%2520receptor%25201-independent%2520mechanism%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2007%26volume%3D101%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">O’Donoghue, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiviott, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolillo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalescot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeymer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aylward, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziecina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contant, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flather, M. D.</span><span> </span><span class="NLM_article-title">Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of thrombin-acute coronary syndromes trial</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=1843-1853&author=M.+L.+O%E2%80%99Donoghueauthor=D.+L.+Bhattauthor=S.+D.+Wiviottauthor=S.+G.+Goodmanauthor=D.+J.+Fitzgeraldauthor=D.+J.+Angiolilloauthor=S.+Gotoauthor=G.+Montalescotauthor=U.+Zeymerauthor=P.+E.+Aylwardauthor=V.+Guettaauthor=D.+Dudekauthor=R.+Ziecinaauthor=C.+F.+Contantauthor=M.+D.+Flather&title=Safety+and+tolerability+of+atopaxar+in+the+treatment+of+patients+with+acute+coronary+syndromes%3A+the+lessons+from+antagonizing+the+cellular+effects+of+thrombin-acute+coronary+syndromes+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DM.%2BL.%26aulast%3DBhatt%26aufirst%3DD.%2BL.%26aulast%3DWiviott%26aufirst%3DS.%2BD.%26aulast%3DGoodman%26aufirst%3DS.%2BG.%26aulast%3DFitzgerald%26aufirst%3DD.%2BJ.%26aulast%3DAngiolillo%26aufirst%3DD.%2BJ.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DMontalescot%26aufirst%3DG.%26aulast%3DZeymer%26aufirst%3DU.%26aulast%3DAylward%26aufirst%3DP.%2BE.%26aulast%3DGuetta%26aufirst%3DV.%26aulast%3DDudek%26aufirst%3DD.%26aulast%3DZiecina%26aufirst%3DR.%26aulast%3DContant%26aufirst%3DC.%2BF.%26aulast%3DFlather%26aufirst%3DM.%2BD.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520atopaxar%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520acute%2520coronary%2520syndromes%253A%2520the%2520lessons%2520from%2520antagonizing%2520the%2520cellular%2520effects%2520of%2520thrombin-acute%2520coronary%2520syndromes%2520trial%26jtitle%3DCirculation%26date%3D2011%26volume%3D123%26spage%3D1843%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Wiviott, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flather, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donoghue, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cura, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aylward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guetta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contant, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolillo, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, D. L.</span><span> </span><span class="NLM_article-title">Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of thrombin-coronary artery disease trial</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1161%2FCIRCULATIONAHA.110.001404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21502571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVynsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2011&pages=1854-1863&author=S.+D.+Wiviottauthor=M.+D.+Flatherauthor=M.+L.+O%E2%80%99Donoghueauthor=S.+Gotoauthor=D.+J.+Fitzgeraldauthor=F.+Curaauthor=P.+Aylwardauthor=V.+Guettaauthor=D.+Dudekauthor=C.+F.+Contantauthor=D.+J.+Angiolilloauthor=D.+L.+Bhatt&title=Randomized+trial+of+atopaxar+in+the+treatment+of+patients+with+coronary+artery+disease%3A+the+lessons+from+antagonizing+the+cellular+effect+of+thrombin-coronary+artery+disease+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease: The Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease Trial</span></div><div class="casAuthors">Wiviott, Stephen D.; Flather, Marcus D.; O'Donoghue, Michelle L.; Goto, Shinya; Fitzgerald, Desmond J.; Cura, Fernando; Aylward, Philip; Guetta, Victor; Dudek, Dariusz; Contant, Charles F.; Angiolillo, Dominick J.; Bhatt, Deepak L.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1854-1863</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Thrombin is a key mediator of platelet activation.  Atopaxar is a reversible protease-activated receptor-1 antagonist that interferes with thrombin-mediated platelet effects.  The phase II Lessons From Antagonizing the Cellular Effect of Thrombin-Coronary Artery Disease (LANCELOT-CAD) trial examd. the safety and tolerability of prolonged therapy with atopaxar in subjects with CAD.  Subjects with a qualifying history were randomized in a double-blind fashion to 3 dosing regimens of atopaxar (50, 100, or 200 mg daily) or matching placebo for 24 wk and followed up for an addnl. 4 wk.  The key safety end points were bleeding according to the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) and Thrombolysis in Myocardial Infarction (TIMI) classifications.  Secondary objectives included platelet aggregation and major adverse cardiac events.  720 Subjects were randomized.  Overall bleeding rates tended to be higher with atopaxar compared with placebo by CURE criteria (placebo, 0.6%; atopaxar, 3.9%; relative risk, 6.82, P=0.03; 50 mg, 3.9%; 100 mg, 1.7%; 200 mg, 5.9%; P for trend=0.01) and TIMI criteria (placebo, 6.8%; atopaxar, 10.3%; relative risk, 1.52, P=0.17; 50 mg, 9.9%; 100 mg, 8.1%; 200 mg, 12.9%; P for trend=0.07).  There was no difference in major bleeding.  Major adverse cardiac events were numerically lower in the atopaxar subjects.  All atopaxar regimens achieved high levels of platelet inhibition.  A transient elevation in liver transaminases and dose-dependent QTc prolongation without apparent complications were obsd. in higher-dose atopaxar treatment groups.  In this dose-ranging study of patients with CAD, treatment with atopaxar resulted in platelet inhibition, more minor bleeding, and numerically but not statistically fewer ischemic events.  Larger-scale trials are needed to det. whether these patterns translate into clin. meaningful effects.  Clin. TRIAL REGISTRATION-: URL: http://www.ClinicalTrials.gov.  Unique identifier: NCT00312052.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9dgWqGgNN8LVg90H21EOLACvtfcHk0lhlFJnOubmrwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVynsbw%253D&md5=4e7fec4a660ef09121e0f6090cfcf86c</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.110.001404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.110.001404%26sid%3Dliteratum%253Aachs%26aulast%3DWiviott%26aufirst%3DS.%2BD.%26aulast%3DFlather%26aufirst%3DM.%2BD.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DM.%2BL.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DD.%2BJ.%26aulast%3DCura%26aufirst%3DF.%26aulast%3DAylward%26aufirst%3DP.%26aulast%3DGuetta%26aufirst%3DV.%26aulast%3DDudek%26aufirst%3DD.%26aulast%3DContant%26aufirst%3DC.%2BF.%26aulast%3DAngiolillo%26aufirst%3DD.%2BJ.%26aulast%3DBhatt%26aufirst%3DD.%2BL.%26atitle%3DRandomized%2520trial%2520of%2520atopaxar%2520in%2520the%2520treatment%2520of%2520patients%2520with%2520coronary%2520artery%2520disease%253A%2520the%2520lessons%2520from%2520antagonizing%2520the%2520cellular%2520effect%2520of%2520thrombin-coronary%2520artery%2520disease%2520trial%26jtitle%3DCirculation%26date%3D2011%26volume%3D123%26spage%3D1854%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5884</span><span class="NLM_x">–</span> <span class="NLM_lpage">5887</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5884-5887&author=S.+Chackalamannilauthor=Y.+Xiaauthor=W.+J.+Greenleeauthor=M.+Clasbyauthor=D.+Dollerauthor=H.+Tsaiauthor=T.+Asberomauthor=M.+Czarnieckiauthor=H.+S.+Ahnauthor=G.+Boykowauthor=C.+Fosterauthor=J.+Agans-Fantuzziauthor=M.+Bryantauthor=J.+Lauauthor=M.+Chintala&title=Discovery+of+potent+orally+active+thrombin+receptor+%28protease+activated+receptor+1%29+antagonists+as+novel+antithrombotic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents</span></div><div class="casAuthors">Chackalamannil, Samuel; Xia, Yan; Greenlee, William J.; Clasby, Martin; Doller, Dario; Tsai, Hsingan; Asberom, Theodros; Czarniecki, Michael; Ahn, Ho-Sam; Boykow, George; Foster, Carolyn; Agans-Fantuzzi, Jacqueline; Bryant, Matthew; Lau, Janice; Chintala, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5884-5887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structurally novel thrombin receptor (protease activated receptor 1, PAR-1) antagonists based on the natural product himbacine are described.  The prototypical PAR-1 antagonist 55 showed a Ki of 2.7 nM in the binding assay, making it the most potent PAR-1 antagonist reported.  55 Was highly active in several functional assays, showed excellent oral bioavailability in rat and monkey models, and showed complete inhibition of agonist-induced ex vivo platelet aggregation in cynomolgus monkeys after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBkDEp-8JKu7Vg90H21EOLACvtfcHk0lhp2ciOcoyTPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wiurs%253D&md5=5fd450717cefc13b24daef89cd52054c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm0502236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502236%26sid%3Dliteratum%253Aachs%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DClasby%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520potent%2520orally%2520active%2520thrombin%2520receptor%2520%2528protease%2520activated%2520receptor%25201%2529%2520antagonists%2520as%2520novel%2520antithrombotic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5884%26epage%3D5887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span> </span><span class="NLM_article-title">Himbacine derived thrombin receptor (PAR-1) antagonists: structure–activity relationship of the lactone ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4969</span><span class="NLM_x">–</span> <span class="NLM_lpage">4972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4969-4972&author=Y.+Xiaauthor=S.+Chackalamannilauthor=T.+M.+Chanauthor=M.+Czarnieckiauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=H.+Tsaiauthor=Y.+Wangauthor=H.+S.+Ahnauthor=G.+C.+Boykowauthor=A.+T.+McPhail&title=Himbacine+derived+thrombin+receptor+%28PAR-1%29+antagonists%3A+structure%E2%80%93activity+relationship+of+the+lactone+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%2BC.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26atitle%3DHimbacine%2520derived%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%253A%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520the%2520lactone%2520ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4969%26epage%3D4972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4509</span><span class="NLM_x">–</span> <span class="NLM_lpage">4513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4509-4513&author=Y.+Xiaauthor=S.+Chackalamannilauthor=M.+Clasbyauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=H.+Tsaiauthor=J.+Agans-Fantuzziauthor=H.+S.+Ahnauthor=G.+C.+Boykowauthor=Y.+Hsiehauthor=C.+A.+Lunnauthor=M.+Chintala&title=Himbacine+derived+thrombin+receptor+%28PAR-1%29+antagonists%3A+SAR+of+the+pyridine+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DClasby%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%2BC.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DLunn%26aufirst%3DC.%2BA.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DHimbacine%2520derived%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%253A%2520SAR%2520of%2520the%2520pyridine%2520ring%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4509%26epage%3D4513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Clasby, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, J.</span><span> </span><span class="NLM_article-title">Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1544</span><span class="NLM_x">–</span> <span class="NLM_lpage">1548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1544-1548&author=M.+C.+Clasbyauthor=S.+Chackalamannilauthor=M.+Czarnieckiauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=Y.+Linauthor=H.+Tsaiauthor=Y.+Xiaauthor=H.+S.+Ahnauthor=J.+Agans-Fantuzziauthor=G.+Boykowauthor=M.+Chintalaauthor=C.+Fosterauthor=M.+Bryantauthor=J.+Lau&title=Discovery+and+synthesis+of+a+novel+series+of+quinoline-based+thrombin+receptor+%28PAR-1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClasby%26aufirst%3DM.%2BC.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DChintala%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DLau%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520a%2520novel%2520series%2520of%2520quinoline-based%2520thrombin%2520receptor%2520%2528PAR-1%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1544%26epage%3D1548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Clasby, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPhail, A. T.</span><span> </span><span class="NLM_article-title">Himbacine derived thrombin receptor antagonists: discovery of a new tricyclic core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3647</span><span class="NLM_x">–</span> <span class="NLM_lpage">3651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3647-3651&author=M.+C.+Clasbyauthor=S.+Chackalamannilauthor=M.+Czarnieckiauthor=D.+Dollerauthor=K.+Eagenauthor=W.+J.+Greenleeauthor=Y.+Linauthor=J.+R.+Tagatauthor=H.+Tsaiauthor=Y.+Xiaauthor=H.+S.+Ahnauthor=J.+Agans-Fantuzziauthor=G.+Boykowauthor=M.+Chintalaauthor=Y.+Hsiehauthor=A.+T.+McPhail&title=Himbacine+derived+thrombin+receptor+antagonists%3A+discovery+of+a+new+tricyclic+core"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClasby%26aufirst%3DM.%2BC.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DDoller%26aufirst%3DD.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DChintala%26aufirst%3DM.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DMcPhail%26aufirst%3DA.%2BT.%26atitle%3DHimbacine%2520derived%2520thrombin%2520receptor%2520antagonists%253A%2520discovery%2520of%2520a%2520new%2520tricyclic%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3647%26epage%3D3651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Chelliah, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eagen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clasby, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palamanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5147</span><span class="NLM_x">–</span> <span class="NLM_lpage">5160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070704k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5147-5160&author=M.+V.+Chelliahauthor=S.+Chackalamannilauthor=Y.+Xiaauthor=K.+Eagenauthor=M.+C.+Clasbyauthor=X.+Gaoauthor=W.+J.+Greenleeauthor=H.+S.+Ahnauthor=J.+Agans-Fantuzziauthor=G.+Boykowauthor=Y.+Hsiehauthor=M.+Bryantauthor=J.+Palamandaauthor=T.+M.+Chanauthor=D.+Heskauthor=M.+Chintala&title=Heterotricyclic+himbacine+analogs+as+potent%2C+orally+active+thrombin+receptor+%28protease+activated+receptor-1%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1021%2Fjm070704k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070704k%26sid%3Dliteratum%253Aachs%26aulast%3DChelliah%26aufirst%3DM.%2BV.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DEagen%26aufirst%3DK.%26aulast%3DClasby%26aufirst%3DM.%2BC.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBryant%26aufirst%3DM.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DT.%2BM.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DHeterotricyclic%2520himbacine%2520analogs%2520as%2520potent%252C%2520orally%2520active%2520thrombin%2520receptor%2520%2528protease%2520activated%2520receptor-1%2529%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5147%26epage%3D5160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palamanda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agans-Fantuzzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3061</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800180e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ghu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3061-3064&author=S.+Chackalamannilauthor=Y.+Wangauthor=W.+J.+Greenleeauthor=Z.+Huauthor=Y.+Xiaauthor=H.+S.+Ahnauthor=G.+Boykowauthor=Y.+Hsiehauthor=J.+Palamandaauthor=J.+Agans-Fantuzziauthor=S.+Kurowskiauthor=M.+Grazianoauthor=M.+Chintala&title=Discovery+of+a+novel%2C+orally+active+himbacine-based+thrombin+receptor+antagonist+%28SCH+530348%29+with+potent+antiplatelet+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity</span></div><div class="casAuthors">Chackalamannil, Samuel; Wang, Yuguang; Greenlee, William J.; Hu, Zhiyong; Xia, Yan; Ahn, Ho-Sam; Boykow, George; Hsieh, Yunsheng; Palamanda, Jairam; Agans-Fantuzzi, Jacqueline; Kurowski, Stan; Graziano, Michael; Chintala, Madhu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3061-3064</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of an exceptionally potent series of thrombin receptor (PAR-1) antagonists based on the natural product himbacine is described.  Optimization of this series has led to the discovery of 4 (SCH 530348), a potent, oral antiplatelet agent that is currently undergoing Phase-III clin. trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKpr_OJqfuEbVg90H21EOLACvtfcHk0lhCakhhsrH6gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ghu70%253D&md5=228c224e173cdb77b448943bdbec6838</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fjm800180e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800180e%26sid%3Dliteratum%253Aachs%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DPalamanda%26aufirst%3DJ.%26aulast%3DAgans-Fantuzzi%26aufirst%3DJ.%26aulast%3DKurowski%26aufirst%3DS.%26aulast%3DGraziano%26aufirst%3DM.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%252C%2520orally%2520active%2520himbacine-based%2520thrombin%2520receptor%2520antagonist%2520%2528SCH%2520530348%2529%2520with%2520potent%2520antiplatelet%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3061%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Becker, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moliterno, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieper, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziada, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahaffey, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Werf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veltri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, R. A.</span><span> </span><span class="NLM_article-title">Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">919</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=919-928&author=R.+C.+Beckerauthor=D.+J.+Moliternoauthor=L.+K.+Jenningsauthor=K.+S.+Pieperauthor=J.+Peiauthor=A.+Niedermanauthor=K.+M.+Ziadaauthor=G.+Bermanauthor=J.+Stronyauthor=D.+Josephauthor=K.+W.+Mahaffeyauthor=F.+Van+de+Werfauthor=E.+Veltriauthor=R.+A.+Harrington&title=Safety+and+tolerability+of+SCH+530348+in+patients+undergoing+non-urgent+percutaneous+coronary+intervention%3A+a+randomised%2C+double-blind%2C+placebo-controlled+phase+II+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DR.%2BC.%26aulast%3DMoliterno%26aufirst%3DD.%2BJ.%26aulast%3DJennings%26aufirst%3DL.%2BK.%26aulast%3DPieper%26aufirst%3DK.%2BS.%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DNiederman%26aufirst%3DA.%26aulast%3DZiada%26aufirst%3DK.%2BM.%26aulast%3DBerman%26aufirst%3DG.%26aulast%3DStrony%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DMahaffey%26aufirst%3DK.%2BW.%26aulast%3DVan%2Bde%2BWerf%26aufirst%3DF.%26aulast%3DVeltri%26aufirst%3DE.%26aulast%3DHarrington%26aufirst%3DR.%2BA.%26atitle%3DSafety%2520and%2520tolerability%2520of%2520SCH%2520530348%2520in%2520patients%2520undergoing%2520non-urgent%2520percutaneous%2520coronary%2520intervention%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520phase%2520II%2520study%26jtitle%3DLancet%26date%3D2009%26volume%3D14%26spage%3D919%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">The TRA·CER Executive and Steering Committees.</span><span> </span><span class="NLM_article-title"> The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA·CER) trial: study design and rationale</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=327-334&author=The+TRA%C2%B7CER+Executive+and+Steering+Committees.&title=+The+Thrombin+Receptor+Antagonist+for+Clinical+Event+Reduction+in+Acute+Coronary+Syndrome+%28TRA%C2%B7CER%29+trial%3A+study+design+and+rationale"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D%2520The%2520Thrombin%2520Receptor%2520Antagonist%2520for%2520Clinical%2520Event%2520Reduction%2520in%2520Acute%2520Coronary%2520Syndrome%2520%2528TRA%25C2%25B7CER%2529%2520trial%253A%2520study%2520design%2520and%2520rationale%26jtitle%3DAm.%2520Heart%2520J.%26date%3D2009%26volume%3D158%26spage%3D327%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Morrow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scirica, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, K. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veltri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaca, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCabe, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunwald, E.</span><span> </span><span class="NLM_article-title">Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the thrombin-receptor antagonist in secondary prevention of atherothrombotic ischemic events (TRA 2°P)-TIMI 50 trial</span> <span class="citation_source-journal">Am. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=335-341&author=D.+Morrowauthor=B.+Sciricaauthor=K.+A.+A.+Foxauthor=G.+Bermanauthor=J.+Stronyauthor=E.+Veltriauthor=M.+P.+Bonacaauthor=P.+Fishauthor=C.+H.+McCabeauthor=E.+Braunwald&title=Evaluation+of+a+novel+antiplatelet+agent+for+secondary+prevention+in+patients+with+a+history+of+atherosclerotic+disease%3A+design+and+rationale+for+the+thrombin-receptor+antagonist+in+secondary+prevention+of+atherothrombotic+ischemic+events+%28TRA+2%C2%B0P%29-TIMI+50+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorrow%26aufirst%3DD.%26aulast%3DScirica%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DK.%2BA.%2BA.%26aulast%3DBerman%26aufirst%3DG.%26aulast%3DStrony%26aufirst%3DJ.%26aulast%3DVeltri%26aufirst%3DE.%26aulast%3DBonaca%26aufirst%3DM.%2BP.%26aulast%3DFish%26aufirst%3DP.%26aulast%3DMcCabe%26aufirst%3DC.%2BH.%26aulast%3DBraunwald%26aufirst%3DE.%26atitle%3DEvaluation%2520of%2520a%2520novel%2520antiplatelet%2520agent%2520for%2520secondary%2520prevention%2520in%2520patients%2520with%2520a%2520history%2520of%2520atherosclerotic%2520disease%253A%2520design%2520and%2520rationale%2520for%2520the%2520thrombin-receptor%2520antagonist%2520in%2520secondary%2520prevention%2520of%2520atherothrombotic%2520ischemic%2520events%2520%2528TRA%25202%25C2%25B0P%2529-TIMI%252050%2520trial%26jtitle%3DAm.%2520Heart%2520J.%26date%3D2009%26volume%3D158%26spage%3D335%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykow, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurowski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintala, M.</span><span> </span><span class="NLM_article-title">Discovery of a vorapaxar analog with increased aqueous solubility</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6676</span><span class="NLM_x">–</span> <span class="NLM_lpage">6679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6676-6679&author=Y.+Xiaauthor=S.+Chackalamannilauthor=W.+J.+Greenleeauthor=Y.+Wangauthor=Z.+Huauthor=Y.+Rootauthor=J.+Wongauthor=J.+Kongauthor=H.+S.+Ahnauthor=G.+Boykowauthor=Y.+Hsiehauthor=S.+Kurowskiauthor=M.+Chintala&title=Discovery+of+a+vorapaxar+analog+with+increased+aqueous+solubility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DRoot%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DBoykow%26aufirst%3DG.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DKurowski%26aufirst%3DS.%26aulast%3DChintala%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520vorapaxar%2520analog%2520with%2520increased%2520aqueous%2520solubility%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6676%26epage%3D6679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraval, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirabel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loubat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pignier, C. B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal-Wollbold, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cussac, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span> </span><span class="NLM_article-title">Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5826</span><span class="NLM_x">–</span> <span class="NLM_lpage">5836</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900553j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5826-5836&author=M.+Perezauthor=M.+Lamotheauthor=C.+Maravalauthor=E.+Mirabelauthor=C.+Loubatauthor=B.+Plantyauthor=C.+Hornauthor=J.+Michauxauthor=R.+Letienneauthor=C.+B.+A.+Pignierauthor=F.+Nadal-Wollboldauthor=D.+Cussacauthor=L.+De+Vriesauthor=B.+Le+Grand&title=Discovery+of+novel+protease+activated+receptors+1+antagonists+with+potent+antithrombotic+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Protease Activated Receptors 1 Antagonists with Potent Antithrombotic Activity in Vivo</span></div><div class="casAuthors">Perez, Michel; Lamothe, Marie; Maraval, Catherine; Mirabel, Etienne; Loubat, Chantal; Planty, Bruno; Horn, Clemens; Michaux, Julien; Marrot, Sebastien; Letienne, Robert; Pignier, Christophe; Bocquet, Arnaud; Nadal-Wollbold, Florence; Cussac, Didier; de Vries, Luc; Le Grand, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5826-5836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protease activated receptors (PARs) or thrombin receptors constitute a class of G-protein-coupled receptors (GPCRs) implicated in the activation of many physiol. mechanisms.  Thus, thrombin activates many cell types such as vascular smooth muscle cells, leukocytes, endothelial cells, and platelets via activation of these receptors.  In humans, thrombin-induced platelet aggregation is mediated by one subtype of these receptors, termed PAR1.  This article describes the discovery of new antagonists of these receptors and more specifically two compds.: 2-[5-oxo-5-(4-pyridin-2-ylpiperazin-1-yl)penta-1,3-dienyl]benzonitrile 36 (F 16618) and 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone 39 (F 16357), obtained after optimization.  Both compds. are able to inhibit SFLLR-induced human platelet aggregation and display antithrombotic activity in an arteriovenous shunt model in the rat after iv or oral administration.  Furthermore, these compds. are devoid of bleeding side effects often obsd. with other types of antiplatelet drugs, which constitutes a promising advantage for this new class of antithrombotic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP7LSnzu0p9bVg90H21EOLACvtfcHk0lgt73A9uiNtlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vK&md5=c288af1cc48500c62138f6cb7b833e76</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm900553j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900553j%26sid%3Dliteratum%253Aachs%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DLamothe%26aufirst%3DM.%26aulast%3DMaraval%26aufirst%3DC.%26aulast%3DMirabel%26aufirst%3DE.%26aulast%3DLoubat%26aufirst%3DC.%26aulast%3DPlanty%26aufirst%3DB.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DMichaux%26aufirst%3DJ.%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DPignier%26aufirst%3DC.%2BB.%2BA.%26aulast%3DNadal-Wollbold%26aufirst%3DF.%26aulast%3DCussac%26aufirst%3DD.%26aulast%3DDe%2BVries%26aufirst%3DL.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520novel%2520protease%2520activated%2520receptors%25201%2520antagonists%2520with%2520potent%2520antithrombotic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5826%26epage%3D5836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leparq-Panissie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calmettes, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadal-Wollbold, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span> </span><span class="NLM_article-title">Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1616-1621&author=R.+Letienneauthor=A.+Leparq-Panissieauthor=Y.+Calmettesauthor=F.+Nadal-Wollboldauthor=M.+Perezauthor=B.+Le+Grand&title=Antithrombotic+activity+of+F+16618%2C+a+new+PAR1+antagonist+evaluated+in+extracorporeal+arterio-venous+shunt+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DLeparq-Panissie%26aufirst%3DA.%26aulast%3DCalmettes%26aufirst%3DY.%26aulast%3DNadal-Wollbold%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26atitle%3DAntithrombotic%2520activity%2520of%2520F%252016618%252C%2520a%2520new%2520PAR1%2520antagonist%2520evaluated%2520in%2520extracorporeal%2520arterio-venous%2520shunt%2520in%2520the%2520rat%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1616%26epage%3D1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Chieng-Yane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocquet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letienne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourbon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sablayrolles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatem, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lompre, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Dufilho, M.</span><span> </span><span class="NLM_article-title">Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.110.175182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21139058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=643-651&author=P.+Chieng-Yaneauthor=A.+Bocquetauthor=R.+Letienneauthor=T.+Bourbonauthor=S.+Sablayrollesauthor=M.+Perezauthor=S.+N.+Hatemauthor=A.+M.+Lompreauthor=B.+Le+Grandauthor=M.+David-Dufilho&title=Protease-activated+receptor-1+antagonist+F+16618+reduces+arterial+restenosis+by+down-regulation+of+tumor+necrosis+factor+%CE%B1+and+matrix+metalloproteinase+7+expression%2C+migration%2C+and+proliferation+of+vascular+smooth+muscle+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells</span></div><div class="casAuthors">Chieng-Yane, Pauline; Bocquet, Arnaud; Letienne, Robert; Bourbon, Thierry; Sablayrolles, Sylvie; Perez, Michel; Hatem, Stephane Nicolas; Lompre, Anne-Marie; Le Grand, Bruno; David-Dufilho, Monique</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">643-651</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Wound healing after angioplasty or stenting is assocd. with increased prodn. of thrombin and the activation of protease-activated receptor 1 (PAR1).  The aim of the present study was to examine the effects of a new selective PAR1 antagonist, 2-[5-oxo-5-(4-pyridin-2-ylpiperazin-1-yl)-penta-1,3-dienyl]-benzonitrile (F 16618), in restenosis and vascular smooth muscle cell (SMC) proliferation and migration using both in vivo and in vitro approaches.  Daily oral administration of F 16618 inhibited the restenosis induced by balloon angioplasty on rat carotid artery in a dose-dependent manner.  Furthermore, single i.v. administration of F 16618 during the angioplasty procedure was sufficient to protect the carotid artery against restenosis.  In vitro, F 16618 inhibited the growth of human aortic SMCs in a concn.-dependent manner with maximal effects at 10 μM.  At that concn., F 16618 also prevented thrombin-mediated SMC migration.  In vivo, oral and i.v. F 16618 treatments reduced by 30 and 50% the expression of the inflammatory cytokine tumor necrosis factor α (TNFα) 24 h after angioplasty.  However, only acute i.v. administration prevented the induction of matrix metalloproteinase 7 expression.  In contrast, F 16618 treatments had no effect on early SMC de-differentiation and transcription of monocyte chemoattractant protein-1 and interleukin-6 and late re-endothelialization of injured arteries.  Furthermore, F 16618 compensated for the carotid endothelium loss by inhibiting PAR1-mediated contraction.  Altogether, these data demonstrate that PAR1 antagonists such as F 16618 are a highly effective treatment of restenosis after vascular injury, by inhibition of TNFα, matrix metalloproteinase 7, and SMC migration and proliferation in addn. to an antithrombotic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopXB-r0SGYHrVg90H21EOLACvtfcHk0lhso6Fh7pRK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqsbs%253D&md5=878d7114d1b114a6a4ee4ed492d8ac69</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.175182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.175182%26sid%3Dliteratum%253Aachs%26aulast%3DChieng-Yane%26aufirst%3DP.%26aulast%3DBocquet%26aufirst%3DA.%26aulast%3DLetienne%26aufirst%3DR.%26aulast%3DBourbon%26aufirst%3DT.%26aulast%3DSablayrolles%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DHatem%26aufirst%3DS.%2BN.%26aulast%3DLompre%26aufirst%3DA.%2BM.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DDavid-Dufilho%26aufirst%3DM.%26atitle%3DProtease-activated%2520receptor-1%2520antagonist%2520F%252016618%2520reduces%2520arterial%2520restenosis%2520by%2520down-regulation%2520of%2520tumor%2520necrosis%2520factor%2520%25CE%25B1%2520and%2520matrix%2520metalloproteinase%25207%2520expression%252C%2520migration%252C%2520and%2520proliferation%2520of%2520vascular%2520smooth%2520muscle%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D643%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Rilatt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirabel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span> </span><span class="NLM_article-title">Discovery and SAR of small molecule PAR1 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=903-906&author=I.+Rilattauthor=E.+Mirabelauthor=B.+Le+Grandauthor=M.+Perez&title=Discovery+and+SAR+of+small+molecule+PAR1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRilatt%26aufirst%3DI.%26aulast%3DMirabel%26aufirst%3DE.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPerez%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520small%2520molecule%2520PAR1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D903%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Planty, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraval, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Grand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, M.</span><span> </span><span class="NLM_article-title">Exploration of a new series of PAR1 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1735-1739&author=B.+Plantyauthor=C.+Pujolauthor=M.+Lamotheauthor=C.+Maravalauthor=C.+Hornauthor=B.+Le+Grandauthor=M.+Perez&title=Exploration+of+a+new+series+of+PAR1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanty%26aufirst%3DB.%26aulast%3DPujol%26aufirst%3DC.%26aulast%3DLamothe%26aufirst%3DM.%26aulast%3DMaraval%26aufirst%3DC.%26aulast%3DHorn%26aufirst%3DC.%26aulast%3DLe%2BGrand%26aufirst%3DB.%26aulast%3DPerez%26aufirst%3DM.%26atitle%3DExploration%2520of%2520a%2520new%2520series%2520of%2520PAR1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1735%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellars, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade-Gordon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baruch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span> </span><span class="NLM_article-title">A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">8363</span><span class="NLM_x">–</span> <span class="NLM_lpage">8368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=8363-8368&author=K.+K.+Hansenauthor=P.+M.+Shermanauthor=L.+Cellarsauthor=P.+Andrade-Gordonauthor=Z.+Panauthor=A.+Baruchauthor=J.+L.+Wallaceauthor=M.+D.+Hollenbergauthor=N.+Vergnolle&title=A+major+role+for+proteolytic+activity+and+proteinase-activated+receptor-2+in+the+pathogenesis+of+infectious+colitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DSherman%26aufirst%3DP.%2BM.%26aulast%3DCellars%26aufirst%3DL.%26aulast%3DAndrade-Gordon%26aufirst%3DP.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DBaruch%26aufirst%3DA.%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26aulast%3DVergnolle%26aufirst%3DN.%26atitle%3DA%2520major%2520role%2520for%2520proteolytic%2520activity%2520and%2520proteinase-activated%2520receptor-2%2520in%2520the%2520pathogenesis%2520of%2520infectious%2520colitis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D8363%26epage%3D8368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Kanke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=15655521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtlKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2005&pages=212-219&issue=2&author=T.+Kankeauthor=H.+Ishiwataauthor=M.+Kabeyaauthor=M.+Sakaauthor=T.+Doiauthor=Y.+Hattoriauthor=A.+Kawabataauthor=R.+Plevin&title=2-Furoyl-LIGRL-NH2%2C+a+potent+agonist+for+proteinase-activated+receptor-2%2C+as+a+gastric+mucosal+cytoprotective+agent+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice</span></div><div class="casAuthors">Kawabata, Atsufumi; Oono, Yuko; Yonezawa, Daiki; Hiramatsu, Kaori; Inoi, Naoki; Sekiguchi, Fumiko; Honjo, Masami; Hirofuchi, Michiko; Kanke, Toru; Ishiwata, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-219</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 Proteinase-activated receptor-2 (PAR2), expressed in capsaicin-sensitive sensory neurons, plays a protective role in gastric mucosa.  The present study evaluated gastric mucosal cytoprotective effect of 2-furoyl-LIGRL-NH2, a novel highly potent PAR2 agonist, in ddY mice and in wild-type and PAR2-knockout mice of C57BL/6 background.  2 Gastric mucosal injury was created by oral administration of HCl/ethanol soln. in the mice.  The native PAR2-activating peptide SLIGRL-NH2, administered i.p. at 0.3-1 μmol kg-1 in combination with amastatin, an aminopeptidase inhibitor, but not alone, revealed gastric mucosal protection in ddY mice, which was abolished by ablation of capsaicin-sensitive sensory neurons.  3 I.p. administration of 2-furoyl-LIGRL-NH2 at 0.1 μmol kg-1, without combined treatment with amastatin, exhibited gastric mucosal cytoprotective activity in ddY mice, the potency being much greater than SLIGRL-NH2 in combination with amastatin.  This effect was also inhibited by capsaicin pretreatment.  4 Oral administration of 2-furoyl-LIGRL-NH2 at 0.003-0.03 μmol kg-1 also protected against gastric mucosal lesion in a capsaicin-reversible manner in ddY mice.  5 I.p. 2-furoyl-LIGRL-NH2 at 0.1-0.3 μmol kg-1 caused prompt salivation in anesthetized mice, whereas its oral administration at 0.003-1 μmol kg-1 was incapable of eliciting salivation.  6 In wild-type, but not PAR2-knockout, mice of C57BL/6 background, i.p. administration of 2-furoyl-LIGRL-NH2 caused gastric mucosal protection.  7 Thus, 2-furoyl-LIGRL-NH2 is considered a potent and orally available gastric mucosal protective agent.  Our data also substantiate a role for PAR2 in gastric mucosal protection and the selective nature of 2-furoyl-LIGRL-NH2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJJ4uwdPOe_bVg90H21EOLACvtfcHk0lhqXGPLeojWwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtlKrtA%253D%253D&md5=5648b534ea47c179c4976bb31287f111</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DIshiwata%26aufirst%3DH.%26aulast%3DKabeya%26aufirst%3DM.%26aulast%3DSaka%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DKawabata%26aufirst%3DA.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3D2-Furoyl-LIGRL-NH2%252C%2520a%2520potent%2520agonist%2520for%2520proteinase-activated%2520receptor-2%252C%2520as%2520a%2520gastric%2520mucosal%2520cytoprotective%2520agent%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D144%26issue%3D2%26spage%3D212%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">McGuire, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saifeddine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triggle, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, M. D.</span><span> </span><span class="NLM_article-title">2-Furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.103.064584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=14976230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=1124-1131&author=J.+J.+McGuireauthor=M.+Saifeddineauthor=C.+R.+Triggleauthor=K.+Sunauthor=M.+D.+Hollenberg&title=2-Furoyl-LIGRLO-amide%3A+a+potent+and+selective+proteinase-activated+receptor+2+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">2-Furoyl-LIGRLO-amide: A potent and selective proteinase-activated receptor 2 agonist</span></div><div class="casAuthors">McGuire, John J.; Saifeddine, Mahmoud; Triggle, Chris R.; Sun, Kimberly; Hollenberg, Morley D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-1131</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A peptide corresponding to a proteinase-activated receptor 2 (PAR2)-activating peptide with an N-terminal furoyl group modification, 2-furoyl-LIGRLO-NH2, was assessed for PAR2-dependent and -independent biol. activities.  2-Furoyl-LIGRLO-NH2 was equally effective to and 10 to 25 times more potent than SLIGRL-NH2 for increasing intracellular calcium in cultured human and rat PAR2-expressing cells, resp.  In bioassays of tissue PAR2 activity, measured as arterial vasodilation and hyperpolarization, 2-furoyl-LIGRLO-NH2 was 10 to 300 times more potent than SLIGRL-NH2.  Unlike trans-cinnamoyl-LIGRLO-NH2, 2-furoyl-LIGRLO-NH2 did not cause a prominent non-PAR2-mediated contraction of murine femoral arteries.  In conclusion, 2-furoyl-LIGRLO-NH2 represents the most potent and selective activator of PAR2 in biol. systems described to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh-GCZZfqQLLVg90H21EOLACvtfcHk0lhqXGPLeojWwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCnt7s%253D&md5=c25d1d3335bce33b0081e2fa9f72bb93</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.064584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.064584%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuire%26aufirst%3DJ.%2BJ.%26aulast%3DSaifeddine%26aufirst%3DM.%26aulast%3DTriggle%26aufirst%3DC.%2BR.%26aulast%3DSun%26aufirst%3DK.%26aulast%3DHollenberg%26aufirst%3DM.%2BD.%26atitle%3D2-Furoyl-LIGRLO-amide%253A%2520a%2520potent%2520and%2520selective%2520proteinase-activated%2520receptor%25202%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D1124%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Barry, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotterell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Novel agonists and antagonists for human protease activated receptor 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7428</span><span class="NLM_x">–</span> <span class="NLM_lpage">7440</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100984y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7428-7440&author=G.+D.+Barryauthor=J.+Y.+Suenauthor=G.+T.+Leauthor=A.+Cotterellauthor=R.+C.+Reidauthor=D.+P.+Fairlie&title=Novel+agonists+and+antagonists+for+human+protease+activated+receptor+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm100984y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100984y%26sid%3Dliteratum%253Aachs%26aulast%3DBarry%26aufirst%3DG.%2BD.%26aulast%3DSuen%26aufirst%3DJ.%2BY.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DCotterell%26aufirst%3DA.%26aulast%3DReid%26aufirst%3DR.%2BC.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DNovel%2520agonists%2520and%2520antagonists%2520for%2520human%2520protease%2520activated%2520receptor%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7428%26epage%3D7440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Boitano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagner, J.</span><span> </span><span class="NLM_article-title">Potent agonists of the protease activated receptor 2 (PAR2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1313</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013049" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1308-1313&author=S.+Boitanoauthor=A.+N.+Flynnauthor=S.+M.+Schulzauthor=J.+Hoffmanauthor=T.+J.+Priceauthor=J.+Vagner&title=Potent+agonists+of+the+protease+activated+receptor+2+%28PAR2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1021%2Fjm1013049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013049%26sid%3Dliteratum%253Aachs%26aulast%3DBoitano%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DA.%2BN.%26aulast%3DSchulz%26aufirst%3DS.%2BM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DVagner%26aufirst%3DJ.%26atitle%3DPotent%2520agonists%2520of%2520the%2520protease%2520activated%2520receptor%25202%2520%2528PAR2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1308%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Flynn, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillu, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asiedu, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boitano, S.</span><span> </span><span class="NLM_article-title">The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH<sub>2</sub> and 6-aminonicotinyl-LIGRL-NH<sub>2</sub> stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">19076</span><span class="NLM_x">–</span> <span class="NLM_lpage">190788</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=19076-190788&issue=21&author=A.+N.+Flynnauthor=D.+V.+Tilluauthor=M.+N.+Asieduauthor=J.+Hoffmanauthor=J.+Vagnerauthor=T.+J.+Priceauthor=S.+Boitano&title=The+protease-activated+receptor-2-specific+agonists+2-aminothiazol-4-yl-LIGRL-NH2+and+6-aminonicotinyl-LIGRL-NH2+stimulate+multiple+signaling+pathways+to+induce+physiological+responses+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlynn%26aufirst%3DA.%2BN.%26aulast%3DTillu%26aufirst%3DD.%2BV.%26aulast%3DAsiedu%26aufirst%3DM.%2BN.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DVagner%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DT.%2BJ.%26aulast%3DBoitano%26aufirst%3DS.%26atitle%3DThe%2520protease-activated%2520receptor-2-specific%2520agonists%25202-aminothiazol-4-yl-LIGRL-NH2%2520and%25206-aminonicotinyl-LIGRL-NH2%2520stimulate%2520multiple%2520signaling%2520pathways%2520to%2520induce%2520physiological%2520responses%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D21%26spage%3D19076%26epage%3D190788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Kanke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">371</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1476-5381.2009.00342.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19719785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKlsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=361-371&author=T.+Kankeauthor=M.+Kabeyaauthor=S.+Kuboauthor=S.+Kondoauthor=K.+Yasuokaauthor=J.+Tagashiraauthor=H.+Ishiwataauthor=M.+Sakaauthor=T.+Furuyamaauthor=T.+Nishiyamaauthor=T.+Doiauthor=Y.+Hattoriauthor=A.+Kawabataauthor=M.+R.+Cunninghamauthor=R.+Plevin&title=Novel+antagonists+for+proteinase-activated+receptor+2%3A+inhibition+of+cellular+and+vascular+responses+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo</span></div><div class="casAuthors">Kanke, T.; Kabeya, M.; Kubo, S.; Kondo, S.; Yasuoka, K.; Tagashira, J.; Ishiwata, H.; Saka, M.; Furuyama, T.; Nishiyama, T.; Doi, T.; Hattori, Y.; Kawabata, A.; Cunningham, M. R.; Plevin, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">361-371</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Proteinase-activated receptor 2 (PAR2) is a G-protein coupled receptor assocd. with many pathophysiol. functions.  To date, the development of PAR2 antagonists has been limited.  Here, we identify a no. of novel peptide-mimetic PAR2 antagonists and demonstrate inhibitory effects on PAR2-mediated intracellular signalling pathways and vascular responses.  The peptide-mimetic compd. library based on the structures of PAR2 agonist peptides were screened for inhibition of PAR2-induced calcium mobilisation in human keratinocytes.  Representative compds. were further evaluated by radioligand binding and inhibition of NFκB transcriptional activity and IL-8 prodn.  The vascular effects of the antagonists were assessed using in vitro and in vivo models.  Key results: Two compds., K-12940 and K-14585, significantly reduced SLIGKV-induced Ca2+ mobilisation in primary human keratinocytes.  Both K-12940 and K-14585 exhibited competitive inhibition for the binding of a high-affinity radiolabeled PAR2-ligand, [3H]-2-furoyl-LIGRL-NH2, to human PAR2 with Ki values of 1.94 and 0.627 μM resp.  NFκB reporter activity and IL-8 prodn. were also significantly reduced.  Furthermore, relaxation of rat-isolated aorta induced by SLIGRL-NH2 was inhibited competitively by K-14585.  K-14585 also significantly lowered plasma extravasation in the dorsal skin of guinea pigs and reduced salivation in mice.  K-12940 and K-14585 antagonized PAR2 competitively, resulting in inhibition of PAR2-mediated signalling and physiol. responses both in vitro and in vivo.  These peptide-mimetic PAR2 antagonists could be useful in evaluating PAR2-mediated biol. events and might lead to a new generation of therapeutically useful antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkxA51-GthUrVg90H21EOLACvtfcHk0ljaO3sYejJUjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKlsr3P&md5=3ab8f0b7fb2c36e7989ed217f82f95df</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00342.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00342.x%26sid%3Dliteratum%253Aachs%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DKabeya%26aufirst%3DM.%26aulast%3DKubo%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DYasuoka%26aufirst%3DK.%26aulast%3DTagashira%26aufirst%3DJ.%26aulast%3DIshiwata%26aufirst%3DH.%26aulast%3DSaka%26aufirst%3DM.%26aulast%3DFuruyama%26aufirst%3DT.%26aulast%3DNishiyama%26aufirst%3DT.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DKawabata%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DM.%2BR.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3DNovel%2520antagonists%2520for%2520proteinase-activated%2520receptor%25202%253A%2520inhibition%2520of%2520cellular%2520and%2520vascular%2520responses%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D361%26epage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Goh, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1704</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1476-5381.2009.00415.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=19917067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Whtr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1695-1704&author=F.+G.+Gohauthor=P.+Y.+Ngauthor=M.+Nilssonauthor=T.+Kankeauthor=R.+Plevin&title=Dual+effect+of+the+novel+peptide+antagonist+K-14585+on+proteinase-activated+receptor-2-mediated+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling</span></div><div class="casAuthors">Goh, Fui Goon; Ng, Pei Yuen; Nilsson, Mary; Kanke, Toru; Plevin, Robin</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1695-1704</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and purpose: Here we have examd. the effects of the novel peptide antagonist K-14585 on proteinase-activated receptor (PAR)2-mediated intracellular signalling events.  Exptl. approach: Using NCTC2544 cells expressing PAR2, we assessed the effects of K-14585 on PAR2-mediated [3H] inositol phosphate accumulation, MAP kinase activation, p65 NFκB phosphorylation and DNA binding and IL-8 prodn.  Key results: Pretreatment with K-14585 (5 μM) inhibited [3H] inositol phosphate levels stimulated by PAR2-activating peptide Ser-Leu-Ile-Gly-Lys-Val (SLIGKV-OH) in PAR2-expressing NCTC2544 cells.  K-14585 pretreatment did not influence PAR2-mediated extracellular regulated kinase activation but inhibited p38 MAP kinase phosphorylation.  At a higher concn. (30 μM), K-14585 alone stimulated p38 MAP kinase activation.  These effects were replicated in EAhy926 cells, endogenously expressing PAR2, but not in parental or PAR4-expressing NCTC2544 cells, suggesting these effects were PAR2-dependent.  SLIGKV-mediated stimulation of p38 MAP kinase phosphorylation was substantially reduced by the Gq/11 inhibitor YM-254890, without affecting K-14585-mediated phosphorylation.  Pretreatment with K-14585 inhibited PAR2-mediated p65 NF-κB phosphorylation and NFκB-DNA binding.  K-14585 (30 μM) alone stimulated comparable NFβB reporter activity to SLIGKV-OH.  K-14585 inhibited SLIGKV-stimulated IL-8 prodn., but given alone increased IL-8.  While SLIGKV-induced IL-8 formation was reduced by both SB203580 and YM-254890, the response to K-14585 was sensitive to SB203580 but not YM-254890.  Conclusions and implications: These data reveal that K-14585 has a duality of action functioning both as an antagonist and agonist due to either partial agonist actions or possible agonist-directed signalling.  The data also suggest two modes of p38 MAP kinase activation emanating from PAR2, one Gq/11-dependent and the other Gq/11-independent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru7YeTp95Mq7Vg90H21EOLACvtfcHk0ljaO3sYejJUjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Whtr%252FM&md5=d6301cb6ad0a18fe58c7425a9c6bee8a</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00415.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00415.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoh%26aufirst%3DF.%2BG.%26aulast%3DNg%26aufirst%3DP.%2BY.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DKanke%26aufirst%3DT.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3DDual%2520effect%2520of%2520the%2520novel%2520peptide%2520antagonist%2520K-14585%2520on%2520proteinase-activated%2520receptor-2-mediated%2520signalling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1695%26epage%3D1704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Suen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halili, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotterell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1423</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1476-5381.2011.01610.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=21806599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Ohurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1413-1423&issue=5&author=J.+Y.+Suenauthor=G.+D.+Barryauthor=R.+J.+Lohmanauthor=M.+A.+Haliliauthor=A.+J.+Cotterellauthor=G.+T.+Leauthor=D.+P.+Fairlie&title=Modulating+human+proteinase+activated+receptor+2+with+a+novel+antagonist+%28GB88%29+and+agonist+%28GB110%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)</span></div><div class="casAuthors">Suen, J. Y.; Barry, G. D.; Lohman, R. J.; Halili, M. A.; Cotterell, A. J.; Le, G. T.; Fairlie, D. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1413-1423</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Many cells express proteinase activated receptor 2 (PAR2) on their plasma membrane.  PAR2 is activated by proteolytic enzymes, such as trypsin and tryptase that cleave the receptor N-terminus, inititating signalling to intracellular G proteins.  Studies on PAR2 have relied heavily upon activating effects of proteases and peptide agonists that lack stability and bioavailability in vivo.  Exptl. Approach: A novel small mol. agonist GB110 and an antagonist GB88 were characterized in vitro against trypsin, peptide agonists, PAR2 antibody, PAR1 agonists and flow cytometry, in seven cell lines using intracellular Ca2+ mobilization and examd. in vivo against PAR2- and PAR1-induced rat paw edema.  Key Results: GB110 is a potent non-peptidic agonist activating PAR2-mediated Ca2+ release in HT29 cells (EC50 ∼200 nM) and six other human cell lines, inducing PAR2 internalization.  GB88 is a unique PAR2 antagonist, inhibiting PAR2 activated Ca2+ release (IC50 ∼2 μM) induced by native (trypsin) or synthetic peptide and non-peptide agonists.  GB88 was a competitive and surmountable antagonist of agonist 2f-LIGRLO-NH2, a competitive but insurmountable antagonist of agonist GB110, and a non-competitive insurmountable antagonist of trypsin.  GB88 was orally active and anti-inflammatory in vivo, inhibiting acute rat paw edema elicited by agonist GB110 and proteolytic or peptide agonists of PAR2 but not by corresponding agonists of PAR1 or PAR4.  Conclusions and Implications: The novel PAR2 agonist and antagonist modulate intracellular Ca2+ and rat paw edema, providing novel mol. tools for examg. PAR2-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQGZvYtKqS_7Vg90H21EOLACvtfcHk0ljY5H1a7f0w5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Ohurw%253D&md5=d9c85910ce574bd19350258b8724d809</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01610.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01610.x%26sid%3Dliteratum%253Aachs%26aulast%3DSuen%26aufirst%3DJ.%2BY.%26aulast%3DBarry%26aufirst%3DG.%2BD.%26aulast%3DLohman%26aufirst%3DR.%2BJ.%26aulast%3DHalili%26aufirst%3DM.%2BA.%26aulast%3DCotterell%26aufirst%3DA.%2BJ.%26aulast%3DLe%26aufirst%3DG.%2BT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DModulating%2520human%2520proteinase%2520activated%2520receptor%25202%2520with%2520a%2520novel%2520antagonist%2520%2528GB88%2529%2520and%2520agonist%2520%2528GB110%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26issue%3D5%26spage%3D1413%26epage%3D1423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Lohman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotterell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Antagonism of protease activated receptor 2 protects against experimental colitis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.111.187062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=22028393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2012&pages=256-265&author=R.+J.+Lohmanauthor=A.+J.+Cotterellauthor=J.+Suenauthor=L.+Liuauthor=T.+A.+Doauthor=D.+A.+Veseyauthor=D.+P.+Fairlie&title=Antagonism+of+protease+activated+receptor+2+protects+against+experimental+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of protease-activated receptor 2 protects against experimental colitis</span></div><div class="casAuthors">Lohman, Rink-Jan; Cotterell, Adam J.; Suen, Jacky; Liu, Ligong; Do, Anh T.; Vesey, David A.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-265</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Many trypsin-like serine proteases such as β-tryptase are involved in the pathogenesis of colitis and inflammatory bowel diseases.  Inhibitors of individual proteases show limited efficacy in treating such conditions, but also probably disrupt digestive and defensive functions of proteases.  Here, we investigate whether masking their common target, protease-activated receptor 2 (PAR2), is an effective therapeutic strategy for treating acute and chronic exptl. colitis in rats.  A novel PAR2 antagonist (5-isoxazoyl-Cha-Ile-spiro[indene-1,4'-piperidine]; GB88) was evaluated for the blockade of intracellular calcium release in colonocytes and anti-inflammatory activity in acute (PAR2 agonist-induced) vs. chronic [2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced] models of colitis in Wistar rats.  Disease progression (disease activity index, wt. loss, and mortality) and postmortem colonic histopathol. (inflammation, bowel wall thickness, and myeloperoxidase) were measured.  PAR2 and tryptase colocalization were investigated by using immunohistochem.  GB88 was a more potent antagonist of PAR2 activation in colonocytes than another reported compd., N1-3-methylbutyryl-N4-6-aminohexanoyl-piperazine (ENMD-1068) (IC50 8 μM vs. 5 mM).  Acute colonic inflammation induced in rats by the PAR2 agonist SLIGRL-NH2 was inhibited by oral administration of GB88 (10 mg/kg) with markedly reduced edema, mucin depletion, PAR2 receptor internalization, and mastocytosis.  Chronic TNBS-induced colitis in rats was ameliorated by GB88 (10 mg/kg/day p.o.), which reduced mortality and pathol. (including colon obstruction, ulceration, wall thickness, and myeloperoxidase release) more effectively than the clin. used drug sulfasalazine (100 mg/kg/day p.o.).  These disease-modifying properties for the PAR2 antagonist in both acute and chronic exptl. colitis strongly support a pathogenic role for PAR2 and PAR2-activating proteases and therapeutic potential for PAR2 antagonism in inflammatory diseases of the colon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUq443e9Ln5rVg90H21EOLACvtfcHk0ljY5H1a7f0w5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSltLs%253D&md5=7624171941696f6796965801ca6cd3d6</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.187062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.187062%26sid%3Dliteratum%253Aachs%26aulast%3DLohman%26aufirst%3DR.%2BJ.%26aulast%3DCotterell%26aufirst%3DA.%2BJ.%26aulast%3DSuen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDo%26aufirst%3DT.%2BA.%26aulast%3DVesey%26aufirst%3DD.%2BA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DAntagonism%2520of%2520protease%2520activated%2520receptor%25202%2520protects%2520against%2520experimental%2520colitis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D340%26spage%3D256%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Seitzberg, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winther Lund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandrup Bertozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherbukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective small-molecule PAR-2 agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5490</span><span class="NLM_x">–</span> <span class="NLM_lpage">5493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800754r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5490-5493&author=J.+G.+Seitzbergauthor=A.+E.+Knappauthor=B.+Winther+Lundauthor=S.+Mandrup+Bertozziauthor=E.+A.+Currierauthor=J.+Maauthor=V.+Sherbukhinauthor=E.+S.+Bursteinauthor=R.+Olsson&title=Discovery+of+potent+and+selective+small-molecule+PAR-2+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fjm800754r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800754r%26sid%3Dliteratum%253Aachs%26aulast%3DSeitzberg%26aufirst%3DJ.%2BG.%26aulast%3DKnapp%26aufirst%3DA.%2BE.%26aulast%3DWinther%2BLund%26aufirst%3DB.%26aulast%3DMandrup%2BBertozzi%26aufirst%3DS.%26aulast%3DCurrier%26aufirst%3DE.%2BA.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DSherbukhin%26aufirst%3DV.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DOlsson%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520small-molecule%2520PAR-2%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5490%26epage%3D5493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Gardell, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seitzberg, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffer, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabatabaei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lameh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelzer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burstein, E. S.</span><span> </span><span class="NLM_article-title">Identification and characterization of novel small-molecule protease-activated receptor 2 agonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.108.142570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18768780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2008&pages=799-808&author=L.+R.+Gardellauthor=J.+N.+Maauthor=J.+G.+Seitzbergauthor=A.+E.+Knappauthor=H.+H.+Schifferauthor=A.+Tabatabaeiauthor=C.+Davisauthor=K.+K.+Wongauthor=B.+W.+Lundauthor=N.+R.+Nashauthor=Y.+Gaoauthor=J.+Lamehauthor=K.+Schmelzerauthor=R.+Olssonauthor=E.+S.+Burstein&title=Identification+and+characterization+of+novel+small-molecule+protease-activated+receptor+2+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of novel small-molecule protease-activated receptor 2 agonists</span></div><div class="casAuthors">Gardell, Luis R.; Ma, Jian-Nong; Seitzberg, Jimmi Gerner; Knapp, Anne E.; Schiffer, Hans H.; Tabatabaei, Ali; Davis, Christopher N.; Owens, Michelle; Clemons, Bryan; Wong, Kenneth K.; Lund, Birgitte; Nash, Norman R.; Gao, Yan; Lameh, Jelveh; Schmelzer, Kara; Olsson, Roger; Burstein, Ethan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">799-808</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We report the first small-mol. protease-activated receptor (PAR) 2 agonists, AC-55541 [N-[[1-(3-bromo-phenyl)-eth-(E)-ylidene-hydrazinocarbonyl]-(4-oxo-3,4-dihydro-phthalazin-1-yl)-methyl]-benzamide] and AC-264613 [2-oxo-4-phenyl-pyrrolidine-3-carboxylic acid [1-(3-bromo-phenyl)-(E/Z)-ethylidene]-hydrazide], each representing a distinct chem. series.  AC-55541 and AC-264613 each activated PAR2 signaling in cellular proliferation assays, phosphatidylinositol hydrolysis assays, and Ca2+ mobilization assays, with potencies ranging from 200 to 1000 nM for AC-55541 and 30 to 100 nM for AC-264613.  In comparison, the PAR2-activating peptide 2-furoyl-LIGRLO-NH2 had similar potency, whereas SLIGRL-NH2 was 30 to 300 times less potent.  Neither AC-55541 nor AC-264613 had activity at any of the other PAR receptor subtypes, nor did they have any significant affinity for over 30 other mol. targets involved in nociception.  Visualization of EYFP-tagged PAR2 receptors showed that each compd. stimulated internalization of PAR2 receptors.  AC-55541 and AC-264613 were well absorbed when administered i.p. to rats, each reaching micromolar peak plasma concns.  AC-55541 and AC-264613 were each stable to metab. by liver microsomes and maintained sustained exposure in rats, with elimination half-lives of 6.1 and 2.5 h, resp.  Intra-paw administration of AC-55541 or AC-264613 elicited robust and persistent thermal hyperalgesia and edema.  Co-administration of either a tachykinin 1 (neurokinin 1) receptor antagonist or a transient receptor potential vanilloid (TRPV) 1 antagonist completely blocked these effects.  Systemic administration of either AC-55541 or AC-264613 produced a similar degree of hyperalgesia as was obsd. when the compds. were administered locally.  These compds. represent novel small-mol. PAR2 agonists that will be useful in probing the physiol. functions of PAR2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocBrndF1NxnLVg90H21EOLACvtfcHk0lgrjQKdAzEzYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCjtLvE&md5=4d4117820181e1664c97dec51e43660f</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.142570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.142570%26sid%3Dliteratum%253Aachs%26aulast%3DGardell%26aufirst%3DL.%2BR.%26aulast%3DMa%26aufirst%3DJ.%2BN.%26aulast%3DSeitzberg%26aufirst%3DJ.%2BG.%26aulast%3DKnapp%26aufirst%3DA.%2BE.%26aulast%3DSchiffer%26aufirst%3DH.%2BH.%26aulast%3DTabatabaei%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DLund%26aufirst%3DB.%2BW.%26aulast%3DNash%26aufirst%3DN.%2BR.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DLameh%26aufirst%3DJ.%26aulast%3DSchmelzer%26aufirst%3DK.%26aulast%3DOlsson%26aufirst%3DR.%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520novel%2520small-molecule%2520protease-activated%2520receptor%25202%2520agonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D327%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Wu, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, C. M.</span><span> </span><span class="NLM_article-title">YD-3, a novel inhibitor of protease-induced platelet activation</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">1289</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1038%2Fsj.bjp.0703437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=10903968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFOnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1289-1296&author=C.+C.+Wuauthor=S.+W.+Huangauthor=T.+L.+Hwangauthor=S.+C.+Kuoauthor=F.+Y.+Leeauthor=C.+M.+Teng&title=YD-3%2C+a+novel+inhibitor+of+protease-induced+platelet+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">YD-3, a novel inhibitor of protease-induced platelet activation</span></div><div class="casAuthors">Wu, Chin-Chung; Huang, Shiow-Wen; Hwang, Tsong-Long; Kuo, Sheng-Chu; Lee, Fang-Yu; Teng, Che-Ming</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1289-1296</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 In the present study, the antiplatelet effects and mechanisms of a new synthetic compd. YD-3 [1-benzyl-3(ethoxycarbonylphenyl)-indazole] were examd.  2 YD-3 inhibited the aggregation of washed rabbit platelets caused by thrombin (IC50 = 28.3 μM), but had no or little inhibitory effect on that induced by arachidonic acid, collagen, platelet-activating factor (PAF) or U46619.  YD-3 also suppressed generation of inositol phosphates caused by thrombin.  On the other hand, thrombin-induced fibrin formation was not affected by YD-3, indicating YD-3 does not inhibit the proteolytic activity of thrombin.  3 In washed human platelets, however, YD-3 had only mild inhibitory effect on the low concn. (0.05 u ml-1) of thrombin-induced human platelet aggregation, and did not affect that induced by higher concns. (≥ 0.1 u ml-1) of thrombin or SFLLRN, the protease-activated receptor 1 (PAR1) agonist peptide.  By contrast, YD-3 inhibited both human and rabbit platelet aggregation elicited by trypsin with IC50 values of 38.1 μM and 5.7 μM, resp.  4 YD-3, at 100 μM, had no effect on ristocetin-induced glycoprotein Ib (GPIb)-dependent aggregation of human platelets.  In addn., platelets treated with chymotrypsin, which cleaves GPIb, enhanced rather than attenuated the inhibition of YD-3 on thrombin-induced human platelet aggregation.  These data indicate that GPIb plays no role in the antiplatelet effect of YD-3.  5 In SFLLRN-desensitized human platelets, high concn. of thrombin (1 u ml-1) could still elicit intracellular Ca2+ mobilization, and the rise of [Ca2+]i was prevented by either leupeptin or YD-3.  6 Our results suggest that YD-3 inhibits a non-PAR1 thrombin receptor which mediates the major effect of thrombin in rabbit platelets, but in human platelets, this receptor function becomes significant only when the function of PAR1 has been blocked or attenuated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow5TqMmsXlxLVg90H21EOLACvtfcHk0lgrjQKdAzEzYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFOnsLo%253D&md5=6e0d63eb4540a7395bba15167018a30d</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703437%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BC.%26aulast%3DHuang%26aufirst%3DS.%2BW.%26aulast%3DHwang%26aufirst%3DT.%2BL.%26aulast%3DKuo%26aufirst%3DS.%2BC.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DTeng%26aufirst%3DC.%2BM.%26atitle%3DYD-3%252C%2520a%2520novel%2520inhibitor%2520of%2520protease-induced%2520platelet%2520activation%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D1289%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Wielders, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennaghmouch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reutelingsperger, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bevers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhout, T.</span><span> </span><span class="NLM_article-title">Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1111%2Fj.1538-7836.2007.02364.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=17166251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktFCisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=571-576&author=S.+J.+Wieldersauthor=A.+Bennaghmouchauthor=C.+P.+Reutelingspergerauthor=E.+M.+Beversauthor=T.+Lindhout&title=Anticoagulant+and+antithrombotic+properties+of+intracellular+protease-activated+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists</span></div><div class="casAuthors">Wielders, S. J. H.; Bennaghmouch, A.; Reutelingsperger, C. P. M.; Bevers, E. M.; Lindhout, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">571-576</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Background: Blockade of the thrombin receptors protease-activated receptor (PAR)1 and PAR4 with pepducins, cell-penetrating lipopeptides based on the third intracellular loop of PAR1 and PAR4, effectively inhibits platelet aggregation.  We have previously shown that PAR1 pepducin also exerts an anticoagulant activity by partial inhibition of the thrombin plus collagen-induced externalization of phosphatidylserine (PS) at the platelet plasma membrane.  Objective: In the present study we examd. the effects of PAR1 and PAR4 pepducins on tissue factor (TF)-initiated thrombin generation in platelet-rich plasma (PRP) and the interaction between PAR4 pepducin-loaded mouse platelets and a growing thrombus to confirm the relevance of the in vitro data.  Results: Localization of pepducins at the inner leaflet of the plasma membrane was confirmed with a fluorescence resonance energy transfer assay.  Both the PAR1 pepducin, P1Pal12, and the PAR4 pepducin, P4pal10, inhibited TF-initiated thrombin generation in PRP.  Concns. of P1pal12 and P4pal10, which blocked the thrombin-induced influx of extracellular calcium ions and inhibited platelet aggregation, reduced the rate of thrombin generation during the propagation phase by 38% and 36%, resp.  Whether this anticoagulant effect is relevant in inhibiting in vivo arterial thrombin growth is uncertain because P4pal10 prevented the incorporation of platelets in a growing thrombus.  Conclusions: Our findings suggest that in spite of their potential anticoagulant activities the in vivo antithrombotic effect of intracellular PAR pepducins is mainly based on inhibiting platelet-platelet interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5pIkYfalvnbVg90H21EOLACvtfcHk0lgrjQKdAzEzYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktFCisrw%253D&md5=09e6fd68dd6ed0b256168dd8cd8bd604</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2007.02364.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2007.02364.x%26sid%3Dliteratum%253Aachs%26aulast%3DWielders%26aufirst%3DS.%2BJ.%26aulast%3DBennaghmouch%26aufirst%3DA.%26aulast%3DReutelingsperger%26aufirst%3DC.%2BP.%26aulast%3DBevers%26aufirst%3DE.%2BM.%26aulast%3DLindhout%26aufirst%3DT.%26atitle%3DAnticoagulant%2520and%2520antithrombotic%2520properties%2520of%2520intracellular%2520protease-activated%2520receptor%2520antagonists%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2007%26volume%3D5%26spage%3D571%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Strande, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, J. E.</span><span> </span><span class="NLM_article-title">Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signalling</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1045</span><span class="NLM_x">–</span> <span class="NLM_lpage">1054</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm300407t&amp;key=10.1124%2Fjpet.107.133595" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm300407t&amp;key=18055876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm300407t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=1045-1054&issue=3&author=J.+L.+Strandeauthor=A.+Hsuauthor=J.+Suauthor=X.+Fuauthor=G.+J.+Grossauthor=J.+E.+Baker&title=Inhibiting+protease-activated+receptor+4+limits+myocardial+ischemia%2Freperfusion+injury+in+rat+hearts+by+unmasking+adenosine+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling</span></div><div class="casAuthors">Strande, Jennifer L.; Hsu, Anna; Su, Jidong; Fu, Xiangping; Gross, Garrett J.; Baker, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1045-1054</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Harnessing endogenous cardioprotectants is a novel therapeutic strategy to combat ischemia/reperfusion (I/R) injury.  Thrombin causes I/R injury, whereas exogenous adenosine prevents I/R injury.  We hypothesized that blocking thrombin receptor activation with a protease-activated receptor (PAR) 4 antagonist would unmask the cardioprotective effects of endogenous adenosine.  The protective role of two structurally unrelated PAR4 antagonists, trans-cinnamoyl-YPGKF-amide (tc-Y-NH2) and palmitoyl-SGRRYGHALR-amide (P4pal10), were evaluated in two rat models of myocardial I/R injury.  P4pal10 (10 μg/kg) treatment before ischemia significantly decreased infarct size (IS) by 31, 21, and 19% when given before, during, and after ischemia in the in vivo model.  Tc-Y-NH2 (5 μM) treatment before ischemia decreased IS by 51% in the in vitro model and increased recovery of ventricular function by 26%.  To assess whether the cardioprotective effects of PAR4 blockade were due to endogenous adenosine, isolated hearts were treated with a nonselective adenosine receptor blocker, 8-sulfaphenyltheophylline (8-SPT), and tc-Y-NH2 before ischemia.  8-SPT abolished the protective effects of tc-Y-NH2 but did not affect IS when given alone.  Adenosine-mediated survival pathways were then explored.  The cardioprotective effects of tc-Y-NH2 were abolished by inhibition of Akt (wortmannin), extracellular signal-regulated kinase 1/2 [PD98059 (2'-amino-3'-methoxyflavone)], nitric-oxide synthase [NG-monomethyl-L-arginine (L-NMA)], and KATP channels (glibenclamide).  PD98059, L-NMA, and glibenclamide alone had no effect on cardioprotection in vitro.  Furthermore, inhibition of mitochondrial KATP channels [5-hydroxydecanoic acid (5-HD)] and sarcolemmal KATP channels (sodium (5-(2-(5-chloro-2-methoxybenzamido)ethyl)-2-methoxyphenylsulfonyl)(methylcarbamothioyl)amide; HMR 1098) abolished P4pal10-induced cardioprotection in vivo.  Thrombin receptor blockade by PAR4 inhibition provides protection against injury from myocardial I/R by unmasking adenosine receptor signaling and supports the hypothesis of a coupling between thrombin receptors and adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Uuu5KE0fObVg90H21EOLACvtfcHk0ljnJ0de2xtC0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVajsL8%253D&md5=e83c6b4d639ed63493f07305bfe9ccb2</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133595%26sid%3Dliteratum%253Aachs%26aulast%3DStrande%26aufirst%3DJ.%2BL.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DGross%26aufirst%3DG.%2BJ.%26aulast%3DBaker%26aufirst%3DJ.%2BE.%26atitle%3DInhibiting%2520protease-activated%2520receptor%25204%2520limits%2520myocardial%2520ischemia%252Freperfusion%2520injury%2520in%2520rat%2520hearts%2520by%2520unmasking%2520adenosine%2520signalling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26issue%3D3%26spage%3D1045%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Slofstra, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijlsma, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groot, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitsma, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhout, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cate, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spek, C. A.</span><span> </span><span class="NLM_article-title">Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">3176</span><span class="NLM_x">–</span> <span class="NLM_lpage">3182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2007&pages=3176-3182&issue=9&author=S.+H.+Slofstraauthor=M.+F.+Bijlsmaauthor=A.+P.+Grootauthor=P.+H.+Reitsmaauthor=T.+Lindhoutauthor=H.+Cateauthor=C.+A.+Spek&title=Protease-activated+receptor-4+inhibition+protects+from+multiorgan+failure+in+a+murine+model+of+systemic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSlofstra%26aufirst%3DS.%2BH.%26aulast%3DBijlsma%26aufirst%3DM.%2BF.%26aulast%3DGroot%26aufirst%3DA.%2BP.%26aulast%3DReitsma%26aufirst%3DP.%2BH.%26aulast%3DLindhout%26aufirst%3DT.%26aulast%3DCate%26aufirst%3DH.%26aulast%3DSpek%26aufirst%3DC.%2BA.%26atitle%3DProtease-activated%2520receptor-4%2520inhibition%2520protects%2520from%2520multiorgan%2520failure%2520in%2520a%2520murine%2520model%2520of%2520systemic%2520inflammation%26jtitle%3DBlood%26date%3D2007%26volume%3D110%26issue%3D9%26spage%3D3176%26epage%3D3182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300407t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-15%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm300407t%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300407t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                708KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799639c284e2521","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
